key: cord-0007009-0fu1h820
authors: nan
title: Posters
date: 2010-09-10
journal: Arch Gynecol Obstet
DOI: 10.1007/s00404-010-1634-7
sha: 71ae4b14455f6eab8b48991e357c86cf25cf652c
doc_id: 7009
cord_uid: 0fu1h820

nan

position 677 of the MTHFR cDNA (677C [ T) produces a thermolabile form of the enzyme with significantly reduced enzymic activity. We have shown previously that the MTHFR 677C [ T mutation strongly affects the ovarian response to recombinant FSH during controlled hyperstimulation. As this genetic variation is associated with increased plasma homocysteine (hcy) levels, we investigated whether hcy may influence the gene expression of CYP11, CYP19, and StAR which are important enzymes involved in the steroid metabolism of human granulosa cells (GC). Materials and methods: Immortalized HGL5 cells were cultured for a total of 5 days in M-199 medium supplemented with 10% fetal calf serum and 0, 25, 100, or 200 lM D/L-hcy. Total RNA was extracted and reverse transcribed to cDNA. Gene expression was determined by real-time PCR. The calculation of relative expression ratios was carried out with the Relative Expression Software Tool (REST) version 2008. Results: Exposure of HGL5 GC to hcy significantly enhanced the expression of CYP19 mRNA in a dose-dependent manner. Incubation with 25 lM D/L-hcy increased CYP19 mRNA expression 4.29-fold (CI 95%: 2.05-10.99; p \ 0.001), 100 lM D/L-hcy 8.04-fold (CI 95%: 1.76-43.85 ; p \ 0.05) and 200 lM D/L-hcy 10.58-fold (CI 95%: 1.76-79.66 ; p \ 0.0001). In contrast, there was no significant effect on CYP11 and StAR expression. Conclusions: The present study demonstrates that hcy specifically augments CYP19 mRNA expression in human luteinized granulosa cells, suggesting an interference of hcy with specific steps of steroid metabolism in human GC. This might be one mechanism by which the MTHFR 677C [ T mutation affects ovarian responsiveness in controlled ovarian hyperstimulation cycles.

PO-Endo 01.08 Two heterozygote mutations of DHH gene in one patient with complete XY gonadal dysgenesis and polyneuropathy: treatment and outcome case report Objective: We report about the complex diagnosis and treatment modalities of a patient with rare sexual differentiation disorder caused by two heterozygous mutations (mutation in exon 1.1 het. c.83 8/ insCCGGG and exon 2 het. c.554C [ G [S185W]) reported for the first time in the DHH (desert hedgehog) gene with a 46 XY male karyotype.

A 24 year old patient was admitted for gonadectomy of streak gonads after emergency surgery for impalement injury caused by cohabitation trial. The patient with previously diagnosed XY gonadal dysgenesis and symptoms of polyneuropathy particularly in lower limbs (status post removal of several distal phalanges), has been neglecting the diagnosis for 5 years. She presented a primarily juvenile external genital with a 2 cm wide and 7 cm long vagina and accompanying epithelial atrophy. A gonadectomy with removal of two streak gonads was performed. A local substitution of estriol and systemic substitution of estradiol was begun. Results: Sertoli type epithelial cells and leydig-like cells were detected within the streak gonads. In the removed streak gonads no evidence of neoplasia has been found. The patient was diagnosed with uterine aplasia and lacking prostate gland. Five months after treatment initiation, cohabitation is possible. The patient still suffers from a polyneuropathy, especially in the distal parts of lower limbs. Sural nerve motoric compound action potential (MCAP) was bilaterally not detectable and tibial nerve MCAP was extremely reduced. Conclusions: The described mutations demonstrate a very rare combination of gonadal dysgenesis and polyneuropathy. In this rare case of 46XY male karyotype, female phenotype and complete gonadal dysgenesis with juvenile external gonads and polyneuropathy, a multidisciplinary approach from gynaecologists, neurologists, genetics and psychologists can aid the patient in creating an acceptable sexual and psychosocial consciousness.

PO-Endo 01.09 Characterization of adult stem cells in endometrial biopsies obtained during routine diagnostics *Andreas Schu¨ring 1 , Nicole Schulte 1 , Ludwig Kiesel 1 , Martin Go¨tte 1 1 University Clinic Münster, Obstetrics and Gynecology, Münster, Germany Objective: Human endometrium displays a highly regenerative capacity possibly owed to adult stem cell activity. It is hypothesized that disorders of the endometrium such as endometriosis and endometrial carcinoma are associated with a disorder of stem cell function. As a limiting factor of experimental studies to date only uteri from hysterectomies were used to assess stem cell activity. We conducted this study to characterize stem cells of the superficial layers of the stratum superficial, accessible by diagnostic endometrial biopsy in a routine clinical setting. We wanted to show that minimal invasive endometrial biopsies are an eligible tool to obtain multi-potent stem cells to enable studies in larger patient populations. Materials and methods: 36 patients underwent routine endometrial biopsy during diagnostics prior to infertility therapy. Endometrial stroma cells were isolated by immunodepletion and the expression of stem cell markers was analyzed by quantitative real time PCR and FACS analysis. Differentiation potential and cloning efficiency of serially passaged cell clones were studied in vitro. Results: Endometrial stroma cell clones derived from endometrial biopsies displayed characteristic properties of stem cells including clonality, long time cultivation, multipotent differentiation potential and expression of the stem cell markers CD 146, CD73, Msi-1, Notch-1 and Sox-2. Conclusions: Adult stem cells can be obtained from endometrial biopsies in a routine diagnostic setting. These findings will stimulate and accelerate stem cell based studies to develop innovative diagnostic and therapeutic concepts of endometrial disorders in large patient populations. Furthermore these results let appear the endometrium as a promising source for induced pluripotent stem cell generation (iPS).

PO-Endo 01.10 Pharmacodynamic effects of chlormadinone acetate (CMA) on prostaglandin biosynthesis in human endometrium beneficial effect by a stronger reduction of prostaglandin biosynthesis PO-Endo 01.12 Successful pregnancy after laparoscopic uterosacropexy in a young woman with total uterine prolapse *Wiebke Zempel 1 , Anna Go¨sling 1 , Peter Hillemanns 1 , Hermann Hertel 1 1

Objective: Need for fertility preserving prolapse surgery in a 37 year old woman. Materials and methods: In September of 2005 a healthy 37-year old woman had a spontaneous delivery of a 3590 g child. In May 2006 she frequented our urogynecological unit because of a symptomatic descensus uteri et vaginae III°(dyspareunia, restriction of sports activities and worse influence of quality of live in general). Hysterectomy and anterior and posterior repair was recommended to the patient e.m. But the woman's wish was to preserve their fertility. In the case of uncompleted family planning a uterus preserving approach was necessary. After urodynamic examination (no marked stress incontinence was found) we decided with the couple to perform a minimal invasive uterosacropexy. We performed standard laparoscopy. The retroperitoneal space on the right side of the rectum between cervix, cul de sac and sacrum os was opened. The right ureter was identifying and pushed laterally. Two sutures through the longitudinal anterior ligament and the cervix was supplied. A small polypropylene mesh was fixed on the cervix with the two sutures. From vaginally the uterus was pushed up and the mesh was fixed corresponding on the longitudinal anterior sacrum ligament. The peritoneum was closed to prevent any delay associated with the use of the mesh. Postoperatively a minimal descensus was the result. The patient had no complaints and was delivered after 6 days. Results: The patient became pregnant spontaneously 6 months later. In July 2007 the patient had a primary, uncomplicated caesarean section (wish of the patient to prevent a secondary prolapse) in the 38th week of pregnancy. A mature boy with a weight of 3605 g was born.

Conclusions: This case report is an example of laparoscopic uterosacropexy as a successful minimal invasive approach to preserve fertility in young women with total uterine prolapse.

PO-Geb 01.01 What expectations do pregnant women have of modern obstetric departments?

importance was the possibility to get to know the obstetric staff before delivery. For the respondents it was relevant that a single midwife attended during labour. Friendliness of the personnel and state-of-theart medicine were considered to be very important. The presentation of the labour ward regarding ambience, colours and light was more important than the modernity or the offer of alternative medicine. A 24 h in-house consultant, attendance of a physician during second stage of labour, as well as a neonatal intensive care unit were also rated high. Most pregnant women preferred on ward lactation counselling. On the maternity ward, quality and variety of food and ambience were rated high. The respondents appreciated the opportunity to have the second routine examination of the neonate at the obstetric department. During puerperium, most women desired care by a midwife. Conclusions: According to this comprehensive survey, there are three key-factors for an ideal delivery and the choice of the obstetric department: safety, friendliness of the staff and a good standard of comfort. Obstetric units should give pregnant women the opportunity to get acquainted with the hospital and the staff ahead of birth. Objective: The preterm premature rupture of the membranes (PPROM) is defined as rupture of the amniotic membranes prior to 37 weeks of gestation. PPROM occurs in approximately 3% of all pregnancies and is responsible for a third of all preterm births. In 0.6-0.7% of all pregnancies PPROM occurs at or before 26 weeks of gestation and is associated with high perinatal morbidity and mortality. Previous preterm delivery, history of or current cervical incompetence, cerclage, history of PPROM and tobacco use could be identified as risk factors for PPROM at 14-24 weeks. The purpose of this study was to identify risk factors for PPROM prior to 28 weeks of gestation in pregnant women treated at the Department of Obstetrics and Gynecology at the University Hospital Vienna. Materials and methods: This retrospective study included all patients (n = 56) with PPROM prior to 29 weeks of gestation during the years [2007] [2008] [2009] . Statistical analysis is going to be performed using SPSS version 16. Results: The evaluation of all data is still in progress and the results are going to be presented at the congress. Objective: The last three decades have been marked with copious attempts to reduce health care related financial costs. The field of obstetrics has been hit especially hard, particularly in conjunction with regressive birth rates. The aim of this work was to elucidate which informational resources and which ultimate decision making criteria play a role for women who are choosing a birthing location. Materials and methods: From December 2008-April 2009, 183 women were reviewed post partum at the Jena University Hospital. 108 questionnaires were returned fully completed. The battery of questions encompasses informational resources and decision making criteria helpful in choosing a birthing location. In this work, several parameters concerning satisfaction, as well as anticipation, of the women were evaluated. Results: Pregnant women and women in childbed are a very wellinformed and demanding audience. The most important resources are the internet, tours through the clinic and individual guidance by the gynaecologist or midwife. The most important determinants in the decision making process were identified by the respondents as: good reputation of the physicians and regional proximity of the clinic to the respondent's residence. Alternative methods of delivery were not named as items of interest. Individual counselling for breast feeding has a high priority and aids in identifying the most fitting clinic. Pregnant women highly value the 24-h presence of a doctor, modern and readily available equipment and the integration of a level 1 perinatal center in the clinic. Aspects of satisfaction and anticipation of the respondents were also ascertained in the questionnaire. The women expectations were predominantly either met or exceeded. Conclusions: The better evaluation of anticipation and decision making criteria of pregnant women can aid in optimizing the public representation of an obstetrics clinic, while unearthing potential areas of development.

PO-Geb 01.05 Severe hypertriglyceridemia in a case of a 31 year old pregnant female after necrotizing pancreatitis and dry cough. A thrombosis with pulmonary embolism was diagnosed. Under treatment with 3 l of oxygen and anticoagulation she was in stable condition. Aim was the prolongation of pregnancy for 3 weeks to reduce the risk of embolism during delivery. Because of contractions and suspicious CTG the delivery was carried out six days later by cesarian with block of the right vs. iliaca com. by balloon catheder. Thrombectomy was performed in the same session.

PO-Geb 01.12 The pivotal role of protein inhibitors of activated STATs (PIAS) in regulating trophoblastic functions Objective: The placenta is of utmost importance for fetal growth and well-being. Defective placentation and impaired placental circulation may result in anomalies of fetal growth. Growth factors and cytokines in the amniotic fluid may reflect changes in placental function and fetal growth. Therefore, it was our aim to investigate whether 3D placental volume parameters, intraplacental circulation and different amniotic fluid parameters are associated with birth weight. Materials and methods: At the University Hospital of Erlangen 210 patients with singleton pregnancy and gestational age between 15 + 0 and 17 + 6 weeks were included in our study. Fetal biometry with regard to biparietal diameter (BPD), head circumference (HC), abdominal circumference (AC) and femur length (FL) was routinely performed. Placental volume and vascularization were assessed by 3D ultrasound and 3D power Doppler. Placental volume (PV), four placental ratios (PR1 = PV/BPD; PR2 = PV/HC; PR3 = PV/AC, PR4 = PV/FL) and vascularization indices (VI, FI, VFI) were calculated. Visfatin, leptin, endoglin, VEGF and PIGF were measured in the amniotic fluid. Results: While in linear regression analysis both PV, the four placental ratios, VI and VFI had a significant influence on birth weight only FI significantly predicted birth weight below the 10th percentile in logistic regression. Leptin and Visfatin in the amniotic fluid were significantly associated with birth weight and VEGF with PV/FI in linear regression analysis. Conclusions: Second trimester placental volume and vascularization parameters correlate with birth weight. Additionally leptin and visfatin in the amniotic fluid have influence on fetal development. Therefore, placental volumetry and vascularization show potential for identifying fetal growth anomalies.

PO-Geb 01.14 Fetal anemia in consequence of massive fetomaternal transfusion syndrome Objective: Fetomaternal transfusion syndrome is the leakage of fetal erythrocytes into the maternal circulation. Massive loss of red blood cells can lead to fetal anemia and in consequence to fetal death. Typical symptoms of this rare event are reduced fetal movements, sinusoidal heart rate patterns in the cardiotocography, fetal hydrops and other sonographic fetal anemia-related findings like an increased systolic velocity in the middle cerebral artery. Materials and methods: We present a case of severe fetomaternal transfusion syndrome that was diagnosed during the 28th week of pregnancy. The patient felt a decrease in fetal movements, the fetal heart trace showed a silent pattern and sonographic evaluation showed a discrete fetal hydrops as well as an increased velocity in the middle cerebral artery (V max [95 centile). In suspicion of a lifethreatening fetal anemia, an emergency caesarean section was performed. The premature infant was born with a significantly reduced hemoglobin of 1.6 g/dl, was treated immediately by neonatal blood transfusion and transferred to neonatal intensive care unit. Maternal blood analysis showed a massive fetomaternal bleeding with 4.9% fetal erythrocytes in the maternal blood circulation. The pathological examination of the placenta showed an expanded intervillous hematoma and inclusion of necrotic choreonic villi was found, so that fetal anemia in consequence of both, fetomaternal transfusion and fetoplacental bleeding was diagnosed. The influence of obstetric and neonatal factors on the counts of CD34+ and CD133+ cells in the collected cord blood in order to optimize the cord blood donor selection Labor induction with prostaglandins: is BMI a relevant parameter? 1 UK-SH, Frauenklinik, Kiel, Germany, 2 UK-SH, Neonatologie, Kiel, Germany

Objective: Among the manoeuvers used in the second stage of labor uterine fundal pressure is one of the most controversial. Fundal pressure involves application of manual pressure to the uppermost part of the uterus directed towards the birth canal in an attempt to assist spontaneous vaginal delivery and to avoid prolonged second stage or the need for operative procedures. Estimations concerning its prevalence range up to 5% of all deliveries. No confirmed benefit of this technique has been documented yet and some potentially lifethreatening adverse events such as rib fractures or uterine rupture on the maternal side as well as neonatal central nervous system or brachial plexus injuries have been described in this context. Materials and methods: The aim of this study is to examine the effect of the external pressure on the intra-uterine milieu. The pressure produced by the Kristeller Manoeuver is quantified by an inflatable ballon fixed to the practitioners forearm and is displayed in a pressure curve in mm H 2 O-units. Pressure alterations in the uterus during the manoeuver are likewise measured by a common intra-uterine sensor-tip catheter. Results: We present data of the Kristeller Manoeuver on 5 pregnant women concerning obstetrical outcome of mother and child. Besides the description of the duration of second stage of labor and possible complications we focus on the differences between the external pressure applied by the manoeuvre and the pressure measured simultaneously in the uterus. Conclusions: The role of fundal pressure during labor remains poorly evaluated and controversial. Recent studies showed that its application was ineffective in shortening the second stage of labor. Because of the associated risks and the questionable clinical benefit exact quantification of the effects of this manoeuver in relation to the intrauterine pressure changes is of paramount importance.

PO-Geb 01.20 High-dose intravenous iron treatment in pregnancy and puerperium: safety and efficacy Objective: Oral iron showed to be insufficient when it is about to treat severe iron deficiency anemia. Parenteral iron preparations available till now were superior to oral iron but could only be administered in a limited dosage because of the risk of adverse reactions. Ferric carboxymaltose (FCM, Ferinject Ò ) is a new formulation for intravenous iron treatment making possible the application of a large amount of iron combined with a very low incidence of adverse reactions. Till now no data are available for the direct comparison of the previous used preparation Ferric-hydroxide-saccharate (FHS, Venofer Ò ) and FCM. Materials and methods: In the pregnancy group a total of 52 women between 20 an 39 weeks of gestation were treated either with FCM (15 mg/kg bodyweight, max. 1000 mg i.v.) or FHS (2 9 200 mg i.v., in part repeatedly) 204 women in childbed were treated in the same period of time identically to the pregnancy group. Indication for treatment was a clinically relevant anemia. In both groups the increase in hemoglobin level, the ferritin level and the incidence of adverse reactions were recorded and compared. Results: The pregnancy groups were statistically comparable regarding gestational and maternal age, ferritin levels, pre-and posttherapeutic hemoglobin levels. 2 patients (8.3%) presented mild and transient adverse events after administration of FCM, 5 patients (17.9%) after FHS. Corresponding results for the postpartum group were found regarding the same parameters. 5 patients (4.9%) presented mild and transient adverse events after FCM-administration. 6 patients (5.9%) after FHS administration. Conclusions: Treatment with FCM is well tolerated. Both substances share a similar safety profile. FCM treatment mostly requires only a single administration; the risk for adverse events is decreased by 50% compared to treatment with FHS which requires at least two administrations cycles. FCM provides a better patient's comfort and a better cost-effectiveness. dilation. The Bishop score has proven to be suitable for predicting onset and progress of labor as well as successful labor induction followed by spontaneous vaginal delivery. However, its specificity in patients with low scores is unsatisfactory. Many studies have confirmed the value of sonographic measurement of cervical length for predicting imminent spontaneous delivery in preterm and term births. None the less, there is a disagreement on its effectiveness in predicting a successful labor induction. Ultrasound elastography is a new tool for imaging and estimation of tissue elasticity, whose usefulness in obstetrics has not been investigated yet. Goal of the study is to evaluate the feasibility and reproducibility of cervical elastography measurement (strain and displacement) in late weeks of gestation. Intra-and interobserver variability was also evaluated. Materials and methods: Prospective pilot study assessing cervical elastographic pattern in patients undergoing labour induction for medical indications and in post term pregnancies. Ultrasound was performed using a 9 mHz vaginal probe (Aplio XG ultrasound system, Toshiba Medical Systems). Raw data were collected under standardized conditions and analyzed depending on different pattern of measurement (for example localization, dimension and form of region of interest). Results: Cervical elastography in late weeks of gestation is feasible. Different patterns of measurement influenced elastographic analysis. Preliminary results will be extensively discussed. Conclusions: Ultrasound elastography is a new tool for imaging and estimation of cervical elasticity modifications during pregnancy. Further studies are needed to evaluate its clinical value for prediction of a successful labor induction.

PO-Geb 01.22 Does fetal sex of twin pairs affect pregnancy outcome? Objective: It is proposed that the gender of twin fetuses influences the pregnancy and fetal outcome. The objective of this retrospective investigation was to evaluate the impact of fetal gender on preterm birth and further pregnancy outcome. Materials and methods: Our analysis is based on data raised over 7 years covering 342 twin pairs at the department for gynecology and obstetrics of the university hospital of Schleswig-Holstein, Campus Kiel. As arbitrative parameters the rate of preterm birth, the average age of pregnancy, the reason for delivery, the APGAR-Score, the fetal blood sampling rate and the mortality rate were evaluated. Also regarding the condition of the amniae the hitherto pronounced relationship between pregnancy outcome and fetal sex of twin pairs were scrutinized. Results: In twin pregnancies with one or two male fetuses the preterm birth rate was higher (delivery B28 weeks: 13.5% vs 7.1%, p = 0.01) and the APGAR-Score lower (APGAR 5 min: 8.8 vs 9.1, p = 0.03), as was the rate of vaginal birth (29.8% vs 38.4%, p = 0.02). These findings showed to be independent from the condition of the amniae and were found in comparable peculiarity in mono or dichordial twinpregnancies. The fetal gender did not affect the reason for delivery, the fetal blood sampling rate and the mortality rate. Conclusions: Male fetal sex is a risk factor for preterm birth and a poor outcome in the perinatal period.

Objective: To evaluate the management and outcomes of pregnancies affected by gestational diabetes mellitus (GDM) and impaired glucose tolerance (IGT). Materials and methods: We retrospectively analysed the pregnancy course of 124 women affected by IGT, 130 affected by GDM and 674 women with a negative glucose challenge test, who delivered in our Obstetrics Clinic between 2000 and 2006. Data was analysed by R(version 2.9.2) considering significant p \ 0.05. Also a multivariate analysis was performed. Results: Mean age at delivery was 33.7 years (± 4.8) . In the 32.63% of cases the diagnosis was made after the 28th gestational week, while in two cases with a history of previous GDM it was made before the 10th gestational week. The glycate haemoglobin was higher than 6.5% in 1.43% of IGT and 5.41% of GDM. 19.33% of GDM and 4.5% of IGT needed insulin therapy. Birth traumatic lesions were significantly more prevalent among newborns of women with GDM than of healthy women (3.36% vs. 1.93%, p \ 0.05). Among women with IGT there was a higher incidence of macrosomia, and the sole case of intrauterine death. By multivariate analysis, both GDM and IGT resulted independent risk factors for respiratory distress syndrome (RDS). Among the 59 patients with GDM who completed the post-partum follow up, 13.5% reported a persistent IGT and 6.7% a diabetes mellitus type 2. Conclusions: GDM and IGT are independent risk factors for RDS, and women with IGT seem to have worse pregnancy outcomes compared with controls or women with GDM. By gestational disorders of the glucose metabolism, it is important to make women aware of their gestational risks, as also of the possible persistence of a glucose dysmetabolism in the post-partum.

PO-Geb 01.24 Prenatal presentation of chromosomal aberration del 7 (q32) Materials and methods: We present 2 cases with the prenatal diagnosis of chromosomal aberration del 7(q32). Case 1 was a 26 year old woman, VG IIP, which was referred at 22 weeks of gestation due to a suspected microcephaly. After finding and counseling the diagnosis, the parents decided for termination of pregnancy. Case 2 was 36 year old woman, IIIG IIP, referred at 27 weeks of gestation due to IUGR for further examination. Results: As common symptoms the fetuses demonstrated IUGR and severe microcephaly. Furthermore we found cerebral midline defects (corpus-callosum-agenesis and holoprosencephaly) in both fetuses. In addition renal anomalies were diagnosed (bilateral hydronephrosis and right sided renal agenesis). Further symptoms which were only revealed in one fetus were median cleft lip and palate, periventricular VSD and agenesis of os sacrum. Postnatal symptoms were coloboma and deep asymmetric insertion of the ears. Conclusions: As common symptoms in both affected fetuses we found IUGR, microcephaly, cerebral midline defects and renal anomalies. The cerebral anomalies can be explained by the holoprosencephaly-gene SHH involved in the affected chromosomal region. Due to the high number of deleted genes ([50) there is a wide variation of additional symptoms in our cases and in literature. In case of prenatal diagnosis of chromosomal aberration del 7 (q32) the parents has to be counseled about a bad prognosis.

PO-Geb 01.25 Case report: massive respiratory dysfunction as sign of fulminant postpartum dilatative cardiomyopathy *Nele Freerksen 1 , Ulrich Pecks 1 , Nicolai Maass 1 , Ivo Meinhold-Heerlein 1 , Dirk Oliver Bauerschlag 1 1 Universitätsklinikum Aachen, Frauenklinik für Gynäkologie und Geburtshilfe, Aachen, Germany

Objective: Referral of a 35 year-old gravida 3, para 2 at 40 + 3 weeks with regular labor and progressive respiratory dysfunction: coughing with putrid, bloody mucus, tachycardia, orthopnea, decreased peripheral O 2 -saturation und need of oxygenation. Anamnesis revealed symptoms of a pulmonary infect. An antibiotic therapy was immediately initiated. About an hour after arrival the patient's respiratory situation deteriorated rapidly despite oxygenation by mask. Decision to perform a secondary caesarean section was made; upon arrival in the operating room the patient's O 2 -saturation had dropped below 80%, requiring emergency caesarean section. A healthy infant was delivered while the surgical intervention was uncomplicated. Postsurgically, the patient was referred to the intensive care unit, still being intubated. Over the next days further investigations revealed a pulmonary embolism and pathological cardiomegaly, while laboratory results showed an increase in pro-BNP. Further diagnostics showed massive left ventricular failure (ejection fraction 15%; NYHA IV). Cardiac biopsy was performed, resulting in diagnosis of postpartum dilatative cardiomyopathy (PPCM). Despite medication with bromocriptine and levosimendan, cardiac function continued to decrease, requiring surgical intervention and implantation of an intracorporal, left-ventricular assist device (HeartMateII Ò ). Following surgery, cardiac function progressively improved and stabilized. The patient was discharged 5 weeks postpartum in stabilized health and will continue to be closely cardiologically monitored as an out-patient. As of now, it is unclear how long the cardiac-assist device will be left with the patient and what kind of further therapy is needed after explantation. Conclusions: Postpartum dilatative cardiomyopathy (PPCM) is a rare condition in pregnant women and the cause is still unknown. PPCM should be considered as a differential diagnosis if otherwise healthy pregnant women present with an acute respiratory dysfunction.

PO-Geb 01.26 Serum levels of free ß-HCG and PAPP-A measured by electrochemiluminescence immunoassay: influence on diagnostic performance of first trimester screening reinfection or active infection rates leading to high risk of transmission among couples.

PO-Geb 01.28 Prenatal diagnosis of fetal pulmonary malformations *Ann-Katrin Morr 1 , Wolfgang Thomas 1 , Monika Rehn 1 , Johannes Dietl 1 1 Universitätsfrauenklinik, Würzburg, Germany

Objective: Congenital pulmonary airway malformation is a rare, but the most common developmental anomaly of the respiratory tract (suggested incidence 1:8300-35000 live births) with a variable prognosis depended on the size of the malformation and the presence of fetal hydrops. Materials and methods: A 38-year-old primiparous woman was incidentally diagnosed for congenital pulmonary airway malformation at 19 weeks of gestation during second trimester screening. Ultrasound showed macrocystic malformation of the left lung with polyhydramnios and marked mediastinal shift causing cardiac dextroposition and appearance of a hypoplastic right lung. No other associated anomalies were seen. Despite the suggested poor prognosis the patient decided to continue the pregnancy. She presented at 26 gestational weeks with preterm contractions and rupture of membranes. Due to funis presentation and fetal bradycardia, cesarean section was performed (Apgar score 4/6/8; 700 g). The preterm infant had a severe respiratory distress syndrome, the prenatal diagnose was confirmed. After nine days puncture of a large pulmonary cyst was performed, followed by partial resection of the left lower pulmonary lobe at the age of four months. After 1 year the infant showed a good development without severe impairment of pulmonary function. Conclusions: Prenatal diagnosis of congenital pulmonary airway malformations has increased due to routine ultrasound examination. Poor prognostic signs include large lesions, bilateral lung involvement, polyhydramnios and mediastinal shift, resulting in cardiac compression, fetal hydrops and pulmonary hypoplasia. There are no reliable prenatal criteria for determining fetal or neonatal outcome. In cases of fetal hydrops thoraco-amniotic drainage or open fetal surgery might be an option. For postnatal symptomatic patients surgical resection is the definitive treatment, it may also be performed to prevent recurrent infection and malignant transformation.

PO-Geb 01.29 Stimulation of umbilical cord blood cells with gram-positive lysates from vaginal swabs: a model system to investigate immunemodulatory effects of clinically relevant gram-positive bacteria on the fetal innate immune system immunemodulatory effects of different clinically relevant gram-positive bacteria Streptococcus, Staphylococcus and Enterococcus isolates on the innate immune system of the fetus. Gram-positive bacteria include various molecular patterns, e.g. lipoteichonic acids, peptidoglycans, lipoproteins, lipopeptides but also CpG motif-containing nucleic acids revealing strong immunemodulatory properties on the innate and adaptive immune system of adults. Therefore, bacterial strains from Streptococcus, Staphylococcus and Enterococcus were isolated from vaginal swabs of pregnant women and cultured in LB medium. These were used to stimulate freshly prepared umbilical cord blood cells. Pam, different PGs and CpG where additionally tested as well as the gram-negative LPS of E. coli partly serving as negative respectively positive controls. The immunemodulatory effects were determined by analysis of preselected marker cyto-and chemokines from the supernatants of stimulated cells measured by ELISA or Luminex technology. The analysis of preselected marker (pro-, antiinflammatory, TH1-or TH2)-cytokines and chemokines from the supernatants of the stimulated cells provided valuable insight in the capacity of these bacteria to activate and modulate the fetal immune system and thus contributed to a rational estimation of the importance of these pathogens in pregnancy complications. A kind of ranking in cytokine-release of the different examined gram-positive bacteria could be found which means there might be considered more or less aggressive gram-positive bacteria concerning prematurity.

PO-Geb 01.31 Gastroschisis: sonographic findings, perinatal management and postnatal outcome PO-Geb 01.34 Gestational diabetes, comparison of the management and neonatal outcome over the time of a decade right ventricular hypertrophy as a sign of beginning cardiac Materials and methods: The patient is a 28 year old woman, gravida 1, at 17 weeks of gestation. The patient presented an inappropriate abdominal growth for the gestational week with no clinical symptoms. A cystical tumor larger than 25 cm, which filled almost the whole abdomen, was diagnosed through ultrasound during a screening examination. With the suspicion of an ovarian process a laparotomy was then performed in a peripheric hospital. The uterus and the adnexa were without pathological findings and, because of the retroperitoneal location and the unclear origin of the tumor, the operation was terminated. After the patient was transferred to our clinic we performed a relaparotomy. Preoperative tumor markers and routine lab test were normal, the MRI described a 18 9 25 cm big multilocular mass, with clear delimitation and with unclear organ of origin, which compressed the V. cava inferior. The operative site presented a 25 cm firm elastic tumor located in the retroperitoneal space and filling almost the whole abdomen. The left kidney was displaced far to the right. The upper abdomen and pelvis were without pathological findings, the peritoneum was smooth. The 4620 g heavy cyst was removed in toto without difficulty. The patient had an uncomplicated postoperative evolution, so she was discharged on the 7th postoperative day. The histology described an adrenal pseudocyst and parts of an adrenal gland. In order to prevent a transient adrenal failure we started oral substitution therapy with corticoids which could be completely tapered afterwards. The pregnancy proceeded uneventfully, the patient delivered at term a healthy 3100 g girl. Conclusions: Adrenal pseudocysts can be treated by surgical excision during pregnancy, without posing a risk to the mother or the child. A good pregnancy outcome is, as reported in the case above, absolutely possible.

PO-Geb 01.40 Anti-Muellerian hormone during pregnancy lymphonodectomy the treatment is an oncologically safe procedure for very carefully selected young patients with the desire of fertility conservation. Pregnancy following RVT is associated with a variety of adverse pregnancy outcomes including second-trimester loss, preterm delivery and very rare improper attachment of the placenta. Closely monitoring a pregnancy after radical vaginal trachelectomy is a very important and often a challenging job to the responsible physician. This is a report of a 38 year old patient, who underwent radical vaginal trachelectomy at the age of 30. 8 years later the Patient underwent ovarial stimulation and became pregnant using an IVF protocol. First semester screening and second trimenon scan showed no abnormalities concerning the fetus. At 23 + 5 weeks the patient presented with severe vaginal bleeding and the placenta praevia was first diagnosed. The parametrical area was highly vasculated and beginning signs of infiltration of the placenta into the myometrium in terms of a placenta increta could not be ruled out. Due to repeated vaginal bleeding we administered betamethasone to accelerate fetal lung maturity. At time of the abstract we target a delivery between 28+ and 32+ weeks by caesarian section balancing the risk of premature delivery versus bleeding and abruption of the placenta. Objective: Selective serotonin reuptake inhibitors like paroxetine are used to treat major depression, anxiety and obsessive-compulsive disorder during the childbearing years. In late 2005 the U.S. Food and Drug Administration recommended to avoid paroxetine in pregnancy because of an increased risk of cardiovascular malformations. Since that time there is an ongoing controversial debate about the safety of paroxetine during pregnancy. Materials and methods: In a prospective follow-up study we collected data of pregnancy outcomes after medication with paroxetine (n = 222) between 1990 and 2009. Our national Teratology Information Service (TIS) was contacted by physicians and patients after exposure to paroxetine in the first trimester. We compared the results with a control group (n = 733) of our TIS in the same interval, which was not or not severely exposed. Results: Both samples did not differ in gestational age at first contact (median: paroxetine group 50 days vs control group 51 days). After exposure to paroxetine 20 patients (20/222 = 9.0%) preferred termination of pregnancy. The incidence of elective terminations of pregnancy was much higher (p \ 0.001) after medication with paroxetine than in the control group (19/733 = 2.6%). The other 202 documented pregnancies ended with spontaneous abortion in 23 cases and live births in 179 cases. The abortion rate (23/202 = 11.4%) did not differ significantly from the control group (81/714 = 11.3%). Four congenital anomalies were reported after intrauterine exposure to paroxetine: clubfeet after exposure throughout pregnancy (40 mg/ day), large naevus flammeus after maternal medication up to wk 7 (100 mg/day), spastic torticollis after medication up to wk 12 (20 mg/ day), unilateral renal agenesia (10 mg/day, long term medication). The rate of congenital anomalies was not increased after application of paroxetine in early pregnancy (4/179 = 2.2% vs 25/633 = 3.9%; relative risk 0.56; 95% confidence interval 0.17, 1.67). Conclusions: Our prospective controlled follow-up study does not support the assumption of a teratogenic effect of paroxetine. 

Objective: Paroxysmal nocturnal hemoglobinuria (PNH) is a rare form of hemolytic anaemia, resulting from the clonal expansion of hematopoietic stem cells that have somatic mutations in the X-linked gene PIG-A. It is characterised clinically by haemolytic anaemia, bone marrow failure and thromboembolic events in unusual locations, which are the leading cause of mortality in PNH. Since 2007 there has been a new disease modifying treatment with eculizumab, a humanised monoclonal antibody that inhibits complement factor C5. Materials and methods: A 30 year old woman 33 weeks pregnant was referred to our hospital because of lower back pain in the ileosacral area on the left side since three days that started while she was vacuum cleaning. There was no history of prior trauma. The patient had been diagnosed with PNH in 1999. She had dysphagia and anaemia which required PRBC transfusions but had no known thromboembolic events. The patient has been treated with eculizumab since 2008. So far she had been doing well with her pregnancy, her haemoglobin has remained stable around 8-10 g/ dl and her platelets around 90-120 G/l. Physical examination showed normal neurological status, there was normal development of the fetus, no costophrenic angle tenderness. An MRI showed a hypodense area in the left sided sacral bone consistent with fracture. There was no sign of a venous thrombosis on the MRI and the D-dimers were low making a thromboembolic event as a cause of the pain unlikely. Medical induction of labour is planned for 38 weeks of pregnancy. Conclusions: A Medline search revealed about 100 reported cases of pregnancy in women with PNH, in only 11 of which eculizumab treatment was reported. In none of the cases spontaneous fractures have been reported. In our opinion this rare case should prompt us for further investigation.

PO-Geb 01.44 Allergen induced cytokine release in human placentae: a possible role in fetal programming of allergies?

Results: After application of relevant allergens in perfusion medium, a significant time-dependent release of TNF-a and IL-6 was detectable in placentae of mothers suffering apple allergy compared to those from healthy mothers. The expression of the other interleukins and histamine was not remarkably altered. Conclusions: Allergens can induce allergy related effects, which may disturb the immunological balance at the feto-maternal interface and might prime the developing fetal immune system for facilitated later susceptibility for allergic sensitizations.

PO-Geb 01.45 Pregnancy with maternal TGA (transposition of great arteries) and NYHA II-III°* Objective: Pregnancies with maternal congenital heart defects (CHDs) are very heterogenic requiring interdisciplinary cooperation. The congenital TGA counts as a severe cyanotic vitium, which even after surgical correction during infancy need lifelong cardiologic medical care. Doctors are increasingly confronted with the desires of patients to have children whereas obstetricians are hardly able to refer to any cases due to few available data. We report of a 29-year-old 2nd gravida/ nullipara at 24 + 2 weeks of gestation (WOG) and congenital TGA with surgical intervention during infancy (balloon-atrio-septostomie, atrial reversal after Senning). She presents with tricuspid insufficiency I°, ventricular extra systole, sinus bradycardia, NYHA II-III°. Fetal development was in line with time (690 g), no malformations, pathologic Doppler ultrasonography of umbilica (Resistance Index RI [ 95th percentile)-and both uterine arteries (RI [ 95th percentile), tricuspid and mitral insufficiency 1°and minimal aortic insufficiency. Maternal echocardiography: borderline enlarged system ventricle with global hypokinetic contractions, reduced ejection fraction (0.37), hypertrophic interventricular septum, insufficiency of anatomic tricuspid-and functional mitral valve, minimal aortic valve insufficiency. Pathologic increased doppler-sonography of the uterine artery is associated with an increased risk for pre-eclampsia. By this particular patient and preexisting cardiac damage increased blood pressure can lead to cardiac arrest. Admittance at 26 WOG, control of echocardiography, brain natriuretic peptide and clinical symptoms. Regular fetal growth-and Doppler control, cardiotocogram and induction of lung development were performed. Scheduled cesarean in spinal anesthesia and endocarditic prophylaxis was planned and performed at 32 WOG with birth of a healthy newborn developed right for time. Post cesarean course normal. Discharge in unchanged cardiologic status. Conclusions: Pregnancies in women with congenital heart defects require an early interdisciplinary surveillance of heart function. Date of delivery by cesarean depends of the heart function.

PO-Geb 01.46 Bloom syndrome and pregnancy: a case report The Bloom syndrome is a rare, autosomal recessive disorder characterized by a pre-and postnatal proportionate growth deficiency, characteristic dermatologic lesions and a strong predisposition to a wide range of cancers. Male patients are infertile, whereas in female patients fertility is generally reduced. Up to now there have only been five reported cases of pregnancies in Bloom Syndrome patients. This case is a clinical Report of a 25 year old woman with Bloom Syndrome, initially diagnosed at the age of 13. After three miscarriages, in the fourth pregnancy she was successfully treated for preterm labor at 32 weeks, as well as gestational diabetes. At 36 weeks she was delivered of a healthy male infant by cesarean section, following a therapy resistant pyelonephritis.

PO-Geb 01.47 Screening for partner abuse during pregnancy in a German Maternity Hospital Objective: Domestic violence (DV) is a serious health problem, which is known to be associated with adverse pregnancy outcomes, such as preterm birth. Hence, diverse professional health bodies recommend routine screening during pregnancy. In Germany a large cohort study has shown that one in four women has been suffering from partner abuse. However, data in pregnancy are lacking in Germany. This has let us to conduct a prospective cohort study. Materials and methods: 585 pregnant women attending the antenatal clinics in a large German teaching hospital were approached. 111 women agreed to participate in an interview conducted in a separate room by a trained person. A standardized questionnaire was used; socio-demographic data were assessed. Results: Of 111 pregnant women questioned, 31 (27.9%) admitted to physical and/or psychological violence by a partner during pregnancy. Most women screened thought that routine screening should be part of antenatal care in Germany. Conclusions: Screening for DV in pregnancy should be part of routine antenatal care in Germany. Specific guidelines are needed.

PO-Geb 01.48 Management of pregnancy in a patient with anal and total uterine prolapse after congenital bladder extrophy: a case report adamant. Pessary treatment was not necessary and could have possibly led to further complications.

PO-Geb 01.49 Cerclage and cervical occlusion for prevention of preterm birth: a nine year single institution review *Nicole Ochsenbein-Ko¨lble 1 , Suraj Elavumkudy 1 , Juozas Kurmanavicius 1 , Roland Zimmermann 1 1 Clinic of Obstetrics, Department of Obstetrics and Gynecology, University Hospital Zurich, Zurich, Switzerland Objective: To compare the outcomes of prophylactic, therapeutic and emergency cerclage ± cervical occlusion (CO). Materials and methods: A retrospective study was performed including data of 186 singleton pregnancies who received a prophylactic (n = 78), therapeutic (n = 64) or emergency (n = 44) cerclage ± CO and delivered at University Hospital of Zurich in 2000-08. Outcomes observed were as follows: Pregnancy loss before 24 weeks, prolongation of pregnancy, preterm delivery before 28 or 34 weeks, presence of preterm prelabour rupture of membranes (PPROM), clinical chorioamnionitis necessitating delivery and neonatal survival. Results: Mean gestational age at time of prophylactic, therapeutic and emergency cerclage ± CO was 16.6 ± 3.4 weeks, 21.0 ± 4.2 weeks and 23.0 ± 3.6 weeks, respectively. Pregnancy loss rate before 24 weeks was 0, 6 and 23% in the prophylactic, therapeutic and emergency cerclage ± CO group, respectively. Mean prolongation of pregnancy was 20.7 ± 5 weeks, 14.7 ± 6 weeks and 7.4 ± 6.1 weeks after prophylactic, therapeutic and emergency cerclage ± CO, respectively. Four%, 14% and 48% of patients delivered \28 weeks, 10, 27 and 61% of patients delivered\34 weeks and 73, 63 and 32% of patients delivered at term after prophylactic, therapeutic and emergency cerclage ± CO, respectively. PPROM and clinical chorioamnionitis complicated 14, 19 and 34%, and 6, 3 and 39% of pregnancies after prophylactic, therapeutic and emergency cerclage ± CO, respectively. Neonatal survival rate was 100, 91 and 64% after prophylactic, therapeutic and emergency cerclage ± CO respectively. Conclusions: The presented data suggest that cerclage ± CO can prolong pregnancy and increase the change of viable pregnancy outcome. The presence of bulging membranes seems to be associated with higher rates of PPROM and chorioamnionitis as well as shorter prolongation of pregnancy. Objective: There is a little information on the incidence and prevalence of Toxoplasmosis infection in Lagos/Nigeria. The risk of congenital infection in sero-positive pregnant women has been found to produce congenital abnormalities and spontaneous abortion even in developed countries. The aim of the study is to determine the seroprevalence of Toxoplasmosis antibody in prepregnancy class population of men and women. Setting: A Prenatal Diagnosis and Therapy Centre of a Tertiary Hospital in Lagos. Study and design: This is a cross sectional study of men and women attending the prepregnancy class facilities in the centre.

Materials and methods: Between June 1997 and December 2009, the seroprevalence of Toxoplasmosis was determined in this study in 2,273 men and women. A total of 803 Toxoplasmosis IgG seropositive, were screened for IgM seropositivity using ELISA kits. Results: A total of 344 (52.4%) males out of 656, 796 (49.2%) females out of 1,617 were found to be susceptible to Toxoplasmosis. The infection seropositivity rate related to prior infection was 47.6% (312) males and 50.8% (821) in females. CMV IgM seropositivity was found in 17.6% (40) out of 227 males and 22% (127) out of 576 females. Conclusions: This prevalence of Toxoplasmosis antibody in prepregnancy class population of men and women shows high susceptibility and reinfection or active infection rates leading to high risk of transmission among couples.

PO-Geb 01.51 Is ectopic pregnancy really increased in ART? *Barbara Oriol 1 , Antonio Pellicer 2 , Juan Antonio Garcia Velasco 3 1 Technische Universität München, Frauenklinik und Poliklinik, Munich, Germany, 2 Instituto Valenciano de Infertilidad-IVI, Valencia, Spain, 3 Instituto Valenciano de Infertilidad-IVI, Madrid, Spain

Objective: Assisted reproductive techniques (ART) have been considered a risk factor for ectopic pregnancy (EP). We have studied the incidence of EP in 76.077 ART cycles. Furthermore, the recurrence of EP has been estimated after a subsequent spontaneous pregnancy in 15%; we analysed if ART increases the risk of recurrence in this subgroup. Materials and methods: Between the years 2000 and 2008, 633 EPs were diagnosed after ART at our Institution. Retrospective analysis was performed, calculating the incidence of EP in relation to the total number of gestations after ART. For patients with a history of EP, we calculated the recurrence rate after ART. Results: The general incidence of EP was 2.24% per pregnancy after ART. For different techniques the incidence was: 2.61% with general IVF (3.2% after IVF only, and 2.50% after ICSI), and 2.08% after thawed-embryo transfer which is not significantly different from the incidence after fresh embryo transfer. Age at stimulation onset did not predict the risk of EP. With different stimulation protocols, EP-incidence was higher if clomifen citrate (p = 0.006) or an antagonist protocol (p = 0.008) were used, as compared to the long protocol with GnRHanalogs. The number of days with stimulation, total gonadotropin doses, estradiol peak and number of oocytes retrieved did not significantly differ in women with EP as compared to intrauterine gestations after IVF. In the group of patients with at least one previous EP, the recurrence rate per pregnancy after ART was 8.26%. According to the treatment, the recurrence rate per gestation was: 11.5% after IVF; 4.9% after thawedembryo transfer; 17.5% after IUI; and 14.3% after timed intercourse. Conclusions: In our series the incidence of EP after ART was not increased when compared to the 2% for the general population. What's more, the recurrence of EP was not increased after ART.

PO-Geb 01.52 Management of large, persistent adnexal masses in pregnancy approximately 1-6% of these masses are malignant. Ultrasound examination is the primary modality used to detect and evaluate ovarian masses in pregnancy. If sonography is inconclusive, magnetic resonance imaging (MRI) is the preferred additional modality for imaging the pelvis and to assess the risk of malignancy. Materials and methods: We performed a review of cases which were seen at our department in a period between 2005 and 2010. We included all suspected adnexal masses with a maximal diameter of 7 cm or more diagnosed in ultrasound examinations during pregnancy. Masses which showed spontaneous remission over pregnancy were excluded from this review. In every case, expert-ultrasound examination was performed. All cases were histopathological clarified. Results: 18 cases were included to this study. In 8 (44.4%) cases, additional MRI diagnostic was performed. 5 (27.7%) patients had to undergo surgical intervention during pregnancy because of acute indication or suspected malignancy. One pregnancy had to be interrupted in the 13th gestational week out of medical indication. The other 12 masses were monitored at close intervals over pregnancy; surgical therapy was performed during caesarean section or surgical intervention after spontaneous delivery. In total, the interventions delivered histopathological results of 2N ovarii, 3 borderline ovarian tumors, 1 dysgerminoma of the ovary and 12 benign masses. Conclusions: The management of huge adnexal masses during pregnancy can be challenging for the patient and the clinician and involves the evaluation of sometimes competing maternal and fetal risks and benefits. Potential malignancy clearly has an influence on the decision for intervention versus expectant management. In these reviewed cases, correct classification of the masses by expert-ultrasound and additional MRI-examination was possible in most of the included cases.

PO-Geb 01.53 Severe H1N1-infection during pregnancy: a case report *Sandy Bowkalow 1 , Martin Brauer 2 , Walter Groß 3 , Ekkehard Schleußner 4 1 Jena University Hospital, Friedrich Schiller University, Department of Obstetrics and Gynecology, Jena, Germany, 2 Jena University Hospital, Friedrich Schiller University, Department of Anaestesiology and Intensive Care, Jena, Germany, 3 SRH hospital, Department of Obstetrics and Gynecology, Gera, Germany, 4 Jena University Hospital, Friedrich Schiller University, Department of Obstetrics and Gynecology, Jena, Germany H1N1 is known to induce fulminant courses in youths and young adults. We report the case of a 24 year old patient (4th gravid, 2nd para) encountered for fever up to 38°C during 20th week of a so far uncomplicated pregnancy. Ultrasound examination and urine testing was inconspicuous. The throat complaints relieved during the antibiotic therapy. In the next days the patient developed dyspnoea and rising cyanosis. The patient had to be intubated on the 5th day because of decreasing oxygen saturation. Coincidentally a progressive pancytopenia and increasing inflammatory activity was recorded. Echocardiography, blood cultures, and bronchial lavage brought no pathological findings. The cranial, thoracic, and abdominal computer tomography showed the ARDS and hepatomegalie but no other pathological findings. Recent HIV, CMV, HSV, classical influenza, and parainfluenza-infections were excluded. A H1N1-infection was confirmed by PCR on the 6th day. The antiviral therapy was changed from Zanamivir to Oseltamivir. Extracorporeal membrane oxygenation became necessary because of insufficient oxygen saturation by mechanical ventilation. At this time pregnancy seemed to be unimpaired. Suddenly a spontaneous expulsion of the fetus occurred on the 7th day (weight 460 g, no anomalies detectable). No curettage post abortem was necessary. As a result of the antiviral therapy H1N1-DNA was not detectable at day 16. Despite all affords the respiratory situation could not be improved significantly. Additionally the patient developed a multiorgan failure during the time course and died on the 28th day of treatment. The recent case illustrates a very dangerous and impressive course of a H1N1-infection.

PO-Geb 01.54 Adnexal torsion after ovaropexie in pregnancy *Alexandra Budau 1 , Volker Jaspers 1 , Gabriele Bonatz 1 1 Augusta Kranken-Anstalt, Gynäkologie und Geburtshilfe, Bochum, Germany

Objective: Adnexal torsion is a rare event of emergency in pregnancy, because it is usually associated with functional cysts or tumours of the ovary. We report an ovarian torsion in the second trimester of pregnancy, after a history of previous multiples torsions without pregnancy and a status after ovaropexie. Materials and methods: Case presentation: A 27 year old woman presented in the 19th week of her first pregnancy with severe pain in her left lower back pain irradiating into the right leg. She reported intermittent nausea and vomiting without fever or other abdominal or urinary symptoms. She had been treated for polycystic ovaries for 3 years with three laparoscopies within the last 14 months for ovarian torsion and an ovaropexie at the last operation. After analgetic treatment the pain resolved after a few hours, as it did in another two times of clinical admissions. At any time blood values were normal. The abdominal sonography showed a normally developed pregnancy without an adnexal mass or free fluid. Due to the recurrent pain and the previous history, laparoscopy was performed in the 20th week and revealed an haemorrhagic torted ovary without signs of infection. An ovariectomy was performed. Histology proofed the diagnosis. Postoperative recovery was uneventful with a normally ongoing pregnancy. Results: Because of the pregnancy diagnosis was made with a delay of about 10 days. This was due to the limited possibilities of diagnostic methods and the untypical presentation of symptoms. However, the removal of the left ovary could be performed without further harm to the patient or the fetus. Conclusions: Adnexal torsion in pregnancy is an emergency with high potential risks for patient and pregnancy. It should be considered in the differential diagnosis of acute lower abdominal or back pain, since it can present with untypical symptoms. Risk factors should be evaluated.

Objective: We have shown previously that automated measurement of sFlt1 and PlGF is a reliable tool in the assessment of preeclampsia (PE). The sFlt1/PlGF ratio (ratio) is superior over the single measurement of sFlt1 or PlGF in PE diagnosis. The aim of this study was to characterize the ratio in different types of hypertensive pregnancy disorders. Secondly, we wanted to prove whether the ratio helps to identify women at risk for immediate delivery. Materials and methods: In a multicenter case control trial we investigated 126 patients with PE/HELLP, 35 with pregnancy induced hypertension (PIH), 45 with chronic hypertension (cHTN) and 328 controls. SFlt1 and PlGF were measured in serum samples on an automated Elecsys platform. To evaluate the ratio in the course of pregnancy, different timeframes (24-27 +6, 28-33 +6, [34 weeks) were investigated. Hazard Ratios adjusted for gestational age for preeclamptic women in the upper quartile of the ratio were calculated. Results: PE patients showed a higher ratio compared to controls, whereas the ratio was the higher the earlier pregnancy was complicated by PE (668 ± 104 vs. 3.38 ± 0.61 for 24-27 + 6 weeks; 436 ± 63.9 vs. 11.0 ± 3.72 for 28-33 + 6 weeks; 143 ± 18.1 vs. 29.5 ± 5.63 for [34 weeks). However, patients with cHTN and PIH had a significantly lower ratio than patients with PE/HELLP (p \ 0.001). Overall, a ratio [422 was associated with a 3.5 higher risk of immediate delivery (95% Confidence Interval: 1.98-6.19 ). Pregnancy was significantly prolonged in preeclamptic women with a ratio below the fourth quartile (p \ 0.001). Conclusions: The automated measurement of the sFlt1/PlGF ratio is able to discriminate between different types of pregnancy-related hypertensive disorders. The measurement of the ratio is able to provide a short-term prediction of pregnancy duration and outcome. Thus, the ratio gives additional valuable information on the severity of the disease and can therefore be used to adapt clinical management.

PO-Geb 01.56 Influence of progressive muscle relaxation training on anxiety and depression levels during pregnancy and puerperium Objective: Relaxation training is an integral part of psychosomatic prenatal classes. The aim of this study was to determine whether progressive muscle relaxation training affects anxiety and depression levels during pregnancy and puerperium. Another aspect was to assess the satisfaction of the participants regarding the PMR-courses. Materials and methods: A total of 100 women attended this study. The control group, consisting of 50 women, received only general prenatal care. The other 50 women of the intervention group took part in a progressive muscle relaxation training for 5 weeks including one guided group session each week and the instruction to practice at home regularly. In both groups Anxiety (STAI) and depression (BDI) were measured three times: before and after 5 weeks of intervention and during puerperium. The level of satisfaction regarding the subjective effectivity was assessed at the end of the intervention period. There were no significant differences between the intervention and control groups regarding the age, parity, gravidity and frequency of complications at the beginning of the study. Results: During the study progress a successive decrease of the State-Anxiety could be observed in the total number of participants (p = 0.004). This trend could also be shown in the two separate groups. Because of the higher level of State-Anxiety scores in the control group (mean 40.88; SD 11.76) compared to the intervention group (mean 37.54; SD 7.36), a significant change could only be exhibited in the control group (p = 0.004). No significant differences could be shown in the PMR-group (p = 0.279), probably because of the lower mean levels of State-Anxiety at the beginning of the study. A decrease of the Trait-Anxiety levels of the total of the participants could also be observed (p \ 0.05 and p \ 0.01). A significant reduction of the Trait-Anxiety during pregnancy and in the puerperium could be shown for both groups. There were no significant differences between control group and PMR-group. A reduction of depression levels could be detected at all three points of investigation in the total number of participants (p \ 0.01). This significant effect could only be shown in the PMR-group (p \ 0.05) if groups were looked at separately. After the weeks of PMR training the satisfaction and subjective learning effect of the PMR-group participants was assessed. 86.4% of the women stated an obvious improvement of their relaxation abilities. 97.7% of the PMR-group would attend another course during a following pregnancy as far as there would be one offered. All participants declared that they would recommend PMR to other pregnant women. Conclusions: An additional offer of PMR-courses to the general prenatal care leads to an improvement of subjective relaxation abilities during pregnancy and gains a high acceptance within the participants. PMR leads to a reduction of depression scores during pregnancy. No significant effect on State and Trait-Anxiety could be shown in this study, maybe because of the small number of participants.

PO-Geb 01.57 Acute abdomen in pregnancy caused by torsion of an appendix epiploica *Julia Ferie´1, Hamudi El-Armouche 2 , Jürgen Tepel 2 , Yves Garnier 1 1 Klinikum Osnabrück, Department of Obstetrics and Gynaecology, Osnabrück, Germany, 2 Klinikum Osnabrück, Department of Surgery, Osnabrück, Germany

Objective: To increase the awareness of rare causes of lower abdominal pain in pregnancy Materials and methods: A 30 year old G3 P0 presented at 24 + 2 weeks of gestation with right lower quadrant pain since the previous evening. The ultrasound scan showed a normal singleton pregnancy with a normal amount of amniotic fluid. Cervical length was 34 mm. No contractions were visualized on the CTG. Laboratory results did not show elevated inflammatory markers. Localized right lower quadrant pain with marked guarding led to the decision of undertaking a laparotomy. A perioperative bolus tocolysis was given. Following a pararectal incision, a necrotic appendix epiplioca was found at the location of maximal pain. No ascites, no intraabdominal pus and no localized inflammatory reaction could be found. The adipose tissue including its peritoneal basis and the completely unremarkable appendix were removed. Bolus tocolysis was stopped 24 h after the operation. Results: Histological examination revealed old necrosis of adipose tissue with localized fresh haemorrhages suggesting repeated torsion of an appendix epiploica. Postoperative treatment included a course of iv Cefuroxim. The further recovery was uneventful. Conclusions: Differential diagnoses of acute right lower quadrant pain in pregnancy should include less common causes such as torsion of an appendix epiploica.

Arch Gynecol Obstet (2010) Objective: Micro-RNAs are recently detected key regulators of the immune system and of carcinogenic processes, but their function in pregnancy is poorly investigated yet. Leukemia Inhibitory Factor (LIF), is a cytokine which plays a crucial role in human reproduction and which triggers trophoblast invasion via Signal Transducer and Activator of Transcription 3 (STAT3). Therefore, we aimed to determinate LIF-regulated micro-RNAs in a choriocarcinoma cell line model to their potential involvement in control of invasion. Materials and methods: JEG-3 choriocarcinoma cells were stimulated with LIF for 1 to 24 h, and total mRNA was isolated. Phosphorylation of signal transducers ERK1/2 (thr 702 and tyr 704) and STAT3 (ser 727 and tyr 705) was assessed by gel electrophoresis and Western blotting. STAT3 gene expression was analyzed as control of induction by RT-PCR. Expression of five different micro-RNAs, which are either known to be expressed in placental tissue or involved in tumor invasion, was quantified at six time points by qRT-PCR. Results: ERK1/2 and STAT3 were phosphorylated from 10 to 30 min after LIF stimulation. Three micro-RNA, miR-9, miR-141 and let-7g, were time-dependently down-regulated by LIF with a peak after 4 h of treatment, which correlates with an increase of STAT3 expression. Colorectal carcinoma presenting during pregnancy is uncommon [1] . We present a 27 year old woman who was admitted to hospital because of lower abdominal pain in the 27th week of gestation. The ultrasonic examination revealed a retrocervical tumor, suspected to be a myoma with central necrosis. Because of increasing and unbearable pain as the only symptom of an otherwise unremarkable clinical picture, a caesarean section of a healthy child was accomplished in the 30th week. Intraoperatively, a tumour of 9 cm diameter was seen in the rectovaginal septum. Fearing major bleeding, and under the misleading assumption of a myoma no further exploration was done. After 4 weeks of continuing pain a re-laparotomy was performed. The frozen section revealed a highly malignant epithelial tumour probably originating from the paramesonephric duct, germ cell or anal tissue. It was decided to do an en bloc resection of the uterus, posterior wall of the vagina, rectum and the adjacent part of the sigma. A temporary artificial anus was placed. Histology and further staging revealed a HPV associated tumour of the anus pT4 pN0 (0/17), M0, R1, G3(L0,V0). Following surgery, radio-chemotherapy was completed.

One year after the first diagnosis a reanastomosis of the intestines was done. In the process no residue of tumour in the anal's blunt was found. With this case history we want to draw the attention to poorly symptomatic malignancies of the pelvic and genital region which may arise during pregnancy. Their signs and symptoms may be mistaken, and thus responsible for the late diagnosis. Although malignancies are generally rare during pregnancy, any atypical sign and/or symptom must be examined thoroughly.

PO-Geb 01.60 Ultrasound-guided laser coagulation of the umbilical cord in acardiac twins *Laura de Vries 1 , Stefan Koch 2 , Yvonne Mu¨ller-Koch 3 , Dieter Grab 1 1 Klinikum Harlaching, Frauenklinik, Munich, Germany, 2 Gynäkologische Praxis, Munich, Germany, 3 Praxis für Humangenetik, Munich, Germany

We present two cases of successful treatment of twin reversed arterial perfusion (TRAP) sequence by ultrasound-guided laser coagulation of the acardiac twins' umbilical vessels. At 21st and 18th gestational weeks, respectively, ultrasound-guided laser coagulation of the intraabdominal part of the acardiacs' umbilical vessels was performed (Neodym YAG laser, 60 Watt). Blood flow was successfully stopped and both pregnancies carried on uneventfully. In order to prevent the pump-twin from congestive heart failure, different surgical methods such as fetoscopic laser or bipolar forceps coagulation of the acardiac's umbilical cord have been applied. Ultrasound-guided laser vaporisation of intraabdominal umbilical vessels is a simple and minimal-invasive procedure to cease perfusion of the acardiac twin and may replace the more invasive fetoscopic approaches in selected cases.

PO-Geb 01.61 Blood group immunization: rhesus incompatibility versus Kell incompatibility. Differences in the course of fetal disease *Gabriele Fries 1 , Silke Jacob 1 , Rainer Bald 1 1 Klinikum Leverkusen, Pränatalmedizin, Leverkusen, Germany

Objective: The Kell-antibody induced fetal anemia represents an exception beneath the fetal blood group immunizations. The Kellantibody blocks early erythropoetic cells and thus leads to a hypoproductive anemia. We want to demonstrate the differences in the course of disease between Kell incompatibility and Rhesus incompatibility. Materials and methods: Since 2006 we treated 23 pregnancies with blood group immunization induced fetal anemia in our department; 16 of these pregnancies with Rhesus incompatibility and 7 with Kell incompatibility. 117 intrauterine transfusions were performed. Results: We found considerable differences in the number of necessary transfusions per pregnancy, the lowest hemoglobin level, the time between transfusions and the gestational age of the first transfusion between Rhesus incompatibility and Kell incompatibility. The differences could not shown to be statistically significant because of the relatively small number of patients.

We are able to demonstrate with our cohort of patients that the Kell incompatibility is due to its pathogenesis more aggressive than the Rhesus incompatibility. Therefore patients with Kell incompatibility need closer follow up than other patients with blood group immunization in pregnancy.

Arch Gynecol Obstet (2010) 

Objective: There are few data available on managing adnexal masses in pregnant patients. Most of these are benign tumors such as mature cystic teratomas and cystadenomas. Rates of malignancy range from 3.6 to 6.8 percent of persistent masses. Materials and methods: A 22-year-old woman, gravida I, para 0, presented with a huge, asymptomatic left adnexal tumor, incidentally diagnosed at the gestational age of 31 + 2 weeks. Abdominal ultrasound showed a multilocular cystic left adnexal tumor with thin septations measuring 142 mm 9 86 mm 9 134 mm. Fetal development was appropriate for gestational age. CA 125 was elevated up to 102.9 IU/ml. Close clinical and sonographic monitoring was conducted initially. Because of rapid enlargement and increasingly massive upper abdominal pain a longitudinal laparotomy with cesarean section and left ovarectomy with removing of the cystic mass was performed in the 33 + 5 week of pregnancy. Histologically, a 2000 g multilocular mucinous cystadenoma measuring 250 mm 9 200 mm 9 600 mm was identified. The premature infant had to be treated for RDS postnatal with complete reconvalescence after 12 days.

Conclusions: Conservative treatment of adnexal masses during pregnancy requires close monitoring of the patients to prevent maternal and fetal complications. The rapid enlargement of the ovarian mass during pregnancy might indicate a steroid hormoneresponsiveness of the tumor.

PO-Geb 01.63 Diagnostic tools to evaluate suspected placenta percreta *Verena Geyer 1 , Annette Ruppert 1 , Rolf Kreienberg 1 , Frank Reister 1 1 Universität Ulm, Department of Obstetrics and Gynecology, Ulm, Germany

Objective: According to the literature abnormal placentation such as placenta accreta, increta or percreta occurs in 1:7000 deliveries, whereas placenta percreta makes up 5-7% of these cases of abnormally deep placental invasion. This high risk condition for mother and fetus requires an early and correct diagnosis and planning of delivery. Materials and methods: In a retrospective study we searched 10102 deliveries between 1/2006 and 4/2010 in one perinatal centre. 10 cases of placenta percreta were identified. We retrospectively investigated the diagnostic tools that had been applied. It was correlated with the clinical history and the therapeutic approach. Results: 8/10 women had MRI whereas the depth of infiltration was correctly measured in 6/8 cases. Cystoscopy was performed in 5 cases. An infiltration of the bladder wall occurred in two patients. Ultrasound could not reliably rule out bladder invasion. All but one patients had previous caesarean sections, 4 had curettages. The incidence of placenta praevia totalis was 6/10. Hysterectomy was performed in 4/10 cases. The presence of risk factors such as history of caesarean sections, curettages and placenta praevia-especially when combined-should rise awareness for abnormally deep placentation. If placenta percreta is suspected by ultrasound, MRI andin doubtful cases-cystoscopy should be performed. Leaving the placenta in situ in cases of suspected or confirmed bladder infiltration appears to be beneficial.

PO-Geb 01.64 Molecular blood genotyping in rare rhesus blood group variants: a case report of a rhesus positive baby in two rhesus negative parents *Christian Breymann 1 , Andrea Siderow 2 , Mahmood Schams 3 1 Hirslanden Clinics, Obstetrics, Zurich, Switzerland, 2 Blutspendedienst Zuerich, Immunhämatologie, Zurich, Switzerland, 3 Hirslanden Clinics, Pediatrics, Zurich, Switzerland

Objective: This case report shows the necessity of molecular blood group genotyping in a newborn that was apparently Rh pos. in two Rh negative parents. Materials and methods: Parents presented with paternal Rh-(Ccddee) and maternal Rh-(ccddee) and no Rh Prophylaxis was performed primarily. Surprisingly blood group determination was inconclusive in repeated gel and titration assessments and concluded a baby probably rhesus positive. Molecular BG genotyping (PCR-SSP) then revealed a rhesus partial D (Dv) variant CcDvee, K-. Then father was tested again and revealed A (+) CcDvee, Type VII, which proved paternal transmission of blood group variant.

Conclusions: In this case only genetic BG typing revealed a partial RhD variant which enables the counseling for blood transfusion as donor or receptor in the individuals and counseling for future pregnancies, namely Rh prophylaxis.

The endoglycosidase heparanase is not differently expressed in term placentas of women with gestational diabetes or uncomplicated pregnancies PO-Geb 01.66

The clinical significance of base excess (BE B ) and BE Ecf *Volker Michael Roemer 1 , 1 Institut für feto-maternale Medizin, Detmold, Germany

Objective: BE B (ctH B,act + (mmol/l)) is important since it might reflect lactate acidosis due to hypoxia; In vivo ctH B + is dependent from pCO 2 . Independence is achieved when using the extended extracellular fluid (Ecf) reducing cHb to 1/3 (foetus: about 1/4). Correction of ctH + to normally low fetal oxygen saturation by reoxygenation rises ctH B + leading to four variables: ctH B,act + , ctH Ecf,act + (called Standard BE), ctH B,ox + . and ctH Ecf,ox + . . Which variable is most appropriate for perinatal acid-base studies? Materials and methods: The APGAR-and the WAS-score were used measuring neonatal vigour and FHR characteristics of 475 foetuses delivered vaginally. FHR was evaluated by computation of the WAS-Index referring to: (FHF*w1) * (OZF*w2) * (OZA*w3) -1 . The three weighting functions w1-w3 were determined using optimizing software. WAS-score denotes the mean of the last 30 WAS-indices. Results: In vivo ctH B,act + is closely correlated with pCO 2 : r = -0.288, P \ 10 -4 ; ctH + Ecf,act becomes independent from pCO 2 : r = -0.0068, P = 0.881. The two blood gases pCO 2 and pO 2 are inversely correlated (P ( 10 -4 ). The 1-Min. APGAR is best correlated with pH,UA (r = 0.4078, P \ 10 -4 ,Spearman's Rho = 0.307). Correction of ctH + to sO 2 (%) yields: ctH B,ox Objective: To provide the latest descriptive data about infant survival and morbidity after extremely preterm birth in infants with gestational age (GA) of \25 weeks in relationship to parameters which may predict preterm delivery. As well as to advance prenatal and perinatal care and to update clinical guidelines. Materials and methods: Center-based retrospective study of mothers and their extremely preterm infants with a GA of \25 weeks to compare survival rates due to infectious disease, birth weight and multiples in the unit of obstetrics at the Johann Wolfgang Goethe-University Frankfurt/Main, during 2000 -2009 . Results: 80 mothers were identified. Out of all mothers 15 had experienced once, 7 twice and 4 three or more times a previous miscarriage, a previous stillbirth or neonatal death. The current pregnancy was the result of artificial reproduction in 8 of the women. Parameters of an infectious disease were demonstrated: 24 mothers had increased C-reactive protein (CRP), 46 mothers had increased leukocytes and 25 mothers had elevated temperature. The relation of several parameters to the birth weight and to the antenatal treatment of corticosteroids was shown. 94 infants with a GA \25 + 0/7 were identified. Out of these infants 43 were stillborn or died in the delivery room and 51 were admitted to the ICU. The neonatal morbidity and mortality is demonstrated including mechanical ventilation, retinopathy of prematurity (ROP), periventricular hemorrhage, periventricular leukomalacia. Conclusions: The survival rate increased in addiction to the GA and a lower risk of infant death was associated with perinatal treatment such as antenatal corticosteroids which both stands in accordance with previous studies. Furthermore the present study could show the relation to maternal disease, birth weight and multiples. Because of the low number of cases multicenter studies are recommended to evaluate further relevance of risk factors.

PO-Geb 01.68 Accuracy of intrapartum detection of Group B streptococcus with a new rapid PCR assay in a maternity ward Objective: Early onset neonatal sepsis due to Group B streptococci (GBS) is responsible for severe morbidity and mortality of newborns. The optimal strategy consists of intrapartum antibiotic prophylaxis given to patients who are tested positive for GBS in the antenatal culture-based screening and a risk based approach for cases of unknown GBS status. Recently a new rapid real-time polymerase chain reaction (PCR) assay for intrapartal detection of GBS become available. Herein we test the accuracy and acceptability of the PCR based test in the daily routine of the labour ward. Materials and methods: A prospective study was conducted. All pregnant women in the maternity ward from 25 weeks' gestation on giving birth with a risk of premature birth, or with a planned cesarean section were included. Patients under 25 weeks were excluded. Selective GBS culture (gold standard) and a molecular GBS test (Xpert GBS) were performed routinely on specimen. Results: We prospectively enrolled 124 pregnant women from April 2009 to April 2010 in our hospital. As compared to the selective culture, the molecular GBS test had a sensitivity of 96% and a specificity of 95%. The positive predictive value of 83% and negative predictive value of 99% were registered. Most of the errors it the molecular GBS group were based on ineffective management in the labour ward. Conclusions: The PCR based molecular GBS test is a accurate tool to identify intrapartum GBS vaginal colonization. The use in a daily routine of a maternity ward is possible but there is a learning curve how to analyse the specimen, and therefore professional training is necessary in order to minimize the human source of errors.

PO-Geb 01.69 Severe ovarian hyperstimulation syndrome (OHSS) in a spontaneous pregnancy: diagnose of fetal triploidy. A rare disease Materials and methods: We report a case of a woman in the 11th week of gestation, presenting a severe OHSS with abdominal pain, ascites, pleural effusion and severe hyperemesis gravidarum after spontaneous pregnancy. A triploidy of fetus was diagnosed. OHSS declined after legal induced abortion. Results: The patient, a gravida 2 para 1, was admitted in the 11th week of gestation. A transvaginal ultrasound showed a living fetus with a biparietal diameter of 13.4 mm and a crown-rump-length of 43.0 mm with a large nuchal oedema (3.13 mm). The ovaries were enlarged to 15 cm in diameter with multiple cysts on both sides. Ascites was present. The free ß-HCG value was 1932 U/l (36.0905 Mom), serum-HCG was elevated up to 584689 U/l, PAPP A was 2.237 U/l (1.1354 Mom) . A chromosomal abnormality was suspected and chorionic villous sampling subsequently performed. The cytogenetics of long-term chromosome chorionic villous culture showed a complete triploidy (69, XXX). A legal abortion was induced and performed. Material was sent to the pathologist, who described no signs of a choriocarcinoma. Triploidy was confirmed. The patient was discharged 2 days after the abortion with only mild complaints of abdominal pain and hyperemesis. Serum-HCG declined to 52770 U/l and was controlled within the next 14 weeks until it reached to a negative value. Conclusions: To conclude, this case highlights two aspects of this rare disease: first, one must be aware of the occurrence of OHSS in spontaneous pregnancy, especially if additional pathologies such as triploidy are present and second, ß-HCG do not decrease immediately after pregnancy, but may persist during weeks after abortion.

PO-Geb 01.70 Management of fetal urethral valve with reflux, dilated urether, urinoma of left kidney and uremic ascites *Anja Forster 1 , Burkhard Schauf 1 1 Sozialstiftung Bamberg, Frauenklinik, Bamberg, Germany

Objective: Dilatation of kidneys is often seen in fetuses. Normally there is no specific therapy necessary, pregnancy is prolonged until due date if amniotic fluid index an renal function are normal. We present a case of fetal hydronephrosis based on urethral valve presenting in 29th week of pregnancy with urinoma of the left kidney and uremic ascites. Materials and methods: First visit was in 20th week with mild dilated bladder and mild hydronephrosis of both kidneys. No additional markers for chromosomal abnormalities were found. Reevaluation took place in 28th week showing the same and a slightly dilated right urether. In 29th week the patient was send by gynecologist due to ascites. Ultrasound examination showed a severe urinoma of left kidney and a non-dilated bladder, pelvis of the right kidney and both urethers and ascites. Pregnancy was prolonged, lung ripening was induced. Ascites was resorbed in the following week, reflux into the left kidney and a hypertrophic bladder were detected. In 33rd week the fetus showed severe dilatation of the right pelvis of the kidney and a dilated right urether. Delivery was performed by c-sectio. Results: Post partum the urinoma was drained and the hypertrophic bladder was drained by suprapubic catheter. Severe reflux from the bladder especially to the left pelvis of the kidney was found. There were no hinds for any complications due to the uremic ascites in pregnancy. The baby was discharged after 6 weeks with suprapubic catheter, ureteroscopic operation of the valve and reimplantation of urethers if necessary is planned with the age of 3 month after functional testing of both kidneys. Fetal kidney insufficiency with an-/oligohydramnion after ACE-inhibitor/sartane treatment during pregnancy: a case report *Filiz Markfeld-Erol 1 , Susanne Markert 1 , Juliane Farthmann 1 , Mirjam Kunze 1 , Heinrich Pro¨mpeler 1 1 University Freiburg, Gynecology /Obstetrics, Freiburg, Germany Objective: We present cases of two patients with adverse effects of the contraindicated ACE-inhibitors treatment during pregnancy. In one case the patient continued the treatment because of unrecognized pregnancy, in the other the ACE-inhibitor treatment was continued despite of known pregnancy. Materials and methods: Patients were a 27-and a 36-year old Igravida/0-para with arterial hypertension, insulin dependent diabetes mellitus, diabetic nephropathy and diabetic retinopathy. During both pregnancies, in the 2nd trimenon (23rd and 26th week of gestation) an an-/oligohydramnion was diagnosed by ultrasound. Results: Both neonates had reduced kidney function at delivery and were treated in the department of paediatric nephrology. In both cases the kidney function improved after several months. Conclusions: In the second half of pregnancy ACE-inhibitor treatment may cause a decreased circulation of the placenta with consecutive fetal hypotonia, oligohydramnion an anuria of the newborn with the need for dialysis. By a reduced tonus of the kidney-vessels a hypoxis dysgenesia of the kidney tubuli occur which cause a decreased fetal urine production. Beyond the 16th week of gestation the fetal urine production is the main part of the amniotic fluid, therefore the oligohydramnion is a consequence of anuria. Occasional a hypoplasia of the cranial bones is described, probably also explained by the reduced perfusion. A deterioration of the kidney function of older children, after intrauterine exposition t ACE-inhibitors in the 3rd trimenon and only temporary anuric kidney failure, is described. It is necessary that patients with contraindicated medication during pregnancy have safe contraception and these patients are to be informed about the risks of treatment. The adverse effect of the ACE-inhibitor treatment needs to be considered as a differential diagnosis of reduced amniotic fluid diagnosed by ultrasound.

PO-Geb 01.72 Prophylactic cerclage: influence of the timing on prolongation of pregnancy 

Objective: Prophylactic cerclage is a widely used procedure to decrease the risk of prematurity. The optimal timing of this operation is still under discussion. Materials and methods: By means of a retrospective study, all cerclages performed in the Dr. Horst Schmidt Kliniken 2008 -2009 were analyzed for the duration of pregnancy, fetal morbidity and mortality and maternal outcome. Results: In 39 women a cerclage was performed, 13 of which had an additional suture of the os externum in terms of a total occlusion of the cervix. The operations were performed between 12 and 26 weeks of gestation. One patient was lost for follow up. Two pregnancies ended as late miscarriages, one of them caused by a parvovirus B19induced extreme fetal anemia. The remaining 37 pregnancies continued beyond 30 weeks of gestation with no major inflammation-related perinatal complications. 26 pregnancies persisted for more than 37 weeks. Plotting the operation date (gestational week) against the duration of pregnancy-expressed in percentile prolongationyielded a hyperbolic-shaped curve with a sharp decline when the cerclage was performed after 22 weeks. Conclusions: Patients at risk for cervical incompetence resulting in prematurity have an enhanced benefit when the cerclage is performed early i.e. before 22 weeks of gestation.

PO-Geb 01.73 Challenging the MALDI-ToF-MS serum profiling analysis to distinguish women with preeclampsia from matching controls in a multicenter study using a clinical approach Objective: We recently demonstrated that serum analysis using affinity based MALDI-ToF-MS is capable to distinguish between patients with early-onset preeclampsia (PE) and matched controls (CN). The method is in detailed description by Pecks et al. 2010 . We now aimed to evaluate the potential diagnostic value of this method in a multicenter setting. Materials and methods: A total of 127 Serum samples of preeclamptic (n = 60) and healthy pregnant women (n = 67) were collected in 4 perinatal care centers. Serum analysis was performed as described previously using MALDI-ToF-MS. Statistical analysis was performed with the ClinProTools (Bruker Daltonik) software package. Results: Our previous results could be confirmed by repeated measuring of the identical samples. Established rules however displayed restricted applicability to center 2, 3 and 4 since predefined cut off values failed at differing peak intensities. Standardizing intensities center-wise by grouping peak intensities of PEs and CNs provided applicability over all centers apart from center 4 where no CNs were available. Therefore those samples were excluded from further calculation. Aiming to improve accuracy on the m/z values, internal calibration based on calculated masses from single and double charged transthyretin ([m + H]+:13,761 Da; [m + H]2+:6,881 Da) was introduced. Newly added samples with larger biological variability amended the pre-established analysis and sample classification reached a sensitivity of 87.8% and a specificity of 73.1%. Note that separate calculations for early-onset PEs only revealed a sensitivity of 90.6% and specificity of 87.2% which are quite comparable to the previously published data. Conclusions: Our results imply that MALDI-ToF-MS serum-profiling together with center-wise standardization offers a robust method to classify PE from CN over several centers. Furthermore the used peak ratios might hold potential information about subclasses of PE. This is subject of current investigations.

PO-Geb 01.74 Prevalence of IgM antibodies to Cytomegalovirus, Toxoplasmosis, Rubella, Chlamydia, Parvovirus and Herpes Simplex virus infection in women with bad obstetrics history *Godwin Ajayi 1 , Sunday Omilabu 2 , S Badaru 2 , Oluseyi Ogunsola 1 , Adeola Alamu 1 1 College of Medicine, University of Lagos, Prenatal Diagnosis and Therapy Centre and Department of Obstetrics and Gynaecology, Lagos, Nigeria, 2 College of Medicine, University of Lagos, Microbiology, Lagos, Nigeria

Objective: Maternal infection plays a critical role in pregnancy wastage and their occurrence in women with bad obstetrics history. To find out the prevalence of IgM antibodies to Cytomegalovirus, Toxoplasmosis, Rubella, Chlamydia, Parvovirus and Herpes Simplex virus infection in women with bad obstetrics history. Setting: A Prenatal Diagnosis and Therapy Centre of a Tertiary Hospital in Lagos. This is a cross sectional study. Materials and methods: Between June, 2000 and December, 2009 , blood samples were obtained from 200 pregnant women with bad obstetrics history and 200 pregnant women without bad obstetrics history. Samples were centrifuged, separated and stored at -20°C until assay was carried out for IgM seropositivity using ELISA kits. Results: 162 (81%) were positive for CMV, Rubella, Toxoplasmosis, Chlamydia, Parvovirus and Herpes Simplex virus alone or in combination. The highest percentage of the antibodies to CMV, Rubella, Toxoplasmosis, Chlamydia, Parvovirus and Herpes Simplex virus was in cases of abortion. Conclusions: Our study shows a strong association of these pathogens with bad obstetrics history. Therefore screening and early diagnosis of these agents in patients can help in proper management of these cases.

Objective: Midwifery associations are about to identify the primary outcomes for mother and child in Germany with a home birth or birth centre setting. The study question here was: What are the outcomes when mothers giving birth post-term have their babies at home or in a birth centre? Materials and methods: We used routine data collected by QUAG for a retrospective cohort study with an analysis based on the place where birth started (transfers during and after birth included). The out-ofhospital-births were documented by midwives all over Germany between [2000] [2001] [2002] [2003] [2004] (about 80% of all out-of-hospital births and 1.5% of all births in Germany). The study population included 42,154 women starting birth at home or in a birth centre. We compared women at term (control group, n = 39,830; Ipara n = 14,031,[Ipara n = 25,799) versus women post term (study group, n = 1,092; Ipara n = 458, [Ipara n = 634). Odds ratio and 95% confidence intervals were calculated.

Arch Gynecol Obstet (2010) 282 (Suppl 1):S63-S270

Results: The rate of meconium-stained amniotic fluid was higher in the study groups (for Ipara: OR 2.0, 95% CI = 1.5-2.8) as asphyxia was slightly higher (for Ipara: OR 2.4, 95% CI = 1.2-4.7). Caesarean section and transfer were twice as high in the study group, for Ipara and [Ipara. Prolonged labour was significantly higher in the study groups during the first stage of labour (for Ipara: OR 2.7, 95% CI = 2.2-3.3) but not in the second stage. Both maternal and infant outcomes show differences but no dramatic changes compared to term birth. The rise in transmission to hospital and surgical birth can be seen as an example for good cooperation between midwives and hospitals.

Conclusions: Midwives in the out-of-hospital-birth-setting in Germany are skilled to care for women, who go over their due date. 

Objective: Endometriosis, mostly located within the pelvis is prevalent in 5-10% of all women; however the time from the first symptoms to diagnosis usually is 3-11 years. Endometriosis of the rectus abdominis muscle is very rare, and difficult to diagnose. It is often caused by grafting endometrial cells to the muscle during a laparotomy, mostly a caesarean section. Rectus abdominis endometriosis can cause severe pain. Materials and methods: We report the case of a 7 cm-endometrioma located in the rectus abdominis muscle causing severe pain 13 years after caesarean section and discuss causes, diagnostic and treatment approaches.

Results: A 43-year-old woman presented with strong periodic abdominal pain (9/10 on visual analog pain scale (VAPS)), increasingly limiting her mobility since 8 month. Due to an intrauterine device, the patient did not menstruate and not link the episodes of pain to her menstrual cycle. Anamnestic dysmenorrhoe (3/10 on VAPS) since her menarche waned with oral contraceptives and rose again after the cesarean section 13 years ago. A coloscopy and a computertomographie of the abdomen did not identify the cause of pain. Ultrasound did show a multinodal tumour (70 9 40 9 50 mm) in the abdominal muscle and fascia and endometriosis of the bladder. A wide resection of the tumour, including surrounding muscle fibres and fascia was performed entering via the caesarean section scar. Besides one spot of endometriosis on the bladder no intraabdominal endometriosis was found, substantiating the suspicion of the long dating back caesarean section as cause. The histological examination of the specimen revealed ectopic endometrial tissue.

Conclusions: Endometriosis of the abdominal wall can cause symptoms even more than a decade after the causing operation. Although it is very rare the clinician has to keep it in mind for the differential diagnosis of abdominal pain.

PO-Gyn 01.02 Endometriosis of perirectal lymph nodes in deep infiltrating endometriosis of the rectosigmoid colon: a new therapeutical consequence to be considered?

Objective: Repeated finding of typical endometrial and tuber glands and stroma in the cortex of an perirectal lymph node and accompanying lymphatic vessel in a case of a rectosigmoid endometriosis in a 29 year old patient with deep infiltration endometriosis of the rectosigmoid colon. Materials and methods: Retrospective case-report and review of the literature.

Results: Confirmation of endometriotic lesion in pericolic lymph nodes and lymphatic vessel in a patient being diagnosed with endometriosis in the rectosigmoid with a lesion size of 2.5 cm in diameter and a lesion thickness of 1.5 cm.

Conclusions: We can confirm the repeated findings of endometriotic lesions in local perirectal lymph nodes and especially accompanying lymphatic vessel, which could be a sign of at least regional or maybe even systemic spread. Likewise unclear as the question of origination is the clinical importance in means of surgical (e.g. standard sentinel LN?) and/ or other therapeutical consequences such as adjuvant hormonal therapies and potential patient benefit in terms of a lower recurrence rate or at least a longer interval of being pain free to legitimate such new procedures. Therefore a prospective study would be reasonable to evaluate possible benefits. Objective: Endometriosis is one of the most common gynecological diseases. Although it has been the subject of numerous scientific investigations, its pathogenesis is as yet unexplained. Irrespective of models for the pathogenesis of endometriosis (metaplastic or transplantation theory) invasiveness, cell differentiation, and cell survival should have an essential role in the disease. To gain further insight into the transcriptional changes that take place before and after the development of endometriosis, we carried out microarray analysis of normal peritoneum from healthy donors and endometriosis patients as well as peritoneal endometriotic lesions. Materials and methods: The present study investigated transcriptional differences between normal human peritoneum (n = 14), corresponding peritoneal tissue from endometriosis patients (n = 11) and pelvic endometriotic lesions (n = 21) by microarray hybridization, real-time polymerase chain reaction (PCR) and immunohistochemistry.

Results: Cluster analysis of microarray data revealed two large transcriptionally related groups of genes. The first cluster contained genes overexpressed in endometriotic lesions and included glandular markers as CDH1 and members of the claudin gene family which are typically expressed in endometrium tissue. Both human peritoneum from patients without endometriosis as well as phenotypic normal peritoneal tissue from endometriosis patients displayed strongly reduced levels of those genes indicating the absence of endometrium cells. In contrast the second cluster encompasses genes showing elevated expression in peritoneum from patients without endometriosis but reduced levels in phenotypic normal peritoneal tissue from endometriosis patients as well as in endometriotic lesions. Conclusions: Microarray profiling reveals differences between normal peritoneal tissues from healthy donors and endometriosis patients which may a role in the establishment of this disease. Objective: Endometriosis is a highly prevalent gynecological disease severely affecting the patient's quality of life. To analyze the mechanisms involved in the disease and to identify new molecular targets for the development of effective therapies, small animal models are an important approach. Herein, we report for the first time the use of high-resolution ultrasound imaging for the in vivo analysis of intraperitoneal endometriotic lesions in mice. Materials and methods: Intraperitoneal endometriotic lesions (n = 32) were surgically induced in 8 C57BL/6 mice by transplanting 4 uterine tissue samples into each animal. The volume of developing lesions, their stroma and cysts were analyzed by means of a 40 MHz ultrasound probe (Vevo770, Visualsonics) directly after transplantation as well as at days 7, 14, 21 and 28. At the end of the experiments, the animals were laparotomized for volume measurement of endometriotic lesions by means of a caliper and histology. Results: The noninvasive ultrasound technology allows for the repetitive and quantitative analysis of endometriotic lesion growth (d0: 0.90 ± 0.04 mm 3 ; d28: 2.04 ± 0.34 mm 3 ; p \ 0.05), and adhesion formation with a low intra-and interobserver variability (r 2 = 0.977 and r 2 = 0.970). Moreover, it enables to easily differentiate between endometrial cysts and stroma. Accordingly, volume measurements of both endometrial cysts and stroma indicate that the initial establishment of endometriotic lesions is associated with enhanced cellular proliferation, followed by a phase of increased secretory activity of endometrial glands. Results of the ultrasound analysis correlate well with measurements of lesion volumes by caliper and histology (r 2 = 0.874 and r 2 = 0.939).

Conclusions: High-resolution ultrasound imaging represents an important tool for future preclinical small animal studies, which focus on the pathophysiology of endometriosis and the development of new treatment strategies.

PO-Gyn 01.06 Patients with endometriosis in gynecological rehabilitation present paper describes the initial status quo of patients at admission to inpatient rehabilitation and outcome parameters 2.5 years after discharge. The specific feature of the rehabilitation programme is an integrated education module especially developed for endometriosis. Materials and methods: Between 2003 and 2005 all patients with endometriosis were asked to take part in the study until attaining the number of 300 cases. They filled out questionnaires at admission and 2.5 years after discharge. The questionnaires included amongst others items concerning the severity of disease, quality of life (SF12) and the evaluation of single therapeutic modules.

Results: The response rate on admission was very good (86%, n = 258). The average age of the patients was 37.4 years. 73.2% of the patients were employed. The average time of incapacity for work was 9.8 weeks within the last 12 month. More than 50% of the patients were rated stage III and IV on endometriosis. In comparison with patients suffering from breast cancer or cardiac insufficiency patients with endometriosis rated their physical as well as their mental quality of life considerably worse. 127 patients took part at the follow-up survey (=49%). Above all their ratings on coping and pain showed substantial improvements. Within the education modules those units dealing with information and physical exercise were rated as having been especially helpful. The SF12 showed significant improvements of 4.0 points on the mental scale and 2.17 on the physical scale.

Conclusions: In-patient rehabilitation does reach a sample of highly stressed women who represent a difficult to treat group in inpatient and outpatient care. Rehabilitation can achieve sustainably positive effects, which are worth to be evaluated further in detail.

PO-Gyn 01.07 Acute bleeding by deep infiltrating endometriosis in a second trimester pregnancy: a case report and review of literature A 34 year old 2G/1P with a gestational age of 26 weeks was admitted at the labor board with acute abdominal pain. The gynecological examination showed signs of an acute abdomen with a very painful palpation. Ultrasound examination showed free fluid within the abdomen. The pregnancy showed no signs of growth retardation with a normal CTG. The pain was analgetic resistant and infection parameters were slightly elevated. The Laparotomy reviewed a normal appendix and 500 ml of blood within the abdominal cavity. The bleeding was due to papillary and nodular structures of unknown dignity on the peritoneal surface of the uterus and especially close to the recto-vaginal space. Pathological analysis showed a deep infiltrating endometriosis. Bleeding could be stopped by using an argon beamer for the distinct uterine surface bleedings and by application of a fleece, covered with human fibrinogen and human thrombin (TachoSil Ò ), for a diffuse bleeding close to the recto-vaginal space. After eleven days the patient could be discharged in a good condition and pregnancy could be further prolonged. A review of literature, concerning these rare but relevant cases, will be given.

PO-Gyn 01.08 Menorrhagia and dysmenorrhea related to adenomyosis with or without uterine leiomyomata: long-term symptom control, frequency of re-interventions and quality-of-life after uterine artery embolisation Results: Adverse events associated with dienogest were mostly mild or moderate in intensity and related to low withdrawal rates. The most commonly reported adverse-drug reactions (ADRs) were headache (9.0%), acne (5.1%), and nausea (4.2%). Incidences of hypoestrogenic ADRs were less common with dienogest than LA. Laboratory parameters-including lipid and hormone variables-and vital signs remained generally stable during dienogest treatment. Change in body weight was not different from placebo (mean ± SD 12-week change: 0.3 ± 1.3 kg and 0.4 ± 1.4 kg, respectively). The number (mean ± SD) of bleeding/spotting days during 90-day WHO reference period 1 in dienogest-treated women (25.1 ± 16.9) was similar to placebo (22.4 ± 9.6); however; the bleeding pattern was more variable with dienogest. A progressive reduction in bleeding intensity over time was observed during 90-day WHO reference periods 2-4. Conclusions: Pooled analyses from the study program confirm the favourable safety profile of dienogest in the treatment of endometriosis.

PO-Gyn 01.10 Expression of glucose transporter 1 (GLUT-1) in human endometrial tissue, peritoneal endometriotic lesions and deep infiltrating endometriosis Objective: Recent studies implicate that estrogen and progesterone play an role in the regulation of glucose metabolism by affecting the facilitative glucose transporter (GLUT) in endometrial tissue. There is some evidence that defective glucose metabolism leads to infertility due to changes in late secretory endometrium and decidualization. Like in malignancies, GLUT-1 seems to be one of the major factors in hypoxia, which might play an essential functional role in endometriosis. There are only few data concerning GLUT-1 expression in eutopic and ectopic endometrium of women with endometriosis. Materials and methods: Using immunohistochemistry (EnVision FLEX-Kit (Darko Germany)), GLUT-1 expression was examined in endometrium, in peritoneal and in deep infiltrating endometriosis (DIE). Tissues were collected from 30 women with DIE who underwent rectum resection combined with hysteroscopy and curettage. A modified Remmele-Stegener-IHC-Score (0-3) was used for data analysis. Statistical analysis Mann-Whitney-Test was performed.

Results: In eutopic endometrium GLUT-1 expression was positive in epithelium cells as well as in stroma cells. In ectopic lesions mainly epithelium cells were positive. No expression was detectable in eutopic endometrium of the proliferative phase. GLUT-1 expression was strong in the late secretory phase (p \ 0.001) in eutopic endometrium and in epithelium cells of DIE (p \ 0.01). Conclusions: We support the hypothesis that GLUT-1 is important for a sufficient glucose metabolism in eutopic endometrium. GLUT-1 is known to be a part of the hypoxia induced survival pathway. Our data suggests that there is a difference in the metabolism of stroma and epithelia cells in ectopic endometrial tissue due to hypoxia. Higher levels of steroid hormones receptors known to be common in patients with endometriosis. The cycle-dependent up-regulation of GLUT-1 in late the secretory phase is an indication for an endocrine modulation. This supports the idea that hormonal imbalance leads to endometrial dysfunction due to an altered glucose metabolism. Objective: Endometriosis is a benign but chronic disease and is often associated with pelvic pain and infertility in affected females. Endometriotic cells show increased proliferation, resistance to apoptosis, and epithelial endometriotic cells have an increased level of VEGF, an important factor in angiogenesis. We investigate the effects of Cordycepin on proliferation and survival and on the expression of VEGF in epithelial endometriotic cells. Cordycepin (3 0 -deoxyadenosine) is found in the parasitic fungus Cordyceps militaris and has biological activity including anticancer activity. Cordycepin is an inhibitor of poly(A) polymerase (PAP) and inhibits mRNA polyadenylation, leading to shortening of the poly(A)-tail of newly synthesized mRNAs, to de-stabilization of these mRNAs, and to disruption of proteins synthesis. Materials and methods: Immortalized 11z cell cultures were treated with various concentrations of Cordycepin. The effects on proliferation (MTT-assay); expression of p21, cyclins, and VEGF (immunoblotting); apoptosis activation (immunoblotting), and VEGF secretion (ELISA) were determined. Results: Cordycepin treatment inhibited the proliferation of 11z epithelial endometriotic cells, accompanied by upregulation of the cell cycle inhibitor p21 and downregulation of the cell cycle promoter cyclin D1. Cordycepin inhibited the phosphorylation of the p38 MAP kinase, leading to downregulation of this cytoprotective signaling pathway and thus contributing to inhibition of proliferation and survival. Cordycepin downregulated VEGF expression and reduced the amount of VEGF secreted into the culture medium. Cordycepin activated caspase-dependent, intrinsic apoptosis, as documented by the proteolytic cleavage of caspase-9, caspase-3, and the PARP-1 precursors into their fragments. Conclusions: Cordycepin inhibits proliferation, VEGF production and secretion, and survival of epithelial endometriotic cells and therefore negatively affects three processes crucial to endometriosis. The PAPinhibitor Cordycepin may therefore be a potential candidate to encounter endometriosis, perhaps presenting a possible alternative to currently available medical treatments against endometriosis.

PO-Gyn 01.12 Size and spatial orientation of peritoneally fixed uterine tissue samples crucially determine growth and cyst formation of surgically induced endometriotic lesions in mice Materials and methods: Intraperitoneal endometriotic lesions were surgically induced in 22 C57BL/6 mice by transplanting uterine tissue samples into each animal. By means of noninvasive high-resolution ultrasound imaging over a time period of 4 weeks, we analyzed the growth and cyst formation of the lesions in dependency of the mode of transplantation (syngeneic vs. autologous), the type of tissue, which was fixed adjacent to the peritoneum (endometrium vs. perimetrium), and the size of transplanted uterine tissue samples (2 mm vs. 3 mm).

Results: Developing endometriotic lesions exhibited an increased growth rate (d28: 342.4 ± 62.0%) with many proliferating cell nuclear antigen (PCNA)-positive cells in the endometrial glands and stroma, when the perimetrium with the underlying myometrium was sutured to the peritoneum, in comparison to controls (d28: 133.5 ± 31.8%). In the group of 3 mm uterine tissue grafts lesion growth was decreased (d28: 183.1 ± 44.4%), when compared to 2 mm samples (d28: 294.2 ± 32.5%). However, the larger grafts developed significantly more cysts throughout the observation period than the smaller ones. Interestingly, there was no difference between syngeneic and autologous endometriotic lesions.

Conclusions: Taken together, our findings contribute to increase the standardization and reliability of future studies, performed in the frequently used mouse model of surgically induced intraperitoneal endometriosis.

PO-Gyn 01.13 TVT results in women with stress urinary incontinence and intrinsic sphincter deficiency: pelvic floor ultrasound evaluation Objective: The aim of the study was to evaluate the influence of urethral mobility, tape positioning, and profilometry on outcome after TVT placement in women with stress urinary incontinence (SUI) and intrinsic sphincter deficiency (ISD). Materials and methods: In 43 women with maximal urethral closure pressure (MUCP) = \ 20 cm H2O TVT was performed with the incision starting at 1/3 of the ultrasonographically measured urethral length (1/3-rule, standard technique at our departments). In 2 patients, due to very little urethral mobility, the operation was done according to the 1/2 formula (as for TVT-O placement in our departments). Pelvic floor ultrasound was performed under standardized conditions using a 5-9 MHz vaginal probe. The parameters measured included urethral length, linear urethral dorsocaudal movement (LUDM), longitudinal urethral tape localization (LUTL), and distance between hypoechoic urethra and tape (DHUT). After 6 months the patients were divided into 2 groups: cured versus not cured. Results: 37/43 (86%) and 2/2 (100%) of patients were cured after 6 months. Our results suggest that urethral mobility and tape position affected cure results, while urethra pressure profilometry did not (MUCP between 5 and 20 cm H 2 O). In women with good urethral mobility, especially hypermobility, suboptimal tape positioning (slightly increased DHUT and/or distance from center of urethral length (DCU)) may still lead to continence. Tapes not positioned optimally in women with low urethral mobility usually do not restore continence.

Conclusions: Our results suggest that urethral mobility and tape position are the most important factors affecting outcome of TVT placement for SUI in women with ISD.

PO-Gyn 01.14 Impact of birth on levator morphology with 3D ultrasound early postpartum: a prospective observational study Table 1) . Presence of LAM defects was significantly higher in group A than in group B, with OR = 7.13 (IC95%:3-16.8) ( Table 2 ). In group A, 42 (37%) levator defects were found: 36 (36.3%) after spontaneous and 6 (50%) after operative deliveries. In group B, 6 (6.7%) levator defects were found: 2 (2.9%) after primary (2 pluriparae), 4 (18%) after secondary sections (4 nulliparae).

Conclusions: Our findings suggest that, in comparison to cesarean section, vaginal delivery modifies and damages LAM. The risk of levator trauma after vaginal delivery is more than 7 times higher than after cesarean section. Our data also show, that secondary cesarean section has no complete preventive effect on LAM trauma. Objective: After sacrocolpopexy, de novo bowel, urinary and sexual dysfunctions are described. These dysfunctions could be caused by injury of the autonomous nerves of the presacral space. The aim of our study is to describe the course of the autonomous nerves of the presacral space and to find the best nerve preserving approach for sacropexy. Materials and methods: The autonomous nerves of the presacral space are dissected on six specially preserved female cadavers. Our analysis of the autonomic innervation focused on the following parameters: the exposition of the superior hypogastric plexus with the right and left hypogastric nerves; the dissection of the right sympathetic trunk, paying particular attention to the sacral splanchnic nerves; and the exposition of the ventral rami of the sacral spinal nerves S1-S4 with identification of the origin of the pelvic splanchnic nerves. Results: The superior hypogastric plexus is located in front of the abdominal aorta and its bifurcation and deviates to the left of the midsagittal plane. At the level of the promontory, or just below, the superior hypogastric plexus branches into two hypogastric nerves that run in front of the sacrum. In the presacral space the parasympathetic pelvic splanchnic nerves from the ventral rami of the sacral spinal nerves (S2-S3) join the hypogastric nerves, forming the inferior hypogastric plexus on both sides. From the inferior hypogastric plexus, nerve fibres spread out bilaterally to the pelvic organs. In 2 of 6 cadavers sacral splanchnic nerves could be identified leading from the sacral sympathetic ganglion S1 of the sympathetic trunk to the inferior hypogastric plexus. The anterior longitudinal ligament above the promontory is a safe area for sacopexy. Thus awareness of the autonomous nerves in the presacral space may significantly improve functional outcomes of sacrocolpopexy.

PO-Gyn 01.16 Uterine artery embolization as a treatment option for symptomatic adenomyosis presence of heterotopic endometrial glands and stroma in the myometrium with adjacent myometrial hyperplasia. Epithelial and stromal elements are situated at least 2.5 mm below the endometrial-myometrial junction. Adenomyosis appears in two forms: diffuse (adenomyosis) or focal (adenomyoma) and coexisting myomas are common. This study was performed to evaluate the MR imaging appearance and clinical response of patients undergoing uterine artery embolization for the treatment of adenomyosis. Materials and methods: A retrospective analysis of 15 premenopausal women with adenomyosis, who underwent uterine artery embolization was performed. The diagnosis of adenomyosis was based on established MR imaging criteria. Follow-up MR imaging was performed and at the same time clinical response was assessed at 1, 3, 6, 12 months after embolization. Objective: Our objective was to investigate the effect of uterine myoma (fibroid) on the morphological structure of the uterine tube. Materials and methods: A retrospective, comparative study has been carried out on 100 uterine tubes of 50 women at reproductive age, with using histological, immunohistochemical and morphometrical methods. The data were obtained on peculiarities of the structure of different part, thickness of the layers, changes of the arterial and venous blood vessels supply, nervous tissues and microarchitecture of the uterine tube wall in various phases of menstrual cycle in uterus myoma group. The data was compared with histological and morphometrical data from 60 cases from control group without genital tract pathology. The data was analysed statistically. Results: In the preliminary analysis of the 50 cases (100 Failopian tubes) with uterine myoma, we found morphological abnormalities Fallopian tubes, which were classified, as mild, moderate and severe. We found evidence of severe morphological abnormalities in 50

Fallopian tubes (50%). In 48 Fallopian tubes (48%) we observed moderate abnormalities, and in 2 Fallopian tubes (2%)-mild grade of abnormalities.

Conclusions: We conclude, that evidence based changes in morphological structures of the uterine tube in uterus myoma group could play a significant role as a morphological substrate for clinical data associated with significantly lower outcome of assisted reproductive technology. Our findings have implication on the use of diagnostic and therapeutic strategies in women with uterus myoma who seek fertility assessment and treatment.

PO-Gyn 01.20 Long-term results of UAE for symptomatic leiomyomata Objective: Intravenous leiomyomatosis (IVL) is a rare benign disease characterized by nodular masses of histologically benign looking smooth muscle cells growing within the uterine or extrauterine venous system. IVL imitates a malignant neoplasm concerning the pattern of growth and extension. Unusual growth patterns and recurrent forms may be seen as shown in this case report. Materials and methods: We report the case of a 42-year-old woman who was referred to our hospital for a big abdominopelvic tumor. Last history revealed abdominal pain and dyspnoea. An excretory urogram showed an urinary stasis on the right side. A magnetic resonance imaging of the pelvis demonstrated the presence of a tumor of the uterus with bladder impression, measuring 12 cm. Physical examination revealed a mobile uterus with a non-fixed tender mass in the pelvis, transvaginal ultrasound the presence of a myomatous uterus. Cystography was negative despite the impression of the bladder. Laboratory findings were normal. In an explorative laparotomy the abdominal tumor was resected and a total hysterectomy without adnexectomy was performed. Histological examination indicated intravenous leiomyomatosis of the uterus. The patient was followed up in our hospital every four months. Three years later the woman presented with a new tumorous mass at the right ovary. Gynaecological ultrasound was suspicious for sactosalpinx. Diagnostic laparoscopy was first performed followed by laparotomy. On surgical exploration an intraligamental myoma was found on the right pelvic side and successfully resected. Histological examination confirmed the intraoperative diagnosis of an intraligamental leiomyoma. Conclusions: IVL is an uncommon neoplasm of the uterus that usually follows a benign course. Nevertheless, metastatic potential seems to play a role in intravenous leiomyomatosis and its recurrence. PO-Gyn 01.25 Angiogenesis and lymphangiogenesis in ectopic human endometrial lesions in mouse models of endometriosis Objective: Endometriosis, characterized by the presence of ectopic endometrium outside the uterine cavity mainly causing dysmenorrhoea, abdominal pain and subfertility, affects 10-20% of women of reproductive phase. Current therapeutical treatment, however, is still insufficient since it is associated with high recurrence rate and unwanted side effects. To develop novel therapeutical approaches, the cell biological mechanisms underlying this disease have to be evaluated. We here focussed on angiogenesis in endometriotic lesions as well as on lymphangiogenesis, the role of which in the pathogenesis of endometriosis is still not understood, in two different immunodeficient mouse strains after transplantation in different ectopic locations. Materials and methods: Human premenopausal endometrium was implanted subcutaneously (s.c.) as well as intraperitoneally (i.p.) into immunodeficient nude mice and Rag1-/-mice and cultured for up to 12 weeks. While nude mice lack functional T-lymphocytes, Rag1-/mice in addition lack functional B-lymphocytes. After 4, 8 and 12 weeks, blood vessel endothelia were evaluated by immunohistochemical staining with anti-CD31, mature pericytes stabilizing the vessels with anti-alpha smooth muscle actin (a-SMA), and lymphatic vessels with anti-LYVE-1.

Results: Implanted ectopic lesions showed a well preserved morphology up to 12 weeks of culturing independent of mouse strain used or localization (s.c. or i.p.). Blood and lymphatic vessels grown into the ectopic lesions were observed after subcutaneous as well as intraperitoneal transplantation. Amount of blood and lymphatic vessels as well as depth of invasion into the human tissue increased with time of culturing. In parallel, all specimens investigated showed blood vessels stabilized by pericytes. Microvessel density of stabilized blood vessel as well as ingrown lymph vessels revealed to be slightly enhanced in intraperitoneal compared to subcutaneously implanted lesions. Conclusions: Human endometrial tissue is well preserved after subcutaneous as well as intraperitoneal transplantation in both immunodeficient mouse strains and is invaded by lymphatic as well as by blood vessels which in part are stabilized by pericytes. Trial is an open-label, multicenter randomized controlled, Phase III study for early, HER2/ neu-positive breast cancer patients. The study will compare the disease free survival after randomisation in patients treated with 3 cycles of Epirubicin-Fluorouracil-Cyclophosphamide-chemotherapy (FEC) 500/100/500, followed by 3 cycles of Docetaxel (D) 100 q3w versus 3 cycles FEC 500/100/500, followed by 3 cycles of Docetaxel 75 (D) q3w and Gemcitabine (G) 1000 d1,8 q3w, in both arms followed by anti-HER2 treatment. All women will be required to have HER2/neupositive disease and histopathological proof of axillary lymph node metastases (pN1-3) or high risk node negative disease, defined as: pT2 or histopathological grade 3, or age \35 or negative hormone receptor. Evidence of distant disease is an exclusion criterium. After R0 resection of the primary tumor, patients will be randomized to one of the treatment arms. Furthermore, a translational research program will focus on the role of CTCs as valuable marker of treatment failure and early disease progression. At three predefined time points peripheral blood will be drawn.

Results: A total number of 799 patients is planned to be recruited, start was in June 2008. Results of the toxicity analysis and the translational research program will be available at the end of treatment (*June 2011 PO-Onko 01.11 HistoCore Ò : a new single-use core cut breast biopsy system following innovations: complete handle with one hand, alternatively full resp. halfautomatical biopsy, minimizing of the haematoma by a shortened needle peak and in the first time the additional possibility of the locking and resetting of the coaxial needle.

Results: In 24 of the 25 lesions (accordant 96%) the malignancy was confirmed, at 1 lesion (accordant 4%) there was the histological result B3 and the histology of the following operation was benign, a papilloma.

The new single-use breast biopsy system (HistoCore Ò ) is a technical innovative, perfected and applicable diagnostic method especially with the possibility of the locking and resetting of the coaxial needle under aseptic conditions, because a sterilisation is not necessary (one-time disposable product). Under these considerations as well as the analysis of the costs/reimbursement this product is a real competition to the established high speed core cut breast biopsy systems.

PO-Onko 01.12 Facial paralysis by contralateral metastasis in parotid gland in advanced breast cancer: case report Objective: Breast cancer is the most common malignancy of women and nearly responsible for 27% of all female malignant diseases in general. Despite improved screening methods at time of diagnosis 6 to 10% of women have a primary metastatic breast cancer. The way of metastasis of breast cancer may be hematogenous and lymphatic. The most common ways include regional metastasis, axillary lymph nodes and distant metastasis in lung, liver or bone. Metastasis of breast carcinoma in the parotid gland are very rare. So far in literature only few cases have been reported. Materials and methods: Described in this case report is a 74-year-old woman with an invasive lobular carcinoma of the left breast, which represents 3 years after initial diagnosis a nodular change in the cicatrice of the mastectomy. The patient also had a contralateral peripheral facial paralysis, caused by a distant metastasis in the right parotid gland. Conclusions: Patients with breast cancer and a new onset swelling of the parotid gland, or an acute peripheral facial paralysis may have a differential diagnosis of metastasis of breast cancer. If there is a histologically classified adenocarcinoma of the parotid gland it should be thought of a potential metastasis of breast cancer. If necessary a breast diagnosis should be encouraged to search for primary malignancy. In this situation, according to the personal disease progress, a palliative surgical repair is performed, followed by irradiation to achieve local control.

PO-Onko 01.13 Importance of the matrix metalloprotease 1G/2G promoter polymorphism for breast cancer incidence Interim data for correlation of centralized pathology (HR, proliferation) and RS will be presented.

The PlanB trial will for the first time allow for a prospective comparison of centralized pathology and invasion markers with a modern multigene signature as part of a randomized multicenter clinical trial. Objective: This study proves the feasibility of using innovative freehand SPECT (fhSPECT, CSS300 SurgicEye GmbH) for axillary lymphatic mapping in breast cancer patients and defines the border conditions for large scale comparison studies. Materials and methods: To date, 14 patients undergoing sentinel lymph node (SLN) biopsy were recruited and scanned intraoperatively using fhSPECT before excision of SLNs. The localization of SLNs with fhSPECT was compared to the position of SLNs detected using gamma probe and blue dye. Results: Preoperatively, 22 primary and 4 secondary SLNs were mapped with conventional scintigraphy. In the pre-excision scan (performed in 13 of 14 patients) fhSPECT managed to map all but 2 SLNs in the identical position as compared to node location at planar scintigrams (23/25). Gamma probe failed to detect any SLN in 2 patients and mapped in total 17 of 26 nodes. 18 SLNs were resected and confirmed to be radioactive. FhSPECT detected 8 remaining lymph nodes in 8 patients after removal of the SLN. In 3 cases additionally detected nodes were resected and confirmed to be radioactive, while in 5 cases no additional lymph nodes were removed as radioactive uptake was low. Pre-excision fhSPECT acquisitions took approx. 3.3 min (SD, 1.3 min) while post-excision scans took 3.2 min (SD, 1.0 min). The surgical procedure was extended by 12 min (6 min before incision and 6 min after excision of SLNs).

Conclusions: Preliminary experience indicates that intraoperative imaging with fhSPECT for lymphatic mapping in breast cancer patients is feasible. Alteration of the surgical workflow can be considered minimal given potential clinical advantages like intraoperative 3D realtime imaging, documentation of complete resection and minimized invasivity. Due to the promising results fhSPECT will be further evaluated in ongoing studies. This research was partly funded by the DFG's SFB-824 and SurgicEye GmbH. Objective: Gene expression profiling has recently been used to identify a group of high proliferating estrogen receptor positive breast cancers (the luminal B subtype), which are associated with a prognosis that is even worse than that of high proliferating estrogen receptor negative tumors. The analysis of those tumors might provide valuable information about breast cancer biology and could be helpful for adjuvant or neoadjuvant treatment decisions. Materials and methods: To gain insight into genes which play a role in estrogen receptor signalling we analyzed microarray data from breast cancer specimens. Genes were identified showing strong expression in high proliferating ER-positive tumors but no expression in either Ki67-/ER+ or Ki67+/ER-samples. Among these genes the Na + /H + exchanger regulatory factor NHERF1 was found. We assessed the clinical relevance using a total of 2469 breast cancers.

Results: Our analysis indicates that enhanced NHERF1 expression is associated with metastatic progression and poor prognosis of breast cancer patients. We found no correlation between NHERF1 and the nodal status as well as age, but positive correlations for tumor size (P \ 0.001), grade (P \ 0.001) and erbb2 (P = 0.033). Weak NHERF1 expression correlated with longer disease free survival (DFS) in grade 1 and 2 tumors, but not in grade 3 breast cancers. Since NHERF1 expression is strongly linked to the presence of ER, the predictive value for endocrine treatment was analyzed. For samples with weak or none NHERF1 expression a treatment benefit was observed (P = 0.007). While untreated patients display a 10 yr DFS rate of 67.2 ± 3.8%, endocrine treatment resulted in 80.1 ± 4.0%. In contrast no differences in disease free survival were found for corresponding NHERF1 expressing breast cancers. Heinrich Heine University, Gynecology &Obstetrics, Düsseldorf, Germany

Objective: Neuroendocrine tumors of the breast are rare malignancy in general, their prevalence is about 0.1% of all breast cancer and less than 1% of all neuroendocrine tumors. They arise most commonly in the bronchopulmonary system and gastrointestinal tract. We present a case of bilateral breast cancer with two different histological types which already showed pulmonary metastases likely of the neuroendocrine cancer and discuss the clinical management.

A 65 year-old women presented with an ulcerated right breast mass with pain and enlarged breast.

Arch Gynecol Obstet (2010) 282 (Suppl 1):S63-S270

Mammography revealed also a malignancy in the left breast. A bilateral biopsy was performed and a neuroendocrine carcinoma was diagnosed on the left side, and an invasive ductal carcinoma in the right breast. She received a bilateral mastectomy with axillary lymphnode dissection by tumor size of 9 cm each side. In the CT-scan were detected multiple pulmonary metastases which could be verified in an octreotide scan (PET-scan) most likely for neuroendocrine metastases.

Results: A bilateral breast cancer (left bifocal, solid, neuroendocrine carcinoma, and right bifocal, solid invasive ductal carcinoma) with predominantly neuroendocrine lung metastases has been diagnosed. Because of the two cancer types we started a therapy with somatostatin-analogs (lanreotid) which has been claimed as a useful therapy for metastatic neuroendocrine tumors and a standard palliative chemotherapy (taxan with bevacizumab) for metastatic breast cancer. After 3 cycles a restaging has to be performed and further management as 90 Yttrium-Dotatoc (somatostatin analogue) has to be discussed.

The neuroendocrine carcinoma of the breast is very rare. There is no standard treatment protocol and a large variety of chemotherapy protocols have been employed in treating this disease. Systematic therapy principles are based on poor data base and are extrapolated from studies of non breast neuroendocrine carcinomas. Results: Circulating Tregs were significantly reduced by 50% within the first 14 days of therapy. In the further observational period, however, Treg numbers recovered completely. Nevertheless, we detected a significant increase in tumor-specific memory TCs, which were maintained at high levels throughout the entire study. We observed disease stabilization (SD) in almost 60% of the patients after 3 months of treatment. In patients with SD a significant increase in tumor-reactive TCs was found as compared to pretreatment levels. In a follow-up analysis, we observed a significant correlation between the overall survival of patients and the frequencies of tumor-reactive TCs after cyclophosphamide treatment. Objective: Recent findings present the tumor microenvironment as an innovative therapeutic target in cancer therapy. Fibroblasts have been identified to play an important role in breast cancer progression. Our aim was to analyze the effect of normal mammary fibroblasts on gene expression in human breast epithelial cells and it's correlation to clinical data. Materials and methods: Nonmalignant HMT3522 S1 human breast epithelial cells were cultured in 3D-collagen-gels as mono-or coculture with normal human mammary fibroblasts. Gene expression profiles of S1-cells from 3D-culture were analyzed using the Affymetrix HG-U133 Plus 2.0 GeneChip. Signal values were calculated by means of RMA using R Bioconductor 2.4, then log2 transformed. Transcripts with a log ratio C±1.5 were defined as differentially expressed. Using published microarray profiles of 295 human breast tumors with associated clinical data hierarchical cluster and Kaplan Meier analysis were performed to stratify the patients according to the generated gene expression profiles.

Results: S1-cells in coculture differentiated into polarized acinus like structures and underwent growth arrest after 10 day of culture, whereas S1-cells in monoculture showed unorganized and progressive growth. 99 transcripts were upregulated in S1-cells from co-compared to monoculture. Functions of these genes mainly relate to extracellular matrix constitution and differentiation. 36 transcripts were upregulated in S1-cells from monoculture, predominantly involved in cell cycle regulation. Hierarchical cluster analysis stratified the patients into poor and good prognosis groups. Kaplan Meier analysis showed that 21 selected genes were highly informative in identifying patients with poor or good outcome (p \ 0.01).

Conclusions: Gene expression changes in human breast epithelial cells induced by normal mammary fibroblasts provide gene expression profiles that clearly stratify patients into prognostic groups. Our 3D-culture-model proves to be a valuable in vitro model for research and emphasizes the relevance of the tumor microenvironment as target for breast cancer therapy.

PO-Onko 01.22 Impact of BRCA1 on expression of microtubulusassociated proteins in-vitro and in-situ Objective: The tumor microenvironment plays a major role in tumor control and progression. Manipulation of the tumormicroenvironment can induce the reversion of the malignant tumor cell phenotype. Thus little is known about the underlying mechanisms. The aim of this study was to elucidate the reversion process and to identify the molecular signature of revertable and non-revertable tumors. Materials and methods: Primary breast cancer cells (PBC) were isolated from fresh surgical specimen from 13 patients with primary invasive breast cancer and cultured in 3D collagen gels as either mono-or coculture with normal human mammary fibroblasts (HMF). After 10 days of culture collagen gels were fixed and cell growth and morphology was evaluated by immunoflourescence. Gene expression profiles of 5 revertable and 5 non-revertable tumors were analyzed using the Affy-metrix HG-U133 Plus 2.0 GeneChip. qRT-PCR was performed to validate the array results.

Results: In 5 out of 13 cultures PBCs in HMF-cocultures differentiated into polarized acinus like structures, whereas PBCs in 3D monocultures showed unorganized and progressive growth. Reversion was characterized by the expression of golgi apparatus at the apical cell pole or by basally localized b1and 4-intergrin, indicating the formation of a basalmembran surrounding the acinus. Gene expression analysis revealed 42 upregulated transcripts in the revertable tumors, mainly related to cell adhesion, signal transduction and transcription. 49 transcripts with known functions in e.g. mRNA splicing and cellular transport were downregulated. qRT-PCR analysis of 7 genes validated the array results. Conclusions: Our results prove that normal fibroblast can induce reversion of the malignant phenotype of PBCs in co-culture. This significant role of fibroblasts in controlling cancer progression reveals them as a viable target for new breast cancer therapies.

Knockdown of icb-1 gene affects both lactoferrin and E-cadherin expression and the differentiating effect of all-trans retinoic acid and vitamin D3 on MCF-7 breast cancer cells further approach the function of icb-1 in differentiation of breast and endometrial cancer cells, we now examined the effects of an icb-1 gene knockdown on expression of differentiation markers E-cadherin and lactoferrin and on the differentiating effect of all-trans retinoic acid (ATRA) and vitamin D3. MCF-7 breast cancer and HEC1B endometrial cancer cells were stably transfected with an icb-1 shRNA plasmid followed by G418 selection. Knockdown of icb-1 gene was confirmed by real time RT-PCR. Expression of differentiation markers also was analyzed by qPCR. Knockdown of icb-1 inhibited upregulation of Ecadherin triggered by ATRA treatment both in MCF-7 and in HEC-1B cells. Upregulation of E-cadherin induced by vitamin D3 or insulin/ IGF1 was also blocked in MCF-7 (icb-1 knockdown) cells. Furthermore, knockdown of icb-1 gene inhibited upregulation of lactoferrin gene in MCF-7 cells treated with ATRA, vitamin D3 or insulin/IGF1. Our data support our hypothesis that icb-1 is involved in differentiation processes of breast and endometrial cancer cells. Icb-1 is suggested to be a mediator of differentiation signals to breast cancer cells triggered by ATRA, vitamin D3 and insulin/IGF1.

Evaluation of microRNA expression profiles of formalin-fixed paraffin-embedded breast cancer specimens to predict locoregional recurrence after mastectomy Objective: To date the risk assessment for locoregional recurrence after mastectomy is still based on conventional measures of tumor size and nodal status. To tailor the indication for Postmastectomy Radiotherapy (PMRT), prognostic markers that correlate with relapse of locoregional breast cancer have to be defined. MicroRNAs (miR-NA) are 20-25nt non-coding RNAs that have been extensively implicated in several human cancer, including breast cancer due to modulation of post-transcriptional gene expression. Materials and methods: MiRNA was extracted (Qiagen) from formalin-fixed and paraffin-embedded archived breast cancer tissue for ten cases with recurrence and ten cases without recurrence (matched pairs regarding age, histology, hormonal receptor status). Global miRNA expression profile was performed on all samples using Taq-Man microarrays (Applied Biosystems) containing 752 human miRNAs (representing 85% of human miRNAs in the miRBase 15.0 database). Results: Unsupervised hierarchical clustering of the two case groups based on miRNA expression profiles detected eight miRNAs that were differentially expressed (p-value \ 0,1), including miR-34c (underexpressed) and miR-450b (overexpressed). MiR-34c had previously been shown to be a critical regulator of targets involved in cell cycle control, apoptosis and DNA repair. Conclusions: Our findings are under way to identify cases with high risk of recurrence to administer individualized therapy. To confirm the pattern of differential expression shown by microarray analysis, quantitative RT-PCR of this eight selected miRNAs has to be performed on further matched pair cases (a total of 68 cases). These results will be presented at the DGGG conference. Objective: Breast cancer is the most common cancer in women and the Wnt signaling pathway is activated in 50% of the cases. Wnt-1, in particular, is known to regulate the progression of cancer as it promotes cell proliferation and prolongs cell survival. In this study, we investigated the effects of mifepristone (RU-486) on the expression of the proto-oncogene Wnt-1 and its effects on proliferation and apoptosis of breast cancer cells. PO-Onko 01.29 Distribution of G-protein-coupled estrogen receptor GPR30 in primary breast cancer and its prognostic significance

The immunostaining pattern of GPR30 was correlated to various clinicopathological variables and patient outcome including relapsefree survival (RFS) and 5-year overall survival (OS) . The association of all tested factors with the risk of recurrence under anti-hormonal therapy was studied by logistic regression analysis, and survival by Cox uni-and multivariate regression method. Results: GPR30 expression was detected in 56.1% of the breast cancer specimens investigated and positively correlated to overexpression of HER2 (P = 0.008) and development of metastasis (P = 0.047). In a trend analysis, a correlation of GPR30 expression with shorter RFS was observed (HR = 3.97; 95% CI, 1.319-5.709; P = 0.011). Survival analysis also showed that GPR30 was negatively correlated to RFS, but not to OS. In a subset of patients treated with tamoxifen, as opposed to aromatase inhibitors, GPR30 positivity was associated with a significantly decreased RFS (HR = 2.666; 95% CI, 1.335-5.324; P = 0.005). Moreover, this association remained significant in multivariate analysis.

Conclusions: This is the first study showing that the expression of the new estrogen receptor GPR30 in breast cancer cells independently predicts a short RFS in patients treated with tamoxifen. GPR30 expression correlates significantly to HER2 overexpression. These data are consistent with our recent results obtained in vitro.

PO-Onko 01.30 Is the expression of Rad51 an independent prognostic marker of recurrence free survival breast cancer patients? Objective: High-level expression of Rad51, a key factor in homologous recombination, has been observed in a variety of human malignancies. This study was aimed to evaluate Rad51 expression to serve as prognostic marker for the disease free survival in invasive breast cancer. Materials and methods: A total of 143 invasive breast cancer tumours which had been diagnosed between 1992 and 1998 were analysed immunohistochemically. The expression of rad 51 and Ki67 was determined, the conventional parameters were re-evaluated. The median age of the patients was 63 years (range 32-91 years). The median follow up was 62 month (range 4-120 month). 41% of the patients suffered a distant metastasis, 28% a local recurrence. Results: Patients whose tumours displayed high-level Rad51 expression showed a significantly shorter median recurrence free survival (p = 0.033, log-rank test) as well as a distant free survival (p = 0.024, log-rank test). Similarly Ki-67 appeared as an independent prognostic parameter related to recurrence free survival and overall survival (p = 0.0001, log rank test). T status, N status, M status, clinical stage and histological tumour grade were significant prognostic markers in univariate Cox survival analysis as well.

Conclusions: Our results suggest that Rad51 expression provides additional prognostic information for surgically treated breast cancer patients. We hypothesise that the decreased survival of breast cancer patients with high-level expression of Rad51 is related to an enhanced propensity of tumour cells for survival, antiapoptosis and chemo-/ radioresistance. Results: Within the tumor microenvironment, the cancer cells are the major source of CXCL9, thus making them the appropriate cell type to study CXCL9 regulation. PGE 2 significantly reduces IFN-c mediated CXCL9 release from MCF-7 and MDA-MB 231 cells, and inhibition of endogenous cyclooxygenases by indomethacin or aspirin correspondingly augments this secretion. However, the COX-2 specific antagonist celecoxib has PGE 2 -agonistic effects and impairs CXCL9 release, probably via COX independent mechanisms. Conclusions: Suppressing endogenous PGE 2 by cyclooxygenase inhibition increases CXCL9 release from breast cancer cells and is therefore a pharmacologic candidate to enhance intratumoral immune infiltration. However, due to COX independent mechanisms the choice of the appropriate COX inhibitor seems to be crucial. The predictive value of CXCL9 as a novel biomarker and its correlation with COX overexpression in human breast cancer is discussed.

PO-Onko 01.32 Automated breast ultrasound in breast diagnostics: first experience of an unicentral pilot study Materials and methods: Prospective analysis of an unselected group of patients from 9/2009 to 2/2010 at the University Hospital Homburg/ Saar, Department of Gynaecology. All Patients received a conventional breast ultrasound and mammography. Additionally all patients were examined by an automated breast ultrasound system (Somo-Vu). Classification of these findings were made according to BIRADS criteria and afterwards compared to the findings collected by conventional methods (handheld breast ultrasound and mammography).

Results: A total of n = 110 patients received an automated ultrasound breast scan plus a handheld breast ultrasound and mammography. Findings (BIRADS I-V) in conventional investigation methods could be reproduced by automated breast scan in 82% of all cases. A discrepancy of BIRADS-classification could be shown in 33% of the investigations. Additional findings could be detected by automated breast scan in 18 patients ( Objective: Two stereotactically guided vacuum-assisted breast biopsy systems were compared measuring time-effectiveness and quality of harvested material. Materials and methods: 146 patients with suspicious microcalcifications on mammography were included in the study. Biopsies were carried out with either the Mammotome Ò Breast Biopsy System from Ethicon Endo-Surgery (11/8G) or the Suros Surgical's ATEC Ò Sapphire-system (12/9G). Lesions with a diameter smaller than 15 mm on mammography were biopsied with 11G (n = 37)/12G (n = 38) devices whereas lesions larger than 15 mm were targeted with 8G (n = 34)/9G (n = 37). Time-effectiveness was evaluated. Histological quality was judged by a pathologist in a blinded fashion according to a specimen grading classification. Results: Median overall-time for the Ethicon-system was 879 s (11G) and 934 s (8G), for the Suros-system 671 s (12G) and 673 s (9G). The Suros-system displays a significantly shorter overall-time for small and large biopsy devices (U-test, p \ 0.001). Time-savings were 268 s for 12G-and 245 s 9G-Suros-system. Comparing the histologic quality the Ethicon-system shows significantly higher values for the large and the small system (Chi-square test, p \ 0. 001).

Conclusions: Both biopsy systems meet all requirements for daily practice. The Suros-system was significantly faster, the Ethicon system provided a significantly better histological quality. Objective: Leiomyomas of the uterus are the main reason for hysterectomies. The potential mechanism of malignant transformation from leiomyomas to leiomyosarcomas is still debated. The aim of this study was the evaluation of Mucin-1 (VU-4-H5), Galectin-1 and Galectin-3 in human myometrium and leiomyomas and its comparison to leiomyosarcomas in order to elucidate a potential pathway for malignant transformation of leiomyomas. Materials and methods: Tissues from human myometrium, leiomyomas and leiomyosarcomas were obtained from 160 patients. 44 women received a laparoscopic myomectomy, 35 women received surgical intervention because of leiomyosarcomas. Samples from myomas, myometrium and leiomyosarcoma were analyzed regarding expression of MUC-1, Gal-1 and Gal-3 by immunohistochemical staining of paraffin-embedded material. Analysis was by the Kruskal-Wallis-test and Mann-Whitney test. Results: We found a significant up-regulated expression of MUC1 (VU4-H5) in leiomyomas (p = 0.007) and leiomyosarcomas (p = 0.039) as compared to myometrium. In contrast there were no significant differences in expression of Gal-3 in tissues from myometrium, myomas and leiomyosarcomas. Concerning Gal-1 expression, differences were not significant comparing myometrium and leiomyosarcomas (p = 0.277). Only myomas had elevated levels of Gal-1 compared to myometrium (p = 0.007) and leiomyosarcoma (p \ 0.0001).

Conclusions: MUC1 and Gal-1 might be useful in the future to evaluate the potential of leiomyomas to transform into leiomyosarcomas and, therefore, help in risk adapted consultation and adjusted treatment. Inhibition of MUC1 and Gal-1 might be an encouraging target in therapeutic developments.

Overexpression of HLA-G in tumor-associated macrophages in ovarian cancer: implications for tumor immune escape specimens from ovarian cancer or in malignant ascites and is known to inhibit NK cell function. In ovarian cancer, immune tolerance inversely correlates with prognosis. Accordingly, the objective of the current study was to analyze the expression and induction of HLA-G as well as its role in tumour immune escape in ovarian cancer. Materials and methods: Membranous HLA-G was evaluated by flow cytometry, immunohistochemistry and double immunofluorescent staining. mRNA expression levels of HLA-G were measured by real time PCR. Soluble HLA-G and IL-6 in malignant and benign effusions were determined by ELISA. NK cell function was measured by a luciferase-based cytotoxicity assay. Macrophages used in cytotoxicity assays were stimulated by IL-6 and membranous HLA-G was blocked by specific antibodies.

Results: Flow cytometric analysis of ovarian cancer cells and immunohistochemistry of tumour sections showed only minimal expression of HLA-G in malignant cells. Immunohistochemical and double immunofluorescence staining revealed that HLA-G is mostly expressed in tumour-associated macrophages (TAM, CD68+ cells).

Macrophages stimulated with malignant ascites show higher HLA-G mRNA levels. Soluble HLA-G and IL-6 were increased in ascites of ovarian cancer patients compared to benign effusions as demonstrated by ELISA. IL-6 increased membranous HLA-G expression in macrophages. Cytotoxicity studies showed that IL-6 treated macrophages inhibit tumour cell lysis by NK cells, which could be reversed by HLA-G-specific antibodies.

Conclusions: Our observations demonstrate that HLA-G is not a marker of malignant cells but expressed in tumour-associated macrophages. IL-6 may contribute to elevated HLA-G expression in macrophages. Macrophage-bound HLA-G inhibits NK cell function. Thus, expression of HLA-G may be a new immunosuppressive effector mechanism of tumour-associated macrophages. We present the case of a 45-year-old female with a body weight of 210 kg who was referred to our institution because of a suspected ovarian mass, progressive abdominal distension and massive ascites. CA125 was elevated at 967 kU/L. Preoperatively the patient was treated symptomatically with repeated paracentesis over 16 days draining 32 L of serous, exsudative fluid with Psammom bodies but no malignant cells. An explorative laparotomy was performed with hysterectomy, bilateral salpingoophorectomy, omentectomy, appendectomy and peritoneal biopsies. Intraoperatively additional 24 L of ascites were drained. Histology revealed adenofibroma of both ovaries with transition to borderline ovarian tumors (BOT). Implants of the omentum were confirmed to be non-invasive by reference pathology. Postoperatively the clinical course was unremarkable with a significant CA125 decrease, no more relevant ascites and a postoperative body weight of 146 kg. Based on the clinical and pathological findings this patient suffered from a Pseudo-Meigs' syndrome presenting with a FIGO stage IIIb BOT and non-invasive implants associated with the largest amount of ascites ever reported for BOT. Objective: The so-called Schloffer tumor is a very rare inflammatory pseudotumor of the abdominal wall, which normally occurs many years after abdominal surgery or trauma. Materials and methods: We report the case of a 70-year-old woman, who was referred to our hospital with histologically proven endometrial cancer. Almost 30 years ago the patient has had a unilateral oophorectomy by laparotomy. On CT-scan a bone-like structure was described as an additional finding. During abdominal hysterectomy a rigidification of the abdominal wall was found and a bone-like tumor removed from the abdominal wall. In the following x-ray of the tumor, typical trabecular structures of bone were described. Also histological preparation revealed a bone-like tissue and was described as a Schloffer tumor. Objective: Squamous cell carcinoma of the vulva with angiosarcomatoid components are rare malignant tumors of the female genital tract. Materials and methods: A 64-years-old woman who initially presented a squamous cell carcinoma of the vulva (FIGO II, pT2, pN2, G2, R0) underwent a radical vulvectomy with bilateral inguinalfemoral lymphadenectomy followed by adjuvant chemo-radiation in December 2007. Nine months later she presented a lesion in the left inguinal region. Histopathology showed a recurrence of vulvar cancer. We did a radical excision of the lesion and reconstruction with a myocutaneous flap. Five weeks later two small tumours appeared in the scar of myocutaneous flap. The histopathology showed a squamous cell carcinoma with angiosarcomatoid components, a review of the primary tumour-tissue also presented angiosarcomatoid aspects. Because of sudden recurrence of a now high malignant (G3-4) tumour entity we decided a systemic therapy with Caelyx (pegylated liposomal Doxorubicin, 20 mg/m 2 ) and Bevacizumab (10 mg/m 2 ) repeated every 2 weeks. Results: After 10 cycles of systemic chemo-and antibody therapy clinical examination showed a partial of one and a complete response of the other lesion in the left inguinal region. Residua were local excised and the histological examination underlined the CR/PR. After systemic treatment and final operation we can report an 11-months recurrence-free follow up. Objective: Breast angiosarcoma may occur de novo, or as a complication of radiation therapy for mammary carcinoma. Radiationinduced angiosarcoma of the breast is being reported with increasing frequency as a result of the increased use of radiation therapy in conjunction with breast conservation surgery Materials and methods: A case of coetaneous angiosarcoma of the breast that arose in irradiated skin tissue in a 71 year-old woman who had previously undergone treatment for breast carcinoma is reported. Initial diagnosis was reported as bilateral breast cancer (9 year ago) and the patient underwent breast conserving operation (BCO) and radiation of the breasts. Clinical examination shows multifocal blue areas (2-3 cm) in left breast. The diagnosis of angiosarcoma was made by skin biopsy performed by the patient's gynaecologist on routine followup examination. Ultrasound-and mammography examination shows regularly breast parenchyma. The patient was treated with mastectomy.

Conclusions: With the increasing use of breast conservation therapy for breast cancer, reports of postradiation angiosarcoma have increased. Angiosarcomas may present with bruiselike skin discoloration, which may delay the diagnosis. Multifocal blue areas may be suspect for angiosarcoma. Imaging findings are nonspecific. For the histological diagnosis of angiosarcoma a skin biopsy should be performed. Surgical resection with mastectomy is the usual treatment for postradiation angiosarcoma.

The decision to perform a sentinel lymph node biopsy is a prognostic factor Results: In a follow up time of 14 to 65 months and a median of 34.6 months a very low rate of relapse was found. Besides 4 events of intra mammary recrudescence, 5 peripheral metastases (1%) were documented. Analysing the biology of the tumors, there was a significant higher rate of estrogen-and progesterone positive cancers than in the normal distribution. In contrast, there was a significant rare frequency of positive HER2neu oncogene amplification found. Only a few cancers with a high proliferation index were documented as well.

Conclusions: By deciding to perform an SNB, a selection is made which is apparently associated with a high chance of histological free sentinel lymph nodes and as we can show here also an advantageous biology of the cancer and therefore a more favorable prognosis. This explains the low rate of metastases in our patient population.

PO-Onko 01.48 Concept of study: vinorelbine and tyverb in advanced 1-2 L ErbB2+ metastatic breast cancer

Hospital de Navarre, Services of Oncology and Pharmacy, Pamplona, Spain, 9 GalaxoSmithKline, Uxbridge, UK Objective: Primary endpoint: Assessment of progression-free survival (PFS) in women with ErbB2-overexpressing metastatic breast cancer, treated with either a combination of lapatinib and vinorelbine or lapatinib and capecitabine. Secondary endpoints: Overall response rate, complete and partial response, overall survival, duration and time of response, clinical benefit rate, quantitative and qualitative toxicities and description of the pharmacokinetic of vinorelbine alone or in combination with lapatinib. Materials and methods: VITAL is a randomized, parallel-arm, openlabel, multi-centre, phase II study and evaluates the efficacy and safety of lapatinib combined with vinorelbine or capecitabine in women with ErbB2-overexpressive metastatic breast cancer, who received previously only one chemotherapeutic regime. About 105 patients will be included and randomized 2:1:

• G-protein coupled receptor GPR30 is proposed to act as a membranebound estrogen receptor. In contrast to ERa, activation of GPR30 is able to exert growth-inhibitory effects on tumor cells under certain conditions. In this study we examined, to what extent GPR30 activation would be able to modulate the antitumoral effect of HER2targeting antibody trastuzumab. For this purpose, we studied the effect of GPR30 agonist G1 alone and in combination with trastuzumab on proliferation and gene expression of breast cancer cell lines SKBR-3, BT-474 (both HER2-overexpressors) and MDA-MB-231 cells as negative control. All cell lines employed were GPR30positive. Proliferation was examined by means of the resazurin-based Cell Titer Blue assay, gene expression was analyzed by means of real time RT-PCR. Treatment with G1 alone inhibited cell growth of all cell lines tested in a dose-dependent manner, and growth inhibition positively correlated with GPR30 expression level. Addition of G1 significantly increased the antiproliferative effect of trastuzumab on BT-474 and SKBR3 cells. On the molecular level, this additive effect of G1 and trastuzumab was accompanied by downregulation of c-fos and cyclin A2 expression. In conclusion, we demonstrated that GPR30 agonist G1 is able to increase the antiproliferative effect of trastuzumab in vitro. The relevance of these data in the clinical setting has to be examined in further studies. Objective: LBP or discomfort is common during pregnancy. Because the pain should be expected to some degree by most women, especially in the late period of pregnancy, referral to a health care specialist is often delayed. We report of a young woman who developed LBP during her third pregnancy. Unfortunately, final diagnosis of lumbar metastases of a breast cancer (BC) was delayed. Algorithm of diagnosis and oncological management of the problem are presented in this report. Materials and methods: Patient (25y, P3, G4, 33 + 1 week of gestation) with a family history of BC suffered from LBP, which was associated with third trimester pregnancy and lead to partial immobilization and hospitalization. Moderate LBP as well as lumb in the breast were existing since breast feeding period of her last pregnancy as reported by the patient,.

Results: Pregnancy was without complication but right breast showed a lumb, that was self-detected by the patient. An inflammatory, multicentrical carcinoma of the right upper quadrant and biopsy specimen was found (TNM: T4b, cN1, cM1, G2, Rx, Her2/neu 2+, genetic testing was denied by the patient). Irritation of S1 and neurological deficiency was seen. Pregnancy was ended in 36th week and diagnostic steps were completed (CT, MRI, serum markers). Metastases in spine, lung, liver were found. Patient received radiation of breast and spine lesions and chemotherapy was administered (Taxol/ Avastin/Bisphosphonates). Follow up of palliative situation lasted 24 months. Conclusions: LBP or discomfort is common during pregnancy and mostly interpreted as pregnancy associated symptoms. We present a severe case of systemic metastases of a newly diagnosed inflammatory breast cancer in a very young pregnant patient. The presented case should teach to be aware of these exceptional findings and differential diagnosis, especially in case of a family history for breast cancer and breast lumb.

PO-Onko 01.52 Lobaplatin as single agent and in combination with TRAIL inhibits the growth of triple negative p53 negative breast cancers also by induction of necroptosis Objective: The leading question of this prospective, exploratory cohort study is to evaluate if the BCCT.core (breast cancer conservative treatment.cosmetic results) software, a semi-automated objective symmetry evaluation tool, is able to predict patient's perspective on aesthetics before and after breast conserving therapy. As the BCCT.core software is only semi-automated, it is moreover necessary to assess the inter-rater reliability. Materials and methods: 128 patients with one sided, primary breast cancer, treated conservatively were included. To evaluate the relationship between objective and subjective measurements of breast aesthetics we compared the BCCT.core software results with the scores of the Aesthetic Status of the BCTOS (Breast Cancer Treatment Outcome Scale) preoperatively, shortly and 1 year after surgery. The inter-rater reliability for the BCCT.core software was assessed by calculating agreement rates and multiple kappa (mk) coefficients for four different raters; the agreement between the BCCT.core software and the BCTOS by analysing agreement rates and weighted kappa (wk) coefficients.

Results: The inter-rater reliability for the semi-automated BCCT.core software was very good indicated by agreement rates up to 84% (mk = 0.80). The agreement rates of the BCCT.core software and the BCTOS Aesthetic Status ranged between 35% and 60% according to the different times of assessment (wk = 0.37 at best). The patients seem to judge their aesthetic outcome more positively than the BCCT.core software.

Conclusions: The inter-rater reliability of the BCCT.core software is very good, but it shows only fair agreement with patient's perspective on aesthetic outcome measured by the Aesthetic Status of the BCTOS. A prediction of patient's perspective by the software is hence not possible. Objective: Heterotopic pregnancy is a multiple pregnancy with one normal implantation in the uterus and one ectopic pregnancy. It has a prevalence of 0.08-1.9% and an incidence from 1:2,600 to 1:30,000 in normal conception. Sonographic identification is very specific, but has low sensitivity. Signs of normal pregnancy associated with abdominal pain and an adnexal mass are the most significant symptoms, final diagnosis has to be verified by laparoscopy.

A 30 year-old GIV/PII attended the emergency department with acute abdominal pain and vaginal bleeding 2 weeks after voluntary interruption of a sonographically documented, intrauterine pregnancy in the 5th week of gestation elsewhere. It was a spontaneous conception. She underwent laparoscopic appendectomy two months ago, where also an infection with Chlamydia trachomatis was found, which has not been treated. Hb 12.9 g/dl, Beta-HCG 2152mlU/ml. Transvaginal sonography revealed an empty uterus and a regular right ovary. The 17 9 11 9 12 mm mass on the left ovary was suspected to be a corpus luteum cyst. IV Antibiotic treatment was started for the Chlamydia infection and the patient was hospitalised for surveillance. On the 3rd day the patient developed acute abdominal syndrome and instability of circulation. Emergency laparoscopy was carried out and a left ruptured tubal ectopic pregnancy and hemoperitoneum (2000 ml) were found. Histological examination verified the tubal pregnancy. The lady recovered well and was discharged on the 4th postoperative day after ferinject infusion. Conclusions: Only very few heterotopic pregnancy cases have been reported in natural cycles like our patient had. Salpingitis primarily because of Chlamydia is the main cause of tubal pregnancy and seems to play a crucial role also in this case. After diagnosis of intrauterine pregnancy, adnexal sites should always be assessed carefully for heterotopic pregnancy in order to prevent secondary rupture and excessive intra abdominal bleeding. We describe a case of a 30-year-old woman, who was referred to our gynecological outpatient clinic for suspected missed miscarriage at gestational age of 10 weeks. This was the second pregnancy after the first has been ended in a first trimester miscarriage five months before. A transvaginal scan performed by an expert revealed an intrauterine pregnancy with a gestational sac of a mean diameter of 23 mm with an embryo of 6 mm length and negative cardiac activity. As the patient had a scan report of this pregnancy performed 3 weeks before, the diagnosis of a missed miscarriage could be confirmed. A corpus luteum cyst was seen in the left ovary. The right ovary was enlarged with a unilocular cyst of 59 mm in largest diameter. The cyst was of hypoechoic content and showed echogenic papillary projections around the inner wall, which were moderate vascularised with colour Doppler. The scan report summarized a missed miscarriage and a right ovarian cyst, which was highly suspicious of a borderline tumour. All tumour markers showed normal levels, except of a slightly increased CA 125 of 49.9 kU/l (0-35). The patient was informed about all findings and recommended to have a right ovarectomy, which she agreed to. A laparoscopic ovarectomy and curettage was performed and a frozen section revealed a serous papillary borderline tumour, which was confirmed on final histology. Follow up management was planned for half year control visits for the next 3 years, followed by yearly control visits for a period of 2 years.

PO-Onko 01.63 Importance of the 4G/5G PAI-1 promoter polymorphisms for ovarian cancer incidence Objective: PAI-1 (plasminogen activator inhibitor-1) is an important protein in tumor progression and is a prognostic and predictive marker in breast cancer. Its clinical relevance in ovarian cancer is less well studied. PAI-1 gene expression is regulated by several growth factors and cytokines. In addition, a 4G/5G polymorphism in the promoter region of this gene has been shown to influence PAI-1 gene activity. In contrast to the 4G genotype, the 5G genotype contains an additional guanine in the PAI-1 promoter at position -675. It has been assumed that this additional guanine allows a transcriptional repressor to bind to this site and downregulate PAI-1 expression. We studied the importance of this promoter region for the incidence of ovarian cancer. Materials and methods: We genotyped 105 patients suffering from ovarian, tube and peritoneal carcinoma and 157 age-matched women with no diagnosed gynecological cancer. Genomic DNA was isolated from blood and the promoter region containing the 4G/5G-polymorphism site amplified by PCR. Genotyping was done by restriction site analysis.

Results: There was no difference in the distribution of the genotypes in patient and control group. However, we found that patients carrying the 5G/5G genotype tend to be less likely to develop ascites and tend to show lower FIGO stage. In addition, there was a tendency that the 4G allele was overrepresented in patients with serous ovarian cancer.

Conclusions: Alterations in PAI-1 expression by the 4G/5G promoter polymorphism does not seem to have any importance for the chance to develop ovarian cancer. However, patients who have developed an ovarian cancer may sooner progress when they carry the 4G PAI-1 allele.

PO-Onko 01.64 A tension-free mesh used for the treatment of apical and anterior vaginal prolapses in continent and incontinent women *Samir Sawalhe 1 , 1 Krankenhaus Dingolfing, Gynäkologie, Dingolfing, Germany

To assess the safety, efficacy and functional results of Nazca TC, a tension-free mesh used for the treatment of apical and anterior vaginal prolapses in continent and incontinent women. The rational of this procedure is to create new sufficient barrier mechanism to repair anterior vaginal hernias and support the urinary bladder including the vaginal apex and the bladder neck using one mesh. Surgical technique: A median incision is carried out in the anterior vaginal wall starting 21/2 cm from the external urethral meatus to the uterine cervix or to the apex of the vagina in post hysterectomy patients. The urinary bladder is dissected all the way to the sciatic spine. Tow small skin-incisions are made on each side of the Alba line 1 cm cranially and 1 cm laterally from the upper edge of the pubic bone. Additional two small skin-incisions are made in the posterior area of the obturatory foramen. A proper needle is introduced laterally to the urethra and guided pre publically between the insertion of the ischio-cavernosus muscle and the pubic bone along the major labia to the previously made supra pubic incisions. The armpit of the mesh is connected to the tip of the needle and brought to the supra pubic region. The mesh remains tension free in the sub med-urethral segment. The posterior arm tip of the mesh are brought around the arcus tendineus of the levator ani muscles closed to the ischiadic spine and connected to the trans obturatory inserted helix tip. The helix is carefully pulled out. The posterior segment of the mesh is fixed to the cervix or to the sacro-uterine ligaments with non resorbable stitches. The vaginal wound is closed in the usual manner in overlappingtechnique till the perineal body that was corrected when necessary.

Regulation of the retinoid-X-receptor a and the leptin receptor pathway in choriocarcinoma cells in vitro retinoic acid (ATRA) and the PPARc agonist 15-Deoxy-D12,14prostaglandin J2 (15d-J2) on the expression of RXRa and Ob-R in choriocarcinoma cells in vitro. Materials and methods: The choriocarcinoma cells BeWo and JEG-3 were stimulated with 10 nmol/ml 9-cisRA, ATRA and 15d-J2 for 24 h, respectively 48 h. Anti-RXRa or anti-Ob-R served as primary antibodies. The intensity of the stained cells was determined by a semiquantitative score. In real-time TaqMan PCR (RT-PCR) Ob-R and RXRa were analyzed after cell stimulation with 9-cisRA and 15d-J2 for 1, 2, 3, 4 and 8 h. Placental tissue from spontaneous miscarriages was incubated with M30 CytoDEATH antibody (M30) as well as RXRa or Ob-R and stained using a double-immunofluorescence method.

Results: 9-cisRA, ATRA and 15d-J2 downregulated RXRa expression in BeWo and JEG-3. Immunocytochemistry could be verified on mRNA level with RT-PCR. Retinoids enhanced Ob-R expression in JEG-3 which could be demonstrated via dotblot and RT-PCR. 15d-J2 had no effect on Ob-R expression. Double-immunofluorescent staining showed a simultaneous expression of M30 and RXR/Ob-R in extravillous trophoblasts (EVT).

Conclusions: The impact of the retinoids on Ob-R expression underlines the interaction of RXRa with the Ob-R pathway and highlights their cross talk in the signal transduction cascade. Downregulation of RXRa expression in stimulated choriocarcinoma cells might serve as a protection against apoptosis as miscarriage is associated with apoptosis of EVT. Upregulation of Ob-R might be understood as a response to low leptin levels found in miscarriage. Objective: Supracervical hysterectomy is discussed to be a good alternative to complete hysterectomy. Semm advised to excide the cervical channel vaginally to reduce the risk of cervical stump carcinoma and spotting. We here report our stump infection and spotting rate after usual LASH and LASH with additional laparoscopic excision of the cervical channel (eLASH). Materials and methods: 260 premenopausal patients underwent LASH at our institution between January 2006 and June 2009. Until July 2007 we detached the cervix rather straight and coagulated the remaining cervical channel (LASH). Since July 2007 we excided the cervical channel laparoscopically (Ultracision) and coagulated the remaining very small cervical channel (eLash). All patients were asked to fill in a self administered questionnaire concerning the spotting rate, postoperative infections and smoking attitudes. Results: We had a response rate of 70% (n = 183). 88 patient of the LASH group and 85 patients of the eLASH group completed the questionnaire. Questionnaire was incompletely filled in by nine patients. We had a postoperative stump infection rate of 6.8% (6/88) in the Lash group and 5.9% (5/85) in the eLASH group. No statistic significant differences between smokers and non-smokers were found. 21.6% (19/88) of the LASH group and 5.9% (5/85) of the eLASH group reported on spotting continuing more than 1 year after operation.

The laparoscopic excision of the cervical channel reduces the spotting rate. Stump infection rate is moderate and comparable to LASH. There seems to be no negative influence concerning smoking and infection rate. Objective: Postmenopausal bleeding occurs in 80-95% of patients with endometrial cancer. The differential diagnosis includes a broad range of conditions, but the vast majority of postmenopausal women who present with irregular or excessive vaginal bleeding have benign disease. The aim of this study was to evaluate retrospectively the value of transvaginal sonography for the detection of endometrial disease in postmenopausal women with bleeding. Materials and methods: The women were examined in the Department of Gynaecology of the General Hospital in Didimoticho during the time period from January 1998 to December 2008. None of them were on hormone replacement therapy and all had amenorrhea for more than 2 years.

Results: This study involved 60 postmenopausal women aged 47-66 years (Median 56.5). Transvaginal sonography was performed in 60 women. About 97.5% of the malignant diseases were discovered in study-women, whose endometrial thickness was above 4 mm, but we found endometrial cancer in 2.5% of the cases, in women, whose endometrial thickness was below 4 mm. A satisfactory visualization of the endometrium has been obtained in all 60 examined cases. The thinnest endometrium was 0 mm while the thickest one was 10 mm. Of the 60 study-patients, four had endometrial cancer, three had atypical hyperplasia, eight had complex hyperplasia, ten had simple hyperplasia, twenty-two had an atrophic endometrium and twelve had polyps. Endometritis was found in one case of the study population. Histology was available in all cases.

Conclusions: Concerning the age in the study patients, we confirm that endometrial cancer occurs at any age, but more commonly in ages above 58 years. In postmenopausal symptomatic women premalignancy or malignancy causes of bleeding can not be excluded with just transvaginal ultrasound and a fractional curettage is necessary.

PO-Onko 01.68

The first description of docetaxel-induced recall inflammatory skin reaction after previous drug extravasation *Frauke Kramer 1 , Franziska Rinnau 1 , Cordula Schippert 1 , Peter Hillemanns 1 , Tjoung-Won Park-Simon 1 10 of 26 tumor afflicted lymph nodes followed by irradiation, our patient received multiple chemotherapeutic regimes and antiestrogenic therapies between 1997 and 2008. In the course, she developed lung, osseous and liver metastases, whereas re-induction with taxane-containing chemotherapy always led to tumor remission with less side effects and good general state of health. Drug extravasation of docetaxel in the antecubital fossa occurred and was treated with hyaluronidase s.c. and application of cold packs. A few days after the following chemotherapy cycle, she developed a severe erythema with edema, hotness on touch, and pain in the area of previous extravasation necessitating treatment with local steroids, analgetics and antibiotics. The recall dermatitis continued to exacerbate after each course of systemic docetaxel chemotherapy, and finally led to termination of this therapy. In conclusion, recall soft tissue injury after the use of docetaxel in a site of previous extravasation is a new type of skin toxic effect of this chemotherapeutic drug. When skin damage seems to have been fully resolved, caution is needed after an episode of drug extravasation. Even after a therapy interruption of several weeks, resumption of chemotherapy with docetaxel might lead to recrudescence of the inflammatory skin reaction. Objective: Primary pulmonary choriocarcinoma is a rare disease with only 25 reported cases in literature so far. In this report we present the case of a 31-year-old female with primary pulmonary choriocarcinoma initially noticed because of a positive urine pregnancy test. Materials and methods: A 31-year-old woman presented to our outpatient department of gynaecology. A urine pregnancy test performed by the patient because of a delayed period had shown a positive result although her husband is sterilized and the patient was under oral contraceptives because of skin problems. A gynaecologic ultrasound showed normal anatomy and no signs of pregnancy. Quantitative b-HCG serum levels were 516 U/l. A laparoscopy failed to reveal an ectopic pregnancy. Biopsies of both ovaries showed no signs of malignancy or scarring which would have been consistent with old trophoblastic disease or ovarian choriocarcinoma. A D&C obtained no trophoblastic tissue and the endometrium was described as being in the secretory phase. Over several weeks, b-HCG-levels raised up 812 U/l. In order to rule out a mediastinal extragonadal germ cell tumor a CT-scan of the thorax was performed, revealing a peripheral nodule of 1.6 cm 9 1.7 cm in the right upper lobe of the lung. A diagnostic operative excision of the tumor was performed, revealing a choriocarcinoma. At 3 weeks postsurgery b-HCG dropped to less than 5 U/l. Further staging of the patient using PET-CT showed no hypermetabolic lesions, making a metastatic disease highly unlikely. The patient is at well being and refused adjuvant chemotherapy. Conclusions: Besides the common differential diagnosis of elevated b-HCG levels one should also consider extragonadal choriocarcinomas. The diagnosis is of great importance for the patient, because notably primary pulmonary choriocarcinomas are mostly unresponsive to surgical and chemotherapeutic treatment. In addition they are associated with a poor prognosis. Objective: Hypoglycemia in the context of a paraneoplastic secretion of insulin-like peptide (IGF-II) is rarely described in Oncology. It can lead to severe adverse effects up to hypoglycemic coma (de Groot et al., 2007) .

A 60 year old patient with metastatic breast cancer was admitted to our hospital in pre-comatose state. The laboratory data revealed glucose of 9 mg/dl, other blood parameters were normal. Under treatment with constant infusions of glucose (100 ml/ h, 20%) patient's state normalised rapidly. Eight years ago a primary breast carcinoma with bone metastases was diagnosed (stage: ypT3/ ypN2/cM1/G2/hormone receptors positive/Her2-neu negative). Over the years the patient developed metastases in liver and lung. Recently she obtained her 5th-line chemotherapy containing Caelyx, Faslodex and bisphosphonates. Due to significantly decreased levels of IGF1-, Insulin-and C-Peptid and a normal IGF-II, the suspicion of a paraneoplastic hypoglycemia was raised, which was substantiated by a progress in imaging and serology (CA 15-3 [ 3000kU/l). Under glucose infusions, glucocorticoides (Dexamethason 4 mg/day) and somatostatines (Octreotid 100 lg/d) the patient was free of symptoms.

Conclusions: Paraneoplastic hypoglycemia is a rare emergency case in oncology. It can contribute to either primary diagnosis or awareness of progression of cancer. The rapid diagnosis and immediate treatment in terms of a specific tumor-therapy is of central interest. In the palliative situation the symptomatic treatment has priority (de Groot et al., 2007 Objective: GTD forms a heterogeneous group of abnormal trophoblastic tissues. Choriocarcinoma (CC) is a malignant form of GTD. CC is much more likely than other types of GTD to grow quickly and spread to organs away from the uterus. We present a rare case of exclusive lung manifestation of CC, initially treated as ectopic pregnancy (EP). State of the art algorithms of diagnostic and therapeutic regimen as well as current classifications are given. Materials and methods: Patient (30 year, G2,P2) presented 12 months after term spontaneous delivery with metrorrhagia. Subsequent hCGslevels persisted high. Ultrasound, hysteroscopy and laparoscopy were performed, revealing neither intra-nor EP. Curettage were performed but histology showed not trophoblast tissue. Methotrexate (MTX) was given but hCGs-levels persisted indicated MTX-resistant trophoblastic disease. A PET scan was performed showing a singular apical lesion of the right lung which corresponded with a subpleural nodule in CT-scan. Resection (VATS) was performed and histologic examination revealed CC. Results: The Lesion was classified GTD Stage II/III high risk (WHO Index score [7) and resection was followed by EMA-CO. The lesion was cleared after this regimen and hCGs decreased. Conclusions: High risk GTD spread to genital structures or lungs and without treatment prognosis is generally poor. In this presented case 12 months after delivery a high risk CC occurred. Patient had no evidence of GTD in genitary organs, but a single lesion of CC in the lung as found in a PET scan. Standard treatment is usually an intensive combination chemotherapy regimen such as EMA-CO in combination with surgical removal if possible. Blood hCGs levels serve as tumour markers indicating response or resistance to chemotherapy. All different staging systems (FIGO, WHO scoring system and the currently adopted TNM-system) are able to define high risk patients as prerequisite for state of the art therapy.

PO-Onko 01.73 YT521 isoform 1 and 2 exert the same impact on CD44 alternative splicing in vivo Objective: YT521 acts as a splicing factor in alternative splicing mechanism. The existence of two isoforms was confirmed due to exon 6 inclusion (isoform 1) and exon 6 exclusion (isoform 2). Recently, isoform 1 was identified as a prognostic factor for endometrial cancer, while isoform 2 was rarely detected in this tumour type. However, exon 6 is not located in YT521 functional domain YTH and its skipping will not give rise to downstream nucleotide frameshift. Here we explored whether isoform 2 is as functional as isoform 1. Materials and methods: Increasing amounts of expression plasmids of YT521 isoform 1 and isoform 2 were co-transfected in cancer cell lines with constant amounts of a minigene containing CD44 v4/v5 (ESTGLv2), respectively. The influence of both YT521 isoforms on alternative splicing profiles of ESTGLv2 was examined by RT-PCR with primers specific for the ESTGLv2 minigene.

Results: In a concentration-dependent manner, both YT51 protein isoforms cause a similar increase of CD44 v4 inclusion in minigene ESTGLv2 (p \ 0.01). Thus, the protein YT521 isoforms 1 and 2, originating from inclusion or exclusion of YT521 exon 6, respectively, display no difference in affecting alternative splicing pattern of CD44.

Conclusions: YT521 isoform 2 displays a similar function in alternative splicing like isoform1 in in vivo assay. Thus, the different expression levels of these two isoforms in endometrial cancer might be caused by their tissue-specific distribution.

PO-Onko 01.74 Exenteration in the treatment of advanced or recurrent vulvar and vaginal cancer *Dirk Michael Forner 1 , Bjoern Lampe 1 1 Kaiserswerther Diakonie, Department of Gynaecology and Obstetrics, Düsseldorf, Germany

Objective: Vulvar and vaginal cancer are the rarest of all genital carcinomas. While in advanced primary cancer pelvic exenteration (PE) can be an alternative to chemoradiation, PE is often the only therapy available in cases of recurrence. Materials and methods: In a retrospective study we analyzed patients having undergone exenteration for vulvar or vaginal cancer in our department within the last 10 years. Results: We identified 28 patients, 22 of them suffering from vulvar cancer, the other 6 from vaginal cancer. 8 of the vulvar malignancies were primary, 14 a recurrence, in vaginal cancer it were 5 and one, respectively. 18 patients presented with a stage FIGO III, in 9 patients the disease had advanced to stage IV. In 11 patients the disease had spread to the inguinal lymph nodes, in 3 patients also to pelvic nodes. At the end of surgery, all patients were macroscopically free of tumor, which was confirmed microscopically in 21 patients (75%, R0), the other 7 patients (25%, R1) having microscopic tumor remnants (n = 2, 7%) or lymphangiosis found in the surgical margins (n = 5, 18%). Over all patients, mean time of survival was 68 months, 5 year survival rate (5 YSR) 42%. For patients with primary disease mean survival was 74 months and 5 YSR 47%, for the others 47 months and 29%, respectively. Spread of disease to lymphatic nodes showed a decrease in survival: Patients with free lymph nodes lived a mean of 89 months and had a 5 YSR of 85% vs. 32 months and 36%, respectively, for patients with tumorous spread to the nodes (p = 0.05) Conclusions: PE is a therapeutic option in advanced primary or relapsed vulvar or vaginal carcinoma, offering median-to long-term survival for a considerable part of patients. Carcinomatous spread to regional lymph nodes is the most important prognostic factor. S120 Arch Gynecol Obstet (2010) 

Objective: Malignant gestational trophoblastic neoplasia (GTN) is a rare gynecologic entity. Although there is a risk of metastatic disease, most women with GTN can be successfully managed with preservation of their normal reproductive function. Materials and methods: We report the case of a 27 year old nulliparous, who was transferred to our hospital with elevated ß-HCG levels after two curettages following an incomplete abortion. After 13 cycles of methotrexate, ß-HCG Level reached the detection limit, however transvaginal sonography showed a highly vascularised uterine tumor. Operative hysteroscopy was performed; because of the high risk of hemorrhage, complete resection was not achieved. Pathological findings showed amorphi-necrotic tissue without viable cells. After a 3 year follow up, no relapse has occurred and a recovery of menstruation taken place.

Conclusions: A ''watch and wait'' strategy with regular ultrasound scans and close meshed ß-HCG level control can be an option in treating patients with residual disease after GTN.

The small vulvar cancer of the anterior fourchette: a specific tumor entity? Objective: The incidence of vulvar cancer in young women has increased in Germany during the last decade. The mean age has dropped significantly (by about 8 years) and we observed an increase of small tumors located between clitoris and urethra. We initiated a multicenter study in Germany asking members of the Study Group for Colposcopy and gynecological centers specialized in the treatment of vulvar cancer to provide tumor samples from patients with invasive tumors (max. T2) strongly located between clitoris and urethra. Objective: Epidermal growth factor receptor (EGFR, HER-1) and HER-2 are transmembrane receptors that possess tyrosine kinase activity, playing essential roles in cancerous and physiological conditions. They are, together with HER-3 and HER-4, part of the ErbB family. EGFR-signalling suppresses apoptosis and induces proliferation, invasion, and the formation of metastases in cancer cells. Our objective was to compare the expression of EGFR and HER-2 in a series of VIN and VSCC tissues.

We performed a tissue micro array (TMA) with specimen from 107 patients with high-grade VIN and 70 patients with vulvar cancer (p16-negative and p16-positive as surrogate marker for HPV-infection). EGFR-and HER-2-expression has been analyzed using immunohistochemistry (IHC). We applied a semiquantitative scoring system from 0 to 3+. For the statistical evaluation EGFR scores were dichotomized by combining negative (0), weak (1+) and moderate positive (2+) versus strong positive (3+) results, which according to other authors is correlating with the amplification of EGFR with a sensitivity of 100% and a specificity of 79%. Results: We found a significantly (p = 0.007) increased EGFR-Expression in vulvar squamous cell cancer (n = 14/59, 23.7%) compared to high-grade VIN (n = 8/106, 7.5%). The staining for HER-2 was negative for all tissue samples, whereas positive controls were positive. Similar results were found for the group of p16-positive tissues only. Conclusions: Our results suggest that the amplification of EGFR plays a considerable role in the progression of high-grade VIN to VSCC. EGFR-amplification observed in 24% of patients with vulvar cancers may be exploited for targeted treatments. In addition, we demonstrate in one of the largest series analyzed so far that HER-2 amplification is not detectable in both VIN and VSCC.

PO-Onko 01.78 Elevated infect parameters after laparoscopic sacropexy: infection or posttraumatic reaction?

performed in case of pre-existing uterus (n = 171). Leucocytes and CRP levels were analysed pre-operatively and four days after operation. Additionally early (day 1-5) and late onset ([1 day after demission, at least day 7) infection rate was analysed. The discriminatory capacity of leucocytes and CRP levels were evaluated by receiver operating characteristic (ROC) analysis. Results: Early infections (wound infections) were found in 8/ 287 = 2.8%. Late onset infections were found in 3/287 = 1.0% (0.66% stump-infection after LASH, 0.33% unknown origin). Areas under ROC curves were low for both leucocytes (0.52, 95% confidence interval 0.37-0.66) and CRP levels (0.60, 95% CI 0.44-0.77), where a value of 1 (or 0) means perfect discrimination and 0.5 corresponds to tossing a coin. Thus thresholds yielding acceptable sensitivity and specificity could not be defined.

We found little evidence to support the diagnostic validity of leucocytes or CRP levels to differentiate infection and traumatic reaction four days after laparoscopic sacropexy. Our findings query the benefit of a routinely determination of leucocytes and CRP levels at that time. However, significance of our findings is limited by the low frequency of infections in the study sample. Sensitivity and specificity of leucocytes and CRP levels maybe better after normalisation of the initial tissue response (day 8-10).

PO-Onko 01.79 Fertility sparing surgery of borderline ovarian tumors: laparoscopy vs. laparotomy Objective: (1) To evaluate the role of minimal invasive surgery of borderline ovarian tumors (BOT) with regard to recurrence rate compared with radical surgical management and (2) to investigate the reproductive outcomes following fertility preservation. Materials and methods: Medical reports of all 69 patients with BOT who underwent surgery between 1996 and 2009 at our institution were reviewed. Outcomes from patients who underwent fertility sparing surgery (FSS) were compared with outcomes from patients with radical surgery defined as hysterectomy, bilateral salpingooophorectomy and infracolic omentectomy. Results: Forty-four patients with BOT were treated laparoscopically and 25 patients underwent laparotomy. One recurrence occurred in a woman treated with radical surgery (1/45) while 5 cases of recurrence were diagnosed in the fertility-sparing group (5/24; premenopausal n = 2, postmenopausal n = 3). The recurrence risk in the fertility sparing group was significantly higher than in radical surgery group (p = 0.021 Fisher Test). No difference regarding recurrence was observed between laparoscopy and laparotomy. No major intra-and postoperative complications occurred when patients were treated laparoscopically. Altogether, 24 patients underwent FSS (laparoscopically 16, laparotomically 8). In both groups, radical surgery and fertility-sparing surgery, 100% survival rate has been assessed. In the FSS group, out of 16 women in child bearing age, 3 had full-term deliveries, one is currently pregnant, 4 are considering to have a child, 4 don't wish to have children, 2 had a secondary radical surgery due to recurrence and 2 were lost to follow-up.

Conclusions: Laparoscopic radical surgery of BOT was feasible and safe. FSS of women in reproductive age carries an increased risk of recurrence. Women beyond child bearing age or who have completed family planning, should be informed about the option of secondary radical surgery. Objective: Fast-track concepts have been applied in many perioperative settings. Short length-of-stay with vaginal hysterectomy has been shown to be feasible and safe. We developed an interdisciplinary fast-track vaginal hysterectomy protocol for selected patients. Materials and methods: Inclusion criteria were planned simple vaginal hysterectomy without concomitant procedures, ASA status 1-2, patient desire, and patient support at home. Patients were operated on early on the day of admission with regional or general anesthesia. Intraoperative points included preemptive analgesia, antibiotic pro-S122 Arch Gynecol Obstet (2010) 282 (Suppl 1):S63-S270 phylaxis, bipolar vessel sealing, and nonuse of drains and catheters. Postoperative points included pain management with PO medications, mobilization on the afternoon of surgery and early eating. Complications and readmissions were recorded. Patients were contacted with a questionnaire at 8 weeks.

Results: 12 patients were enrolled into the protocol in the pilot phase. Seven patients went home on the first, three on the second and two on the third postoperative day. Reasons for extended stays were postoperative nausea and vomiting (PONV) and organizational problems at home. There were no readmissions for complications. Nine women were satisfied with the duration of the stay, three considered it too short.

Conclusions: Fast-track hysterectomy is feasible after accurate patient selection. The main barriers to discharge on day 1 were PONV and organizational problems at home.

PO-Onko 01.82 One step nucleic acid amplification (OSNA) as an intraoperative diagnostic tool for the assessment of the sentinel lymph node status in breast cancer patients

Objective: The detection of sentinel lymph node (SLN) metastases in breast cancer patients is conventionally determined by intra-operative histopathological examination of frozen sections or touch imprints. Due to a poor sensitivity of these techniques, postoperative identification of metastases on paraffin embedded sections can lead to second surgery axillary lymph node dissection. A new molecular assay called One

Step Nucleic Acid Amplification (OSNA) for intra-operative identification of metastatic disease in SLN has been evaluated in several clinical studies. We present here the results from the intraoperative use of OSNA. Materials and methods: OSNA includes a sample preparation step followed by automated measurement of cytokeratin 19 mRNA copy number directly from the homogenate and can be carried out by a technician. Before homogenisation of the whole node a 1 mm middle slice was reserved for histology. 257 SLN from 110 breast cancer patients were investigated. If OSNA was negative then Haematoxylin & Eosin (H&E) staining was performed every 200 lm; in case OSNA was positive, only one H&E section was made.

Results: Fourteen patients were positive and 81 were negative with both methods. In 4 patients OSNA indicated the presence of a macrometastasis and in 9 patients a micrometastasis whereas histology was negative. The positivity rate obtained by OSNA was 24.5%. In one patient a micrometastasis was found in the 1 mm middle slice and OSNA was negative. One SLN was histology +/OSNA-, indicating CK19 low expression on a protein and RNA level.

Conclusions: OSNA is a standardised procedure for intra-operative detection of SLN metastases in breast cancer patients and prevents patients from a diagnostic delay or second surgery. Since most or all of the tissue can be analysed by OSNA, the chance of a sampling bias due to uninvestigated material is very low. Objective: Hysterectomy is the most common gynecologic operation following cesarean section and the large majority of hysterectomies is performed for benign indications [1, 2] . Several surveys in Europe and the USA have shown stable or decreasing hysterectomy rates since the 1980s [1, [3] [4] [5] [6] . We ascertained annual hysterectomy rates in Austria from 1997 to 2008. Results: 35 of 58 questionnaires were returned. 46% of the gynaecologists quoted to ask less than 15% of their patients actively about sexual problems. 69% of the respondents estimated that 10-15% of their patients have a sexual problem and that less than 15% of the patients actively address this kind of problems. Only 6% of the gynaecologists stated to be uncomfortable to talk about sexual problems. Dyspareunia was quoted as the most or second most prevalent diagnosis of female sexual dysfunction in 71% of the questionnaires. Overall the issue of sexual medicine was estimated to be important or very important by over 50% of the respondents.

Conclusions: A high percentage of cases with a subjective suspicion for a sexual problem are not further evaluated though only very few gynaecologists reported to be uncomfortable to address sexual problems. Another interesting finding is the high subjective prevalence of dyspareunia compared to sexual desire disorders or arousal disorders, which is not consistent with results of epidemiologic studies (Lindau et al. 2007 ). This pilot study demonstrates that gynaecologists consider the issue of sexual medicine to be important. In April 2010 an extension of the study is planned to include gynaecologists in private practices. Results: The first analysed probes show differentially expressed genes in the field of hormone and growth factor receptors which could be partially validated by RT-PCR. Differential methylation could be seen in genes which are known to play a role in embryological development. There were no copy number variations found in monozygotic twins in which only one suffered from MRKHS. Conclusions: Gene expression analyses indicate that hormonal feedback systems may play a role in the proper development of the human female genital tract. Nevertheless data from monozygotic twins as well as methylation assays point to epigenetic causes for uterine and vaginal aplasia. In order to get significant and reproducible results the number of experiments has to be increased. Of those 47 complained about cyclic lower abdominal pain. As a first step during surgical treatment the exact phenotype was described. If laparoscopic signs of a hematometra were apparent, recently those uterine horns were excised completely in symptomatic patients. In other cases wedge shaped biopsies were taken from one of the uterine rudiments (n = 10). Results: The majority of patients showed uterine rudiments on both pelvic walls connected by a more or less prominent uterine strip.

Using ultrasound in none of all 192 patients, using MRI only in 5 out of 31 patients endometrium could be clearly differentiated. In a very small number of patients unilateral hematometra was clinically suspected. In 5 of the excised tissue samples proliferating endometrium could be histologically identified. Three of the tissue samples contained structures resembling mullerian ducts.

Conclusions: Within uterine rudiments of MRKH patients proliferating endometrium and structures of mullerian ducts can be found. The existence of functional endometrium cannot be clinically predicted and therefore the excision of uterine rudiments should, in our opinion, so far only be performed in symptomatic patients. Objective: Uterine leiomyomas (UL) result from the monoclonal proliferation of myometrial cells. Despite their high prevalence surprisingly little is known about their pathogenesis. Oncogene-induced senescence (OIS) is a frequent phenomenon in premalignant lesions that leads to a growth arrest mainly by the activation of two potent growth-inhibitory pathways as represented by p16Ink4a and p19Arf. The relevance of OIS for the development of UL has not been addressed, but HMGA2, encoded by a major target gene of recurrent chromosomal abnormalities in UL, has been implicated in the repression of the Ink4a/Arf (CDKN2A) locus. This prompted us to examine if HMGA2 contributes to the growth of leiomyomas by repressing this locus. Materials and methods: Cytogenetic subgroups of uterine leiomyomas were determined by conventional cytogenetics. Gene expression patterns within a possible OIS-network have been studied by quantitative RT-PCR.

Results: Contrary to the expectations, we were able to show that generally UL express significantly higher levels of p19Arf mRNA than myometrium and that UL with 12q14_15 rearrangements showed higher expression levels than UL with other cytogenetic aberrations. Furthermore, the finding of a significant correlation between the expressions of p19Arf and CDKN1A shows that p19Arf triggers senescence rather than apoptosis in UL. Furthermore, the expression levels of HMGA2, p19Arf, and CDKN1A were found to be correlated with the size of the tumors, indicating that an enhanced growth potential is counterbalanced by the p19Arf pathway. Mechanistically, the UL may thus execute a program already present in their cell of origin, where it can be activated to protect the genome, for example, in the case of enhanced proliferation. This also explains the low frequency of malignant transformation towards leiomyosarcomas. Conclusions: In summary, the results identify the p19Arf-TP53-CDKN1A pathway as a major player in the growth control and genomic stability of uterine fibroids.

PO-Onko 01.90 Fatal course of a necrotizing fasciitis during adjuvant chemotherapy in a patient with early-stage breast cancer *Maren Ebers 1 , Kirsten Graubner 1 , Christoph Lindner 1 1 Diakonie-Klinikum Hamburg, Frauenklinik und Brustzentrum, Hamburg, Germany

Objective: Necrotizing fasciitis is a rare, but rapidly progressive, lifethreatening bacterial infection of the soft tissue. Immunocompromised patients, e.g. due to chemotherapy, are more susceptible to develop this disease. Materials and methods: We report a case of a 42-year-old woman with early-stage breast cancer who presented a fulminant course of necrotizing fasciitis during a chemotherapy nadir.

Results: The patient was admitted to our hospital with elevated body temperature, nausea and pain in the left gluteal region, presenting as a small perianal erythema. She had received her last cycle of chemotherapy following the regimen of FEC/DOC nine days before. Blood examination data indicated extreme leukopenia (white blood cell count 300/lL) and an elevated CRP level of 4.36 mg/dL. Following the diagnosis of cellulitis of unknown origin after exclusion of an acute abscess, she received antibiotic therapy and G-CSF injection. Within a few hours her pain worsened, and erythema continued to spread over the left gluteal region and vulva, showing hemorrhagic bullae. Because of this rapid deterioration the patient was transferred to the emergency department of the neighboring university hospital. The CT scan showed an extended phlegmonous inflammation with soft tissue gas from the left upper leg to the gluteus muscle, vulva, perineum and ventral abdominal wall, indicating necrotizing fasciitis. The patient was taken to the operating room immediately and aggressive surgical debridement of the infected tissue was done. Despite all intensive care measures taken, she died from septic and hemorrhagic shock with multi-organ failure about 18 h after first consulting our clinic. Conclusions: Immunosuppression due to chemotherapy predisposes patients to potentially life-threatening bacterial infections. Because necrotizing fasciitis is rare and early aggressive treatment is most important for the outcome of these patients, we want to raise the awareness of this disease.

Materials and methods: Case report. Results: Upon D&C, no sign of malignancy was found. The patient had a laparotomy with partial morcellation of the large uterus. Histologically, a low-malignant endometrial stromal sarcoma (ESS) was found. Two months later, we performed a staging laparoscopy with bilateral salpingoovarectomy. In the area where the ligamenta rotunda were cut during hysterectomy, a suspicious lesion could be shown on both sides. These lesions were completely removed. Histologically, cells of the ESS were found. Laparoscopically, no other lesions could be detected. Conclusions: After morcellation of a low-malignant ESS during hysterectomy, we detected a spread of the ESS per continuitatem to the ligamenta rotunda, but not to the rest of the abdomen.

PO-Onko 01.92 Evaluation of RAD001 (everolimus) in the setting of resistance to letrozole or anastrozole in postmenopausal ER-positive breast cancer patients: BOLERO-2 trial Background:

• Studies detected the mTOR-inhibitor RAD001 as promising drug. The serin/threonine kinase mTOR is a key factor in the intracellular signaling network. It takes part in the regulation of proliferation, angiogenesis and cell metabolism. Defect regulation of mTOR is found in numerous tumours and leads to an increase of cell proliferation and angiogenesis. • In case of resistance to endocrine therapies the mTOR signaling pathway is up-regulated due to crosstalks between signaling pathways. • RAD001 is thought to increase the efficacy of endocrine therapies by inhibiting the mTOR signaling pathway.

Materials and methods: BOLERO-2 (Breast cancer trials of OraL EveROlimus) is a randomised, double-blind, placebo-controlled study that evaluates the efficacy of RAD001 (everolimus) in combination with exemestane in postmenopausal women with ER-positive breast cancer who have local progress or distant metastases and who are resistant to letrozole or anastrozole. The patients receive either exemestane plus RAD001 or exemestane plus placebo. Therapy is continued until progression.

Objective: The primary objective is to show the advantage of exemestane plus RAD001 over exemestane alone in regard to the progression free survival. Secondary objectives are the evaluation of overall survival, response rates, time and duration of response, ECOG performance status, safety and side effects, quality of life as well as pharmacokinetics and serum estradiol levels. Furthermore, the effect of RAD001 on bone marrow and on markers of angiogenesis and apoptosis is investigated. Objective: about 445.000 disabled women live in Bavaria, who face a lot of unique challenges in accessing medical care. They report an insensitivity to their specific health care needs. More than healthy individuals disabled women have a wide array of health-related issues, including multiple concurrent co-morbidities, psychosocial issues, an socioeconomic concerns. Overall, they experience a fragmented health care delivery-system that often is inadequate in important areas such as reproductive health, post-reproductive health and sexuality. In order to address these issues, the Klinikum Dachau institutionalized an outpatient service for disabled women in the rooms of the hospital. The mission of this clinic is to develop a model of comprehensive women-centered care with special focus to their disabilities. Materials and methods: From November 2007 to January 2010 we performed 263 examinations of disabled women, the majority of them had neurologic disorders such as cerebral pulsy, multiple sclerosis, and paraplegia after injuries of the spine. We evaluated the reasons for their presentation and the special needs of gynaecologic care.

Results: Approximately 80% of the women with a median age of 39 years were severely disabled. They needed special assistance and a lifter for climbing the gynaecologic chair. Over 32% of the women presented uterine fibroids, endometriosis or ovarian cysts, irregular menstrual periods and reported deterioration of their neurologic conditions (esp. epilepsia) during menstruation. Together with the growing experience of the gynaecologists questions concerning sexuality and sexual help became more often. The ability to identify and survey a representative sample of disabled women and to develop a database linking demographic, physical disability, economic, and health care access information is a key step in implementing a crossfunctional approach towards improving the level and scope of healthcare for disabled women. patients that need to be counselled, the efficacy and risk of the applied procedures are still poor. We therefore analysed the registry of the network FertiPROTEKT (www.fertiprotekt.eu) which includes 69 infertility and oncology centers in Germany, Switzerland and Austria. Materials and methods: 1280 patients (age 15-40) were counselled regarding fertility preservation before cytotoxic therapies in [2007] [2008] [2009] . Depending on tumour characteristics, oncologic therapeutic regime and time till start of the chemotherapy, patients were treated by ovarian stimulation and cryopreservation of unfertilized and fertilized oocytes, cryopreservation of ovarian tissue, GnRH analogues and/or by transposition of the ovaries. We analysed the characteristics of the patients, spectrum of chosen techniques, number of aspirated and cryopreserved oocytes and complication rates. Objective: The objective of this study was to evaluate the excision of the endocervix during laparoscopic supracervical hysterectomy (LSH) with regard to postoperative cyclical bleeding. Materials and methods: We evaluated 300 patients who underwent LSH for benign bleeding disorders. In 150 patients the uterus was transected from the cervix using a monopolar loop. In a second series of 150 patients a unipolar needle electrode was used for the uterine amputation and the excision of cervical canal. Results: The mean duration of the transsection was 65 s (lap-loop) versus 168 s (needle). There were no differences between both groups regarding mean age, body mass index and uterine weight. The excision of the endocervix was performed without any complications in 148 procedures. Histologic examination of the removed tissue revealed endocervical tissue in 83.3% (n = 125), endometrium in 9.4% (n = 14), cervico-isthmic mucosa in 3.3% (n = 5) and myometrium only in 4% (n = 4). All 300 patients were contacted 12month postoperatively to inquire about bleeding status and 282 (94%) responded. In patients who underwent excision of the endocervix postoperative cyclical bleeding was significantly reduced compared to the control group (1.4% versus 10.7%).

The results of this study indicate that the routine excision of the endocervix is a quick safe procedure which allows a significant reduction of postoperative cyclical bleeding in patients who undergo LSH.v. Objective: Laparoscopic surgery was one of the important developments of the last 3 centuries in medicine. Now further progress to scarless surgery was introduced by attempts of performing surgical interventions in the abdomen cavity only through natural body orifices (NOTES). Preexisting embryonic scar of umbilicus is another option. The problem so far was handling of laparoscope and instruments through one single aperture. New technical developments try to overcome this restrictions and to enable surgery with invisible scars. Materials and methods: We performed 13 Umbilical Single Entry Laprascopies (U-SEL). Procedure: pneumoperitoneum with Veressneedle, three tiny circular incisions at the inner border of the umbilicus, 3 small-headed single-use trocars, a 5 mm-60°-laparoscope, additional to conventional instruments used distally bendable instruments, for tissue extraction Tyco EndoCatch.

Results: Patients aged from 28 to 57. Number of different surgery indications were: sterilisation 5, sterility 2, polycystic ovaries 1, serous cystadenoma 1, dermoid cysts 3. Type of interventions: 3 unilateral adnexectomies, 1 cyst resection, 5 bilateral tubal coagulations, 1 ovarian drilling, 2 adhaesiolysis, 2 chromopertubations, 4 EndoCatch tissue removals. Additionally in 5 cases we used Valchev uterine manipulator. In one case secondary trocar incision in lower abdomen was necessary. 4 patients had additional interventions. Average surgical times were 20% longer. There were no intra-or postoperative complications, except one prolonged wound healing. Degree of patients satisfaction 4-6 weeks after surgery was high.

Conclusions: Adnexal surgery with method described is effective and safe and can be done with low complication rate. Use of special introductory devices and open umbilical incision is not necessary, same goes for traumatic removal of tissue through the vagina. Patients satisfaction with surgery results was high, particularly in case of absent visible scars. Further experiences must show if this method can also be used for interventions on the uterus.

Non-pegylated liposomal doxorubicin as second-line therapy for patients with platinum-refractory recurrent ovarian cancer: preliminary data of a multicenter phase II trial Objective: The prognosis of patients with platinum-refractory recurrent ovarian cancer is poor. There is a need for salvage therapies with anti-tumor activity and acceptable toxicity for maintaining quality of life. Non-pegylated liposomal doxorubicin (Myocet Ò ) is a promising drug fulfilling these demands. We present preliminary data of a multicenter phase II trial to study tolerability of non-pegylated liposomal doxorubicin in second-line setting.

Materials and methods: Patients with platinum-refractory recurrent ovarian cancer received non-pegylated liposomal doxorubicin 75 mg/ m 2 d1q22 and 60 mg/m 2 d1q22 after study dose modification, respectively. Toxicity was evaluated according to CTC-NCI criteria. Quality of life was assessed using the QoL-30-questionnaire. Response was evaluated every three therapy cycles by CT/MRI imaging and course of Ca 125.

Results: 29 patients have been enrolled in the trial so far. 153 cycles of non-pegylated liposomal doxorubicin have been administered altogether. 29 patients were evaluable for toxicity. ORR was 22 %, further activity data will be presented. Main non-hematologic toxicity was nausea and vomiting (16 patients grade I/II), whereas no PPE was observed. A grade III hematologic toxicity occurred in two patients. As a consequence, treatment schedule was modified to 60 mg/m 2 d1q22. After dose reduction no grade III/IV hematologic toxicity was noted. There were three patients with grade III allergic reactions on infusion that could uncomplicatedly be managed. Quality of life could be maintained during treatment according to the QoL-30-questionnaire analysis.

Conclusions: Non-pegylated liposomal doxorubicin administered in a treatment schedule with 60 mg/m 2 d1q22 seems to be well manageable without relevant hematotoxicity and with tolerable nonhematologic toxicity (mainly nausea). Further observations are needed to confirm these preliminary experiences on a larger number of patients.

PO-Onko 01.100 Role of secondary cytoreductive surgery in the 1st relapse of epithelial ovarian cancer: who will benefit? An analysis of 240 consecutive patients 

Objective: In contrast to primary ovarian-cancer (OC), the value of surgery in relapsed OC (ROC) remains unclear. Primary objective of the present study was to evaluate clinical predictors of operability and the impact of tumor-debulking surgery on overall-survival (OS) in patients with the first relapse of OC. Materials and methods: All consecutive patients who underwent secondary tumor-debulking surgery due to the first OC-relapse were prospectively analyzed as based on a validated intraoperative documentation-tool. Logistic-regression-analysis was performed to identify independent predictors of mortality. Conclusions: Absence of ascites, platinum-sensitivity, initial FIGOstage \IV and complete tumor-resection correlate with a significantly better long-term prognosis after ROC-surgery. However, a significant trend of continuously improving survival associated with increasing tumor reduction rates could be identified even in patients where a complete tumor resection is not achievable. Extrapelvic tumorinvolvement, interval to primary diagnosis and age do not seem to have any independent impact on survival.

PO-Onko 01.101

The reverse transcriptase inhibitor Truvada induces cell cycle arrest in ovarian cancer cells Objective: The first HIV drug AZT (azidothymidine) was originally developed as a nucleotide antagonist for cancer treatment purposes, though AZT is currently being replaced for both HIV and cancer treatment by more effective, more specific, and more tolerable drugs.

We re-evaluated current HIV nucleotide antagonists on their potential usefulness as anti-cancer drugs. Materials and methods: Several currently applied HIV NRTIs were tested for their effect on ovarian cancer cells in cell culture by means of cell survival analysis (MTT assay) and cell cycle distribution analysis (FACScan).

Results: Truvada, a combination drug of emtricitabine (a cytidine analogue) and tenofovir (an adenine analogue), significantly induced cell cycle arrest in ovarian cancer cells. Inhibition of cell proliferation was associated with marked changes in the cell cycle distribution and cyclin expression. The Truvada constituents induced BRCA1 activation, suggesting DNA damage-induced by misincorporation of these nucleotide analogues into the DNA. Although the DNA damage and cell cycle arrest did not result in apoptosis, as confirmed by FACS analysis, pre-incubation of ovarian cancer cells with Truvada markedly enhanced the sensitivity of ovarian cancer cells to doxorubicinmediated apoptosis.

Conclusions: The nucleotide reverse transcriptase inhibitor Truvada can induce cell cycle arrest in ovarian cancer cells that could be used to sensitize ovarian cancer cells to doxorubicin-mediated apoptosis.

Evaluation of aberrant promoter methylation as prognostic marker for ovarian cancer Objective: Most cases of ovarian cancer (OvCa) are detected at a late stage thus exhibiting a poor prognosis. The outcome is related to the residual tumour mass and the chemotherapeutic response. To date, no reliable prognostic markers are available for OvCa. Therefore the aim of this pilot study is to evaluate the possible use of epigenetic aberrations as prognostic markers.

Materials and methods: Using methylation-specific PCR we retrospectively analyzed tumour samples for the promoter status of genes known to be methylated in OvCa. These genes are involved in proliferation, apoptosis or drug metabolism. Samples with complete clinical data (n = 25) were classified according to the progression free period ([18 months n = 16; \18 months n = 9). The groups were compared for clinical parameters and methylation frequencies.

Results: Both prognostic groups comprised pT3 tumours (mainly pT3c serous adenocarcinomas) and exhibited the same frequency of lymph node metastasis (67% vs. 69%) and an equal median age (59 and 59.5 years). As expected we detected a higher proportion of incomplete resected tumours within the poor prognosis group (67% vs. 38%) thus confirming the prognostic value of free resection margins. Three genes showed different hypermethylation frequencies in both groups: DAPK 33% vs. 68%; HIC1 56% vs. 38% and OPCML 22% vs. 56% in the poor vs. good prognosis group respectively. Although noticeable these differences do not reach statistical significance (Chi-square test) but should be explored further using larger patient cohorts. Conclusion: The differential outcome-related promoter methylation of some genes points to the possible use of epigenetic aberrations as prognostic markers. At present we are using array-based genomewide methylation analyses to identify genes differently methylated in patient groups exhibiting identical clinical characteristics beside the occurrence of relapse (median time to progression 841 days vs. median recurrence free time 1270 days). Objective: In this multicentric phase III study the combination of PEG-Doxorubicine (30 mg/m 2 ) in combination with carboplatin AUC 5 d1 q 21d, compare with carboplatin and paclitaxel (175 mg/m 2 ) d1 q 21d in the treatment of platin-sensible ([6 month after platin-taxan firstline therapy) ovarian cancer. 976 pts after 1st-or 2nd-line platinumbased therapy who had been pretreated with a taxane were randomized to either C-D. The primary endpoint was PFS. Randomization was stratified according to therapy-free interval of (1) 6-12 months (2) [ 12 months. The patients characters were not different between the both arms. From 4/05 to 09/07, 976 pts were enrolled, 467 to C-D arm and 509 to C-P arm. Pt parameters were well balanced. 85% of C-D and 78% of C-P pts received C 6 cycles. Median follow-up is 21mo.

Overall survival is still too early to be reported (n = 308 deaths). This is the final analysis for PFS and toxicity.

Arch Gynecol Obstet (2010) 282 (Suppl 1):S63-S270 S129

Results: For the trial are below. In 35% of the cases was the time to progression 6 to 12 months. The adverse reaction rate in this group did not differ from the total population. Conclusions: This trial, the largest in relapsed ovarian cancer, showed significant superiority of PLD-carboplatin combination in terms of PFS. In addition, compared to paclitaxel-carboplatin, PLD-carboplatin was well tolerated with lower rates of severe and long-lasting (neuropathy) toxicities. Objective: One severe complication of lymphadenectomy in ovarian cancer patients is postsurgical lymphfistulas causing chyloric ascites. Treatment of this complication ends often in surgical closure of the fistula. Here we report a new conservative treatment of such patients with Somatostatin. This hormone is produced naturally in the pancreas, in particular cells of the gastrointestine and in the hypothalamus. A synthetic Somatostatin is Octreotid which inhibits the production of pancreas enzymes to treat severe bleedings of the gastrointestine and postoperative fistulas of the pancreas and upper gastrointestine. Materials and methods: From January 2007 until April 2010 five patients with massive chylous ascites due to extended lymphadenectomy during Staging laparotomy because of ovarian cancer were treated with the peptide hormone Somatostatin at the department of Gynecology University Hospital Ulm, Germany. All patients had a higher stage of disease. They all had positive lymph nodes and underwent typical radical surgery including pelvin and paraaortal lymphadenectomy. Due to high loss of chylous ascites (average amount of 1000 ml per day) after surgery the patients received a treatment with either Bendatreotid 100 lg 39 a day or Sandostatin 100 lg twice a day accompanied by parenteral nutrition due to fasting.

Results: At the end of the Somatostatin treatment average loss of fluid was 200 ml to a trace. Nutrition carence and parenteral nutrition was followed by a diet with fatfree, followed by fatpoor alimentation. Conclusions: Patients who suffer from massive postoperative chylous ascites after lymphadenectomy often underwent another surgery to treat the fistulas. Rational of the somatostatin treatment was to reduce lymphatic transport by reduction of fatty acid absorbtion in the small intestine to obtain natural closure of the fistula. In our case this treatment worked in all cancer patients so that an attempt with somatostatin should be made in patients suffering from fistulas after lymphadenectomy.

PO-Onko 01.105 Long time results of 178 women with Borderline ovarian cancer: results of the multicenter tumour register of the tumour centre of Berlin

Borderline tumors of the ovary are rare and differ considerably from ovarian cancer in means of tumor biology and disease progression. However, the data base on this very rare entity and its clinical behaviour is weak. To improve this situation clinical data of the Tumour Center Berlin, a joined venture of eight cancer centers in Berlin have been analysed from 2005 to 2008 in regard to epidemiological data and outcome. The median age of patients with borderline tumor of the ovary was 50 years (range 12-90 years) and therefore significantly lower than ovarian cancer patients (range, p etc). The median follow-up period was 21 month (range 0-54). During the analysed period 6 patients died. The 3-year survival rate was 98% and therefore significantly higher than in patients with ovarian cancer. On the basis of these data a prospective data register has been established, which takes special concern in operative aspects and ways of fertility preservation.

PO-Onko 01.106 Malignant ovarian teratoma (neurogenous cell carcinoma) arising from mature dermoid cyst: a case report *Maike Manz 1 , Regine Ga¨tje 1 , Swati Jatekaonkar 1 , Lars Hanker 1 , Manfred Kaufmann 1 1 Universitätsklinik, Gynäkologie/Geburtshilfe, Frankfurt/Main, Germany

Objective: Teratomas are germ cell tumors which in gynaecology mostly occur to be benign (i.e., dermoid cyst). Malignant transformation in females is a rare event (\3%), while male teratomas commonly have malignant entity. The median age of patients with teratomas is during the reproductive years. Female patients who S130 Arch Gynecol Obstet (2010) 282 (Suppl 1):S63-S270 undergo malignant transformation of a formerly benign dermoid cyst are often elderly women. Malignant teratomas have a very poor prognosis. We report about the rare situation of a severe malignant ovarian teratoma in a young female patient.

Results: This 37-year-old patient underwent a laparoscopic excision of a cyst of the left ovary in 04/09. Histology showed a mature teratoma. In June 2009, she recognized loss of life-efficiency and painless proceeding growth of abdominal girth. We performed explorative laparotomy with instantaneous section. Histopathologic results showed a big (dm 16 cm) premature malignant teratoma with hepatic and peritoneal metastases. Final result of tumor notation: pT3c, pN0 (0/37), pM1 (OTH), FIGO IV. For further therapy, the patient was treated with 4 chemotherapy series of Bleomycin, Etoposid und Cisplatin, which led to stable disease till 1/10. Despite that, in 2/10 a routine restaging showed new suspicious liver formations.

We performed re-laparotomy for exploration and resection of these areas. Unfortunately, operation had to be abandoned due to inoperability. Further palliative chemotherapy in combination with autologous stem cell support is intended.

Conclusions: Due to the rare event of malignant transformation of teratomas, no standard guidelines exist for sufficient diagnosis and therapy. R0 surgery should be achieved, but often fails because of late and unspecific clinical symptoms. Regimes with Cisplatin, Vincristin, Mitomycin-C, Bleomycin have been tested, but overall and diseasefree-survival dates were very poor. Due to the rarity of the disease, further investigations on this subject will be needed. Objective: Treatment of recurrent ovarian cancer is still challenging, since standard chemotherapy fails to demonstrate long term disease control in most cases. On the other hand preliminary data indicate, that bevacizumab is active and well tolerated in patients with heavily pre-treated ovarian cancer. Moreover there is some evidence that a so called metronomic (i.e. low dose continuos) application of orally available cytotoxics may increase their antiangiogenic properties. Materials and methods: The aim of this retrospective analysis is to evaluate the feasibility and efficacy of bevacizumab given every 3 weeks (15 mg/kg), combined with orally administered cyclophosphamide (C) and methotrexate (M) according to a metronomic scheduling.

Results: To date a cohort of 17 patients is assessable for safety as a primary endpoint. All of them received prior chemotherapy with a median number of 3 regimens. Key toxicity included fatigue and gastrointestinal disorders such as nausea and vomiting. But no G3/4 side effects except neutropenia were observed. Efficacy analysis is pending.

Conclusions: Our data support that bevacizumab plus metronomic cyclophosphamide and methotrexate is a salvage therapy with a favourable toxicity profile even in heavily pre-treated patients with ovarian cancer. An updated safety and efficacy analysis will be presented at the meeting. Objective: With an incidence of 9660 cases per year ovarian carcinoma represents the fifth most common malignancy in women in Germany. Many approaches in surgical technics and medication e.g. chemotherapy increased over all survival rates. In this study we evaluated the data of the Tumorzentrum Regensburg concerning age at the time of diagnosis as a prognostic factor for over all survival in patients with ovarian carcinoma. Materials and methods: The Cancer Center Regensburg consists of a recording network including the University of Regensburg, 50 hospitals and 1100 medical practices in the region of Oberpfalz and Niederbayern. A retrospective analysis of the data from 1998-2005 with 581 patients was performed. Compared to the expected incidence in this region, this maps 75.9% of cases.

Results: The mean age at the time of diagnosis was 62.5 years for patients registered at the Cancer Center Regensburg compared to 68 years statewide (Germany). 50.4% of the patients were diagnosed at an age younger than 65. 132 patients were diagnosed with early stage disease FIGO I. 62.1% of these patients with favorable prognosis were diagnosed at an age younger than 65. After the median follow up period of 120 months more than 80% of these patients were alive. For patients older than 65 the median overall survival was 99.2 months. 41.3% of patients were diagnosed with stage FIGO III disease. The median overall survival for the cohort of patients older than 65 was 27.8 months, for patients between 50 and 65 51.5 months and for patients younger than 50 105 months. Conclusions: Patients younger than 65 were more often diagnosed with early stage disease. Patients younger than 65 have a better outcome concerning median overall survival. In this study we could show that age is an important prognostic factor for overall survival in patients with ovarian carcinoma.

modified mdr-1 specific CRAd. Objective is the specific induction of oncolysis in chemo-resistant ovarian cancer cells. Materials and methods: MDR1 expression in chemotherapy naïve and pretreated OC cell lines and primary patient cells was determined by RT-PCR. We designed Ad5/3MDR1, a fiber modified mdr1 targeted vector. Replication of and oncolysis by Ad5/3MDR1 was measured in naive and chemotherapy pretreated OC cell lines and primary patient tumor cells. Specificity of the vector was confirmed in co-cultures of pretreated ovarian cancer cells with human fibroblasts. The in vivo efficiency of a combined chemo and gene-therapy administration was studied in an ovarian cancer xenograft mouse model. Results: We could determine significant (p \ 0.05) increased expression levels of MDR1 in pretreated ovarian cancer cell lines and primary patient tumors by RT-PCR. MDR1 promotor activity was significantly increased in chemo resistant ovarian cancer cell lines (7.3-11.5%) and primary patient tumor cells ( Objective: Ovarian cryopreservation allows for fertility preservation in cancer survivors. The developmental potential of ovarian tissue fragments may vary individually and depends on various factors. Here we used the common marmoset monkey as a non-human primate model to study the effects of host treatment and graft duration on the number and morphological integrity of unadvanced follicles in xenografted adult ovarian tissue. Materials and methods: Ovarian tissues were collected from healthy adult marmosets. Tissue fragments were cryopreserved, stored for at least 4 weeks and thawed prior to grafting to ovariectomized and intact nude mice. Grafts were retrieved after 2, 4 and 8 weeks. Following exgrafting, the tissue was routinely processed and evaluated for number and morphological appearance of follicles. Results: Following xenografting of cryopreserved ovarian tissue fragments, the mean number of primordial follicles decreases dramatically 2 weeks post grafting (39.1 ± 4.7 vs 6.9 ± 0.7, p \ 0.05), and then remains unchanged after 4 weeks (6.9 ± 2.2) and 8 weeks (4.8 ± 0.5), respectively. This effect, however, is limited to the subclass of primordial follicles; the population of primary follicles remains stable after grafting when compared to tissues prior to grafting. No significant difference is shown between fresh and cryopreserved tissues regarding the relative number of primordial follicles; however, the proportion of morphologically normal unadvanced follicles is significantly lower in cryopreserved tissues post grafting. Host ovarectomy does not change the ratio between primordial and primary follicles, but allows for a higher mean unadvanced follicle number in grafted fresh tissues (24.8 ± 3.2% vs 12.5 ± 3.6%, p \ 0.05). More advanced follicular stages up to antral follicles were documented. Conclusions: Initial follicular loss following xenografting is consolidated over an extended grafting period, and graft sustainment is positively influenced by host ovarectomy. (Funded by the German Cancer Aid) S132 Arch Gynecol Obstet (2010) Objective: Ovarian tissue cryobanking is a new and promising technique to preserve women's fertility compromised by gonadotoxic therapies. Autologous grafting of frozen ovarian tissue exposes patients to the potential risk of reseeding vital tumor cells. In contrast, the combination of cryopreservation followed by tissue and oocyte in vitro maturation (IVM) might be a safer and therefore preferable alternative for oncologic patients. The aim of this study was to investigate the effect of ovarian tissue cryopreservation on the oocyte's meiotic competence in a mouse model. Materials and methods: Ovaries were collected from 7-to 17-weekold female C57BL/6 mice (n = 9) and cryopreserved following a slow freezing protocol using DMSO, ethylene glycol and sucrose as cryoprotectants. After thawing, oocytes were mechanically isolated with 27G needles and in vitro maturation (IVM) of oocytes was performed for 16-20 h under administration of 1.5 mIU/ml LH and 1.5 mIU/ml FSH. Subsequently, oocytes were classified using an inverted microscope according to their meiotic stage as germinal vesicle (GV), germinal vesicle break down (GVBD) and metaphase II (MII). Oocytes isolated from non-cryopreserved ovaries from comparable mice served as controls.

Results: The number of GV oocytes resuming meiotic development was similar between the two groups. After cryopreservation, 79 out of 90 oocytes (88%) resumed meiosis (GVBD and MII), compared to 114 out of 124 (92%) oocytes, which matured after isolation from fresh tissue, without previous stimulation-or superovulation-treatment of the animals.

Conclusions: Isolation and IVM of murine oocytes derived from cryopreserved ovarian tissue was successfully performed and showed no major difference in meiotic resumption compared to controls. Further investigations evaluating fertilization rates of these in vitro matured oocytes need to be performed. Objective: Gonadotropins are responsible for cyclic transformations in the ovary. Follicle stimulating hormone and luteinizing hormone (FSH and LH) bind to G-protein-coupled receptors and the activation of adenylatcyclase leads to an increase of intracellular cyclic AMP (cAMP). cAMP controls and induces the cAMP-dependent proteinkinase A (PKA) which is important for the regulation of the cell cycle. To gain further information about the signal transduction in human granulosa cells (GCs) after the LH-Peak we performed a PKAspecific Mikro-Array. Analysis were made on mRNA-level. Materials and methods: GCs were collected from seven patients undergoing in-vitro-fertilization at the I. Department of Obstetrics and Gynaecology, Innenstadt, Maistrasse, Ludwig-Maximilians-University. After seven days of cultivation, 100 mU/ml r-LH or plain culture-medium was substituted. Isolation of mRNA was performed after 2 h and mRNA-concentrations were measured photometrically. 300 ng of each culture were pooled and put into a Real-Time (TaqMan Ò Mikro-Array analysing 92 PKA-dependent genes.

Results: Out of a number of 92 simultaneously investigated G-proteinreceptor related genes, substitution of 100 mU/ml r-LH lead to an inhibition of mRNA under 0.6 fold expression compared to the unstimulated control in eight genes. Six genes were upregulated at least 2 fold compared to unstimulated controls. Inhibition of the mRNA for G-protein-coupled receptors corticoreleasing hormone receptor (CRFR) and glucagonreceptor (GCG) could be detected.

Conclusions: LH and FSH bind to G-protein-coupled receptors on their target cells. The results of our study show that high doses of LH inhibit G-protein-coupled receptors in human GCs. Interestingly; CRFR which is involved in stress actions is inhibited. Furthermore, GCGR which is essential for the blood sugar concentration is less expressed after stimulation with LH.

PO-Repro 01.04 Mannose-binding lectin 2 (MBL2) gene polymorphisms and their impact on pregnancy outcome Objective: Genetically determined deficiency of plasma mannosebinding lectin 2 has been shown to predispose to infectious and inflammatory diseases. Low MBL levels have been reported to have negative impact on pregnancy outcome in women with recurrent miscarriages (RM). We investigated the association of MBL2 genotypes and pregnancy outcome in RM-patients. We also did not detect any differences in the frequency of the various MBL2 genotypes in the two subgroups of LRM patients. Compared with the literature, our analyses demonstrated a higher prevalence of the low genotypes in controls (18.5%) than previously reported for European females (6-12%). Conclusions: We failed to confirm the reported increased prevalence of low-producing MBL2 genotypes in idiopathic LRM as well as in LRM with signs of infection. This might be explained by the high frequency of the low genotypes in our controls. Objective: Although several patients may benefit from reduced FSH application, in vitro maturation (IVM) belongs to the rare treatment options in assisted reproduction. We summarize our 5-year IVM experience at the University of Heidelberg. Materials and methods: Women with polycystic ovary syndrome (PCOS) as well as patients after ovarian hyperstimulation syndrome (OHSS) were offered IVM. Stimulation started between day 3-10 of the menstrual cycle and FSH dosage was 125 IU/day over 3 days. Ovulation was induced on the third day of FSH injection or one day after and oocyte retrieval was performed 33-38 h later. Oocytes were cultivated for 24 h in IVM medium. Fertilisation took place one day after oocyte retrieval and embryo transfer two days afterwards.

Results: From February 2005 to December 2009, 115 patients were included and 215 oocyte retrievals (ICSI (n = 125, 59%), IVF (n = 73, 34.4%)) with 177 embryo transfers performed. Main reasons for IVM were: PCOS (64.6%) and OHSS (15.0%). Mean number of oocytes was 8.9/oozyte retrieval with 5.9 (64%) becoming maturated, 2.8 (45.1%) getting fertilized and 2.1 being transferred. Pregnancy rate per transfer was 15.3% (n = 27), with n = 12 live births (6.8%), n = 2 ongoing pregnancies (1.1%), n = 4 abortions (2.3%) and n = 9 biochemical pregnancies (5.1%). In 61 cases, fertilized oocytes were frozen and 32 cryotransfers were performed resulting in 3 pregnancies (1 biochemical, 1 live birth, 1 ongoing pregnancy).

Conclusions: Within the last 5 years, 115 patients with PCOS or OHSS underwent IVM at our department. Although pregnancy rate was low, IVM is very convenient for patients due to low FSH dosages and rare appointments implicating low cost rates.

PO-Repro 01.06 Postpubertal mumps orchitis: a case report 

Objective: The overall reproductive ability of men and women is decreasing with age, leading to an increasing need for reproductive procedures (e.g. IVF, ICSI, IUI). Therefore age-related degenerative changes of the reproductive system should be an important aspect of anti-aging research. Reasons why a couple may not have children are manifold and even unexpected some times, as our case report shows. Materials and methods: At first the cause of infertility in a married couple (male 57 years, female 37 years) was not obvious, since there were only normal findings for the female and the male partner had already two adult children out of his first marriage. However, sperm analysis showed an complete azoospermia. The reason was not as expected, an age related azoospermia, but an epidemic parotitis (mumps), which the male received at the age of 32, years after his two children were born. Mumps is known to cause sterility in men; a postpubertal mumps orchitis is associated in 20-40% of the males with azoospermia. In such cases regular infertility treatment is not successful. However, testicular sperm extraction (TESE) could provide some mobile sperms, enabling Intracytoplasmic sperm injection (ICSI). The case observed, emphasizes two aspects: Firstly, complex reproductive medicine is a powerful tool to overcome severe infertility problems, and secondly, simple, but careful anamnesis of the individual case is important, to exclude misinterpretations.

PO-Repro 01.07 Molecular effects of heparins on the human endometrium are not directly related to the coagulation system *Julia Spratte 1 , Herbert Fluhr 1 , Marek Zygmunt 1 1 University of Greifswald, Department of OB/GYN, Greifswald, Germany

Objective: We have demonstrated that heparins modulate the decidualization of human endometrial stromal cells (ESCs) and the action of the inflammatory cytokines IFN (interferon)-c and TNF (tumor necrosis factor)-a. The molecular mechanisms of these heparin effects are still unknown and it remains open, whether they are associated with classical anticoagulation or not. In the present study we therefore further specified this non-coagulatory mode of action of unfractionated heparin and the clinically well established LMWHs (low molecular weight heparins) in human ESCs in vitro. Materials and methods: Human ESCs derived from hysterectomy specimens were decidualized in vitro using 17b-estradiol and progesterone. The cells were incubated with IFN-c, TNF-a, heparin, dalteparin, enoxaparin, certoparin, dextran sulfate or fondaparinux. The secretion of IGF (insulin-like growth factor)-I was measured by ELISA. IL (interleukin)-6 mRNA expression was determined using real-time RT-PCR. The activation (phosphorylation) of STAT (signal transducer and activator of transcription)-1 was detected by in-cell western assay.

Results: During early decidualization of ESCs heparin enhanced the up-regulation of IGF-I secretion. This dose dependent effect showed a characteristic bell-shaped curve. Similar effects were mimicked by dextran sulfate but not by fondaparinux. The LMWHs certoparin, dalteparin and enoxaparin also showed an augmentation of the IGF-I secretion. Comparable effects of the mentioned agents were seen on TNF-a induced IL-6 as well as IFN-c mediated activation of STAT-1.

Conclusions: Heparin and LMWHs have an influence on the cell biology of the human endometrium. These heparin effects seem to be independent of their classical anticoagulatory function but one could presume a dependency on the electric charge of the molecules. Therefore heparin and LMWHs seem to be an interesting pharmacological approach for the therapy of endometrial pathologies. Especially the effects independent of anticoagulation should be further taken into account.

PO-Repro 01.08 Antigen-presenting cells in pregnant and non pregnant human myometrium Objective: Inflammatory cells and mediators play a crucial role in human parturition. Different populations of leukocytes invade cervix, placenta and fetal membranes as well as the myometrium. Numerous studies have described the decidual immune cell population in preg-S134 Arch Gynecol Obstet (2010) 282 (Suppl 1):S63-S270 nant and non-pregnant endometrium. However, little is known about the presence of immune cells in human myometrium which is in direct contact to the endometrium. Materials and methods: We herein analyzed a broad spectrum of immune cells in human myometrium comparing tissue samples from non-pregnant (n = 8) and pregnant (n = 10) uteri. Applying immunohistochemistry and a panel of antibodies which are specific for Tcells, monocytes, NK-cells, B-cells and antigen presenting cells (CD4, CD8, CD14, CD15, CD16, CD19, CD56, CD68, CD83, HLA-DR, DC-Sign, mastcelltryptase), we characterized the immune cell population of human myometrium. Results: A significantly higher number of CD14, CD15, CD16, DC-SIGN as well as CD4 positive cells was found in myometrium of pregnant compared to non-pregnant uteri, while mast cells were significantly reduced in pregnant myometrium.

Conclusions: All markers found increased in pregnant myometrium indicate monocyte/macrophage lineage cells and thus suggest a possible involvement of these cells in healthy pregnancy maintenance. Monocytes/Macrophages might produce a microenvironment that permits a controlled invasion of trophoblast cells into the myometrium while preventing a rejection of the semiallogenic conceptus and providing an important barrier against invading pathogenes.

PO-Repro 01.09 Cryopreservation of oocytes before chemotherapy in a patient with breast cancer and intrauterine pregnancy Objective: Increasing survival rates of cancer patients and progress in reproductive medicine have resulted in the development of different options of fertility preservation: ovarian stimulation and freezing of fertilized and unfertilized oocytes, ovarian tissue banking, in vitro maturation and medicinal methods like GnRH-agonists during chemotherapy. Short protocol with GnRH-antagonists is usually used for stimulation. If the tumor is oestrogen-dependent, stimulation may be combined with 5 mg letrozol daily applied simultaneously with the gonadotropin. Materials and methods: A 38-year old gravida 2 para 0 with newly diagnosed breast cancer pT2, pN2 (6/12), G2, L1, M0, ER 10/12, PR 10/12, Her2neu 1+ wished to cryopreserve her unfertilized oocytes before chemotherapy (39 FEC, 39 Paclitaxel). A breast ablation had already been performed. We immediately started stimulation in midluteal phase on cycle day 26 with 300 IE HMG, GnRH-antagonists and letrozol 29 250 mg daily during the first five days of stimulation. Ovulation was induced on day 11 (10,000 IE HCG, 0.2 mg Triptorelin). 17 oocytes had been aspirated and cryopreserved with slow freezing. During stimulation luteolysis did surprisingly not occured, so a pregnancy test was performed on day 11 (HCG 3,493 mIU/ml). Sonography showed an intrauterine pregnancy (5+0 SSW). The aspirated follicles showed a normal morphology (metaphase II) despite high progesterone levels during stimulation. The patient decided to interrupt her pregnancy before she started chemotherapy.

Conclusions: This case shows a successful stimulation with cryopreservation of oocytes during pregnancy which had been conceived in the same cycle before stimulation was started in midluteal phase. Stimulation was performed in the shortest possible time maintaining lowest possible levels of estradiole. The quality of oocytes had not been influenced negatively by high progesterone levels in pregnancy. The current study applies the ethics of moral sentimentalism, based on the reflections of David Hume (1711-1767), a Scottish philosopher of the age of enlightenment on the moral status of the embryo. The fact that in Germany abortion is common and socially accepted, while at the same time preimplantation diagnostics (PID) is forbidden, represents a paradox, which we try to explain resorting to the ethical concept of moral sentimentalism. David Hume observed that moral reflections and decisions in humans are rather driven by the passions than by reason. This speculative concept is supported by recently published neuroimaging studies. Scientific innovations are often seen with distrust, due to modern myths, such as Mary Shelley's Frankenstein or Aldous Huxley's ''Brave New World''. Secondly, our Christian background causes a special sensitivity towards science concerning the beginnings of life. Last but not least, in Germany due to our particular history, genetic testing has a negative connotation. Thus, a scientific innovation, such as PID, frequently induces a vague feeling of anxiety in the spectator. Accordingly, such new methods are at first morally rejected by the majority. However, by sheer force of habit these innovations are frequently meet with indifference and finally morally approved in the course of time. This development could be observed in different areas of medicine, such as heart transplant and in vitro fertilization. According to David Hume's ethical concept the different moral value of the embryo in the uterus and in the petri dish are based on different stages of moral adaption. Thus, moral sentimentalism cannot establish the moral status of the embryo as a fixed constant. By clarifying, that our moral judgement does not base exclusively on reason and rationality, it can however raise the ongoing debate paradoxically to a more rational level.

Heparin has anti-inflammatory effects on the human endometrium by interacting with TNF-a-and IFN-csignaling *Herbert Fluhr 1 , Julia Spratte 1 , Marek Zygmunt 1 1

Objective: The pro-inflammatory cytokines tumor necrosis factor (TNF)-a and interferon (IFN)-c are secreted by immune cells and have an influence on the implantation of the embryo in the endometrium. Both mediators seem to play an essential role in the pathophysiology of repeated implantation failure and habitual miscarriages. The use of heparins might be beneficial in the prophylaxis and treatment of these implantation disorders. We therefore investigated whether heparin has a regulatory effect on TNF-a-and IFN-csignaling in human endometrial stromal cells (ESCs) in vitro. Materials and methods: Human ESCs were isolated from hysterectomy specimens and decidualized by the use of 17b-estradiol and progesterone. After incubating the cells with TNF-a or IFN-c with/without heparin the activation of the connected signaling pathways was analysed by flow cytometry (I (inhibitor of) j-Ba, IFN-cR (receptor)), transcription-factor-assays and confocal microscopy (NF (nuclear factor)-jB), In-Cell-Western-assays (STAT (signal transducer and activator of transcription)-1-phosphorylation) as well as real-time RT-PCR (IRF (IFN-response-factor)-1 and Nmi (N-myc-interactor).

Results: In human ESCs heparin had no influence on the TNF-amediated degradation of cytoplasmatic IjBa, but inhibited the transcriptional activity of NF-jB in the nucleus. However, the nuclear translocation of activated NF-jB was not disturbed by heparin. Heparin dose-dependently inhibited the IFN-c-induced phosphorylation of STAT-1 and the consecutive induction of the IRF-1 gene. Thereby heparin interfered with the binding of IFN-c to the cell surface of ESCs. The expression of the IFN-cR was not regulated by heparin. Conclusions: Heparin inhibits signaling pathways of inflammatory cytokines (TNF-a and IFN-c) in human ESCs via different mechanisms. These molecular observations further underline the role of heparin beyond its classical anti-coagulatory effects. In daily practice heparin and its derivates might be interesting anti-inflammatory agents for the improvement of implantation rates in reproductive medicine as well as for the prophylaxis of habitual miscarriages. Objective: To evaluate the outcome of frozen-thawed Embryo transfer (FET) a retrospective analysis was performed comparing the pregnancy rates of patients undergoing FET either in a spontaneous or an artificial cycle. Materials and methods: Data of 203 patients undergoing FET at the Department of Endocrinology and Reproduction in Ulm between 2000 and 2008 were included, retrospectively. 148 women received FET with spontaneous cycle (group A) and 55 women with an artificial cycle (group B). Subgroup analysis was performed in the cohort receiving two embryos in total; n = 93 spontaneous cycle (group A1), n = 36 artificial cycle (group B1). Pregancy rates, endometrial thickness, Estrogen (E2)-, Progesteron (P)-and Luteal Hormone (LH) Levels were measured. Results: In the total cohort, pregnancy rate was 34.5% and 21.8% in the group A and B, respectively without statistical significance; p = 0.084. There was no difference in endometrial thickness or P-Level, but as well LH-level as E2-level were significantly higher in group B than in group A (p \ 0.0001). In the subgroup analysis, pregnancy rate was 37.6% and 27.78% in group A1 and B1, respectively; p = 0.2921. Again there was no difference in endometrial thickness or P-level. LH-level and E2-level were significantly higher in group B1 than in group A1; p = 0.0068 and .0001 respectively.

Conclusions: Our retrospective study shows a trend towards higher pregnancy rates in spontaneous FET compared to artificial FET despite lower estradiol levels and lower endometrial thickness. Large randomized controlled trials are needed to confirm this trend.

PO-Repro 01.13 Cumulus cell glycodelin relates to oocyte maturation Objective: The protein Glycodelin (Gd) shows inhibitory or enhancing effects on the fertilization process depending on its glycosylation pattern. Only the mature oocyte has the best chance to become fertilized, and the surrounding cumulus oophorus cells must create an optimal microenvironment for the passage of the spermatozoa. Therefore the aim of this study was to evaluate the relationship of egg maturity and the amount of Gd in cumulus cells. Materials and methods: Cumulus cell samples derived from 75 individually denuded cumulus oophorus complexes (COCs) of 14 patients attending our clinic for ICSI treatment were stained for Gd. A Gd-staining index (Gd-SI) per oocyte for at least 100 cumulus cells was calculated. The maturity characteristics of the COC and the morphology of the corresponding oocyte after hyaluronidase treatment were evaluated, and at least the calculation of the mean Gd-SIs for the premature, mature and post-mature stages followed. Results: The Gd-SIs are related to egg maturity, since Gd-SIs were the lowest in cumulus cells from premature stages, and during oocyte maturation the Gd-SIs increased (P \ 0.05). Conclusions: The difference in Gd-SIs of oocytes with morphological features of prematurity, maturity and postmaturity indicates that there is a relationship between oocyte maturity and the amount of Gd in the corresponding COC.

Endocrinology PO-Endo 02.01 The ''special'' situation of genetic testing and prenatal diagnosis in Germany: remarks on the influence of history The situation in Germany is quite different to that in Europe and the USA. The legal regulation on prenatal diagnosis and genetic testing are 'special'. In law and in fact this is determined by the act on abortion ( § § 218, 1976, then 1995) , on protection of embryos (Embryonenschutzgesetz, 1990 (Embryonenschutzgesetz, , then 2001 ) and on genetic testing (Gendiagnostikgesetz, 2009). Those regulations are stricter than in other countries. I.e. preimplantation diagnosis (PID) is forbidden. Objective: What are the reasons for those strict legal regulations? Results: Since 1945 we have in Germany a lively debate on questions of genetic testing and prenatal diagnosis. This is dominated on the one side by the organisation of disabled persons (Aktion Mensch) and on the other hand by persons claiming their right of self-determination and also freedom of research. Till today this discussion is going on and the arguments of both sides are reflected in a heterogeneous legislation. Some of the reasons are

• The reference to the Third Reich till today works as discussion stopper • Personal continuities in science and politics • Consequences of KZ medical experimentation in the 1940s • Necessity to break with Third Reich • Increasing Focus on ethical implications of diagnosis and therapy

Conclusions: The situation in Germany is mainly determined by historical experiences and reasons. But there is decreasing knowledge about the situation in the Third Reich, i.e. of the politics of eugenics and euthanasia. So it is hardly possible to discuss without any reservations about genetic testing and prenatal diagnosis in Germany: The influence of history is dominating the discussion about genetic testing and prenatal diagnosis direct or indirect.

Arch Gynecol Obstet (2010) Results: While pelvic ultrasonography and CT were not successful, a selective venous catheterization led to the diagnosis of an occult tumor of the right ovary. Laparoscopic bilateral salpingoophorectomy was performed, and histopathological examination revealed a hilus cell tumor of 7 mm in diameter. After removal of the ovaries, the serum levels of testosterone returned rapidly to the normal range.

Conclusions: Although rare, in postmenopausal women with high testosterone serum levels, a hilus cell tumor should be taken into consideration as differential diagnosis. The performance of selective catheterization is a valid approach to identify the origin of elevated androgen production.

PO-Endo 02.03 Inhibin A, Inhibin B and Activin A in patients with oral contraceptives: are these markers of residual ovarian function?

Results: Group 2 showed a breakup of cyclic secretion of Inhibin A, Inhibin B and Inhibin Pro-a-C. Inhibin A and Inhibin Pro-a-C were suppressed by OC. In group 2, Inhibin B showed an increase by day 4 (higher than control group) and a decrease by day 7. No difference between the two groups could be detected for Activin.

Conclusions: There is a significant effect of OC on ovarian proteohormones: suppression of Inhibin A, Inhibin B and Inhibin Pro-a-C as well as a change in secretion pattern. As we showed a suppression of Inhibin A, B and also Inhibin Pro-a-C, there must be not only a suppression of hormonal release, but also of hormonal synthesis, caused by missing follicular development. Not all follicular endocrine activity is suppressed: We detected an increase of Inhibin B by day 4. This effect could be used to determine an individual minimal hormonal level for a safe contraconceptive action of OCs.

PO-Endo 02.04

The predictive value of antiTPO-antibodies for Hashimoto's thyroiditis and its relevance in gynecology Objective: Hashimoto's thyroiditis (HT) is the most prevalent cause of subclinical or overt hypothyroidism and is known to affect female health issues such as fertility, pregnancy outcome and others negatively. It is mostly defined by elevated levels of auto-antibodies against thyroid peroxidase (antiTPO); based on these, patients are treated. The aim of the study was to evaluate the predictive value of antiTPO for the presence of HT as confirmed by histologic examinations in women undergoing thyroidectomy. Materials and methods: In a preliminary analysis of a prospective study 320 women undergoing thyroidectomy were included. Preoperative antiTPO-levels (normal range: 0-63 IU/mL) were compared to histological results including thyroiditis grading. In addition, all patients answered a questionnaire about general symptoms and female health.

Results: A total of 55 patients (17.2%) revealed elevated preoperative antiTPO-levels. Histological signs of thyroiditis were found in 130 patients (40.6%). Elevated antiTPO-levels were significantly associated with histological result of thyroiditis (p \ 0.01) with positive and negative predictive values, sensitivity and specificity of 90.9, 69.8, 38.5 and 97.4%, respectively. Thyroiditis grading was positively associated with antiTPO-levels (p \ 0.01; r = 0.579). All patients showed euthyroid preoperative TSH-, fT3-and fT4-levels. Several health issues were significantly associated with increased antiTPOlevels such as early miscarriage, chronic irritability and history of breast cancer (p \ 0.01).

Conclusions: Normal antiTPO levels do not rule out lymphocytic thyroid inflammation. HT is diagnosed serologically in only about 40%. AntiTPO-positive patients form a group at risk for several female health issues, who need extensive gynecological and thyreological care. 

Objective: Human endometrial function is controlled by 17ß-estradiol and progesterone as well as many local mediators. Its functions can be also altered by desired effects (e.g. contraceptives) or undesirable side-effects of drugs (e.g. tamoxifen) and environmental chemicals (e.g. pesticides). Besides pure receptor agonists and antagonists selective estrogen receptor modulators (SERMs) and selective progesterone receptor modulators (SPRMs) are in the focus of current research. Many endometrium-specific effects can only insufficiently be assessed in animals due to species differences. Here we describe a cell culture model to assess functional effects of exogenous compounds on human endometrium in vitro. Materials and methods: The human endometrial Ishikawa cell line was applied to study effects of compounds interacting with estrogen and progesterone receptors in a tissue-specific model. Test compounds were applied for 24-48 h. Reverse transcription quantitative real-time PCR (RT-qPCR) with assays from the Universal Probe Library (UPL; Roche) was used as highly sensitive and flexible method to detect chemical effects on the expression pre-selected molecular biomarkers (e.g. progesterone receptor mRNA Objective: To evaluate the efficacy and safety of a complex homeopathic remedy for the treatment of menopausal symptoms compared with placebo.

Materials and methods: 102 peri-and postmenopausal women requiring treatment for menopausal symptoms received treatment for 36 weeks. They were randomized in 3 groups to take as well the homeopathic remedy (29 12 weeks) as placebo (12 weeks Results: Reduction of symptoms after 12 weeks of treatment did not differ between remedy and placebo (-1.4 vs. -2.3 of total score MRS II, p = 0,441) and did not reach clinical significance (-3.5). Treatment with remedy for 24 weeks resulted in a total reduction of menopausal symptoms of -1.7 or -2.0. However reduction of symptoms after 36 weeks in group 1 (M/M/P) and 2 (P/M/M) reached clinical significance (-4.2 and -4.6) including a substantial contribution of placebo (-2.5 vs. -2.6). In contrary reduction of symptoms in group 3 (M/P/M) after 36 weeks (-0.3) did not reach clinical significance. No difference between verum and placebo was found regarding safety.

Conclusions: Treatment with the complex homeopathic remedy for 12 or 24 weeks proved to be safe but did not result in clinical significant improvements of menopausal symptoms. However treatment phases of at least 24 successional weeks should be recommended for further evaluation of efficacy.

PO-Endo 02.07

The degree of cycle irregularity correlates with the grade of endocrine and metabolic disorders in PCOS patients Objective: The PeKnO-Study is a prospective observational study on the influence of perimenopausal luteal phase hormones and ovulation patterns on bone mineral density (BMD) changes over 2 years.

Computer-based cycle monitoring, pre-menstrual serum hormones, and BMD measurements by QCT are used to answer the question: Is there a correlation between decreasing rates of ovulation during the menopausal transition and increased perimenopausal bone loss? Materials and methods: Cycle-length and ovulation were monitored by participants using a commercially available cycle-monitor. Serum hormones and bone-markers were drawn during the luteal phase of every 6th cycle. At baseline and after 2 years, trabecular bone density was determined by QCT in lumbar vertebrae 1-3. Results: 68 women aged 45-53 years have been recruited so far, 50 participants completed the 24 month study. A total of [1200 cycles was evaluated, including 270 cycles with serum parameters. The rate of ovulatory cycles decreased from 67 to 47% during 2 years. The decreasing rate of ovulation correlated significantly with an increased loss of bone density (r = 0.68; p \ 0.001). 13% of the women (95% CI: 5-27%) left the normal range of bone density and were osteogenic after 2 years. After 2 years a total of 29% participating women had osteopenia. The profile analysis will be presented.

The decreasing number of ovulations in the aging ovary seems to influence the bone density of perimenopausal women. This ongoing study will further investigate the connection between anovulatory cycles in pre-and perimenopausal women and the later development of osteoporosis.

Objective: Lately, various nanomaterials have raised interest in numerous potential biomedical applications. C60 fullerenes which consist of 60 carbon atoms in the shape of a football are considered for imaging probes, antioxidants, or drug carriers. However, since they are insoluble in aqueous media it is difficult to study their activities in biological systems. Therefore, organic solvents are used for solubilization of fullerenes in water. The aim was to determine if fullerenes may also be used in ovarian applications by examining the interleukin 6 (IL-6) and 1beta (IL-1beta) production in cultured granulosa cells. Materials and methods: Granulosa cells obtained during in vitro fertilisation treatment were cultured in microplates either with 0.025, 0.1, or 0.4 mg/ml C60 fullerenes, respectively, which were prepared by two methods: a) Wells were coated with a fullerene-methanolsuspension following solvent evaporation and cell seeding. b) Fullerenes dissolved in toluene were transferred into water by sonication and added to the cells. After four days IL-6 and IL-1beta were quantified in the culture supernatant by enzyme-linked immunosorbent assay (ELISA) and compared between fullerene-treated and untreated cells. Results: As shown by ELISA granulosa cells secreted much more IL-6 than IL-1beta. Cells cultured with 0.025 and 0.1 mg/ml C60 fullerenes prepared by the methanol method produced the same amounts of IL-6 and IL-1beta like the controls. Merely cell treatment with 0.4 mg/ml fullerenes resulted in significant 5-fold and 4-fold increases in the IL-6 and IL-1beta concentrations. However, granulosa cells incubated with fullerenes prepared by the toluene method already showed with 0.1 mg/ml significant IL-6 and IL-1beta increases of 39% and 88% in comparison to untreated cells.

Conclusions: Our results show that C60 fullerenes do not influence the IL-6 and IL-1beta production of granulosa cells at the very low dose of 0.025 mg/ml and may be used for diverse ovarian applications.

PO-Endo 02.12

The expression of the vascular-endothelial-growthfactor-receptor Neuropilin-1 reveals a complex angiogenic network at the Human Fetal-Maternal Interface *Anne Christine Porn 1 , Dunja Baston-Bu¨st 1 , Andrea Schanz 1 , Jan-Steffen Kru¨ssel 1 , Wolfgang Janni 1 , Alexandra Petra Hess 1 1 Medical Center Heinrich Heine University Düsseldorf, Department of OB/GYN and REI, Düsseldorf, Germany

Objective: Angiogenesis is required for a successful implantation of the invading blastocyst. The vascular endothelial growth factor (VEGF) is known as an important key player of angiogenesis during the implantation process. Neuropilin-1 (NRP-1) was shown to play a role in angiogenesis in human endometrium during the menstrual cycle. These findings showed that besides VEGF receptor 2 (VEG-FR2) NRP-1 might additionally play a role in the vascular remodelling process during embryo implantation and establishment of a pregnancy. Materials and methods: NRP-1 protein expression was investigated in human trophoblast cell lines (JEG-3, Jar and BeWo) aiming to evaluate the expression of NRP-1 in vitro-as well as in human decidua of all three trimesters of pregnancy by western blot analysis. The localization of NRP-1 in human decidua of all three trimesters of pregnancy was further investigated by immunohistochemistry.

Results: NRP-1 protein was expressed in all cell lines examined.

Corresponding to the analysis of human tissue by western blot, NRP-1 protein was higher expressed in the early pregnancy in comparison to the end of pregnancy. NRP-1 was expressed in the decidua and villi of all samples investigated. Regarding the localization, the strongest expression of NRP-1 was shown in the vessels, stroma and glands of decidua as well as in the invading cytotrophoblast of first trimester samples, followed by a decline in expression towards the third trimester samples with only a moderate to low staining in the decidual compartment of NRP-1, and no to low staining in the corresponding cytotrophoblast.

Conclusions: This is the first study clearly showing the expression of NRP-1 in human decidua and trophoblast suggesting an important role for the VEGF co-receptor NRP-1 besides the established receptor VEGFR2 at the fetal-maternal interface during the process of embryonic implantation and placentation.

PO-Endo 02.13 Signalling cascades mediating decidual chemokine ligand 1 (CXCL1) expression *Dunja Baston-Bu¨st 1 , Jan-Steffen Kru¨ssel 1 , Wolfgang Janni 1 , Alexandra P. Hess 1 1 Medical Center Heinrich Heine University Düsseldorf, Department of OB/GYN and REI, Düsseldorf, Germany

Objective: The early fetal-maternal dialogue is a necessary prerequisite to establish a successful pregnancy. Chemokines like the chemokine ligand 1 (CXCL1) are known to be a key player in the process of decidualization and implantation. Therefore, the aim of this study was to identify the signalling cascades involved in the expression of CXCL1 induced by embryonically derived IL-1ß in human decidua in vitro. Materials and methods: Culture and decidualization (induced by progesterone and cyclo-AMP incubation for 72 h) of immortalized human endometrial stroma cells (dES) (cell line St-T1) was followed by a pre-incubation with MAPKinase, STAT3-and JNK-inhibitor for 2 h and a subsequent treatment with 0.1 ng/ml recombinant human IL-1ß for 48 h. Cell culture supernatants were collected and frozen, RNA and protein isolated after the modified single-step method. Subsequent 2 lg RNA each were reverse transcribed and PCR performed for ß-actin and prolactin mRNA. Supernatant of ß-actin and prolactin positive samples were then measured for CXCL1 secretion via ELISA. Results: Incubation with 25 lM of MAPKinase inhibitor lead to a statistically significant decrease of about 60% of the CXCL1 secretion in dES cell culture supernatants compared to only IL-1ß treated controls. 250 lM of STAT3 and 100 lM of JNK inhibitor reduced the CXCL1 secretion in dES cell culture supernatant of about 35 and 30%, respectively. Conclusions: The early fetal-maternal dialogue between embryonically derived IL-1ß and decidual CXCL1 is primarily mediated via MAPK-signalling in vitro. Chemokines are key players in this early dialogue influencing implantation, angiogenesis and mediating maternal acceptance of the semi-allograft. Further knowledge about these early interactions might increase pregnancy rates after IVFtreatment and reduce implantation-related pathologies, for example pre-eclampsia.

Arch Gynecol Obstet (2010) Objective: Placenta increta is an uncommon and potentially lifethreatening diagnosis. In case of a placenta increta all or part of placenta is adherent to the uterine wall, caused by extensive villous invasion into the myometrium. Usually abnorm placenta localisation is caused either by primary deficiency or secondary damage to the decidua basalis, most commonly considered in patients with a history of uterine surgery and advanced maternal age. Hysterectomy is a common therapeutic intervention, but the results involve the loss of the uterus and the ability to conceive. This raises the question if we can take responsibility of a hysterectomy sparing operative intervention after suitable preparation.

A placenta increta appears in 15% of all cases. In a period from 5/2008 to 4/2010 we noted a number of 13 cases suffering from placenta praevia, 3 of them with the additional diagnosis of placenta increta. 2 of those patients underwent hysterectomy as the only option to control severe and life-threatening hemorrhage. The following case report of a concerned patient shows a successful hysterectomy sparing operative intervention in face of the pre-known risks.

Results: A hysterectomy sparing operative intervention in face of the pre-known risks might be practicable in specific cases and credible preliminary.

Conclusions: Incomplete separation of the placenta after delivery is a high risk of postpartum hemorrhage and undergoing hysterectomy. Reconstruction might be a further operative option to avoid hysterectomy. Cesarean-section should be done by an experienced surgeon and in a facility of available resuscitation and intensive care.

PO-Geb 02.03 Comparison of effectiveness and safety of dinoprostone and misoprostol for labour induction at term *Andrea Kipping 1 , Ekkehard Schleußner 1 1 Jena University Hospital, Friedrich-Schiller-University Jena, Department of Obstetrics, Jena, Germany

Objective: The aim of this study was to compare the effectiveness and safety oral misoprostol with intravaginal dinoprostone applications for assisted labor induction each other and to control group of spontaneous singleton deliveries. The influence of maternal properties on the duration of induction was investigated. Materials and methods: The Jena perinatal database of 5 years (2003) (2004) (2005) (2006) (2007) was analysed, where 644 women initially receiving 50 lg misoprostol and 99 women receiving 1 mg dinoprostone for labor induction. In the misoprostol group, a repeated dose of 100 lg was applied every 4 h until beginning regular contractions. A repeated dose of 1-2 mg was applied every 6 h in the dinoprostone group. Control group data was surveyed from 699 records fulfilling the inclusion criteria.

Results: Maternal age and body weight, gravidity and parity have independently significant effects on duration of labor induction. The mean interval from starting misoprostol to delivery was 18, 3 ± 12, 9 h compared to 25, 5 ± 48, 3 h in the dinoprostone group. Within 24 h after the first medical application 81% of the misoprostol vs. 68% of the dinoprostone group could deliver (p \ 0.05). After misoprostol more women could deliver spontaneously and the number of caesarian section was less (22% vs. 33%; p \ 0.05). A potential or occurring uterus ruptures were noticed in one and two cases after receiving dinoprostone and misoprostol, respectively. A duration of first and second stage of labor \ 8 h was significantly more to record after misoprostol priming compared to the controls (p \ 0.01), whereas the risks of perineal injuries and anaemia were decreased (p \ 0.01).

Conclusions: Due to essential advantages with regards to effectiveness and safety, a labor induction with misoprostol is strongly suggested following an appropriate assessment of potential contraindications.

PO-Geb 02.04 Hellp-syndrome as early complication in molar pregnancy *Linnea Rabe 1 , Irene Alba-Alejandra 1 , Katrin Karl 1 , Ralph Ka¨stner 1 , Franz Kainer 1 1 Universitätsfrauenklinik der LMU München, Munich, Germany

Objective: Preeclampsia and HELLP-syndrome are serious complications of pregnancy. Development of preeclampsia prior to 24 weeks' gestation seems to be associated with hydatidiform mole, a gestational disorder with a very low incidence rate in all pregnancies. The fetal outcome usually is poor and continuation of pregnancy in such cases bears severe maternal risks such as preeclampsia and persistent trophoblastic disease.

Arch Gynecol Obstet (2010) 282 (Suppl 1):S63-S270 S141

Materials and methods: We report a case of a 30-year-old woman with partial molar pregnancy in one placenta of dichorionic diamniotic twins. She presented with hyperemesis, severe hyperthyroidism at 12 + 1 weeks' gestation and markedly elevated beta-hCG levels. On ultrasound examination hydatitiform mole was suspected. Despite growth retardation of both fetus and the risk of severe maternal complications the patient decided to continue pregnancy. Karyotypization analyses revealed a diploid fetus and no placental triploidy. Finally termination of pregnancy was performed at 19 + 6 weeks' gestation due to development of HELLPsyndrome.

Conclusions: Partial molar pregnancy with living fetus of a diploid karyotype poses a challenge for clinical management. Based on currently available information termination of pregnancy seems not to be indicated in such cases if close check-up during and after pregnancy is performed. This case demonstrates the dilemma of clinical management as well as the importance of close check-up even during early pregnancy to prevent life-threatening maternal conditions if the affected pregnancy is continued.

PO-Geb 02.05 Choice of collection system does not influence the quality of umbilical cord blood units Conclusions: Choice of collection system does not increase the yield of hematopoietic stem cells in umbilical cord blood donations. In our study, we could not prove an advantage of the refined collection system using a thicker needle and a satellite bag for rinsing. Since most public cord blood banks struggle for funding and most deliveries are vaginal deliveries, the use of a cheaper bag does not compromise stem cell yield. Objective: Gestational malaria infection and HELLP syndrome show a big overlap in clinical and laboratory findings. Malaria not only increases maternal morbidity and mortality but also contributes to significant perinatal morbidity and mortality. Incubation time between mosquito bite and clinical symptoms may in rare cases exceed two months complicating early diagnosis. This is of specific interest in non-endemic regions like Western-Europe with little expert knowledge and experience of malaria disease and its treatment. Materials and methods: A 34 year-old Primigravida at the beginning of the 36th gestational week presented with fever chills, headache and general malaise which quickly resolved with supportive treatment. CTG-controls showed a slightly increased fetal heart rate with a baseline of 160 bpm. Within two days the laboratory controls revealed aggravating thrombocytopenia, signs of hemolysis and an increase in transaminases to the 1.5-2 fold upper normal limits. At the fourth day after onset of symptoms the patient had a new fever chill. The decision to perform a cesarean section was made because of a pathologic CTG and under the impression of the beginning of a HELLP syndrome. The use of a rapid diagnostic test (Binax now Ò ) after postoperative ongoing recurrent fever chills in a regular quartan pattern together with a history of travels to Cameroon 2 years before and China 3 months ago finally led to the diagnosis of Malaria quartana after two negative thick peripheral blood smears. After treatment with chloroquin as recommended by the German guidelines the patient quickly recovered and was discharged at well being. Conclusions: Malaria in pregnant women can mimic the constellation of a HELLP-Syndrome. A thorough case and travel history together with the newer rapid diagnostic test can help not to miss this curiosity with devastating consequences. Keywords: Pregnancy, Malaria, HELLP-syndrome.

PO-Geb 02.07 Postpartal sexual disorders. Results from the FRAMES (Franconian Maternal Health Evaluation Studies) Results: 85.5% of the women stated that they had sexual relations in the first 6 months after birth. The mean duration before beginning of sexual activity was 9.6 weeks. The mean coital frequency was 4/month. The desire for the sexual intercourse was raised by the women in 4.7%, by the man in 8.0% and by both partners in 87.3%. Noteworthy significant facts: women, who had born a child before, scored their sexuality better; high school degree leads to an later sexual relation and less coital frequency pp; the better the anaesthesia during delivery, the better the impact on postpartal sexuality; helpless during delivery, had less sexual relations and evaluated the sexual feeling more negative; breast feeding had an negative impact on postpartal intimacy; the partner's encouragement was associated with the earlier begin of sexual activity and higher coital frequencies.

Conclusions: A lot of factors influence postpartal sexuality. While personal constitution of the mother cannot be modulated, there are still changeable factors. Therefore sufficient anaesthesia and good supervision of the women during birth should take place to minimize the psychic trauma. To prevent misconceptions, adequate education of the couple should take place in an early stage and the partners support should be highlighted. However, this study could not show significant associations between the form of delivery and the woman's sexual activity pp.

PO-Geb 02.08 Maternal and fetal mortality and morbidity in 10 hospitals in Kano and Kaduna State, Nigeria: reduction of MMR by Quality Assurance in Obstetrics Achieving the Millennium Development Goals 4 and 5 has continued to be a challenge in Nigeria, with a maternal mortality ratio (MMR) being one of the highest in the world. Objective: The activities are aimed towards establishing an Institute of Quality Assurance in Obstetrics to improve the chances of survival for mothers and their children. Materials and methods: The project commenced in January 2008 with 10 hospitals from Kano State and Kaduna State of Nigeria. With an audit the structure of the hospitals were investigated: equipment status and hygienic conditions were established using a ''hospital score''. The hospitals participated in a continuous monthly collection of data pertaining to maternal and child mortality and morbidity. In half yearly quality circles, staff from the participating hospitals discuss under supervision the unrecognizably results of each hospital. Results: The structure and hygienic status of the hospitals exhibited deficits in many areas. There was a close relationship between the ''hospital score'' and maternal mortality. Following the continuously collection of data and discussion of the results, average MMR decreased from 1790/100,000 in first half year 2008 to 0.94/100,000 in second half year 2009. The average FMR remained roughly unchanged during the time of observation: 84.9/1000 in 2008 and 83.5/1000 in 2009. The MMR was related to the total number of deliveries in a hospital, increasing in hospitals with lower delivery rates. A similar relationship was found for FMR. There was no correlation with the CS-rate, which fell from 6.6% in 2008 to 5.3% in 2009. Conclusions: Quality assurance in obstetrics is a continuous process of analysing, discussing and reducing the MMR and FMR with the guidance of an Institute of Quality Assurance. This might be a model Objective: Due to extremely low rates of maternal mortality in the modern medical setting, new indicators for the monitoring of maternal health like need for transfer to an intensive care unit (ICU) have to be identified. This study aims to assess the causes of obstetric admissions to ICUs at the General Hospital of Vienna, Austria, and to evaluate the predictive ability of the APACHE II Scoring System in obstetric patients. Furthermore the most seriously affected patients and the factors most likely associated with severe morbidity are identified. Materials and methods: A retrospective chart review of obstetric patients who were admitted between the second trimester of pregnancy and 6 weeks post partum to an ICU of the General Hospital of Vienna, a tertiary care university hospital, between 1996 and 2009 was carried out. Results: 252 patients were included which makes this data pool one of the largest ones of its kind. The observed mortality rate amounts to 2.8% while the mean one calculated by the APACHE II Scoring system is 13.3%. A majority of patients (77.6%) was admitted for complications associated with pregnancy, the most common indications being (pre-)eclampsia and HELLP (31.6%) and major hemorrhage (32.8%). Objective: Systemic mastocytosis, a rare disorder of mast cell proliferation in connective tissues, may lead to mast cell degranulation due to lots of different stimuli and (medical) drugs. Especially in pregnancy this might lead to life-threatening situations for the mother but also for the unborn. Materials and methods: A 30-year-old german women presented with systemic mastocytosis in her first pregnancy in 20th gestational week for planning her further pregnancy and the mode of delivery. Whole pregnancy the patient had mainly gastro-intestinal symptoms like diarrhoea and enterospasms. She received Prednisolon 10-30 mg in 27th gestational week and improved. Results: We could give birth to a healthy boy by elective Cesarean section with a special pharmaceutical management for the mother. Furthermore, we tried to avoid any stress by providing for a family room and also offered the patient child care whenever needed. A year after her delivery she was diagnosed a steroid-induced Addison 0 s disease. To date she is in 34th gestational week in her second pregnancy. Conclusions: Women with systemic mastocytosis, although rare, need close control and follow-up during pregnancy and confinement. Otherwise a mast cell degranulation may lead to life threatening situations for the mother and her baby. Interdisciplinar counselling is crucial.

PO-Geb 02.11 Management of placenta percreta: delayed planned hysterectomy after arterial embolization *Javier Ortiz 1 , Silvia Lobmaier 1 , Stephanie Pildner von Steinburg 1 , Hermann Berger 2 , KTM Schneider 1 , Marion Kiechle 1 1 Technische Universität München, Frauenklinik rechts der Isar, Munich, Germany, 2 Technische Universität München, Institut für Röntgendiagnostik, Abteilung Interventionelle Radiologie, Munich, Germany

Objective: Major obstetric hemorrhage is the leading cause of maternal morbidity and mortality. Abnormal placentation occurs in approximately 1:2500 pregnancies, including about 5% placenta percreta. It occurs when the villi penetrate the full thickness of the myometrium and may invade neighbouring organs. Approximately 75% of placenta percreta cases are associated with placenta previa. Materials and methods: A 32-year-old woman, gravida 4, para 2 (vaginal delivery, cesarean section), who had been diagnosed with a placenta previa, was referred at 24 weeks of gestation. The findings of our ultrasound examination with color Doppler and MRI were consistent with a diagnosis of placenta previa percreta. The cystoscopy showed no mucosal invasion. An elective cesarean with vertical fundal incision was performed at 33 weeks of gestation. A healthy, 2015-g female was delivered. Hysterectomy was postponed to avoid major bleeding as bladder was closely adhered to uterine wall and massive varicous veins were present. The placenta was not removed. A bilateral transarterial embolization of the uterine arteries was performed by radiologists on the 10th postoperative day. A total hysterectomy was planned. On the day of hysterectomy, endovascular catheters for balloon occlusion were placed within the internal iliac arteries. They were deflated after closure of the vaginal cuff with hemostasis. The estimated blood loss was about 4000 mL. The postoperative recovery was uneventful and the patient was discharged on the 14th postoperative day without any complications. The histopathology of the uterus confirmed a placenta previa percreta. Conclusions: Placenta percreta is a life-threatening condition. The increased frequency of cesarean delivery over the past years has resulted in a greater incidence of abnormal placentation. Every attempt should be made to achieve the diagnosis antenatally, to minimize maternal morbidity. A multidisciplinary approach, the use of new interventions techniques and alternate surgical approaches are the key to successful management.

PO-Geb 02.12 Combination of prostaglandins and mechanical dilatation of the cervix helps to improve induction of labour Objective: Prostaglandins, and especially the synthetic prostaglandin E1 analogue misoprostol, are successfully used for induction of labour in cases with unfavourable cervix. However, prolonged induction-delivery intervals and failure in therapy still occur. The aim of this study was to evaluate a combined treatment of prostaglandins and mechanical dilatation of the cervix, an also established method of cervical ripening, in order to reduce the induction-delivery interval. Materials and methods: In this randomized trial over 100 term pregnancies with indications for induction of labour were included. In both groups, women received a standard therapy with misoprostol. Additionally in the study group, a COOK Ò balloon was inserted in the cervix for a maximum of 24 h. The study was approved by the ethics committee, and informed consent by the patients was obtained. Main outcome parameters were duration of induction of labour, rate of failure in therapy, and rate of adverse events. Results: Compared to the control group, the induction-delivery interval was significantly shorter and failure rate was lower when using the combination of prostaglandins and mechanical dilatation. There was no difference in the incidence of necessary cesarean section and surgical vaginal delivery between both groups. Conclusions: The combination of misoprostol and COOK Ò balloon is very beneficial for induction of labour in cases with unfavourable cervix.

PO-Geb 02.13 Influence of the centralisation of perinatal medicine on perinatal outcome in a maternity clinic with more than 1000 deliveries *Kristin Emde 1 , Kirsten Amos 1 , Wolfgang Simon 1 1 Robert-Bosch-Krankenhaus, Obstetrics and Gynaecology, Stuttgart, Germany

Objective: The initiation of perinatal centres with different characteristics should contribute to a reduction of risks in obstetrics. In this analysis we wanted to explore the effect these measurements have on the clinical outcome in a maternity clinic with more than 1000 deliveries under the same head physician. Materials and methods: We selected 3 years with a similar number of deliveries, first 1995 to account for the time factor, second 2005 before initiation of perinatal centres according to the GSG and third 2007 after the effective initiation. We evaluated the data from the perinatal statistic of Baden-Württemberg and compared our own data with the data from other maternity clinics with a similar number of deliveries and with all deliveries of Baden-Württemberg. Results: In the period 1995 to 2005 first of all the general risk factors changed, as increasing age, obesity, diabetes, other illnesses and state after caesarean section, but not so much the clinical outcome of the newborn. In the aftermath we recognised as intended from GSG a shift to mature babies with a corresponding higher birth weight and a decreasing number of deliveries with risk factors. Accordingly the outcome of the newborn is better which shows the pH at birth and the APGAR score. The difference between the years is not very grave as our clinic has always found itself on a good level of outcome compared to the other maternity clinics of Baden-Württemberg. Conclusions: GSG has lead to the intended changes in clientele in the maternity clinics. Predictable emergencies in peripheral clinics are getting less and thus the clinical outcome better. But the overall perinatal outcome for Baden-Württemberg shows no improvement in spite of the better structure and supply of the perinatal centres.

Arch Gynecol Obstet (2010) Objective: Tissue Doppler Imaging (TDI) echocardiography is a recent imaging tool that allows direct evaluation of myocardial velocities. Cardiac function is often impaired in fetuses with intrauterine growth restriction (IUGR). The aim of this study was to compare radial mechanical velocities measured by Tissue Doppler Imaging (TDI) in pregnancies complicated by IUGR with normal controls. Materials and methods: A prospective study was performed on fetuses with IUGR (n = 37, group 1) and normal fetuses (n = 60, group 2) between the 20th and 40th week of gestation by TDI transversal four chamber view raw data. Ventricular peak velocities of the left (LV) and the right ventricle (RV) were analysed offline with TDIQ-Software (Toshiba Medical Systems).

Results: Radial mechanical ventricular velocities are feasible in all scans. The frame rate was 141 ± 24/s and the mean week of gestation was the 27th ± 5. The velocities of group 1 differ not significantly from group 2 (LV: group 1 14.5 ± 6,7 cm/s; group 2 14.9 ± 8.1 cm/ s, p = 0.75/ RV: group 1 13.5 ± 5.7 cm/s; group 2 12.6 ± 4.7 cm/s, p = 0.181 Objective: The number of babies born by elective caesarean section (CS) has increased dramatically in the last years. Although it is known that CS results in significant changes of the hormonal milieu, there are very few studies related to its metabolic consequences. Present work was therefore addressed to compare the metabolic profile of cord blood serum in newborns born by CS with those born by vaginal delivery (VD). Materials and methods: Cord blood was obtained after 83 deliveries by CS and 98 deliveries by VD from healthy women with normal OGTT at 26-27 weeks of gestation, accurate gestational age, singleton pregnancy and absence of congenital anomalies. Neonatal fat mass was derived from measurement of skinfolds within 72 h postnatal.

Results: Maternal age was slightly higher, pre-pregnancy BMI was similar while gestational age at delivery, birth weight and fat mass were lower in CS vs. VD. Cord blood serum glucose, triglycerides, glycerol, and nonesterified fatty acids, as well as total-saturated, monounsaturated and polyunsaturated fatty acid concentrations were lower but insulin and insulin/glucose ratio were higher in CS than in VD. These differences maintained after adjustment for maternal prepregnancy BMI gestational age at delivery, birth weight and fat mass of neonates.

Conclusions: Lower circulating glucose and lipid levels in newborns born by CS could be related to the known delay in their post-partum surges in catabolic hormones, like catecholamines and cortisol which is further enhanced by hyperinsulinemia. These metabolic changes resulting in lower available circulating substances might contribute to problems in perinatal adaption observed in newborns born by CS without experience of labor.

PO-Geb 02.16 Biobanking and networking: take a chance Objective: fMCG is a non-invasive method to detect magnetic fields generated by electric cardiac currents. Morphology and duration of fetal cardiac time intervals (fCTI) can be analyzed from 20 weeks onwards. With increasing signal quality during gestation. Pregnancies with maternal autoimmune diseases and presence of SSA-/SSB-antibodies are at risk of irreversible fetal AV-node damage through the diaplacental transferred autoantibodies particularly between 18-24th week of gestation. Markers for AV-node affection are missing and a total AV-block only can be diagnosed by ultrasound after manifestation. Early investigation of the cardiac conduction system is necessary for fetal monitoring. A new 156 channel-fMEG device dedicated for obstetrical measurements was used. Our aim was to evaluate fCTI detection starting before 20 weeks to investigate physiological changes of fCTI during gestation and to compare fCTI's between healthy fetuses with fetuses exposed to maternal SSA-/SSB-antibodies. Materials and methods: 95 fMCGs were recorded in healthy fetuses (controls) and 23 in fetuses exposed to SSA-/SSB antibodies (study group) between 15 and 41 weeks of gestational age. After bandpass filtering and signal substraction of the maternal heart signal, automatic and manual signal detection was used to obtain an averaged fMCG-graph to measure fCTI according to recommended MCG standards. Results: fCTI's could be analysed from 17 weeks onwards. Both groups showed increasing P wave-and QRS-duration with GA. Other CTI's increased only in the control group during gestation. PQ interval was longer in the study group (50.8 ms vs. 60.2 ms; p B 0.001).

Conclusions: CTI's of atrial and ventricular depolarization increased with GA in both groups and reflect the growing cardiac muscle. PQ interval was longer in the risk group. This indicates a prolonged transmission at the AV node. PQ-interval could be a possible marker for AV-node affection.

PO-Geb 02.20 Long-term amnioinfusion through a subcutaneously implanted amniotic fluid replacement port system for treatment of PPROM in humans week of gestation due to umbilical cord prolapse. The newborn boy did not have any signs of lung hypoplasia and was successfully extubated one day after delivery. Six months after the delivery the child did not have any deviation from the normal development.

Conclusions: This is the first report of successful use of a subcutaneously implanted AFR port system in humans for long-term amnioinfusion as a treatment of PPROM for prolongation of pregnancy and avoidance of lung hypoplasia.

PO-Geb 02.21 Arterial stiffness of young women with previous gestational diabetes Objective: Gestational diabetes (GDM) is a cardiovascular risk factor later in life. Our aim was to investigate the relationship between carbohydrate intolerance, obesity and arterial stiffness in women with previous GDM (pGDM). Materials and methods: Follow up examination was made in 66 women with pGDM and 27 after normal pregnancy at 38,2 ± 5,4 weeks after delivery. A 75 g 3-hOGTT was performed. Parameters of arterial stiffness (carotid femoral and carotid radial pulse wave velocity (c-fPWV, c-rPWV); carotid augmentation index (c Aix)) was assessed by using PulsePen device. Investigating them is useful, noninvasive method to asses the atherosclerosis and cardiovascular risk. Results: Abnormal glucose tolerance (AGT) was diagnosed in 23 women (IFG:5, IGT:11, IFG + IGT:2, DM:5). We divided the women into 3 groups: 1: without pGDM, normal glucose tolerance (NGT) at the follow up; 2: pGDM but NGT; 3: pGDM and AGT. There was no age difference between the groups (34.2 ± 4.1), but BMI was elevated in those with AGT, same was seen for blood pressure. The values of the area under the curve (AUC) of insulin levels at the OGTT was only lower in the control group. There was no difference among arterial stiffness parameters in the 3 groups. However we found linear association among c-fPWV and BMI and waist hip ratio (WHR) using univariate linear regression analysis (P \ 0.001, R 2 = 0.19, R 2 = 0.28).

In the AGT group were the correlations even stronger (P \ 0.001, R 2 = 0.44, R 2 = 0.65), in the two NGT group weaker (pGDM: P = 0.01, R 2 = 0.13, R 2 = 0.14; control: P = 0.03, R 2 = 0.18). There was no correlation between c-fPWV and BMI in the control group. Conclusions: Our findings could not confirm any difference in arterial stiffness parameters among young women with normal or abnormal carbohydrate tolerance after pGDM or without it. However there is a linear association of c-fPWV, representing the arterial stiffness, and BMI and waist hip ratio. , and all considered women delivered at term, with no significant difference in the Apgar scores between cases and controls. Mean foetal weight at birth was 3512 g (±651.84) in women with GDM and 3148 g (±537.92) in controls, but the difference was not statistically significant. The adiponectin concentration was higher at the 16th gestational week in women who would develop GDM than in controls. The leptine and insulin concentrations in the amniotic fluid were higher in controls, and the plasmatic glucose concentration was higher in GDM, but only the insulin concentrations achieved the statistical significance (p \ 0.05).

Conclusions: Our data suggests that in pregnancies which will be complicated by GDM, amniotic fluid adiponectin is higher and insulin level is lower in the early foetal period, while no statistically differences among plasma concentrations were found. This let us suppose that an earlier alteration in the foetal glucose metabolism would probably influence the later maternal glucose dysmetabolism, and the consequent development of maternal GDM.

PO-Geb 02.23 Placental transport of the amino acid taurine is not altered in preeclampsia (2010) 282 (Suppl 1):S63-S270 S147 pathology; we investigated whether placental taurine transport was reduced in pregnancies complicated by preeclampsia. Materials and methods: The uptake of 3H-taurine over time (10, 20, 40, 60 and 120 min) was investigated using primary villous fragments isolated from placentas of primiparous women with preeclampsia (n = 5) compared to AGA controls (n = 7). Results: Placental taurine uptake increased linearly over time in villous fragments from both preeclamptic and control subjects (p \ 0.0001). However, there was no difference in taurine uptake between preeclamptic (2.85 ± 1.06 pmol/min/mg) and control villous fragments (2.81 ± 0.51 pmol/min/mg, p = 0.94). This included one placenta from a small for gestation age infant ([5th centile) from a preeclamptic pregnancy.

Conclusions: In contrast to IUGR, placental uptake of the amino acid taurine is not decreased in preeclampsia compared to controls. This is consistent with greater villous surface area previously reported in placentas from preeclamptic pregnancies as compared to IUGR pregnancies. These data suggest that placental amino acid transport may not limit placental/fetal nutrient availability in preeclampsia. However, more data is required, especially from preeclamptic pregnancies with growth-restricted infants. Objective: Planned caesarean section is better than planned vaginal birth for the term fetus in the breech presentation. This was the interpretation given by the term breech trial, a randomised multicentre study. A follow up trial with analysis of outcome after 2 years has not shown any differences between vaginal and abdominal deliveries of breech babies. By reason of study design and methods most cases of neonatal death and morbidity in the term breech trial cannot be attributed to the mode of delivery. Materials and methods: Both of our cases deal with women with breech presentation at term. (1) (ECV) . 144 fetuses have successfully been turned into a cephalic presentation (60%). In 108 cases of successful ECV we collected or received data according the delivery. ECV was performed in singleton fetuses in breech position most times beyond 36 + 0 weeks. After information, exclusion of contraindications and consent we performed ECV at the labour ward after half an hour of cardiotocography (CTG), using intravenous Tocolysis with Fenoterol aided by ultrasound and CTG and cesarean stand-by. After the procedure all fetuses were monitored continuously for half an hour or longer by means of CTG, and again the following day. In one case we performed an emergency cesarean section (CS) because of persisting fetal bradycardia.

Results: From 144 Fetuses after successfully ECV only one Fetus turned back immediately after version but remains in cephalic position after a second attempt one week later. We had 2 cases of elective CS, one because of HELLP-syndrome and one because of IUGR. Emergency CS took place in 12 cases. Indications: 4 times pathological CTG changes, 6 times protracted labour during active-phase first-stage labour, and one time second-stage. One time Chorioamnionitis, two times malpresentation of the fetal head. Operative vaginal delivery was performed in 16 cases. Indications: pathological CTG changes 6 times, protracted second-stage 10 times (combined with malpresentation in 5 times). 78 women delivered spontaneously. The rate of vaginal birth after successful ECV was 87%.

Conclusions: ECV remains a safe procedure and should be offered in cases of breech presentation beyond 37 weeks. Successful ECV significantly decreases the cesarean section rate, the higher costs connected with CS and the risks related to breech delivery.

The elective caesarean section and its impact on the newborn There is ongoing debate, whether elective C-section affects health conditions of the newborns. We investigated the outcome of the newborns within the first 24 h after birth, with particular focus on differences between C-section without labor and vaginal delivery. We retrospectively investigated a cohort of all children born in a secondary-care-hospital (Tulln/Lower Austria) between January/ 2007 and December/2008 after the 37th week of gestation, comparing elective caesarean delivery, emergency caesarean delivery and vaginal delivery, in order to show the differences of the rates of admission to a Neonatal-Intensive-Care-Unit (NICU) in the first 24 h after birth, the APGAR-Score and the umbilical cord pH, between these groups. We included 1064 children in this study.

Our results show significant differences in the rates of admission to a NICU. After vaginal delivery only 18 of 678 (2.7%) children, after caesarean section (labored) 19 of 198 (9.6%) and after caesarean section (unlabored) 44 of 188 (23.4%) children required admission to a NICU (p \ 0.001). After adjustment for gestational age and birth weight by means of multiple regression, caesarean delivery still remained an independent risk factor for the newborns' admission to a NICU (OR 6,084; 95% CI 3,438-10,766). Also for the APGAR-Score and the umbilical cord pH we identified significant differences between our study groups. The results of this study clearly show considerable disadvantages of elective C-section for the child regarding the rate of admission to a NICU S148 Arch Gynecol Obstet (2010) 282 (Suppl 1):S63-S270 within the first 24 h after birth as well as an impairment in the ability of the newborn to adapt to the world outside the uterus. These results are in line with the present literature. We conclude from this study that C-section increases the risk of admission to a NICU and the risk of a worse outcome in the newborn within the first 24 h after birth. Different factors that increase the mortality due to sudden infant death syndrome (SIDS) have been statistically proven by several studies. The most important risk factors are sleeping in prone and side position, smoking during pregnancy and in the environment of the child, the so-called ''co-sleeping'', as well as sleeping under too soft and thick coverage and on soft mattresses. The use of a dummy, corooming without co-sleeping and breastfeeding the child are protective factors by different mechanisms, which are not yet completely understood. The aim of the study was to determine to which extend the different risk and protective factors play a role in cases of SIDS in Berlin, Germany. Therefore, the autopsy files of the institutes for forensic medicine in Berlin from the years 2001-2008 and the files of the prosecution were analysed as to the known risk and protective factors. 63% of the children were male, 37% female. The highest death rate was between the 2nd and 4th month of life. 40% of the children were found dead in prone position, 30% in spine and 2.5% in side position. 90% slept with a blanket and 9% had a cushion in the bed. 26% died in their one bed, 14% in the parental bed, the rest elsewhere. 18% had a room of their own, 23% slept in the parental sleeping room. Of those 70% slept in the parental bed. 31.5% were exposed to cigarette smoke before and after birth. Only 8% were breast feeded until death. Most of the results of other studies could be confirmed for the cases of SIDS in Berlin.

PO-Geb 02.28 Induction of labour with Cytotec (Misoprostol) or Dinoprost (Prostin) in postterm nulliparas 1/2007 and 12/2009 , with respect to the gender of the supportive companion. Univariate and multivariate logistic regression was used to assess the influence with respect to the gender of the supportive companion, patient's age, parity (nulliparity vs multiparity), body mass index, induction of labor, fetal birth weight, regional anesthesia, and education of the patient ([10 vs. \10 years of school education).

Results: A total of 1707 women were enrolled in this study. Of those, 1493 women (87%) were accompanied by a male supportive companion and 214 women (13%) were accompanied by a female supportive companion. 1399 women (82%) had a vaginal delivery, whereas 308 (18%) had a vaginal operative delivery or caesarean section. In a univariate analysis, delivery outcome was significantly associated with age (p \ 0.0001), parity (p \ 0.0001), and fetal weight (p = 0.004), but not with gender of the supportive companion (p = 0.8), body mass index (p = 0.1), induction of labor (p = 0.3), regional anesthesia (p = 0.09), and education (p = 0.8). In a multivariate analysis, age (p \ 0.0001), parity (p \ 0.0001), and fetal weight (p = 0.001) were all independent predictors of delivery outcome.

Conclusions: Age, parity, and fetal weight, but not gender of the supportive companion during labor and delivery influences the rate of vaginal-operative deliveries and cesarean deliveries in singleton term pregnancies.

The partograph in daily practice: it's quality that matters. A follow-up after 12 years Objective: Worldwide an estimate of 585,000 women per year die due to factors directly related to pregnancy and childbirth. Substandard care factors and avoidable mistakes at health facilities are the major causes. The partograph has shown to be an important tool to monitor labour. The partograph increases the quality of all observations on the fetus and the mother in labour, is effective in preventing prolonged labour, reduces operative intervention, and improves neonatal outcomes. However, after partograph implementation and training there is only little supervision and assessment of daily practise. This study measures the performance quality of partograph use in three regional hospitals in southern Tanzania. Aim is to compare assessment data of 1996 and 2009 and identify the influence of performance quality on neonatal outcome. Materials and methods: In the present study, an indicator-based quality assessment tool was used developed by German and Tanzanian health care experts. Within the maternity departments, independent observers quantitatively assessed the quality of daily partograph use on an itemized scale from 0 (0%) to 2 (100%). Neonatal outcome was assessed using the 1 min APGAR score. An APGAR \ 7 was classified as unsatisfactory.

Results: Poor partograph-based monitoring was related to unsatisfactory neonatal outcome, with an odds ratio of 2.94 (95% CI = 1.32-6.58; P \ 0.005). A non-significant increase in the performance quality of monitoring normal delivery and a decrease in monitoring complicated delivery was measured.

Conclusions: Evidently the partograph improves the outcome for mother and baby, this study finds that poor performance quality of monitoring labour by partograph appears as a risk factor for unsatisfactory neonatal outcome. At the same time, those women with complicated deliveries seem to receive the monitoring with the least quality. Generally, the use of partograph needs continuous reinforcement and quality assurance to successfully reduce morbidity and mortality for mother and baby. The overall survival rate in isolated congenital diaphragmatic hernia (CDH) is about 60%. The prognosis is determined by the grade of lung hypoplasia and impaired lung development. Transient fetoscopic tracheal occlusion may improve lung growth and thereby outcome. We report a case of an extremely preterm infant, born at 27 weeks gestational age (GA) with diagnosis of isolated left sided CDH, liver herniation and expected lung hypoplasia (Lung to head ratio 0.8).

A 31 year old patient was referred at 21 weeks GA for prenatal diagnostics at our centre. US confirmed the diagnosis of left sided CDH (Lung to head ratio 0.8 (LHR)) with liver herniation. Multidisciplinary counselling considered a prospective management including fetal surgery with tracheal balloon occlusion. At 23 weeks GA the patient developed prolaps of the amnion bag. Lung maturation was induced with betamethason. At 27 3/7 weeks GA rupture of membranes occurred and amnion infection syndrome was suspected. A female infant, birth weight 1060 g (54th percentile) was vaginally delivered (Apgar score: 4/7/8; cord-blood pH 7.4). Postnatal treatment followed a protocol including, prophylactic surfactant and inhaled nitric oxide application, high frequency ventilation and inotropic support. Pulmonary circulation was stabilized and surgical closure of the CDH on NICU was performed at day 6 postnatal age. The patient was extubated on day 14 postnatal age. She developed grade II°i ntraventricular hemorrhage and was discharged at term equivalent age. Follow up at 3 month corrected age shows a normal somatic and neurological development. This is a rare report of a surviving extremely preterm infant with CDH and a LHR \1. One may speculate whether the infant did benefit from preterm delivery before fixation of pulmonary hypertonus occurred. It should be systematically evaluated in CDH with very poor prognosis, whether this may be an alternative procedure.

PO-Geb 02.36 Long-term developmental outcome of preterms after tocolysis with NO donors or betamimetics: an 8 years follow up of the Thuringia Tocolysis Trial long-term effects of the used medication. Whereas there is increasing suspicion for beta mimetic long-term effects (Witter et al. 2009 ) no studies exist about effects of NO donors. To explore the impact of tocolytic therapy with fenoterol (Partusisten Ò ) or nitroglycerid patches (Nitroderm TTS Ò ) on neuropsychological development in children aged 7-9 years. Their mothers participated the prospective randomized multicenter Thuringia Tocolysis Trial 1999 -2002 (Schleussner et al. 2003 . Materials and methods: 19 children intrauterine affected with fenoterol and 21 children after NO tocolysis between the 27th and 34th weeks gestation underwent neuropsychological assessment. All subjects were appropriate for gestational age (delivered after 34 + 0 weeks gestation), without intensive care requirements, invasive procedures, or malformations. The test battery consists of testing cognitive performance (IQ-CPM)) and movement performance (Movement ABC-2), attention test (CPT), parents questionnaires for ADHD symptoms (DISYPS/ADHS), socioeconomic status and child development, general psychiatric problems (CBPL), behavioural problems (SDQ) and children questionnaires for emotional irritability (PFK) and live events(ZLEL).

Results: All children developed within the normal ranges of all performed tests. Significant differences were observed in the parents questionnaire CBPL (p \ 0.05), but also within the normal range of the scale. No significant differences were to detect in all other tests.

Conclusions: Antenatal tocolytic therapy with the NO donor nitroglycerid seems to be without long-term effects on neuropsychological development.

PO-Geb 02.37 Chorioamnionitis, an absolute contraindication for delayed interval delivery? A case report *Petra Bolkenius 1 , Andreas Worms 1 , Sven Ackermann 1 1 Klinikum Darmstadt, Frauenklinik, Darmstadt, Germany

Objective: Implementation of assisted reproduction has increased the incidence of multiple gestations. 1-2% of all twin pregnancies are complicated by premature contractions with following premature rupture of membranes before 26 weeks of pregnancy. Prolongation of pregnancy after the delivery of the first twin can improve the outcome of the remaining twin. This is a case report of fortunate delayed delivery even though chorioamnionitis occurred after very early PROM of the first amnionic sac. Materials and methods: A 33 year old nulliparous woman was admitted to the hospital at 18 + 4 week of gestation of a dichorionic, diamniotic twin pregnancy achieved by assisted reproduction, because of cervical incompetence without premature uterine contraction. The patient was treated with bed rest and antibiotic. Two days later PROM of the first amnionic sac occurred. The mother developed chorioamnionitis and at 21 + 3 week premature labour and stillbirth of the first (male) twin took place. Nevertheless with new antibiotic uterine contractions ceased, CRP declined, a cervical cerclage was placed and the second twin was left in utero. RDS prevention had been carried out at 24 + 0 and 24 + 1 week of gestation. Caesarean section was performed at 24 + 3 weeks and a female infant of 610 g was born successfully.

Conclusions: Each of these pregnancies is a unique medical situation. Therapy is a complex of tocolysis, cervical cerclage, bed rest, antibiotics and RDS prevention with antenatal corticosteroids. In literature we find a mean prolongation interval of 16 (1- Objective: We sought to determine the characteristics of antenatally diagnosed right heart anomalies over a 15 years period in a tertiary referral centre. Materials and methods: In this retrospective analysis the medical records and pediatric charts of 120 fetuses with prenatally confirmed right heart anomalies were reviewed. According to the origin and localization of the morphologically and functionally altered cardiac structures we searched our data base for cases affected by tricuspid dysplasia, tricuspid atresia, Ebstein's anomaly, tetralogy of Fallot (ToF), double outlet right ventricle, pulmonary stenosis/atresia ± VSD. The course of affected fetuses throughout advancing pregnancy and their postnatal outcome with respect to the necessity of surgical interventions were analysed. Follow up ranged from 0.1 to 14.9 years. Results: Targeted ultrasound confirmed diagnosis before 24 gestational weeks in 58% and 42% were detected beyond 24 weeks. Karyotype examination (94/120) revealed fetal aneuploidies in 31%. 35 pregnancies were terminated on parental request, 12 pregnancies resulted in intrauterine demise or spontaneous abortion. From the remainder of 72 live born infants 5 died perinatally, 4 after 3 months and 6 within 1 year of life. ToF accounted for the majority of right heart anomalies (35%), followed by tricuspid disorders (32.5%). 62 fetuses had additional cardiac abnormalities, predominantly occurring when the tricuspid valve was affected (50%). 15 women refused autopsy after TOP or IUFD/postpartal death, in all other cases prenatal diagnosis had been confirmed or further specified. 73.6% of the newborns underwent 1 or more corrective surgical interventions (average 2) resulting in satisfying cardiac function of the survivors.

Conclusions: Prenatal diagnosis of anomalies of the right heart enables their correct classification, assessment of severity of the obstructive lesions (including flow via foramen ovale and ductus arteriosus) as well as proper delivery scheduling and adequate perinatal management.

PO-Geb 02.39 Fetomaternal transfusion syndrome: a case report of life-threatening perinatal complication conditions like a caesarian section or placental abnormalities. We present the case of a patient whose child developed a life-threatening complication due to fetomaternal transfusion. Results: We report the case of a 37 year old woman (GI/P0) who was admitted to the hospital with premature rupture of membranes in the 37th week of pregnancy with previously uncomplicated course of pregnancy. During the initial phase of labor CTG abnormalities developed which mandated an urgent secondary cesarean section. A vital child, appropriate for gestational age, was delivered and-after showing signs of serious anemia-immediately transferred to the neonatal intensive care unit. Haemoglobin concentration was 5 g/dl and the child was transfused with consecutive improvement of the child's cardio-circulatory status. Since no obvious reason for the newborn's anemia could be identified (e.g. no Rhesus/ AB0 incompatibility, no parvovirus B19 infection, no signs of bleeding or premature abruption of the placenta) maternal blood was tested for fetal Hb (HbF) to evaluate for fetomaternal transfusion syndrome. Fetal Hb was significantly elevated in maternal blood (+900%, maternal HbF 5%) proving the child's anemia to be due to fetalmaternal transfusion.

Conclusions: This case report of a serious fetomaternal transfusion syndrome emphasizes the necessity of keeping this differential diagnosis in mind when CTG abnormalities develop and an anemic child is subsequently delivered. Objective: We sought to determine the characteristics and prognostic value of antenatally diagnosed fetal micro-/retrognathia in a mixed referral population. Materials and methods: In this retrospective analysis the medical records and pediatric charts of all pregnancies with the suspicion of fetal micro-/retrognathia were reviewed. During the study period from January 1993 and December 2009 a total of 28.935 pregnancies were screened by ultrasound. A total of 56 eligible cases have been identified. The initial diagnosis was established between 11 + 5 and 35 + 1 gestational weeks. The affected fetuses were classified according to the previously described criteria of micro-/retrognathia. Once the diagnosis has been made a detailed analysis for additional structural defects and/or chromosomal anomalies was carried out. Results: In 33/56 cases (59%) the parents opted for termination of the pregnancy. Four fetuses died immediately after birth, in 5 cases a stillbirth occurred. Karyotype examination was prompted in 43/56 cases (77%). In 38% an abnormal karyotype was found (mainly fetuses with trisomy 18 and triploidy). Additional structural abnormalities mainly affected the musculoskeletal system (44%). 18% of the cases had non-skeletal anomalies (multicystic kidney disease, congenital heart disease and other syndromal disorders). Fourteen fetuses were live-born (25%), of which two infants were healthy and the prenatal diagnosis could not be confirmed. Of the remainder 4/12 fetuses had minor structural abnormalities and showed a favourable postnatal outcome.

Conclusions: The diagnosis of fetal micro-/retrognathia poses a considerable impact on both the antenatal and postnatal outcome of the affected individuals due to its potential association with minor and major structural abnormalities. Thus, detailed sonographic anatomical survey is mandatory. In certain cases adjunctive use of fetal MRI may be reasonable. Once the diagnosis has been confirmed, a comprehensive parental counseling together with pediatricians, oral surgeons and geneticians is needed.

PO-Geb 02.41 Life threatening complication in the postnatal period of a patient with myasthenia gravis Objective: We present a case with a complication from maternal myasthenia gravis and raise awareness for optimization of perinatal management. Materials and methods: The heterogeneous group of congenital and acquired myasthenia syndromes is clinically characterized by an insufficient neuromuscular transmission leading to progressive paresis. In the case of maternal myasthenia gravis both the mother and the child may develop myasthenia symptoms with varying degrees of weakness and progressive fatigability of the skeletal muscles. We present the case of a patient with a life threatening complication due to myasthenia gravis shortly after an elective cesarean section. We emphasize the necessity of interdisciplinary diagnostic and therapeutic strategies during the perinatal period. Results: We report the case of a 38 year old patient with immunemediated myasthenia gravis, who underwent a secondary cesarean section with spinal anesthesia at 35 + 3 weeks of pregnancy, after a premature rupture of membranes. The newborn was transferred to the pediatric hospital for surveillance and did not show any signs of muscular weakness throughout the first week of life. The mother developed a myasthenic crisis characterized by progressive dyspnoea leading to a respiratory insufficiency during the second postpartum day. A generalized seizure with cardiac-circulatory arrest followed. After successful cardiopulmonary resuscitation the patient was transferred to the intensive care unit. The interdisciplinary therapeutic approach included ventilatory assistance via endotracheal intubation, parenteral pyridostigmine, azathioprine and steroids. A stable state was regained, so that after five days of intensive care treatment the patient was transferred to normal ward and in the course of time could be dismissed. Objective: The rupture of an unscarred uterus is a very rare and one of the most dangerous complications in obstetrics, associated with a high risk for maternal and fetal mortality. Materials and methods: A 33-year-old gravida 4, para 2 with 2 prior vaginal deliveries without any complications received 25 lg misoprostol to induce labour at 41 + 4 weeks of gestation. In patient history there was an abortion and the patient underwent curettage. 5 hours 30 min after application of misoprostol the patient presented a sudden pain and a minimal vaginal bleeding while she had mild contractions. Simultaneously a fetal bradycardia was registrated. An emergency Caesarean section was performed. A rupture of the uterus on the left posterior side from uterine fundus to the internal cervix was seen. The cervix itself was unaffected and 2 cm open. The child was lying in the abdominal cavity. After cutting the umbilical cord the baby was given to the attendant paediatrics (NapH 6.82, APGAR 1/5/7). The time from diagnosis to delivery of the baby was 8 min.

A partial placental abruption on the anterior side of the uterus could be demonstrated. The patient underwent a total hysterectomy with a totally blood loss of 1500 ml. Packed red blood cells were substituted. The postoperative inhabitation was without any complications.

Conclusions: The symptoms of a rupture of the uterus have to be recognised as fast as possible to induce immediate emergency interventions. Every induction of labour has a higher risk of an uterus rupture even by an unscarred uterus. It is hypothesized that the pathophysiology of preeclampsia begins with shallow trophoblast invasion leading to placental hypoxia. Hypoxia is a potent stimulus for the release of adenosine. Women with preeclampsia show increased circulating concentrations of adenosine and placental expression of adenosine receptors is increased in preeclampsia. We describe a case of malformation of the umbilical vessels resulting in an IUGR. We explain diagnostic and clinical management. First visit of the 32-year-old first Gravida was in 27 + 5 week showing a dysproportional IUGR, especially of the fetal abdomen. Sonomorphology of the organs was normal, TORCH and amniotic fluid index as well. Doppler of the maternal system showed normal uterine perfusion. Umbilical Doppler was normal but Doppler of Arteria cerebri media (ACM, PI 0.94, RI 0.59) and ductus venosus (DV, PI 1.02) showed pathological results. The fetus did not show any abdominal growing over the next 3 weeks, while the BIP and the femur were growing normally. Doppler did not deteriorate any further but remained as described above. Repeated sonographical screening for fetal malformation resulted in the diagnosis of an anastomosis between the umbilical artery and the umbilical vein in the abdominal wall and a crossing of both umbilical vein in the same location. Pathophysiological patterns focussed on normal Doppler of the umbilical artery while ACM and DV are pathological are discussed as well as management of surveillance and timing of delivery. The baby was delivered by caesarean in 30 + 5 weeks with a weight of 980 g. Objective: Antenatal glucocorticoid (GC) therapy is used to treat women at risk of preterm delivery to enhance fetal lung maturation. There is increasing suspicion that this therapy programs mental and cardiovascular disturbances in later life. To explore the impact of antenatal GC therapy on neuropsychological development in children aged 7-9 years. Materials and methods: 39 children (21 females) treated with 2 9 8 mg betametasone (GC) 24 h apart (and repeatedly if necessary) between the 25th and 34th weeks gestation and 39 controls underwent neuropsychological assessment. Controls were pair-matched for gestational age at delivery, gender, and current age. All subjects were appropriate for gestational age (delivered after 34 + 0 weeks gestation), without intensive care requirements, invasive procedures, or malformations. The test battery consists of testing cognitive performance (IQ-CPM)) and movement performance (Movement ABC-2), attention test (CPT), parents questionnaires for ADHD symptoms (DISYPS/ADHS), socioeconomic status and child development, general psychiatric problems (CBPL), behavioural problems (SDQ) and children questionnaires for emotional irritability (PFK) and live events(ZLEL). A matched pairs analysis by mixed linear models were fitted to examine the impact of antenatal GC exposure.

Results: Significant differences were observed in cognitive performance (IQ) (p = 0.001), movement performance (p = 0.04), ADHD symptoms (p = 0.01) and behavioral problems (p = 0.004), but all within the normal range of the scales. The results have to be thoroughly explored for residual confounding which could not be eliminated by matching.

Conclusions: Antenatal GC-treatment or GC-treatment related factors may cause a long-term influences on neuropsychological development, yet performances in normal range.

PO-Geb 02.49 Changed HPA axis and autonomic stress reactivity of children at school age as long-term effect of antenatal glucocorticoid treatment

Objective: To explore the impact of antenatal Glucocorticoid (GC) therapy on stress reactivity mediated by the autonomic nervous system (ANS) in children aged 7-9 years. Materials and methods: 39 children (21 females) treated with at least 2 9 8 mg betametasone (GC) 24 h apart between the 25th and 34th weeks gestation and 39 controls underwent the Trier Social Stress Test adapted for Children (TSST-C). Controls were pair-matched for gestational age at delivery, gender, and current age. All subjects were appropriate for gestational age (delivered after 34 + 0 weeks), without intensive care requirements, invasive procedures, or malformations. Before, during and after TSST-C salivary cortisol levels were measured. Standard indices of heart rate variability (HRV) were derived from the electrocardiogram as outcome measures: mHR (mean heart rate), SDNN (overall variability), RMSSD, HF (both related to vagal activity), LF (related to vagal and sympathetic activity), LF/HF (sympatho-vagal balance), AIF (autonomic information flow, reflects complex short term ANS mediated communication). A matched pairs analysis by mixed linear models were fitted to examine the impact of antenatal GC exposure on ANS stress response.

Arch Gynecol Obstet (2010) 282 (Suppl 1):S63-S270

Results: Whereas no differences in basal cortisol levels the cortisol stress response was blunted in the GC group (p = 0.015). Significant differences were observed stress test induced for SDNN (p = 0.035), RMSSD (p = 0.030), mHR (p = 0.011), HF (p = 0.001), LF/HF (p \ 0.001) and AIF (p = 0.021). Adjusted for baseline activity TSST-C induced a attenuated increase in mean HR, LF/HF and AIF and a attenuated decrease in SDNN, RMSSR and HF in the GC group compared to controls. This suggests a blunted stress response of all parts of ANS in GC group. The results have to be thoroughly explored for residual confounding which could not be eliminated by matching.

Conclusions: The reduced stress response of the humoral and autonomic nervous system in children may have been programmed by antenatal GC administration.

PO-Geb 02.50 Abruption of placenta praevia: a case report *Christa Schwarzenau-Szydlowski 1 , Anke Redlich 1 , Laura Welger 1 , Serban-Dan Costa 1 1 Otto-von-Guericke-University, Department of Gynaecology and Obstetrics, Magdeburg, Germany

Objective: Vaginal bleeding during the second half of pregnancy is always a threat to mother and fetus. The most important differential diagnoses are placenta praevia and abruption of placenta. Diagnosing placenta praevia does not rule out abruption of placenta, however. This case report demonstrates that placenta praevia is rather a risk factor for abruption of placenta.

A 28 year old woman with a singleton gestation at 26 weeks presented with vaginal bleeding and known placenta praevia. At admission the lively fetus with an estimated weight of 1000 g appeared to be in breech presentation. The ultrasonic scan showed a placenta praevia totalis and normal cervical length. Tocolysis, induction of fetal lung maturity and an antibiotic therapy were conducted. The following day bleeding ceased. In the course of the hospital stay contractions and slight bleeding emerged, but could be controlled. Another ultrasonic scan revealed a hematoma in the region of the cervical os. At gestational age of 28 weeks bleeding restarted, this time accompanied by a diffuse slight abdominal pain. After consultation of our neonatologists the decision was made to carry out caesarean section during which a partial abruption of the placenta was confirmed. The newborn weighed 1400 g and received APGAR-scores of 1/4/9. The following days he remained stable and could be transferred to the hospital of the family's hometown.

Conclusions: This case report illustrates that vaginal bleeding of women with placenta praevia should carefully be questioned concerning abruption of placenta.

PO-Geb 02.51 Breastfeeding rates in Freiburg/Germany Objective: Purpose of this study was to asses the motivation, behaviour and duration of breastfeeding of women delivering in 2 ''babyfriendly Hospitals'' in Freiburg/Germany. Materials and methods: The prospective observational study included 443 births between august and December 2008. We performed a standardized interview the day after delivery in the maternity ward.

Thirty-four women decided for primary weaning. Breastfeeding women were followed up by telephone interview 3, 6 and 12 month after delivery. Statistical analysis was performed with univariate and multivariate regression analysis. Results: 92% started breastfeeding and 61% were still breastfeeding at 6 month. Women still breastfeeding 6 month post partum are significant older, have higher education, had not delivered by elective caesarean section, decided to breastfeed already in pregnancy, were not in doubt about the amount of milk, did not use a pacifier, did not deliver in the university hospital and felt supported by their partners.

In a multivariate analysis the independent variable was higher education.

Conclusions: Breastfeeding promotion should be implemented in school education and pregnancy counselling. Multidisciplinary breastfeeding support could help to sustain breastfeeding continuation as recommended by WHO/UNICEF. 

Objective: First presentation of a 23 years old primigravida in 20 + 3 weeks of gestation for malformation ultrasound scan: normal fetal weight, anhydramnion, bilateral hydronephrosis and megacystis with hypertrophic bladder wall. Last normal amount of amniotic fluid was anamnestic in 14th gestational week. So the strong suspicion of a lower urinary tract obstruction (LUTO) existed. The objective of this case report was to determine whether vesico-amniotic shunting could prolong pregnancy and improve fetal outcome. Materials and methods: The puncture of the fetal urine bladder for kidney function diagnostic (b2-microglobulin, cystatin C, Na + , K + , Cl -) showed a still acceptable kidney function. Amniocentesis revealed a normal male karyotype. To prevent lung hypoplasia a vesico-amniotic shunt was implanted. The following ultrasound examinations showed a regular amount of amniotic fluid and an orthotopic shunt. Furthermore a fetal hydronephrosis on the left side persisted. In week 26 the shunt was dislocated, ascites and fetal hydronephrosis on the left side with normal AFI (amniotic fluid index) was observed. Infant respiratory distress syndrome (IRDS) prophylaxis and re-shunting was conducted. The following examinations demonstrated normal AFI with appropriate fetal development, still hydronephrosis on the left side, no more ascites, shunt in situ. From 35th week amniotic fluid decreased (AFI 7-8), hydronephrosis progressed and a megacystis developed again. Caesarean section was performed in 36 + 5 weeks of gestation. Results: Fetal outcome: 3380 g, Apgar 8/8/9, arterial-pH: 7.29, good cardiopulmonary adaption. Sonographically infravesical obstruction with bladder hypertrophy and bilateral dilated ureters was seen. By micturating cystourethrogram a LUTO was confirmed. Additionally a dysplastic right kidney was suspected. 6-month-follow-up: Left kidney with normal function and dysplastic right kidney in state after urethral stricture and pyelocutaneostomy. The child showed a normal development.

Conclusions: Vesico-amniotic shunting in sonographically suspicion of a LUTO prolongs pregnancy and improves fetal outcome.

PO-Geb 02.55 Case report: diagnosis of familiar Beckwith-Wiedemann syndrome by a small exomphalos at 12 weeks of gestation The 33 year old I-Gravida was referred for a nuchal scan. Her previous medical history was uneventful. However, she reported on a small exomphalos at birth. The ultrasound examination showed a small exomphalos containing bowel only. The crown rump length was S158 Arch Gynecol Obstet (2010) 282 (Suppl 1):S63-S270 67.5 mm, fetal NT 2.9 mm and free b-hCG and PAPP-A were 11.5 MoM and 1.9 MoM, respectively, resulting in an increased risk of trisomy 21 of 1:20 and a risk of trisomy 18/13 of 1:8400. However, the most likely diagnosis was Beckwith-Wiedemann syndrome based on the maternal history, the small exomphalos and the largely increased free b-hCG level. Invasive diagnosis was declined. Initiated by the ultrasound findings, molecular genetic analysis revealed, that the patient herself was affected (mutation in gene CDKN1C).

Meanwhile her sister, a 35 year old II-Gravida I-Para with one healthy child came for a nuchal scan. She also reported on a small exomphalos at birth, otherwise her medical history was uneventful.

Her nuchal scan showed a crown-rump length of 68.1 mm, a fetal NT of 2.0 mm and free b-hCG and PAPP-A levels of 1.0 and 0.4 MoM. Although the risk profile was not indicative for Beckwith-Wiedemann syndrome, the fetus had a similar small exomphalos. Both cases of Beckwith-Wiedemann syndrome were confirmed after birth. Further genetic analysis of the remaining family members showed that the two sisters and one brother were affected by Beckwith-Wiedemann syndrome. Objective: Partial moles arise from the trophoblastic epithelium of the placenta. The availability of ultrasonography has led to early diagnosis. Materials and methods: We present two cases with a partial mole and different pregnancy outcome. Results: In both cases an abnormal placental structure was diagnosed at second trimester ultrasound examination. The first patient presented with transient vaginal bleeding. The fetus had normal anatomy and size for gestational age. An echogenic placenta was located on the right and a normal placenta on the left uterus wall. Amniocentesis revealed a normal karyotype. hCG was 449503 mlU/ml. After pregnancy with decrease of the mole part of the placenta, a healthy child was spontaneously born at 40 weeks of gestation. The histologic examination showed a regressive hydatidiform mole combined with a placental retardation in dichorionic twin pregnancy. Invasive growth did not appear. The second patient had an echogenic placenta with cystic structures and a normal fetus. At 27 + 0 the fetus showed a significant growth retardation and massive increase of the cystic part of the placenta. With normal uterine and umbilical doppler parameters. V max in the middle cerebral artery was elevated. A distinct anemia with hemoglobin 4.7 g/dl, thrombopenia and signs of consumptive coagulopathy was found. Fetal blood transfusions were performed twice. A maximum of hemoglobin 6.8 g/dl was achieved. The preterm delivery through cesarean section was performed because of persistent anaemia and thrombopenia. Blood transfusion after birth was necessary. The histologic examination showed a partial mole with a hypertrophic placenta with no signs of invasive growth. Conclusions: There were no significant differences in the rate of uterine ruptures or the emergency C-sections between the misoprotol and the other methods for induction of labor in women with a single prior uterine scar. Misoprostol has significant rate of success in these cases. Our data do not prove, that a single uterine scar is a contraindication for oral misoprostol. Materials and methods: Blood samples were taken with written consent from 90 healthy women and from the umbilical cord of their babies at delivery for serum ferritin estimation using ELISA method (Diagnostic Automation Inc., USA). Results: The mean ferritin level in maternal blood at delivery was 103.9 ng/ml with a range of (13-516 ng/ml) and 174.6 ng/ml (14-573 ng/ml) in the cord blood.

Conclusions: In the present study, the ferritin level in cord blood is significantly higher than in the maternal blood at delivery. 

Objective: The Marfan syndrome (MFS) is one of the most common inherited disorders of connective tissue with an incidence of approximately 1:5000 individuals. Aortic root disease, leading to aneurysmal dilatation, aortic regurgitation and dissection, is the main cause of morbidity and mortality in the MFS. Pregnancy is a high-risk period for aortic dissection and rupture in women with MFS.

Materials and methods: We report a case of a 26 year old woman with known MFS in a singleton pregnancy at 32 weeks of gestation with acute severe upper back pain. A MRI of the abdomen and backbone suggested a type A aortic dissection prolonging to the common iliac arteries. After extensive counseling and because of the life threatening character of this finding we performed a CT with contrast agent of the thoracic aorta what verified a type B aortic dissection. After fetal lung maturing induction a caesarean section was performed. Child and mother did very well after delivery. The vascular surgeons recommended a yearly diagnostic follow up and a strict antihypertensive therapy with betablockers.

Results: The risk of dissection has been estimated to be approximately 1 percent per year in women with an aortic root diameter B40 mm and 10 percent per year in women with an aortic root diameter [40 mm. Serial clinical assessment should therefore include echocardiographic monitoring. Additionally beta blockers should be given to all MFS patients in an attempt to minimize aortic dilatation and risk of aortic dissection during pregnancy. Moreover preconceptual counseling is important to explain the risks during pregnancy, the restricted lifespan and the possibility of inheritance of MFS.

Conclusions: We recommend a multidisciplinary approach to prenatal care in pregnant women with MFS, preferably at a center with experience in the management of patients with MFS.

PO-Geb/Repro 02.02 Increased concentration of tubular parameters in the amniotic fluid of male fetuses in the 2nd trimester of pregnancy We report on a 28 year old women presenting with a complete hyaditiform mole localized to the cervix. Two months after curettage of missed abortion she presented with severe vaginal bleeding. Clinical examination revealed a lesion of the epithelial outside surface of the cervix. Due to the bleeding immediate surgical intervention was necessary. Histological examination revealed a complete hydatidiform mole. Currently, only three cases of this exceedingly rare diagnosis have been published. Two cases are reporting on a partial hydatidiform mole and only one case on a complete hydatidiform mole. All cases presented with vaginal bleeding and needed surgical intervention, although in one case initially metothrexate was applied. In this case, we hypothesize that the pathogenesis took place in two steps. Initially, during fertilization, a hydatidiform molar pregnancy developed. Normally this abnormal trophoblast tissue would adhere to the endometrium, but in this case we assume that the endometrial linage was damaged and intrauterine implantation was not possible because of the prior curettage. This circumstance provided the possibility for the abnormal trophoblast tissue to pass the endocervix and to emerge into vaginal vault. Presumably, during the curettage an epithelial defect was set on the outside surface of the cervix. This defect was set by clamping the cervix while dilatation. We speculate that this weak spot of the epithelial surface was responsible for the adherence to the cervix and subsequent bleeding was caused by injury of maternal blood vessels. We present a case with cervical hydatidiform mole as a rare differential diagnosis in vaginal bleeding after dilatation and curettage. We speculate that the defect set by dilatation of the cervix has provided the possibility for the adherence of the abnormal trophoblast tissue and therefore propose that careful holding of the cervix with atraumatic clamps while curettage is important to avoid subsequent complications.

PO-Geb/Repro 02.04 Obesity and pregnancy: maternal BMI over 15 years Objective: Macrophage inhibitory cytokine-1 (MIC-1), a novel member of the transforming growth factor-beta (TGF-b) superfamily has recently been described to be produced in high levels by placental tissue. Detected in decreasing levels in sera of women who subsequently miscarried, it is even speculated to play an important role in the establishment and maintenance of pregnancy. So far, little is known about the modulatory effects of MIC-1 on immune cells found in elevated numbers in decidual tissue during pregnancy. We therefore characterized the impact of this factor on dendritic cells (DC), which are thought to play a distinct role in the establishment of peripheral tolerance in pregnancy. Materials and methods and results: To detect the decidual cells expressing MIC-1, immunohistochemical staining, PCR experiments and Western blot analysis were performed. Thereby, we ascertained that it is mainly expressed by trophoblast cells and stromal cells.

Analysing the MIC-1 secretion of decidual cells by ELISA, trophoblast cells and stromal cells again could be characterized as main producers. We then investigated the effects of MIC-1 on immune cells in decidual tissue. Therefore, immature DC were generated from blood-derived monocytes and differentiated in the presence of MIC-1. MIC-1 was able to modulate the phenotype of DCs by decreasing the expression of CD25, CD40 and CD83 during cytokine-induced DC maturation similar to Dexamethasone (Dex), which was used as a S162 Arch Gynecol Obstet (2010) 282 (Suppl 1):S63-S270

control. Furthermore, T-cell stimulatory capacity of DCs was significantly reduced after MIC-1 exposure Conclusions: Thus, we have identified a novel factor that could promote the generation of a tolerogenic micromilieu at the feto-maternal interface.

PO-Geb/Repro 02.07 Is there a risk for pre-eclampsia in pregnancies after ovum donation?

Ulrich Pecks 1 , Nicolai Maass 1 , *Joseph Neulen 2 , 1 University Clinic RWTH Aachen, Obstet. & Gynecol., Aachen, Germany, 2 University Clinic RWTH Aachen, Gyn. Endo. and Reprod. Med., Aachen, Germany

Objective: Pregnancy risks after ovum donation (OD) to patients with ovarian failure or idiopathic low ovarian response are still under debate. As OD is prohibited in Germany couples refer themselves to IVF centres abroad sometimes without adequate information. We present two pregnancies with very early fetal retardation and severe pre-eclampsia resulting in pregnancy terminations for maternal health problems. Materials and methods: In patient 1, 37 year, after unsuccessful ICSI treatments (low ovarian response, andrological subfertility) a singleton pregnancy was achieved after OD. Due to treatment resistant hypertension decompensated mitral regurgitation developed with pulmonary hypertension. Pregnancy was medically terminated in the 20th week. The patient recovered from her nephrological and pulmonary conditions. A low grade compensated mitral incompetence remained. The dead female fetus weighed 120 g. Placenta measured 55 cm 2 and weighed 54 g. Patient 2, 47 year, healthy, primary sterility. Embryo-transfer from OD resulted in a singleton pregnancy. She was referred to our clinic for decompensated hypertension, pulmonary oedema and HELLP-syndrome. Pregnancy was terminated in the 23rd week by Cesarean section. 14 months later she is still treated for hypertension. The dead female fetus weighed 260 g. Placenta measured 100 cm 2 and weighed 201 g. We observed 8 pregnancies during the past 4 years after OD in healthy patients with primary sterility. All pregnancies were complicated by pre-eclamptic symptoms.

Conclusions: Based on literature and the presented data risk of preeclampsia after OD seems to be at least 2-3 times higher than in spontaneous pregnancies (3.4). Lasting conditions may arise in formerly healthy patients. 

Objective: The Fas/Fas-ligand system belongs to a pathway typically inducing apoptosis. It is expressed at the feto-maternal interface and has been assumed to play an important role at the process of implantation. Previously we could show, that human endometrial stromal cells (ESCs) express Fas, but are primarily resistant to Fasmediated apoptosis. Under emerging evidence of Fas playing a role in non-apoptotic signaling, we investigated possible Fas-mediated effects on cytokines/chemokines in ESCs in vitro. Materials and methods: Human ESCs derived from hysterectomy specimens were isolated and decidualized in vitro, using 17b-estradiol and progesterone. After treatment with an activating anti-Fas monoclonal antibody and a caspase-inhibitor the respective amounts of LIF (leukaemia inhibitory factor), IL (interleukin)-11, -6, -8, MCP (monocyte chemoattractant protein)-1 and RANTES (regulated and activated normal T-cell expressed and secreted) were determined by ELISA and real-time RT-PCR. Activation of NF-jB was analyzed by in-cell western assay and nuclear transcription factor assays. The enzymatic activity of caspases was measured using luminescent assays.

Results: Fas-stimulation increased the secretion and expression of LIF and IL-11 in undifferentiated ESCs, whereas IL-8 was upregulated in decidualized cells. Fas-treatment had no impact on the secretion of IL-6, MCP and RANTES. In undifferentiated ESCs there was no activation of NF-jB upon Fas-stimulation. However, the Fas-mediated effects on LIF, IL-11 and -8 were dependent on the activation of caspases.

Conclusions: The Fas/FasL-system selectively modulates cytokines in human ESCs, using distinct signaling pathways and underlining its non-apoptotic function. As the subtle balance between apoptotic and non-apoptotic effects might be essential for the success of early implantation, a better physiological understanding of theses processes could reveal new therapeutic targets for woman suffering from repeated implantation failure.

PO-Geb/Repro 02.11 Illegal termination of pregnancy: vitamin-K-antagonist? Kinder-und Jugendklinik, Universität, Erlangen, Germany

Objective: In Germany there is a number of about 110,000 pregnancies per year terminated. A number of further 90,000 pregnancies are estimated to be terminated without report. There are different options for legal termination of pregnancy by medikaments and surgical procedure. It is supposed that these options are used for illegal termination of pregnancy as well. There are no current reports about other medikaments with different purpose used illegally for termination of pregnancy. Antikoagulation with vitamin-K-antagonists in pregnancy is usually not allowed. However there can be occasions of maternal health problems where vitamin-K-antagonists are needed. In these rare cases the application has to be monitored carefully because of severe site effects for the mother and the baby.

Materials and methods: We report two cases of intoxication with vitamin-K-antagonists in pregnancy where we suppose a self-intoxication of the mother with the intention to get rid of the pregnancy. Results: The current legal and historical options for termination of pregnancy are shown. Conclusions: Self-intoxication with vitamin-K-antagonists seem to be a new current option for illegal termination of pregnancy, gynaecologists should be aware of.

PO-Geb/Repro 02.12 Hormone production and follicular development after in vitro culture of fresh and frozen murine ovarian tissue in a new dynamic culture system Objective: Ovarian tissue autotransplantation in cancer patients seeking fertility preservation may reintroduce malignant cells. Therefore, ovarian tissue cryopreservation followed by oocyte in vitro maturation and fertilization could be a safer option. As a first step to this end, the objective of this study was to establish a new dynamic culture system for fresh and frozen murine ovarian tissue. Materials and methods: 72 ovaries were obtained from 36 female C57BL/6 mice 7-14 weeks old. 18 ovaries were frozen/thawed via slow freezing/rapid thawing protocol. 27 dynamic culture chambers (DCCs) were compared to 21 static culture chambers (SCCs), serving as controls. Each chamber contained 3 ovarian halves cultured in 2 ml blank G-MOPS TM medium (Vitrolife, Sweden) for 6 days (1 estrus cycle) in a 38°C water bath. Estradiol (E2) and Progesterone (P) were measured daily in all effluents to assess folliculogenesis. After 6 days of culture, tissues were examined histologically for viability and follicular development.

Results: DCCs with fresh tissue (n = 21) showed combined E2 and P peaks in 81% of chambers. Viability was 100% in 52.2% of chambers; Corpora Lutea (CL) were seen in all chambers producing E2. DCCs with frozen/thawed tissue (n = 6) showed combined E2 and P peaks in 50% of chambers. Viability was [60% in 50% of chambers; CL were seen in all chambers producing E2. SCCs with fresh tissue (n = 15) showed combined E2 and P peaks in 80% of chambers. Viability was 100% in 26.6% of chambers; CL were seen in all chambers producing E2. SCCs with frozen/thawed tissue (n = 6) showed no E2 peaks. Viability was [60% in 50% of chambers; CL were not seen. Conclusions: We preliminarily established a new dynamic culture system for fresh and frozen ovarian tissue in mice with superior results to the conventional static culture regarding tissue viability and hormone production.

PO-Geb/Repro 02.13 Effect of sperm count and morphology on results of intrauterine insemination Objective: Two new treatments for couples experiencing infertility, cryopreservation of pronuclear stages which is a routine practice in Germany, and cryopreservation of embryos, which is mostly done in foreign countries, gives these couples a chance to make additional attempts at pregnancy. Nonetheless, there is wide-spread debate about the moral and legal status of the early stages of life. This German survey of 700 infertile patients analyzes the attitudes and decisions of patients about potential cryopreserved embryos and their cyropreserved pronucleus stages. Materials and methods: 223 German infertile patients with cryopreserved pronuclear stages in storage for 1-5 years returned completed standardized questionnaire. Several multivariate regression models were performed in order to assess influencing factors that contributed to the infertile couples' decision and attitudes (e.g. socio-demographical factors and individual parameters). Results: The vast majority of German infertile couples (92%) are in favor of an overall legalization of embryonic cryopreservation. Couples are also in favor of donating surplus frozen embryos (69%). The multiple regression analysis showed that there is a high correlation between the extent to which couples were aware of possible risks associated with the freezing, the stage of treatment, the age and religious beliefs of the couples with the couples' opinions about legalization (p \ 0.05). The majority of respondents considered the pronuclear stage as well as the embryo as deserving dignified treatment (40%).

Conclusions: In contrast to the German Embryo Protection Law, infertile German couples are in favor of legalizing the cryopreservation of surplus embryos created as part of a fertility treatment. Infertile German couples are in favor of using supernumerary frozen pronucleus life stages and embryos in a meaningful manner instead of discarding. In general, the findings of the study could help redefine the public debate on the legalization process for embryos and the moral and legal status of embryos in Germany. Objective: ADAM12, a pregnancy associated multi-domain metalloprotease with additional cell adhesion activities, has proteolytic activities directed against insulin-like growth factor binding proteins indicating a regulatory function on the bioavailability of insulin-like growth factors in early pregnancy and placentation. The aim of this study was to examine the course of ADAM12 and human chorionic Arch Gynecol Obstet (2010) 282 (Suppl 1):S63-S270 S165 gonadotropin (total ß-hCG) in early pregnancy after assisted reproduction. Materials and methods: ADAM12 was determined retrospectively from frozen serum samples obtained between day 14 and day 35 after ovulation/ovum pickup from 192 early pregnant women after assisted reproduction (45 after low-dose gonadotropin stimulation with ovulation induction, 22 after in vitro fertilization, 76 after intracytoplasmatic sperm injection, 49 after transfer of cryopreserved pronucleus cells). In all samples previously routine measurement of total ß-hCG had been done. For sensitive measurement of ADAM12 the new DELFIA-ADAM12 assay was slightly modified to lower the detection limit to 0.4 ng/mL. Multiples of the median (MoM) were calculated from ADAM12 results.

Results: In 77% of samples obtained up to day 23 after ovulation/ ovum pickup the ADAM12 levels were below the detection limit. For those samples with elevated ADAM12 levels there was no correlation with gestational age. After day 23 an exponential rise of ADAM12 was observed with increasing gestational age. There was a linear correlation of ADAM12 with total ß-HCG. The ADAM12-MoMs were inversely correlated with the mothers weight (p = 0.016 We present a case of a 31 year-old patient with severe craniocerebral trauma after motor vehicle accident in her 8th week of pregnancy. During the course of intensive care, the case was complicated by recurrent infections and fever, treated with a wide spectrum of antibiotics. The patient was admitted to our emergency room unconscious with severe head trauma after an automobile accident. Multiple skull fractures were accompanied by multiple brain hematomas and cerebral edema. After acknowledgment of the patient's state of pregnancy, radiological diagnostics were limited to head and upper spine. The patient was eventually transferred to intensive care unit ventilated and under analog sedation. In order to maintain an adequate brain perfusion, therapy with catecholamine and noradrenalin was started. In the following months the patient had to undergo intermittent antibiotic therapy with ceftriaxon, imipenem, vancomycin, tazobactam and amphotericin B. Due to repetitive seizures the patient received treatment with carbamazepin. The fetal prognosis under the severe condition and the aggressive therapy of the patient was discussed with family members and the continuation of the pregnancy as well as maximal therapy for the unborn child was decided on. During the following months fetal development was without pathological findings both in ultrasound and fetal heart tracking. In her 15th week of pregnancy, after seven weeks of intensive care treatment, the patient was transferred to a rehabilitation clinic. At this point the patient was capable of breathing spontaneously with stable vital parameters and started to react to her surroundings. Despite fecal incontinence and therefore limited hygienic circumstances, ascending infection did not occur. The patient is now in her 30th week of pregnancy with normal fetal biometry, normal fetoplacental and uteroplacental perfusion, all fetal organs seem to be developed as expected by ultrasound diagnostics. Delivery of the baby is planned at 37 weeks of pregnancy by cesarean section. Objective: Vitamin D is a prohormone that plays an important role in various physiological processes, e.g. calcium metabolism, cellular growth and differentiation, immunity and cardiovascular regulation, and also for maintaining oral health through effects on bone and mineral metabolism and immunomodulatory action by interference with proinflammatory cytokines. The vit D receptor has dual functions as an endocrine receptor and metabolic sensor. The activity of vit D3 in preventing rickets and osteoporosis is well known, but the extent of inadequate supply in Germany is uncertain. Materials and methods: Screening was prospectively performed in the winter period (end of October-April) and included a total of 206 consecutive women, who attended the outpatient endocrine clinic for menopausal complaints or disorders of the menstrual cycle, and who were not on vit D3 substitution. The median age was 54 (range 14-86) years. 25-hydroxy(OH)D3 (25-hydroxycholecalciferol) as the major form of vit D in the circulation was determined by means of a standard serum assay. Vit D deficiency was defined as concentration \20 ng/ml, severe deficiency as serum levels \10 ng/ml. Objective: Prospective analysis of 16 patients undergoing gynaecological laparoscopy using freehand robotic camera-holding device. This study evaluates its introduction into clinical praxis. Materials and methods: A total of 16 patients underwent roboticassisted laparoscopic surgery such as hysterectomy, adnexectomy and cystectomy at the same institution, during the same period and with the same surgeon. Perioperative data (operation time, blood loss, time for assembly, comfort for the surgeon, roboter-handling, obstructions for the surgeon or the assistance caused by roboter) was collected prospectively. Demographic data, pre-existing diseases, previous abdominal or pelvic operations, postoperative development and length of stay were retrieved from patient's records. We used the freehand camera-holder, attached to the surgical table, controlled via surgeon's head movements by a head-mounted optical emitter. Movements are detected by a sensor mounted atop laparoscopic video monitor. The sensor indicates intended direction of motion through displaying a LED arrow. Surgeon initiates and terminates movements with a foot pedal. Results: Mean time from suture to docking the robotic-arm was 5.13 min (r = 2.6 min). 10 procedures were successfully completed without any intra-operative complication. No conversions to laparotomy were necessary. No major intra-or post-operative complications occurred. In only one case post-operative minor complication was detected (suspected urinome). In all cases camerapositioning was steady with barely no inadvertent movements. In 56% human assistance could be saved. Conclusions: Robotic devices permit tremor-free imaging and can eliminate need for assistance. Moreover they offer greater vision control to the surgeon and allow complete autonomy over the laparoscopic surgical view. Further studies comparing roboter-assisted laparoscopy to conventional laparoscopy are needed to prove its superiority in clinical routine.

PO-Gyn 02.02 Secondary cervical stump resection after laparoscopic supracervical hysterectomy No conversion to abdominal hysterectomy was necessary. In the postoperative phase the complication rate was also low with 0.66%. Six patients were identified who had a secondary cervical stump resection (2% of all cases). In three patients cervical stump resection was performed because of atypical endometrial hyperplasia found in the histological examinations of the uterus. Two women had a coincident neoplasm. Another woman developed pain in the cervical stump and had still menstruation bleeding.

Conclusions: LASH is a safe and feasible procedure in women undergoing hysterectomy. However some postoperative problems may occur resulting in secondary cervical stump resection. Those should be taken into account when hysterectomy procedures were discussed with women.

PO-Gyn 02.03 Discriminant function analysis as decision making system for patients considered for pelvic exenteration: decision making before exenteration 

Objective: In this study we compared different techniques of endometrial ablation. Therefore we compared the bipolar impedancecontrolled endometrial ablation (NovaSure) with balloon ablation (ThermaChoice) and endometrial loop resection at 3 years after administration. Materials and methods: A total of 91 women suffering from menorrhagia underwent endometrial ablation in our hospital from January 2007 till March 2010. All patients underwent a diagnostic hysteroscopy and fractional abrasio before endometrial ablation in the same setting. We evaluate the average age, duration of the operation, duration of hospitalisation and intraoperative or postoperative complications retrospectively. Results: At 3 years of follow up we include N = 34 patients in the NovaSure group with an average age of 42.59 years, N = 30 patients in the ThermaChoice group with an average age of 47.39 years and N = 27 patients in the group of endometrial loop resection with an average age of 47.44 years. In the NovaSure group the operation took on average 18.62 min, the average duration of hospitalisation was 1.97 days. In the ThermaChoice group the operation took on average 33.20 min, the average duration of hospitalisation was 1.80 days. In the group of endometrial loop resection the operation took on average 36.67 min, the average duration of hospitalisation was 1.18 days. We found no patient with intra-or postoperative complications. Conclusions: At 3 years follow up, bipolar thermal ablation shows the shortest duration of operation but the longest duration of hospitalisation. The endometrial loop resection was associated with the shortest duration of hospitalisation but the longest duration of operation. Our clinical experience shows a superiority of bipolar impedance-controlled endometrial ablation technique over balloon ablation and endometrial loop resection in the treatment of menorrhagia. We are currently investigating amenorrhoea rates, hysterectomy rate and quality of life associated with the different techniques of endometrial ablation in our hospital; the results are still outstanding and will be published soon.

PO-Gyn 02.05 Prognostic factors for the success of thermal balloon endometrial ablation Women with postoperative amenorrhea were older (p = 0.001) and had statistically significant higher FSH-(p = 0.0) and lower estradiol-levels (p = 0.019) than women who still reported uterine bleeding. ROC analysis found that a FSH-level of 39.65 IU/l implicates a chance of 50% to reach postoperative amenorrhea. Preoperative dysmenorrhea and premenstrual symptoms were associated with a lower postoperative rate of amenorrhea. Postoperative dysmenorrhea and use of non steroidal analgetics seem to influence patients' satisfaction negatively. No difference in postoperative bleeding patterns could be found between satisfied and not satisfied women.

Conclusions: The THERMACHOICE intrauterine balloon system is an effective procedure in women suffering from menorrhagia. Significant prognostic factors for a favourable outcome are increased age and high FSH. Further prospective studies are needed to prove whether the cut off of 39.65 for FSH could be used to select patients with a probably positive result. Uterine position, length and depth and endometrial thickness did not influence any result.

Intraabdominal adhesions: what is our patients' awareness? Objective: Acute and chronic inflammatory processes are supposed to be of relevance in adhesiogenesis. This study was designed to investigate the expression pattern of important inflammatory mediators in peritoneal adhesions. Materials and methods: In 60 male Sprague-Dawley rats a standardized peritoneal defect was performed. On 3rd, 5th, 14th, 30th, 60th and 90th postoperative day 10 animals were sacrificed respectively. The formed adhesions were analyzed using immunohistochemical stains for macrophages/monocytes (CD 68), cyclooxygenase-2 (COX-2) and interleukin-6 (IL-6).

Results: During the whole observation period none of the animals died, or showed signs of infections or complications. At each time point formation of peritoneal adhesions was observed in all animals respectively. A notable expression of CD68 was observed in all animals with a peak on day 3. Although the number of CD68 positive cells decreased over time, CD68 positive stained cells could still be observed even on postoperative day 90. Analysis of COX-2 protein expression levels showed a highly positive staining up to the 90th postoperative day. IL-6 was detected in between the adhesion tissue up to 2 weeks postoperatively, with the highest levels 3 days postoperatively and a continuous decrease until the 14th postoperative day.

Conclusions: The detection of macrophages/monocytes and COX-2 indicate a chronic inflammatory process within peritoneal adhesions. The initially high number of macrophages/monocytes leads to the conclusion that this cell population may be essential in adhesiogenesis. Influencing IL-6 or the IL-6 pathway may serve as a novel target to minimize the formation of postoperative peritoneal adhesion. Surgical procedure: A few weeks prior to the surgical procedure the patient was asked to dilatate the vaginal stump with a vaginal dilatator. Thereby the length of the vaginal pit was about 3 cm. The patient was operated under general anaesthesia. For the endoscopic approach three additional suprapubic incisions are needed. The pouch of Douglas is opened up and a tunnel is prepared between the bladder and rectum. For a better orientation we place a thick Hegar's dilatator into the vaginal stump during this preparation. The tension thread is then passed with a straight needle from the vaginal stump through the prepared tunnel into abdominal cavity and connected to a vaginal dilatator. Cystoscopy and laparoscopy confirm absence of injury of the bladder or rectum. Now the threads in the abdominal cave are retrieved and withdrawn by a laparoscopic grasper after creation of an extra-peritoneal tunnel through to the abdominal wall and fixed at a tension apparatus. Preoperative the patient got an peridural catheter for analgesia during the tension period. Results: Tension was increased day by day. After 10 days the neovagina had a length of 10-12 cm. The tension threads and tension apparatus were removed under general anaesthesia. The patient was informed to use a vaginal dilatator after instillation of oestrogenic cream 1 h twice a day for at least 6 months until onset of regular sexual intercourse.

The endoscopically assisted method for construction of a neovagina gives very good results in cases where there is a vaginal stump. It avoids the stress of a laparotomy, the rate of complication is low, the risk of injury of the bladder can be minimized by doing a cystoscopia during the surgical procedure. However, the most important thing for a satisfying long-term result of this procedure is the regular postoperative dilatation.

PO-Gyn 02.11 Gene expression profiles: a new approach towards the diagnosis of interstitial cystitis/painful bladder syndrome?

Objective: Interstitial cystitis (IC) or painful bladder syndrome (PBS) is a chronic bladder disease with increasing incidence. Today, its diagnosis relies on symptoms evaluation (urgency, frequency, pain) in combination with cystoscopic and histological evidence. A molecular marker for an objective diagnosis is highly desired. Towards this goal, comparative gene expression profiles of bladder biopsies from patients with ulcerative IC/PBS and control patients have been performed. Materials and methods: Cold-cup biopsies from bladder tissue were collected from five ulcerative IC/PBS patients and from six healthy controls. After total-RNA extraction, gene expression profiles have been generated using Affymetrix Human Genome U133 Plus 2.0 expression arrays. HE staining of paraffin sections has been performed. Selected gene expressions were quantified by real-time polymerase chain reaction (TaqMan Assays, Applied Biosystems). Results: GeneChip expression arrays cover all known human mRNAs. More than 31,000 of over 54,000 tested probe sets were present (detection p value .05). The difference between the disease and the control group was significant for over 3,500 signals (t test p value .01), and approximately 1,000 genes showed a disease-to-healthy expression ratio greater than two. The found gene expressions show similarities to patterns from immune system, lymphatic, and autoimmune diseases. The dominant biological processes were the immune and inflammatory reactions. Many of the up-regulated genes were expressed in leukocytes, suggesting leukocyte invasion into the bladder wall. Histopathological data support these findings. Selected gene expressions were tested in bladder biopsies of patients with nonulcerative IC/PBS. Conclusions: Gene expression profiles with total-RNA isolated from bladder biopsies suggest a strong inflammatory infiltration in ulcerative IC/PBS. A current field of research deals with the question whether this is also true for non-ulcerative or early stages of IC/PBS.

Experience with vaginal mini-sling ophira: first interim analysis This System has a polypropylene monofilament mesh for the sub urethral area and two self-fixating arms with multiple fixating points in fishbone design. The tapes are placed mid-urethral low tension anchored to the obturator internus muscle. Pre-operative assessment consisted of a careful history, ICIQ-SF questionnaire, clinical exam, ultrasonic and urodynamics. The patients were re-evaluated 3 months and 6 months after the operation. Results: 39 patients mean age 56 years (range 37-78) underwent Mini sling Ophira placement. 36 patients had a primary Stress urinary incontinence and 3 a recurrent incontinence. The procedure was combined with prolaps-surgery or laparoscopic procedures in six patients. The mean operating time was 10 min (range 7-15 min) in patients with Mini Sling placement alone. We had no significant intraoperative and early postoperative complications such as bladder perforation, urethral injury or bleeding. Postoperative pain was very mild (average 1-2/10). One patient with persistent pain was re-operated with complete removing of the tape. Success rate after 3 month was 92% (n = 36). Two Patients with recurrent or persistent stress urinary incontinence underwent a bulking therapy after 4 month. 6-months follow-up data will be available in October 2010 and will be presented.

Conclusions: According to the interim analysis of our first 39 patients, the placement of Mini Sling Ophira is a safe and efficient method for the treatment of female stress urinary incontinence.

The fat component of the urogenital diaphragm is an important determinant of the success of a conventional anterior wall repair rates of conventional surgery up to 60% of the cases, it is challenging to relate the histological structure of the supporting layer created by the intervention to the clinical outcome. Materials and methods: In eleven patients undergoing a conventional anterior wall repair by reconstruction of the urogenital diaphragm, punch biopsies were taken from the rebuilded diaphragm layer. The relative composition of connective tissue, fat cell, and muscle areas was determined with the Leica Qwin morphometry system (Leica, Cambridge, UK).

Results: The spreading of tissue fractions resulted in 24 ± 10% collagen, 24 ± 16% muscle and 13 ± 15% fat. The percentage of collagen decreased with increasing age (n = 11, r = 0.68, p \ 0.05). Four of the eleven patients presented with a relapse of cystocele. All recurrent descents were at or beyond the hymenal ring (Ba 0 to +5 cm). Age, BMI and parity did not differ between patients with and without relapse, respectively. The relative contribution of the individual tissue components to the composition of the diaphragm revealed no difference between the groups for collagen. The fraction of fat tissue was significantly increased in the group of successful surgery compared to the relapse group (p \ 0.05) whereas the mean fraction of muscle tissue was decreased, though not significantly. In the total group minor values of Ba shift (i.e. actual re-displacement) were correlated to low fractions of muscle tissue (n = 11, r = 0.61, p \ 0.05). No relation was found between BMI and percentage of fat tissue.

Conclusions: The rigidity of the urogenital diaphragm and the success of surgical repair is a function of fat tissue rather than connective or muscular tissue.

PO-Gyn 02.14 Paraurethral injection Bulkamid Ò for the treatment of female urinary incontinence Results: Of 42 treated patients, more than 85% reported a reduction in pad use by more than a half. 6 patients (38%) were completely continent at post-treatment examination. The lower the degree of initial stress incontinence, the higher was the effectiveness of treatment: 100% of the patients with initial stress incontinence grade I achieved at least a reduction of pads use by half, and nearly 60% of these patients became completely continent. In the subgroup with mixed urinary incontinence, the same success rates were observed, and even the presence of hypotensive or hypomobile urethra had no influence on this outcome. No complications were observed.

The paraurethral injection of Bulkamid is a safe and largely complication-free method for the treatment of stress incontinence, regardless of the presence of additional symptoms of urge, a hypotensive or hypo-mobile urethra. The effectiveness of this method depends inversely on the degree of incontinence.

Is there a chance to cure patients with total urinary incontinence?

*Wolfram Jaeger 1 , Cem Cetin 1 , Sabine Bru¨gge 1 , Olga Mirenska 1 1 Evangelisches Krankenhaus, Gynecology, Dortmund-Lütgendortmund, Germany

Objective: In previous studies we observed that the elevation of the perineal body with a mesh fixed between the levator ani muscles and the os sacrum (VARESA I) could substantially improve urge incontinence. We therefore assumed that the combination of VARESA I and a TOT could be helpful in those patients who were totally incontinent (always wet Objective: Mesh extrusion is a common complication in surgery for pelvic organ prolapse (POP). It is hypothesized that local estrogens reduce this complication. We analyzed the association between vaginal estrogen application and mesh extrusion rates in a prospective multicenter study. Materials and methods: 199 women with cystoceles had anterior mesh implantation in 6 German hospitals. The application of local estrogens was recommended pre-and postoperatively. Nevertheless, estrogens were often not used for different reasons. A clinical examination, vaginal fluid pH-value determination and a history were performed preoperatively, 3 and 12 months postoperatively. A vaginal tissue specimen was taken during surgery.

Results: There was no association between menopause status or patients age and extrusion rate. Equally there was no effect between preoperative vaginal estrogen application and extrusion rate (p = 0.8).

But extrusion rate was significant higher in patients using estrogen 3 months postoperatively (p = 0.032) (12 (9%) using estrogen; 0 using no estrogen). Comparing extrusion rates 3 or 12 months postoperatively with the preoperative vaginal fluid pH-value there was no significant association. But 3 months postoperatively vaginal fluid pHvalue was higher in the extrusion group (5.2 vs. 5.8; p = 0.009), this may be a side effect by the vaginal lesion.

Conclusions: In our study, there was no effect between vaginal estrogen application preoperatively and extrusion rate in vaginal mesh surgery, the extrusion rate was even higher using estrogen 3 months postoperatively.

PO-Gyn 02.18 Perigee mesh for treatment of descensus genitalis anterior: efficiency and postoperative outcome Objective: While a pulsion cystocele as a midline defect of the fascia pubocervicalis can be operated by an anterior vaginal kolporrhaphia with good results, this operative treatment is not appropriate for a defect of the anterior vaginal wall caused by a defect of the lateral attachment of the vagina. A mesh system like the Perigee mesh offers a vaginal operative procedure for lateral defects. Materials and methods: 26 of 52 patients, who were treated in our hospital with a Perigee mesh between 2/06 and 11/08 were seen for follow-up. We checked the efficiency of the operation method and the subjective satisfaction rate by use of a questionnaire and a gynecological examination.

Results: In the follow up examination of 26 patients we found 5 relapses type cystocele II°with insufficient apical fixation. Subjectively 23 patients constituted their condition as better or healed, 3 as unchanged and only one as worse than before the surgery. Micturition was better in 15 patients, worse in only one. Preoperatively 12 patients suffered from stress incontinence, of which 10 stated their condition to be better postoperatively. In one patient the stress incontinence was worse, one patient reported a de novo stress incontinence. No patient had pathological residual urine. One patient reported dyspareunia. Only 15 patients still applied vaginal estrogen as it was recommended.

Conclusions: The subjective satisfaction rate was better than the objective results. It seemed to us that the recurrent prolapses were caused by insufficient apical support by the operation. In case of cystoceles with insufficient apical fixation of the vagina the Perigeemesh procedure should be combined with an apical fixation of the vagina, i.e. sacrospinal fixation.

Vaginal sacrocolporectopexy-a safe and cost effective approach for sub-/total uterine and vaginal vault prolapse surgery-description of the method and perioperative results In all patients postoperative recovery had been without complications.

In 17 patients the anatomic results were satisfying with no recurrent apical prolapse so far. All of them described their subjective situation as fully cured. In 2 cases recurrent prolapse occurred after 1 and 8 months. One of them with massive uterovaginal prolapse underwent consecutive abdominal repair. The other patient who primarily underwent LASH and sacral cervicopexy is now scheduled for anterolateral fasciocervicopexy (Waaldijk). Conclusions: Abdominal sacropexy is considered to be a gold standard in prolapse surgery. Combined with the advantages of minimal invasive surgery these short term results appeared as effective and safe. Using suture techniques at the presacral site we found no complications such as vertebral osteomyelitis or mesh expulsion as previously described by others. Objective: The Y-box binding protein YB-1 is involved in a variety of biological functions such as DNA transcription and repair and translational control of protein synthesis. The protein is highly expressed in a number of malignant diseases and is described as an oncogen regarding ovarian cancer in particular. The benign, chronic inflammatory disease endometriosis shares many characteristics with malignant diseases, like strong dissemination and invasion in affected tissues, increased angiogenesis and high numbers of recurrence. The objective of our study was to examine the expression of YB-1 in human endometrium and endometriosis. Materials and methods: Endometrium, endometriotic tissues and peritoneal fluid were obtained from patients undergoing laparoscopy at the Department of Obstetrics and Gynecology of the University of Lübeck. Immunohistochemistry and immunocytochemistry were performed in tissues and primary cultures of epithelial and stromal cells respectively. Cell cultures were prepared from endometriotic tissues and control endometrium and peritoneal macrophages were isolated from peritoneal fluid of patients with endometriosis as well as from healthy controls. YB-1 gene and protein expression were analyzed by quantitative real time PCR and Western Blot. Results: YB-1 was statistically significant and more strongly expressed in endometrium, endometriotic lesions and peritoneal macrophages of patients with endometriosis in comparison to controls. Strongest YB-1 expression was observed in the epithelial compartment of endometriotic lesions. Objective: The complexity of endometriosis and its diverse physical, emotional and social medical impacts pose major problems not only for the patient but also for the physician. Women with endometriosis differ greatly in terms of coping-strategies. The present study aimed to identify different patient groups to improve care. Materials and methods: The population of a study on the development and implementation of an outpatient education programme for women with endometriosis served as the basis of the analysis. Two-step cluster analysis was performed to identify three clusters based on the variables ''age'', ''disease duration'', and ''delayed diagnosis''. A unifactorial variance analysis variance (ANOVA) was used for comparison of mean values. Results: In total, 115 cases were included in the three clusters. The first cluster was a group of 44 women characterized by the highest mean age (44 years) and the longest duration of disease (13 years). Deep exhaustion was the most important symptom in this group. The second cluster consisted of a subgroup with a mean age of 36 years and a disease duration of 3.4 years. These patients had the highest pain scores and the worse quality of life scores. The most striking feature in this group was the extremely long delay in diagnosis, amounting to 16 years on average. The third cluster consisted of young women (31 years) with a short duration of disease (3.4 years) and a short delay in diagnosis (2.1 years) who had a problem-oriented approach to dealing with the disease. Conclusions: We expect that the analysis of psychological comorbidities at the 12-months-follow-up will show starting points to produce strategies for more selective treatment of endometriosis. In particular, it is crucial to identify ''difficult'' patients in Cluster 2 early and to ensure that they receive specific services.

Arch Gynecol Obstet (2010) Conclusions: Complex DIE-cases need special diagnostic and treatment. That leads to an increased demand of the costs due to special diagnostic, therapy and a prolonged duration of stay. We fear that the G-DRG-System is not able to cope the real costs of DIE, which could lead to a reduced quality of treatment of patients with endometriosis.

PO-Onko 02.04 Endometriosis between AFS and ENZIAN: a critical assessment of classification systems for endometriosis staging in an own patient group Objective: Several classification systems are currently in place to classify the disease severity of endometriosis, many of which provide a very detailed description of some aspects of endometriosis. So far there is not one single classification system which would allow to depict the disease in all its facets such as the desire to have children, pain and extent. The AFS classification system is currently the most widely used system of classification, but it does not take deep infiltrating endometriosis into account. This is why, complementary to AFS classification, the ENZIAN score was developed as a staging system which also includes deep infiltrating endometriosis. The aim of the following study is to demonstrate that the ENZIAN score is a proper tool for classifying deep infiltrating endometriosis when combined with the AFS classification system. However, it can be shown that certain localisations of endometriosis may be classified in both systems. Materials and methods: Between 1st January 2009 and 31st January 2010, a total of 219 female patients underwent surgical treatment of endometriosis at Linz General Hospital and were post-operatively classified using the rAFS and ENZIAN scores. Retrospective study.

Results: Classification of endometriosis using AFS and ENZIAN scores to assess disease severity and distribution pattern of deep infiltrating endometriosis.

Conclusions: The AFS classification system has proven a valuable tool in classifying endometriosis at international level. The ENZIAN score is a useful complementary tool to depict deep infiltrating endometriosis, yet needs to be adapted accordingly to avoid double classification in both systems. Both classification systems are to be regarded as morphologically descriptive, the inclusion of pain and the desire to have children as leading symptoms is urgently needed.

PO-Onko 02.05 Endometriosis in Pfannenstiel scar: a case report Objective: To raise the awareness of scar endometriosis. Pathogenesis as well as different approaches to diagnosis, treatment and prevention based on current literature are discussed. Materials and methods: In the present case report a 38 year old G2 P2 presented with premenstrual pain and bloody discharge from her caesarean scar. On ultrasound examination a 13 9 13 9 16 mm nodule was found at the level of the scar tissue. As scar endometriosis was suspected, the nodule was removed under general anesthesia.

Results: Histological findings were compatible with scar endometriosis. The postoperative recovery was uneventful.

Conclusions: Differential diagnosis of scar tissue pain in women following gynaecological or obstetric surgery should include scar endometriosis. Endometriosis is functional endometrial tissue outside the uterine cavity. Abdominal surgery involving the uterine cavity can lead to a spread of endometrial tissue in the abdominal cavity and may also involve the Pfannenstiel scar. Caesarean sections as one of the most frequently performed obstetric operations play a significant role in the development of scar endometriosis with an incidence of up to 1.7%. However, the pathogenesis of scar endometriosis remains unclear and gives rise to many theories. Important methods of preoperative diagnosis are ultrasonography including Doppler, computer tomography and magnet resonance imaging. Surgical removal is the treatment of choice. Histological examination confirms diagnosis. Preventive measures include thorough cleaning of the wound. In case of recurrent lesions malignancy has to be excluded.

Peritoneal fluid level of TNFa, IL-IB, IL-6, IL-8, IL-12 and IL-13 in Nigerian women with endometriosis Therapy Centre and Dept. of Obstetrics and Gynaecology of a Tertiary Hospital in Lagos. Study and Design: A cross sectional study. Materials and methods: Serum and peritoneal fluids samples were obtained from a total of n = 57 women, while undergoing laparotomy for infertility surgery (tubal repair, myomectomy and hysterectomy). Concentration of TNF alpha, IL-IB, IL-6, IL-8, IL-12 and IL-13 were measured in serum and peritoneal fluid. 17 were diagnosed with endometriosis externa, 6 adenomyosis uteri, 16 uterine leiomyoma and 18 normal results. Results: Peritoneal fluid levels of TNF alpha, IL-6, IL-8, were significantly higher in the endometriosis and adenomyosis group (p \ 0.01) respectively. There were no significant differences in the peritoneal fluid levels of IL-1, IL-12 and IL-13 in the entire group.

Conclusions: The elevated levels of TNF alpha, IL-6 and IL-8 in peritoneal fluid but not serum may show the importance of local cytokine profile in serum and peritoneal fluid from infertile women with and without endometriosis. Facts, Problems, and Fictions: 1. The establishment of a Center will lead to a increase of patients 2. The whole team should be able to handle the dramatic increase of complex and very complex cases 3. The Center structure should provide sufficient opportunities for qualification (doctors, nurses and patients) 4. Advanced Endometriosis is a surgical challenge-you will experience the urgent need in surgical training and cooperation. 5. In the out-patients setting, deficiencies in financial resources can lead to restrictions 6. The payment for Endometriosis procedures (diagnostic and treatment) which is based on the G-DRG-System should be optimized in the next future. 7. The growing number of patients will offer the opportunity for basic and clinical research. 8. In Europe, the german model of Centers of Excellence is unique and might influence the future of research and treatment.

PO-Onko 02.08 Expression levels of hnRNP G and hTra2b1 have opposite effects in endometrial cancer biology b Objective: Endometrial cancer (EC) is the most common gynecological malignancy in developed countries. The underlying molecular pathogenesis of EC, however, is poorly understood. Two well characterised alternative splicing factors hnRNP G and hTra2b1 were found exert antagonistic effects on alternative splicing in vitro and in vivo. In this study we explored the impact of these two factors in tumor biology of endometrial cancer (EC). Materials and methods: EC tissues (n = 139) were tested for hnRNP G and hTra2b1 expression on mRNA level by real-time PCR and on protein level by immunohistochemistry.

Results: HTra2b1 mRNA level was found being induced in advanced FIGO stages (p = 0.044). HnRNP G protein nuclear expression was found more prominent in patients without distant organ metastasis (p = 0.033), and in FIGO stages I/II group (p \ 0.001). HTra2b1 protein nuclear levels were elevated in poorly differentiated (p = 0.007) and lymph node metastases (p = 0.003) cancers. Kaplan-Meier survival curves revealed that elevated hnRNP G mRNA (p = 0.029) and protein (p = 0.027) levels were associated with a favourable patient outcome. Elevated hTra2b1 nuclear protein level was correlated with worse overall survival. Multivariate Cox-regression analyses identified nuclear hnRNP G level (hazards ratio 0.468, p = 0.026) as well as hTra2b1 level (hazards ratio 5.760, p = 0.004) as independent prognostic factors for EC progression-free survival.

Our results indicate that the antagonistic functional effects of hnRNP G and hTra2b1 on alternative splicing correlate directly to their opposite clinical effects on EC patient outcome.

The sentinel concept for lymph node staging in endometrial cancer: is it possible? study was to show the practicability of the sentinel concept using an trans-cervical application of the marker preoperative. We record the number of SLN found in lymphscintigraphy, single photon emission computed tomography combined with computed tomography (SPECT/CT) and intra-operative. Materials and methods: Between August 2008 and March 2010 21 patients underwent SLN labeling for staging of endometrial cancer. We applying 10 MBq Technetium-99 m-nanocolloid (2 9 5 MBq; 0.5 ml volume each) trans-cervical into the fundal myometrium. 45 min p.i. planar lymphoscintigraphy was performed followed by SPECT/CT and surgical therapy. We registered the number and location of SLNs in lymphoscintigraphy as well as in SPECT/CT. Additional the number of SLN found intraoperative, lymph nodes found within the obligatory performed conventional lymph node dissection and positive SLN were registered.

Results: Lymphoscintigraphy could be detecting SLNs in 15 of 21 patients, SPECT/CT detecting SLNs in 19 of 21 patients (90.5%).

One of the two patients with non-marked SLN had an distinctive lymph node metastasis in 24 of 50 lymph nodes. One labeled SLN in SPECT/CT (5.3%) could not be found as SLN intraoperative using the gamma probe. Three patients had SLN metastasis as well as further lymph node metastasis. One patient (5.5%) had lymph node metastasis with an unaffected SLN. In average 3 SLN and 34 non-SLN were removed. Conclusions: In endometrial cancer the sentinel concept is possible to perform using a trans-cervical labeling procedure. The SPECT/CT improved the pre-and intraoperative detection of SLNs. It's increased the number of sentinel lymph nodes found during surgery. But, currently a complete lymph node dissection must be carried out obligatory.

PO-Onko 02.10 Cyr61 (CCN1) protein expression as a predictive marker in endometrial cancer Objective: Cysteine rich 61 (Cyr61/CCN1) is involved in a multitude of physiologic and pathologic processes such as cell adhesion, migration, angiogenesis and apoptosis. It is an important player in tumorigenesis due to its pro-angiogenetic activities. Cyr61 undergoes alternative splicing resulting in two different mRNA variants. Hypoxia triggers the predominant expression of only one mRNA variant that is solely capable to code for biologically active protein.

Cyr61 expression studies in endometrial cancers found both, a downregulation as well as an overexpression of the protein. We studied the expression of Cyr61 and its splicing isoforms in endometrial cancer. Materials and methods: Cyr61 protein expression in 138 tissue samples originating from endometrial cancer patients was evaluated by immunohistochemistry (IHC) and correlated to clinicopathologic factors separating histological types I and II. Survival of tumor patients was calculated by using Kaplan-Meier curves and Log-ranktest. In addition, expression of both Cyr61 mRNA variants was investigated in these samples by real-time PCR. Immunhistochemical results were correlated to expression levels of Cyr61 mRNA isoforms. Results: Cyr61 overexpression was detected in 15% of endometrial cancer samples. Multivariant-analyses confirmed correlation of high protein expression levels (IHC) with lymph node metastasis, lymphangioinvasion and tumor-grading. Patients with an overexpression of Cyr61 had a lower overall-survival and a shorter receive-free-survival compared to patients exhibiting low or moderate expression of Cyr61.

We could not find any significant correlation between immunohistochemistry and expression of the protein-generating mRNA transcript.

Conclusions: Overexpression of Cyr61 in endometrial cancer correlates well with poor survival, lymph node metastasis, lymphangioinvasion and tumor-grading. Therefore, it could represent a new molecular marker in predicting survival of patients with estrogendependent endometrial cancer. Posttranslational modifications may account for the discrepancy of Cyr61 protein expression examined by IHC and no significant correlation with expression levels of the protein-generating Cyr61 mRNA variant obtained by realtime PCR.

PO-Onko 02.11 Paraneoplastic peripheral neuropathy in a premenopausal patient with endometrial carcinoma Objective: A paraneoplastic syndrome refers to a group of symptoms which are not directly caused by the primary or metastatic tumor. Paraneoplastic polyneuropathies are most frequently associated with lung cancer and in a gynecological setting with breast cancer. A manifestation in the course of a neoplasm of the female genital organs is an uncommon finding and has only been reported in a few cases.

We report about a 48 year old nullipara who presented with subacute symmetric weakness of the limbs and parestesia. Nerve conduction studies were consistent with sensorimotor neuropathy, biopsy revealed an axonal degeneration. Within 4 months, she turned from a regularly healthy woman into a disabled and wheel-chair depending patient. A suspicious uterine sonogram was found while accomplishing the oncological screening. Curettage was performed, which proved the presence of endometrial adenocarcinoma. Corticosteroid therapy and radical hysterectomy with bilateral adnexectomy was conducted. Secondly a radical lymphonodectomy was performed rendering the final tumor stage: pT1b, pN1 (4/25), G2, R0. Postoperatively the neurological symptoms improved. The patient is now scheduled for a adjuvant radiotherapy.

Conclusions: Neurological symptoms such as neuropathy, paresthesia and weakness, which occur in otherwise healthy women with no medical history, are always suspicious. The phenomenon of a paraneoplastic syndrome can point to an underlying malignancy and can be used as marker of progression or regression of the tumor. Usually paraneoplastic symptoms occur before the tumor is diagnosed. Due to the rarity of PNP, there is no standard treatment, but surgical and/or chemotherapeutical oncological treatment is recommended.

PO-Onko 02.12 Impact of CAIX and TIMP-1 serum levels at the diagnosis of metastatic breast cancer prognosis in breast cancer patients. Therefore, we investigated the prognostic impact of CAIX and TIMP-1 serum levels in a cohort of metastatic breast cancer patients. Materials and methods: Blood samples were taken at first diagnosis of metastatic disease before initiation of therapy in 90 breast cancer patients who were treated at the University Medical Center Hamburg-Eppendorf between 1994 and 2006. CAIX and TIMP-1 were measured by commercially available ELISAs (Oncogene Science, Siemens Healthcare Diagnostics). CAIX levels above the published cut-off of 506 ng/ml and TIMP levels above the cut-off of 454 ng/ml were regarded as elevated.

Results: 21% of the patients (n = 18) had elevated CAIX levels and only 19% of the patients (n = 14) had elevated TIMP-1 levels at the onset of metastatic disease. Increased TIMP-1 levels correlated with HER2/neu negativity (p = 0.017) but no other correlation could be observed between CAIX and/or TIMP-1 and traditional clinicopathological parameters. A shorter overall survival could be seen in the group of patients with increased CAIX levels (17 vs. 32 months; p = 0.029). We were not able to demonstrate a difference with regard to progression-free survival for patients with elevated CAIX serum levels. Elevated TIMP-1 serum levels were not associated with shorter progression-free or overall survival. However, in the subgroup of patients with estrogen receptor negative primary tumors elevated TIMP-1 levels correlated with shorter overall survival (5 vs. 18 months; p = 0.003).

Conclusions: In our group of patients with metastatic breast cancer, we were able to demonstrate a prognostic impact of CAIX and TIMP-1 serum levels.

Multiple tubular adenomas of the breast: a case report and review of the literature Objective: Tubular adenomas of the breast are rare benign lesions mainly diagnosed in women younger than 35 years. In 1982 the classification of adenomas of the breast firstly included tubular adenomas distinguished from fibroadenomas by the predominance of epithelium and relative lack of stroma. These tumors with a reported incidence of about 4% of all benign breast lesions and about 11% of breast adenomas could be misdiagnosed as breast cancer.

We here present a case of bilateral tubular adenomas in a 21 year old Chinese woman. She presented with a palpable tumor mass of the left breast measuring up to 11 cm. She reported a continuous tumor progression within the past 6 years. On physical examination the tumor affected the entire left breast, while lymph nodes were inconspicuous. Breast ultrasound showed a 110 mm solid hypoechoic lesion of the left breast with partially irregular edges and inhomogeneous echo structure. The patient underwent a core biopsy. The histologic examination showed a tubular adenoma without any special histologic features. Therefore a mammography was not performed. Personal pathologic anamnesis revealed a malignant tumor of the parotid gland at the age of 11 years treated with radiation. The patient presented good general health. She underwent a total resection of the tumor in the left breast.

Conclusions: Tubular adenomas are rare lesions of the breast and often difficult to differentiate from breast cancer by clinical examination. Surgical examination is the treatment of choice and allows the correct histopathologic diagnosis. Core biopsy should be performed before surgery to avoid unnecessary misdiagnosis. Materials and methods: The Success C Trial is an open label, multicenter, 2 9 2 factorial design, randomized controlled, phase-III study for early, HER2/neu-negative breast cancer patients. The first randomization of the study will compare the disease free survival in patients treated with 3 cycles of Epirubicin-Fluorouracil-Cyclophosphamide (FEC)-chemotherapy, followed by 3 cycles of Docetaxel (D)-chemotherapy versus 6 cycles of Docetaxel-Cyclophosphamide (DC)-chemotherapy. The second randomization will compare disease free survival in patients with BMI of 24-40 kg/m 2 getting an individual lifestyle intervention versus not getting this lifestyle intervention. Women assigned to the weight reduction arm will receive an intervention program that consists of weight loss, diet and physical activity goals in the framework of a 2-year standardized and structured telephone and mail-based intervention. Furthermore, a translational research program will focus on the role of CTCs as valuable marker of treatment failure and early disease progression. At four predefined timepoints peripheral blood will be drawn. Results: Results of the toxicity analysis and the translational research program will be available by the end of treatment (*June 2012). First conclusions about effects on disease-free-survival are expected 2 years after the end of chemotherapy or lifestyle intervention respectively.

PO-Onko 02.15 Development of breast-dimensions to use in 3Dmamma-scanners in plastic breast surgery computer animated breast modell, to predict the outcome of operations in plastic breast surgery. Materials and methods: The 3D-breastmodell is supposed to be used previously to a plastic surgery procedure of the female breast. The system aims to provide the patient with a visualization of the outcome of the planned operation. The dimensions of 100 probands were determined, medically interpreted and evaluated. In order to provide the 3-D computer program with a basis of standard values, the results were supplied to the program. Objective: The Thomsen-Friedenreich (TF) antigen is an onco-fetal carbohydrate epitope, associated with diverse carcinomas. Former studies showed, that a majority of mamma carcinomas and their disseminated tumor cells in the bone marrow express TF. In this study we investigated the effect of a TF-antibody (NM-TF1) on proliferation and apoptosis of the breast cancer cell line CAMA1 and furthermore alterations in receptor tyrosine kinase-expression in vitro. Materials and methods: After immuncytochemical staining of CAMA1 cell slides with NM-TF1, confirming the positivity of CAMA1 for the TF-antigen, CAMA1 cells were each incubated 48 h with 60 lg/ml NM-TF1 for all following examinations. A Glycophorin antibody functioned as an isotype control applied in the same concentration as NM-TF1. Proliferation rates were measured by a BrdU cell proliferation ELISA, apoptosis rates were determined by nick translation, immunocytochemistry with a M30 Cytodeath antibody and a cell death detection ELISA. Receptor tyrosine kinaseexpression was analyzed by a Phospho-RTK Array and evaluated with the ''Quantikine'' software.

Results: NM-TF1 treated CAMA1 cells showed a significant inhibition of proliferation compared to the control group. Further with regard to apoptosis we found significantly elevated rates confirmed by all three examination methods after incubation with NM-TF1. The analysis of the Phospho-RTK Arrays, showed a down regulation of the Erb B2-, Erb B4-, Eph A1-and Eph A4-receptor phosphorylation for NM-TF1 treated CAMA1 cells.

Conclusions: The TF1-antibody NM-TF1 facilitates an inhibition of proliferation and an elevation of apoptosis in breast cancer cell line CAMA1. Therefore this antibody could be a hopeful candidate for an antibody-based tumor therapy for TF-positive mamma carcinomas. The analysis of the Phospho-RTK-Array allows insights in RTK inhibition. The TF1-antibody affects cell signaling pathways especially of the Erbfamily, which influence not only cell proliferation and apoptosis, but also protein synthesis, cell motility, invasion and metastasis.

Defining clinical and tumor characteristics to predict non-sentinel lymph node status in breast cancer patients with sentinel node metastasis *Livia Kueffner 1 , Laura Scheurer 1 , Verena Weber 1 , Claudius Fridrich 1 , Andreas Gerteis 1 , Wolfgang Simon 1 1 Robert-Bosch-Krankenhaus, Gynäkologie und Geburtshilfe, Stuttgart, Germany

Objective: The current practice is to perform a complete axillary lymph node dissection (ALND) in breast cancer patients with tumorinvolved sentinel lymph nodes, although only some of them have nonsentinel metastasis. In the most cases the axillary staging by sentinel node biopsy is probably sufficient, first of all considering the high morbidity of ALND. We inquired, if there exist any clinical or tumor characteristics, which predict the probability of having non-sentinel involvement.

Materials and methods: We analysed 765 breast cancer patients, who were treated with a sentinel node biopsy in the years 1998 to 2008 in our hospital. If they had sentinel lymph node metastasis, they underwent ALND. We evaluated the following clinical and tumor characteristics as predictors for non-sentinel lymph node involvement: age of patient, menopausal status, localisation of the tumor, tumorsize, tumor histology, tumor grading, hormone receptor status, HER2-status, lymphangiosis carcinomatosa and multifocality of the tumor. Results: 160 patients (21%) had sentinel lymph node metastasis. In 16 patients (10.0% of the 160 patients with sentinel node metastasis) we found a non-sentinel lymph node involvement. Big tumorsize, negative hormone receptor status, negative HER2-status, lymphangiosis carcinomatosa and mutifocality were significantly associated with non-sentinel lymph node involvement. We could not find any correlation of non-sentinel metastasis considering patient's age, menopausal status, tumor localisation, tumor histology or tumor grading. Conclusions: We could show that there exist tumor characteristics, which we correlated to low probability of non-sentinel involvement. In the case of low probability of non-sentinel tumor burden the ALND should be discussed. Changing the current management could be an advantage for many patients. Objective: Breast MRI is superior in the staging of invasive lobular breast cancer (ILC) compared to ultrasound and mammography alone. Yet, evidence that the implementation of breast MRI leads to a benefit for the patient is relatively weak and a it could also lead to an overestimation of the tumor and respectively to an overtreatment of the patient. Materials and methods: At the Heidelberg Breast Unit we included 92 ILC patients in a retrospective but confirmatory analysis who received a preoperative breast MRI and subsequent surgical therapy. If breast MRI revealed additional suspicious lesions or increase in tumor size estimation these cases were presented to a fictitious interdisciplinary preoperative tumorboard. The recommendation of the fictitious tumorboard given without the knowledge of the breast MRI result was compared with the recommendation of the real tumorboard what integrated the results of the breast MRI. In the case of surgical change, we analyzed if this was adequate according to the postoperative pathology findings. Results: New MRI findings resulted in a change of surgical therapy in 23 of all patients (25%). According to the postoperative pathology findings this change was appropriate in 20 of these patients (22%). Assuming a minimal acceptable benefit rate of 5% clinically relevant this change turned out to be significant on a confirmatory basis (p \ 0.0001). Three patients (3%) who underwent mastectomy due to breast MRI, a breast conserving therapy would have been possible. Conclusions: Patients usually benefit from a preoperative breast MRI in terms of appropriate change of surgical change due to breast MRI. The risk of overtreatment on the contrary is limited.

Arch Gynecol Obstet (2010) 282 (Suppl 1):S63-S270

PO-Onko 02.21

Objective: Drug or suicide gene delivery to breast cancer by mesenchymal stem cells (MSCs) has been reported to be a treatment option due to migratory properties of stem cells. In contrast, stem cells have also been shown to enhance tumor growth, metastasis and invasiveness. However, little is known about cytokines involved in the recruitment of MSCs by breast cancer. Here we investigate the interaction between breast cancer cells and MSCs.

Materials and methods: Breast cancer was generated in Balb/C mice (n = 5) by injecting 4T1 cells into the mammary fat pad. Seven days after injection of tumor cells, mice received an i.p. injection of GFP-Luc-labeled human MSCs, which were tracked by bioluminescence. In vitro migration assay were performed to assess migration of MSCs towards conditioned medium of 2 breast cancer cell lines (4T1, MDA-MB231 Objective: Based on evidence from single trials as well as metaanalysis, taxane containing adjuvant chemotherapy has been established as standard treatment in node-positive breast cancer. However, in the MA-21 study, AC-P was significantly inferior to FEC120. We prospectively compared a sequential epirubicin-docetaxel chemotherapy regimen to FEC120. Materials and methods: The ADEBAR study was a multicenter phase III trial (n = 1502) to evaluate whether breast cancer (BC) pts with [4 axillary lymph node metastases benefit from a sequential anthracyclinedocetaxel regimen (E90C-D: 4 cycles epirubicin [E] 90 mg/m 2 plus cyclophosphamide [C] 600 mg/m 2 q21 days followed by 4 cycles docetaxel [D] 100 mg/m 2 q21 days) compared to dose-intensive anthracyclinecontaining chemotherapy (FE120C: 6 cycles E 60 mg/m 2 day 1 + 8, 5-FU 500 mg/m 2 day 1 + 8 and C 75 mg/m 2 day 1-14, q4 weeks). Results: Treatment was stopped prematurely in 3.7% of the pts in the E90C-D arm and in 8.0% in the FE120C arm due to toxicity (p = 0.0009). Antibiotic treatment was given in 10.4% (E90C-D) vs. 19.7% (FE120C), G-CSF support in 39.2% vs 61.4% and erythropoietin stimulation in 8.7% vs. 20.0%, respectively (p \ 0.0001). Haematological toxicity was significantly higher in the FE120C-arm. 128 events of recurrence were observed in the FE120C group and 153 in the E90C-D group. Overall survival in the two groups was not significantly different: HR 0.99, 0.73-1.35, p = 0.99. Subgroup analyses, stratifying for tumor size, lymph node involvement, hormone receptor and HER2-neu status showed no significant difference between the two treatment arms and will be presented in detail.

Conclusions: Different toxicity profiles given, hematological toxicity in the FE120C group was more severe than in the E90C-D. In contrast to AC-P in an earlier study, EC-Doc provides a feasible and effective alternative option to dose-intensified FEC with different safety profile in this high risk breast cancer cohort. Results: Of 405 breast cancer patients 9 were excluded because of incorrect portacath insertions. Among the remaining 396 patients the most frequent complication was thrombosis (9.8%). Surgical complications were infrequent with catheter leakage (0.8%) and pneumothorax (0.5%). We found no significant correlations between the rate of thrombosis and several different clinical variables (primary vs. metastatic disease, tumor size, lymph node status, and histological grading). Moreover no differences were found regarding to the two applied insertion techniques or the chest side in which the portacath was placed. Interestingly, the rates of thrombosis were lower in patients older than 50 years (7.1 vs 14.0%; P = 0.037).

The thrombotic complication rate in breast cancer patients is rare. We found younger age as the only patient related risk factor for the development of port-related thrombosis.

High sensitive pool screening of point mutations in breast cancer using chemiluminescence detection Objective: A nonisotopic pool-screening method of point mutations (e.g. SNP) and small insertions/deletions in genetic samples is presented. Based on a formerly described allele-specific pool-screening, the semi nested PCR is substituted by a one-step method in combination with solid-phase technique and chemiluminometric detection. Materials and methods: The allele-specific PCR was designed to discriminate between T and G changing the amino acid 300 from Cysteine to Glycine in the breast cancer gene 1 (BRCA-1). The PCR products were coupled via their Biotin label to Streptavidin-coated microtiter plates. For chemiluminometric measurement an A(lcaline)-P(hosphatase)-labeled monoclonal anti-Digoxigenin-antibody was added. The antibody detects the PCR products resulting out of the amplification of the mutant allele. AMPPD with amplifier was used as the chemiluminescent substrate for AP. Results: The method is able to detect one mutant allele in a total of 2048 alleles. Pool sizes from 32 up to 128 samples are practicable (=64 to 256 alleles). The signal-to-noise-ratio is better than 3:1 vs. cut-off for pools with 128 specimens.

Conclusions: The method is very useful in following applications: for population studies, especially for rare mutations, for determination of allele frequencies in a population or in modified manner: for screening, e.g. for HIV-or Hepatitis B exclusion in blood donors, for cancer therapy monitoring to evaluate the risk of a minimal residual disease, e.g. Philadelphia chromosome in chronic myeloic leukaemia. Furthermore the use of microtiter plates allows an automated execution of the post PCR steps i) PCR product extraction, and ii) detection & measurement of the mutant allele. The method is able to reduce the costs about 60 to 90% for PCR per sample (depending on pool size).

Arch Gynecol Obstet (2010) patients who had passed all three, n = 160 who had passed two inquiries and n = 228 who had passed only one.

Results: Under therapy the fear of endocrine, operative and radiation therapy gets tendentially less, while fear of chemotherapy seems to stay equal or even to get more. All patients refusing chemotherapy had a higher score of fear in all items. Fear of loss of hair and fear of nausea was always pronounced the most.

Conclusions: There seems to be sort of psychological disposition remaining unchanged under therapy experiences and which complicates the guideline adherent therapy. It has to be discussed, if this could be point of intervention to improve outcome of patients. Objective: Drug therapy management is increasingly complex from the physicians' point of view. According to international studies ward-based clinical pharmacists' interventions (PI) may improve cost-effectiveness as well as treatment outcomes. To assess PI benefits from clinical and quality management perspective a one-year pilot project was initiated. Materials and methods: A clinical pharmacist as part-time staff was implemented on a once-weekly base in the ward round of three operative and/or oncological teams. The scope of duties was systematic chart and medication process analysis, patient-oriented drug information, Adverse-Events-management, optimization of drug substitutions according hospital formulary, avoidance of special medications' orders, improvement of drug storage and reimbursement. Consecutive PI were prospectively recorded and classified in the ADKADokuPIK Ò database from 10/08-7/09. PI's clinical relevance was categorized using the NCC MERP Index out of clinical pharmacist's perspective. Moreover monetary effects on drug costs or reimbursement were estimated and stratified according intervention category groups. Effects on process costs were not considered. Results: Within this time frame 274 PI were documented, among them 60 medication errors: n = 53 NCC MERP categories A-C (no harm), n = 5 category D (no harm but monitoring required) and n = 2 categories E/F (temporary harm, intervention or hospitalization required). Higher severity grades were not recorded. The PI acceptance by physicians or nurses was 90.7%. With €23.603 quantifiable return on investment (ROI) the project-related staff costs were almost completely financed by reduced drug costs or increased reimbursement rates. Measures to optimize DRG-rates were particularly efficient.

Conclusions: The benefit of PI during gynecological ward rounds could be demonstrated out of clinic and quality management perspective. Due to the provided evidence for ROI the project was extended for another year. Further research should identify and quantify the value of improved patient outcomes.

Objective: Conisation for suspected high grade CIN is often performed based solely on abnormal cervical cytology results. LEEP is a common surgical procedure in this context. This study was designed to analyze concordance rates of cytology, colposcopic examination including targeted cervical biopsy and postoperative histology as well as to assess the efficacy of LEEP. Materials and methods: Two-hundred and seventy-four consecutive patients treated with LEEP for CIN at our center were analyzed. All patients underwent Pap-smear, HPV-DNA testing, colposcopy and, if indicated, targeted cervical biopsy/endocervical curettage before and 3-6 months after surgery.

Results: Median age of the patients was 34 years. Preoperative HPV testing was positive for high risk types in 77.9%. All patients underwent a LEEP without further ablative procedures. Complete excision of the lesion could be achieved in 84.3%; in 13.6% pathological findings were ambiguous and in 2.1% the lesion was clearly not excised entirely. Overall complication rate was 5.4% (mainly postoperative bleedings and pain). Of the patients with initial recurrent Pap IIId or Pap IVa 74.1% had a CIN II/III lesion in postoperative histology. Adding colposcopy to preoperative assessment increased concordance with postoperative histology to 88.2%, with additional preoperative targeted biopsy the concordance rate was 95.0%. Median follow-up was 50 months; 9 patients (3.4%) had persistent disease and 4 (1.5%) developed disease recurrence and underwent re-conisation. HPV testing at 3-6 months after surgery was negative in 78.5%; 2 of the patients developing disease recurrence had a persistent HPV infection after LEEP. Conclusions: Assessment of cervical lesions with colposcopy and targeted biopsy is a highly accurate method and can potentially help to avoid overtreatment. Surgical treatment of high grade CIN with LEEP is a safe procedure with low recurrence rates, resulting in a clearance of cervical HPV infection in the majority of cases.

PO-Onko 02.37 Detection of breast cancer cells in lymph node tissue by quantitative alu real-time PCR (1) After occurrence of multiple pulmonary embolisms of patients with ovarian cancer (6 patients in 2 years) the threshold for prophylactic heparinization was subsequently lowered.

(2) Due to insufficient sun protection, exanthema was observed in a high fraction of patients receiving anti-EGFR directed therapies and led to modifications of pre-treatment counselling.

Conclusions: The CIR-system implements a feed back loop which allows identifying and responding to unknown, neglected and underreported events caused by modern oncologic therapies.

PO-Onko 02.39 Caesarean section and simultaneous total mesometrial resection (TMMR) in pregnancy related cervical cancer

The following case report describes the surgical treatment of a 29 year old pregnant woman diagnosed of a poor differentiated invasive cervical cancer by conization in the 27th week of gestational age. The surgical treatment was performed at the 31st week of gestation age after induction of fetal lung maturity. Materials and methods: After consensus on the optimal time of delivery a caesarean section with simultaneous longitudinal laparatomy and a total mesometrial resection (TMMR) according to Höckel including pelvic lymphadenectomy and bilateral salpingectomy was performed. TMMR based on developmentally defined topographic anatomy with nerve-sparing contrary to the classical Wertheim-Meigs-surgery.

The uterus showed no further manifestations of the cervical cancer, the parametria and pelvic lymph nodes and the pelvic wall biopsies being tumor-free. The surgery was very bloodless, the structures were defined clearly due to the bulked tissue. TNM: pT1b1, pN0 (0/51), L1, V0, G3, R0, M0. The preterm baby developed well and the mother had no postoperative complications. No adjuvant treatment is necessary.

Conclusions: There are no recognised guidelines for treatment of pregnancy-related cervical cancer. Thus it must be based on recommendations for non-pregnant women. The therapy has to be adjusted individually considering interest of the mother as well as the unborn. The therapy depends on the gestational age, stage of the cervical cancer, ethnic and individual wishes and psychological aspects. In general, the prognosis of cervical cancer is not worse for pregnant women compared with non pregnant women and the surgery is very bloodless.

PO-Onko 02.40 Differential diagnosis in symptomatic adnexal masses Objective: Thyroid function influences the outcome of human pregnancy as a sufficient availability of thyroid hormones is required for fetal development. Thyroid hormone receptors are expressed in placental tissue from early pregnancy. The aim of our study was to investigate the expression of TRa1 in placentas of normal and miscarried pregnancies and in placentas treated with the progesterone receptor antagonist Misoprostol. Materials and methods: Placental tissue was obtained from 45 patients (n = 15 miscarriage, n = 15 normal pregnancy without Misoprostol treatment, n = 15 normal pregnancy with Misoprostol: 200 mg oral 24 h before induced abortion). Paraffin sections of the placentas were stained with specific antibodies against TR a1 followed by a semiquantitative evaluation and statistical analysis.

Results: TR a1 is expressed in cytotrophoblast cells to a higher degree than in syncytiotrophoblast cells both in miscarried and in normal placentas beside of Misoprostol treatment (p \ 0.04). In addition, TR a1 is upregulated in miscarried placentas as compared to normal placentas (p = 0.001 in syncytiotrophoblast cells). With regard to Misoprostol application before curettage, a downregulation of TR a1 in treated placentas as compared to untreated placentas was observed (p = 0.007 in cytotrophoblast cells). Materials and methods: In this bicentric, blinded trial study serum of postmenopausal patients with estrogen receptor positive breast cancer on non steroidal AI therapy is analyzed concerning clinical symptoms of vaginal atrophy, vaginal dryness and dyspareunia. We analyze serum concentrations of estrogen, estrogen metabolites, FSH, LH, testosteron, androstendion, inhibin, SHBG, DHEAS at Day 0 and 28 (t = -0.5, 0.5, 1, 2, 4, 6, 8, 24 h) . The initial therapy concludes the daily application of one Gynoflor Ò vaginal tablet (0.03 mg estriol) over a period of 28 days (n = 24). In the following eight weeks three tablets per week are given. Further blood samples are drawn at, week 8 and week 12.

Conclusions: The goal of this study is to analyse the potential systemic and local effect of local applied estriol (Gynoflor Ò ) in breast cancer patients on AI treatment. 

Objective: The aim of the study was to improve the operation for breast cancer and to reduce the need for second operations because of S188 Arch Gynecol Obstet (2010) 282 (Suppl 1):S63-S270 insufficient resection margins. Close resection margins in breast cancer operation is the most important risk factor for local recurrence. The prediction of resection margins is important in breast cancer operations. The results of pathological fresh frozen diagnostic for resection margins are not exact enough, and the results of the final histological diagnosis are too late. The study was done to analyse the efficiency of intraoperative ultrasound to define resection margins. Materials and methods: 88 specimens of 81 patients with sonographically detectable tumors were examined with ultrasound before there being sent to the pathologic examination. 507 measurements had been done and correlated with the histological measurement of the resection margins. There was no selection based on the histological tumor type.

Results: In the evaluation of the correlation between the songrafical and histological measurement we could show, that a resection margin of 5 mm by ultrasound correlates to a histological margin of 1 mm in 95% of the cases. The intraoperative ultrasound seems to be a method that is able to give fast and reliable further information to the surgeon about resection margins. This information can help to decide about the necessity to remove additional margins.

Objective: Angiogenesis is an important prerequisite of development and differentiation of organs and tissues, and it plays a key role in tumour growth and metastasis. Angiogenesis factor expression has been implied as a marker for tumour malignity, and it may help to identify patients with a benefit from emerging anti-angiogenetic treatment modalities. The present study examines the relationship between angiogenesis factor expression and clinical tumour criteria. Materials and methods: 81 patients with cervical cancer who underwent follow-up examinations between October 2002 and June 2005 were enrolled, and serum samples were examined for VEGF, bFGF, endostatin and VEGF-R1 by means of an ELISA. Based on an endothel-cell proliferation assay, an angiogenesis score was calculated. Results: Higher endostatin and VEGF expressions indicated advanced disease, and VEGF allowed for a reliable distinction between patients with non-invasive and recurrent disease, respectively. There were no correlations between the angiogenesis score and clinical criteria or individual angiogenesis factors.

Conclusions: The utility of angiogenesis factor notwithstanding, the angiogenesis score assessment's value for the identification of patients who will benefit from anti-angiogenetic treatment is arguable. In contrast, VEGF plasma concentration may be a promising marker for cervical cancer. Conclusions: OCT is a rapid, easy-to-use modality that provides microarchitectural information of the cervical epithelium. Further refinement of this technology will lead to OCT systems with higher resolution and improved image acquisition rates at or near video quality. Therefore, OCT has the potential to become a valuable investigative tool in the management of pre-invasive and invasive cancer of the cervix. Objective: Cervical cancer is the most frequently encountered malignancy during pregnancy. The decision for termination or delay of pregnancy is always a challenge. The presence of nodal metastasis is the most important negative predictive factor and its assessment represents a crucial parameter to decide if pregnancy can safely continue. Cisplatin is recommended to prevent cancer progression during waiting time for fetal maturity but knowledge about passage of platinum through placenta is very limited.

Materials and methods: 18 patients who underwent laparoscopic pelvic lymphadenectomy during pregnancy at Charité-University Berlin and Friedrich-Schiller-University Jena between 1999 and 2009 were analyzed retrospectively. Among these six consecutive patients with cervical cancer diagnosed in second trimester underwent neoadjuvant chemotherapy because of local residual tumor, high risk situation or advanced disease. After 3 cycles (one patient 2) of cisplatin chemotherapy caesarean section together with radical (19 simple) hysterectomy was performed not less than 32 week of gestation. At the time of delivery synchronous samples from maternal blood, umbilicalcord blood and amnion fluid were taken and analysed for cisplatin concentration.

Results: All of the laparoscopic procedures were successful completed; there was no mortality, morbidity, or conversion to laparotomy. Additionally, there was no complication for either mother or child related to the general anesthesia. The mean number of lymph nodes removed was 17 (6-46). Lymph nodes were positive in 16% of the cases (3/18) and these patients received immediate cancer treatment. Cisplatin concentration in the umbilical cord and amnion fluid was 31-60% and 13-43% of the maternal blood, respectively. Objective: Radical vaginal trachelectomy (RVT) is an oncologically safe therapy option in patients with early stage cervical cancer and wish for pregnancy but it is limited to women with lesions measuring less than 2 cm. Neoadjuvant chemotherapy can be applied to downstage the tumour so that patients can become eligible for RVT. We report a case of pregnancy after chemotherapy and RVT.

A 27 year old G 0 patient was diagnosed with adenosquamous cervical cancer stage IB1 (4 cm in diameter) in December 2005 and persisted on fertility-sparing therapy. First, the laparoscopic pelvic and paraaortic lymphadenectomy was performed and showed no metastasis in the lymph nodes. The patient received chemotherapy with Paclitaxel 200 mg/m 2 and Cisplatin 100 mg/m 2 . Goserelin was given for fertility protection. The cycle was repeated after 3 weeks with Cisplatin reduced to 50 mg/m 2 because of creatinine-increase. MRI followed showing tumour reduction to 8 mm.

Results: Except for the creatinine-increase, the chemotherapy was well tolerated. After RVT, only focal carcinoma of 2 mm in diameter was found in the final specimen. The patient recovered and resumed a normal menstrual pattern 6 weeks after surgery. In December 2008 she conceived. She reported no problems during pregnancy except for gestational insulin-dependent diabetes. The cervix measured 25 mm during pregnancy. The patient gave birth to a boy in August 2009 by caesarean section after 38 + 0 gestational weeks. The newborn (weight 3500 g, length 52 cm, APGAR-scores 5/8/10, pH-value 7.28) was monitored on a neonatal ward for 24 h. The patient is followed up regularly and there is no evidence for recurrence.

Conclusions: Neoadjuvant chemotherapy followed by a fertilitysparing surgery may become a valuable option for women with bulky stage cervical cancer who wish to preserve their fertility potential.

PO-Onko 02.53 Chief medical clinic manager: an innovative job description for increase of quality of care and physicians' economic freedom of action *Volker R. Jacobs 1 , Peter Mallmann 1 1 University of Köln, Frauenklinik (OB/GYN), Köln, Germany

Objective: Leadership structures in German hospitals are adjusting parallel to DRG-induced economic reorientation of the health care system. Due to limited resources physicians have to take increasing responsibility not only for the clinical core process of patient care but also for the integration of financial, administrative and organizational aspects. Materials and methods: A Chief Medical Clinic Manager (CMCM) is a new job description and an innovative approach to combine medical competence and business economics embedded at the operational level of care. Ideal qualification is a medical specialist in the clinic's field with practical experience in patient care and leadership as well as in hospital economics and quality control. A CMCM is placed as staff position at a superior level in the clinic, with authorizing competence for the entire physician team and takes part in all daily physicians' meetings.

Results: Main tasks are cost transparency within the clinic, identification and elimination of illegitimate cost drivers, organizational development by structured processes especially focusing on quality of care and guideline-based treatment as well as financial and strategic controlling of all business aspects. A CMCM improves horizontal communication within the department and hospital, induces change management and financial adjustment of care to reimbursement without reducing standard of care. In cooperation with the director of the clinic, a CMCM develops a vision for clinic development, an investment strategy and a business plan. The success parameters are positive clinic's operative results, cost covering care, increased investment rate, employees' satisfaction and implementation of innovations in research and therapy.

A CMCM assures quality of care and increases financial and organizational freedom of action at clinic level in a non-profit public health care system. This concept has been developed over several years and has been proven to be financially successful. The financial return of investment for the clinic is 3-10-fold the income of a CMCM. Objective: Endometriosis is a chronic disease with an enormous economic burden placed on the society. We tried to estimate the financial burden of the inpatient treatment. Materials and methods: The design of the study is a descriptive analysis of data from national impatient database taken from all hospital admissions in Germany. The design of the study is a retrospective one. We identified the number and type of hospital admission involving surgical interventions for endometriosis. We estimated the costs of these hospitalisations to payers in Germany using the DRG rates. 

Objective: Improving the molecular understanding of ovarian cancer development and progression could contribute to novel strategies for the management of this malignancy. Loss of heterozygosity (LOH) is a hint for the inactivation of tumor suppressor genes (TSGs) located in deleted regions. In breast and ovarian cancer frequent LOH has been demonstrated at the chromosomal region 11q23-q25. Materials and methods: Gene expression of candidate gene CRYAB was performed with cancer profiling arrays and RT-PCR. Mutation analysis was done by DHPLC. For functional characterization CRYAB was subcloned in a retroviral vector and transfected in ovarian carcinoma cell lines and correlation of CRYAB expression and chemoresistance was analysed Results: CRYAB (alpha-Crystalin-ß) was downregulated in 56% of ovarian carcinomas (OC), however, 19% of OC displayed more than 2-fold CRYAB overexpression compared to normal tissue. No inactivating mutations could be identified in the coding region. We could demonstrate 8-fold CRYAB overexpression in ADR-resistant compared to ADR sensitive SKOV-3 cells, however CRYAB expression was not induced by ADR or Cisplatin within 96 h. CRYAB expression in transfected SKOV-3 and HEY cells (SKOV-3-/HEY/CRYAB S11-IEG3) was increased 8-fold and over 10-fold, respectively, but no increase in resistance against ADR, Cisplatin, Etoposid could be observed in CRYAB transfected cells. CRYAB expression will be silenced in ADR resistant SKOV-3 by siRNA experiments to confirm that CRYAB overexpression is rather an effect than the cause of chemoresistance in this OC cells. 

Objective: Intestinal malrotation is a rare congenital disease. In most cases first symptoms present during childhood with acute or chronic, partial or total intestinal obstruction, complicated by volvulus or intestinal necrosis. The diagnosis of malrotation in adults is not often taken into consideration leading to a time lack to its recognition. We present a case where symptoms of malrotation were misdiagnosed as endometriosis.

A 36 year old nulliparous woman came to our outpatient clinic suffering from chronic recurrent lower abdominal pain that was independent of menstrual cycle. She had a known endometriosis, so that external colleagues proposed hysterectomy. Until then she has had five laparoscopies, where signs of endometriosis and a mobile blind intestine have been described. In our institution clinical examination, blood count and Ca 12-5 as well as cystoscopy and colonoscopy were normal so that we proposed another laparoscopic examination to evaluate the extent of endometriosis. During this operation no signs of endometriosis could be verified but an abnormal position of the bowel was obvious. The whole small intestine appeared to lie in the right part of the abdomen, the blind intestine was dislocated upwards in the middle right part of the abdomen and the mesentery was dislocated to the right. A contrast enhanced MRI arranged after the operation confirmed suspicion of intestinal malrotation: the small intestine lying on the right side of the abdomen and the colon on the left side. Hysterectomy was not performed.

Conclusions: This case demonstrates that malrotation in adults is a rare but clinically relevant entity, which has to be kept in mind as differential diagnosis to avoid unnecessary examinations or operations. ) . Irradiation was initiated at day 8 after tumor cell injection Radiotherapy was applied on 3 consecutive days in doses of 2 Gy. N-TSP2-Fc was administered by daily intraperitoneally injection. N-TSP2-Fc application was either initiated at day 5 and continued until day 10 after tumor cell injection or was given on 15 consecutive days after completion of radiotherapy. Results: Preliminary data show that treatment with exogenous N-TSP2-Fc before and during radiotherapy may enhance the antitumor effect of irradiation. The growth delay was longer for A431 SCC given N-TSP2-Fc treatment and irradiation than for tumors given radiotherapy alone. After irradiation, A431 tumors given N-TSP2-Fc treatment grew more slowly during the regrowth period than tumors given radiotherapy alone.

Conclusions: Our preliminary data suggest that antiangiogenic N-TSP2-Fc may enhance the antitumor activity of radiotherapy. Further investigations on possible radiosensitizing effects of N-TSP2-Fc are currently being performed. We report on a 30 year old woman presenting with hyperemesis gravidarum and subsequent vomiting at the end of the first trimester. The patient initially presented with nausea and vomiting, without any abdominal pain. Clinical symptoms increased and the patient complained suddenly severe dyspnoe and intractable cough. Therefore immediately a chest x-ray was performed showing a severe left sided diaphragmatic hiatus hernia with an intra-thoracal stomach, making immediate surgical intervention necessary. Diaphragmatic hernias complicating pregnancy are a rare event, they normally occur in later periods of pregnancy due to the rising intra-abdominal pressure caused by the enlargement of the uterus. Also maternal diaphragmatic hernias during pregnancy are usually associated with minor complains. However, they can be life threatening, due to mediastinal shift and cardio-respiratory failure. The majority of maternal diaphragmatic hernias complicating pregnancies occur in antenatal period, most of them in the 3rd trimester. More than 90% of maternal diaphragmatic hernias complicating pregnancy are localized on the left side of the diaphragma. Usually maternal diaphragmatic hernias become clinically obvious in advanced stage of pregnancy, in contrast hyperemesis gravidarum is normally occurring in the first trimester and is usually self-limiting. Guiding symptoms for hyperemesis gravidarum are nausea and vomiting, but can also be unspecific symptoms of a maternal diaphragmatic hernia. Therefore especially mild variants of maternal diaphragmatic hernias in early pregnancy can be misdiagnosed as hyperemesis gravidarum. Nevertheless the rising intra-abdominal pain while vomiting obviously can trigger exacerbation of a pre-existing maternal diaphragmatic hernia. We therefore speculate that there is a direct link between hyperemesis gravidarum and the exacerbation of the pre-existing maternal diaphragmatic hernia. Hence a diaphragmatic hernia should always be excluded, if symptoms of hyperemesis are intractable, mediastinal shift with dyspnoe occurs, failure of conservative treatment especially after 20th week of gestation and in very late onset of assumed hyperemesis gravidarum.

Prevalence of female sexual dysfunctions in the gynecological practice: preliminary results from the EROS-Gyne study

Objective: Aim of the EROS-GYNE study (Epidemiology and recognition of female sexual dysfunction in the gynecologist's practice) was to investigate the prevalence rate of hypoactive sexual desire disorder (HSDD) in the German gynecologist's practice.

The study was conducted in 22 gynecological practices in the South Baden and Rhine-Main region. It comprised a survey which collected data about sexual problems, somatic diseases and depressive symptoms. A subsample of women, who agreed a telephone interview, was interviewed subsequently. This clinically validated interview asked for partnership, sexual satisfaction and complaints. Additionally, we asked for mental disorders. At the end of the interview it was possible to diagnose a sexual disorder. 1644 women were invited by medical staff to fill in the survey prior to their gynecological examination. One question ''Altogether, are you satisfied with your sex life?'' approved to dichotomize in a high-risk group of dissatisfied women and a low-risk group of satisfied women.

The clinical interview was performed in 70 women out of the highrisk group and 71 women out of the low-risk group.

Results: 1558 women filled in the questionnaire. The clinical telephone interview was performed in 141 patients and yielded a prevalence of 17% for acquired HSDD. Women who fulfilled the criteria for HSDD who were likely to suffer from at least moderate depressivity were excluded from this prevalence estimation. Out of the 17% of women with acquired HSDD, almost all patients reported personal distress due to the sexual problem and three out of four patients reported interpersonal problems.

Conclusions: About every sixth patient in gynecological care suffers from acquired HSDD. The recognition and diagnosis of HSDD is necessary since gynecologists are most often the first professional contact person for women suffering from HSDD. This study was funded by an unrestricted grant of Boehringer Ingelheim Germany.

Relevance of the number of metastatic lymph-nodes for disease recurrence in vulvar cancer

Objective: Nodal involvement is the most important prognostic factor for recurrence and survival in vulvar cancer. Adjuvant radiotherapy is currently recommended for [ 2 metastatic nodes by German guidelines. This standard is based on small and heterogeneous patient cohorts. We therefore reanalyzed the impact of the number of affected nodes for disease-recurrence in a large and homogenous cohort. Materials and methods: 157 consecutive patients with primary squamous cell cancer of the vulva treated at our center were analyzed. All patients underwent primary surgery by triple incision resulting in complete tumor resection. Results: Median age was 61 years; 44% had FIGO stage I, 20% stage II, 28% stage III, 8% stage IV disease. 49 patients (31%) had lymphnode metastasis; 21 patients had 1, 13 had 2 and 15 had[2 metastatic lymph-nodes. Median follow-up was 23 months; 22 patients (14%) developed disease-recurrence (77% vulva, 18% groins and 5% both). Patients without nodal involvement had a significantly longer diseasefree survival than the other groups (p \ 0.001). However, the number of metastatic lymph-nodes did not result in a significant difference in disease-free survival; even in patients with only 1 or 2 affected nodes disease-free survival rates were significantly lower compared to nodenegative patients (88% of node-negative patients were disease-free after 2 years and 59, 69 and 27% of the patients with one, 2 and [2 affected nodes). 31% of the patients received adjuvant radiotherapy. There was no significant difference regarding the number of patients receiving adjuvant radiotherapy between the different nodal positive subgroups.

Conclusions: Lymph-node metastases remain the most important prognostic factor in patients with vulvar cancer. In our cohort, the effect of nodal involvement appeared to be independent from the number of metastatic nodes. Therefore, it might be justified to consider adjuvant radiotherapy to the groins even in patients with only one metastatic node. There are a very large number of undetected cases of incontinence patients whose incontinence reduces their quality of life although this could largely be prevented by a preterm intervention. The continence function is one of the first social as well as control functions which is gained within a child's development and is generally considered to be an indicator for other social as well as control functions. Until today different definitions have been used for a complex of symptoms which is called overactive bladder. There is a big prevalence for this complex of symptoms which will increase due to the age development and, therefore, is of great interest. The hyperactive bladder (overactive bladder, OAB) includes the storage symptoms pollakisuria, imperative urge to urinate and nycturia with or without incontinence but these symptoms are always in the absence of local, metabolic, neurological or endocrine pathology. As a consequence the diagnosis ''OAB'' can initially only be suspected in the presence of those symptoms. It will become definite, however, once the symptoms have been properly diagnosed. Today a physician who works at a practise or hospital does not have enough time to review the large number of therapeutic recommendations of different sources and to verify whether the propagated treatment options are scientifically proven. Every year approx. 2 million articles are published in over 10,000 scientific journals. Especially from this point of view the guidelines regarding diagnostics and therapy of the hyperactive bladder are an integral part of the clinical daily routine.

Bulking agents as periurethral injection for the treatment of stress incontinence *Kurt Lobodasch 1 ,

Objective: The prevalence of urinary incontinence leads to social and societal challenges. The bulking therapy is a viable option for patients, with failed alternative operations, anesthetic risks, other contraindications or who reject major surgery. Materials and methods: Meta-analysis of the clinical studies on bulking agent in terms of their valuation in the current guidelines of the German-speaking medical associations. Results: The substances bovine-collagen (Contigen Ò ), silicone (Macroplastique Ò ), hyaluronic-acid Ò (Deflux/Zuidex Ò ) and polyacrylamide (Bulkamid Ò ) differ substantially in terms of their side effect profile and the re-injection rates. Granulomas, abscesses and calcification occurred in particular in hyaluronic-acid and collagen. Urethral erosions were observed during treatment with hyaluronicacid and silicone. Collagen did show a high allergy potential. Migration, embolism and granuloma formation were a potential risk in the treatment with silicone. These complications were not described with Polyarcylamid. The re-injection rates also differed among the agents. The Re-injection rate in the first year after treatment was 43-60% for hyaluronic acid, 31-74% for collagen, 38-52.5% for silicon and 20-44% for the polyacryamid therapy.

Conclusions: In the periurethral injection therapy, the choice of the substance used is crucial both in terms of effectiveness and in terms of safety. The analysis of available bulking agents demonstrated striking differences. General differentiation has to be made for bulking substances in which the gel acts as a carrier material and substances where the gel itself achieves the bulking. A generalized assessment of bulking therapy, as currently observed in the guidelines is therefore not appropriate. The comparison of the substances shows that the Bulking therapy with Bulkamid Ò has a unique benefit-risk profile among the available substances, presents itself as highly feasible, effective, sustainable and safe, and as an option for many patients for whom no (other) causal-oriented treatment option would be available. Objective: Implantation of transobturatoric meshes is frequently used in the surgical treatment of cystocoeles. Wound healing problems with mesh extrusions are frequently observed. We determined bacterial colonisation of the vagina and analyzed the relation to mesh extrusions. Materials and methods: In our prospective multicenter study 200 patients with Cystoceles underwent surgical transobturatoric mesh implantation. The microbiological colonisation and the pH-Value of the vaginal fluid was analyzed before surgery, after 3 months and after 12 months. Results: 194 patients were evaluated either after three months and 186 after 1 year. The extrusion rate at 3 months was 7.2% (14/194) and 5.9% at 12 months. The preoperative ph-values were not statistically different in patients with or without extrusions at 3 or 12 months follow up examination (5.0/5.3 at 3 months resp. 5.0/5.4). A colonisation with physiologic vaginal bacteria was observed in 64% of patients preoperatively, in 68% at 3 months and in 60% at 12 months. Colonisation with physiologic bacteria was not correlated to extrusions at 3 months, but we observed a statistically significant correlation between preoperative physiological colonisation and extrusion rates at 12 months. Patients without an extrusion had a physiological bacterial colonisation in 67.7% in contrast to 34.4% Patients with an extrusion (p = 0.046). A coloisation with pathogenic bacteria like streptococci, staphylococci or pseudomonas species was observed in 17% of patients preoperatively, in 19% at 3 months and in 19% at 12 months. Colonisation with pathogenic bacteria was not correlated to extrusion rates. Conclusions: An unphysiologic bacterial colonisation of the vagina is frequently observed in patients with POP. A colonisation of the vagina with physiological bacteria may prevent mesh extrusions in patients with mesh augmented surgery for POP, but overall mesh extrusion rates were only slightly related to bacterial colonisation of the vagina. Objective: To investigate whether and why the outcome of physical therapy in stress urinary incontinence can be improved by combining one-on-one physical therapy with muscle stimulation using the Galileo (side-alternating vibration platform). Materials and methods: Sixty women were randomized to 3 groups each in 2 studies. Treatment consisted of combined physical therapy and vibration training (Ph + V) in group A, physical therapy alone (Ph) in group B, and vibration training (V) in group C. The 30 patients in the first study received one-on-one Ph + V; the 30 patients in the second study received 2 30 min sessions/week of group physical therapy and 2 individual 8 min sessions/week of vibration training.

Results: In the first study, the cure rate of stress urinary incontinence after 12 weeks of treatment was 40% for Ph + V, 56% for Ph, and 40% for V versus 80% for Ph + V after 24 weeks. The corresponding cure rates in the second study were 50% for Ph + V and 20% for either Ph or V alone versus 72% for Ph + V after 24 weeks. Contractility of the pelvic floor muscles (EMG) significantly improved in both Ph + V groups compared with the groups receiving either Ph or V alone (study 1: +6.8 lV, p = 0.0077; study 2: +7.4 lV, p = 0.0109). In both Ph + V groups, sustained effects were reflected in subjective improvement 3 months after the end of treatment (study 1: improvement in 90% of women; study 2: improvement in 100%).

The best results in terms of cure of stress urinary incontinence, increase in muscle contractility, and sustained effects of treatment were achieved by physical therapy combined with Galileo muscle training administered on a one-on-one basis. The additive effect of these two forms of physical treatment results from the improvement of voluntary motor performance combined with vibratory stimulation of reflective muscles via the monosynaptic stretching reflexes.

PO-Onko 02.68 Case report: suburethral angiomyofibroma Histological examination reported an angiomyofibroma measuring 3.5 9 2.5 9 2 cm. Conclusions: Angiomyofibroma should be considered as a possible diagnosis of a suburethral mass. This case emphasizes the importance of perineal ultrasound examination as an essential part of urogynecological workup.

The influence of bladder volume in the assessment of pelvic organ prolapse Objective: The assessment of the maximum extent of the pelvic organ prolapse (POP) is essential for planning surgical treatment. The effect of bladder fullness on the degree of prolapse has rarely been addressed. This study compare the degree of prolapse using the POP quantification (POPQ) system. Materials and methods: 120 consecutive patients without any prolapse and patients with POP stage I or II according to the POPQ were included. All women were examined with full and empty bladder with maximal straining by a Valsalva effort.

Results: The mean maximal bladder filling was 344 ± 96 mL and the mean residual volume after spontaneous micturition was 24 ± 35 mL. After catheterization of those patients with more than 100 mL residual volume (6 cases) we were able to perform the examination with the mean of residual volume of 18 ± 19 mL. With empty bladder 54% had the same stage, 41% had a one step higher stage and 5% had a two step higher stage of prolaps. There was an increase in the extent of prolapse in the empty bladder setting at all six site-specific points (Aa, Ba, C, D, Ap, Bp; p \ 0.001) but not in the results of genital hiatus, perineal body and total vaginal length.

The bladder filling affected the anatomy of the vagina, especially of the anterior wall and the central compartment in patients with no or moderate prolapse. Therefore we suggest to perform the examination with full bladder to apply the stress test and with empty bladder to evaluate the stage of prolapse. Objective: TVT insertion does not consider individual urethral length. Depending on urethral length, the tape may not come to lie in the optimal functional position. We investigated whether positioning of TVT can be optimized by preoperative ultrasound measurement of urethral length. Materials and methods: Urethral length in 50 women with stress urinary incontinence was measured by preoperative introital ultrasound. The site of incision was marked using the following formula: 1/3 of the measured urethral length = distance of the distal end of the 1.5 cm suburethral incision from the external urethral orifice. Shape of tape, position, and distance from urethral lumen were evaluated by introital ultrasound 6 months postoperatively. Results: After 6 months, 94% were continent, 6% were improved. In 86% tape position was between \70% and [50% of the urethral length; in these cases the likelihood of being cured was significantly higher (p = 0.048). A too distal position was associated with a 17 times greater risk of not being cured. Bladder voiding was disturbed on the first postoperative day in 14% because of TVT-urethra distance \ 3 mm. Tape loosening led to cure in 6/7 patients, while one had persistent voiding dysfunction (unchanged distance \3 mm). Three developed de novo urge (2 with tape-urethra distance \3 mm).

Conclusions: Preoperative sonographic urethral length measurement ensures optimal TVT placement. The optimal site is calculated using the aforementioned formula. Nonoptimal TVT placement is associated with a higher recurrence rate but rarely causes complications.

Complications typically occur when the tape is too close to the urethra.

PO-Onko 02.73 Vertebral osteomyelitis as complication of laparoscopic sacral colpopexy with titanium bone screws Objective: Case report of vertebral osteomyelitis-a rare, severe complication after laparoscopic sacral colpopexy using alloplastic mesh material and titanium bone screws. Materials and methods: 68 year old patient referred as an emergency from a neighboring hospital presented with weakness, pain in both legs and progressive sings of septicemia. Thirty nine days prior to admission she had undergone laparoscopic sacral colpopexy for vaginal vault prolapse performed at the Gynaecological Unit of the same hospital. On MRI intraspinal empyema L3-L5, spondylodiscitis L3-S1 and multiple abscesses of the surrounding soft tissue were diagnosed. Group C Streptococcus was found on blood cultures. Results: Intensive care for septicemia and operative decompression of the spinal canal was immediately performed by neurosurgeons. One day later, after further stabilization of the condition, the patient underwent laparotomy at Dept. of Gynaecology and Obstetrics, Jena University Hospital. Mesh and bone screws were removed. Within the same procedure further dissection and stabilization of the vertebra and the vertebral disc were performed by neurosurgeons. Intraoperative swabs showed E. coli, group C Streptococcus and Morganella morganii. I.v. antibiotics were given according to resistogramm.

Conclusions: Some rare cases of severe complications after the use of titanium bone anchors or screws have been reported so far. Application of nonabsorbable sutures to the presacral ligament instead of tacker or screws to the vertebral bones should be preferred. Objective: Until now, no standardization for ultrasound assessment of the tension-free vaginal tape (TVT) has been established in clinical practice. The aim of this prospective, observational study was to evaluate the position of the tape by using ultrasound and compare this data with clinical postoperative results. Materials and methods: 296 patients with stress urinary incontinence (SUI) were treated with TVT and followed-up in our department. Further 12 patients, who were initially treated in other hospitals, and who had postoperative problems, were included in this study. Dependent on the outcome after 3 months, the patients were divided in groups with and without specific disorders. TVT was evaluated by introital ultrasound. The position of the tape was established by its site, in relation to urethral length [%] and the distance to the hypoechoic center of urethra (HCU) [mm] .

Results: Suitable position of the tape was determined in patients without any postoperative disorders. The position of the tape at rest in relation to urethral length was in the mean 61%. The distance to the HCU was 4.6 ± 1.5 mm. In patients with persistant SUI the tape was more often located under the inner (3 vs. 0%) or outer quarter (29 vs. 13%, p = 0.004). In patients with residual volume the distance to the urethra was significantly lower (2.7 vs. 4.6, p \ 0.001).

Conclusions: Tape position may be regularly investigated by ultrasound. In combination with the clinical outcome, it represents an important method and assists in the planning of a future therapeutic course of action in cases of postoperative disturbances.

Mode of delivery after tension-free vaginal tape procedure: literature review and case report Objective: The popularity of the TVT procedure for treating stress urinary incontinence has led to more women of childbearing age undergoing this surgery. Therefore the incidence of pregnancy after TVT procedure is likely to increase. On the other hand, there is no consensus among obstetricians and gynaecologists for obstetric management of women who have undergone TVT procedure.

We present a review of the current literature and we report the case of a 26 year old woman previously treated with TVT-O.

Results: There exist only a few reports on pregnancy and delivery after midurethral sling procedures. In the literature there is no evidence that an elective caesarean section protects against stress urinary incontinence in cases of pregnancy after TVT procedure. In our case an elective caesarean section was performed at 39 weeks' gestation. Postnatal pelvic floor exercises successfully controlled the incontinence with a recurrence of the stress urinary incontinence 4 months after delivery because of terminating physiotherapy. The woman was re-examined at 17 months postnatal. At this time she was doing well and reported no incontinence symptoms and no symptoms of an overactive bladder. The stress test was negative. Introital ultrasound showed the tape in the same position as before pregnancy and no residual volume. Conclusions: After a review of the literature, the best mode of delivery after TVT procedure is still unclear. Therefore it is not recommended to suggest a prophylactic caesarean section routinely. At present the mode of delivery must be considered individually, taking the woman's priorities into account. Objective: The aim of this study was to compare sexual function and quality of life in women with and without urogynecological dysfunction (stress urinary incontinence, overactive bladder and prolaps genitalis). Materials and methods: A total of 210 women (urogynecological disorders; n = 151 and without such problems; n = 59) from 29 to 89 years old were included. To obtain QoL (Quality of life) and sexual function assessments, the interviewer-administrated pelvic floor questionnaire was used. This validated questionnaire included aspects to bladder dysfunction, bowel dysfunction, pelvic organ Prolaps and sexual function. Women with and without therapy were included.

Results: Of the four domains in the pelvic floor questionnaire, all domains were significantly different between the two groups (p = .05). When comparing the sexual life, 74 of the 151 women with urogynecological disorders were sexual active (49%), in comparison 64% of the control group. 24.5% had a regularly sex life. 24.5% of the sexual active women had experience dyspareunia and 18.6% a coital urinary incontinence, this is 32.5% among the women with stress urinary incontinence. Coital urinary incontinence is more frequently during intercourse in the urogynecological group than the control group.

Conclusions: SUI, OAB and Prolaps genitalis have a detrimental impact on QoL and sexual life. In addition, our findings suggest that women with SUI had more coital incontinence than those with OAB.

The aim of further studies should be to find therapy options for specific therapy to improve the QoL and sex life for these patients.

PO-Onko 02.77 Identification of CAR 4/6 as a new splice variant of the coxsackie adenovirus receptor (CAR) differentially expressed in cervical cancer progression quantification of CAR mRNA in normal tissue and cervical cancer. By generating expression constructs for transfection, we analyzed cell proliferation, anchorage independent growth, migration and invasion. Results: We identified a new splice variant termed CAR4/6 which lacked exon 5. Localization of CAR4/6 in the cell membrane was confirmed by ectopic expression in cell lines. Expression analyses revealed that most normal tissues, including those of the female genital tract, express full length CAR (CAR6/7) but not CAR4/6. In a set of 30 invasive cervical carcinomas, significantly increased levels of both CAR4/6 and CAR6/7 were found in micro-dissected tumor areas compared to normal cervical epithelial tissue. An increase in the ratio between CAR4/6 and CAR6/7 was observed with tumor progression. Ectopic expression of both membrane bound isoforms of CAR in HT1080 cells enhanced the proliferative and invasive properties of these cells. Proliferation and invasion was strongest in cells transfected with CAR4/6. Objective: The determination of the serum beta-human chorionic gonadotropin (HCG) in gynecology serves to verify a pregnancy. But HCG is also a nonspecific tumor marker of malignant tumors of the gastrointestinal tract and for trophoblastic diseases in association with a pregnancy. Materials and methods: We report a case of a 46 year old woman with extreme anemia, hypermenorrhea and an IUD as well as a positive pregnancy test. The patient, however, did not have a gynecological disease, but instead primary metastatic cancer of the stomach with partial choriocarcinomous differentiation. Results: The patient was sent to our hospital because of extreme anemia (Hb 6.1 g/dL) and a weak general condition. A new IUD had been inserted four weeks before. Blood examination data indicated an abnormally high level of HCG (522798 IU/L, normal \5), the hemoglobin concentration was 5.5 g/dL. We performed an abrasion and a laparoscopy to exclude a disturbed intra-/extrauterine pregnancy as well as a trophoblastic tumor. There was no pathology to be found in the pelvis except for a small eminence on the surface of the liver. Microscopically, the abrasive material contained a decidual component. To exclude a tumor of the gastrointestinal tract, we performed an abdominal sonography that showed multiple liver metastases. CT revealed multiple pulmonary metastases as well. The gastrointestinal endoscopy diagnosed a bleeding tumor (5 cm) in the stomach. The biopsy of this confirmed a high-grade tubular adenocarcinoma with partial choriocarcinoma differentiation. The elevated HCG level is caused by the extended metastases and, on the contrary, is responsible for the decidual stroma transformation without any evidence of a pregnancy in the uterus.

Conclusions: The symptoms anemia, hypermenorrhea and a positive HCG are often signs of a disturbed intra-or extrauterine pregnancy. The HCG, however, can also be a sign of a malignant tumor of the gastrointestinal tract. Objective: Due to location vulvar cancer is predestinated for the sentinel concept. We analyzed if the use of the single photon emission computed tomography combined with computed tomography (SPECT/CT) in detection of inguinal sentinel lymph nodes is helpful compared to conventional planar lymphoscintigraphy and improved the intraoperative detection with the gamma probe. Materials and methods: Between August 2008 and March 2010, 16 patients with invasive vulvar cancer received peritumoral intracutaneous injection of 10 MBq technetium-99 m-nanocolloid (4 9 2.5 MBq; 0.5 ml each) followed by planar lymphoscintigraphy 45 min p.i., SPECT/CT and surgery. From tumor stage T1b we performed a complete inguino-femoral lymph node dissection. We recorded the number and localization of sentinel lymph nodes in lymphoscintigraphy and SPECT/CT, non-sentinel lymph nodes and lymph node metastasis found intraoperative.

Results: 16 patients underwent sentinel concept for inguinofemoral lymph node staging. All patients had pre-operative sentinel identification using SPECT/CT and lymphoscintigraphy. The SPECT/CT showed sentinel lymph nodes in all 16 (100%), the lymphoscintigraphy in 15 of 16 (93.8%) patients. With SPECT/CT a non-inguinal sentinel (gluteal) lymph node could be identified in one patient. This sentinel would not be found with routine intraoperative examination using the gamma probe. With lymphoscintigraphy the mean number of detected sentinel lymph nodes was 2.1, with SPECT/CT 4.1 (p \ 0.05). In average 5 sentinel lymph nodes were removed. In 8 patients (50%) a complete lymph node dissection was performed. Four of these patients have sentinel lymph node metastasis without metastasis in further lymph nodes. One patient had lymph node metastasis with an un-affected sentinel. No patient with tumor stage T1a had sentinel metastasis.

Conclusions: The sentinel concept in vulvar cancer becomes routine in the surgical treatment of vulvar cancer. The pre-operative SPECT/ CT improved the detection of inguinal and non inguinal regional sentinel lymph nodes compared to conventional lymphoscintigraphy and made the intraoperative detection easier to perform.

The influence of elder berries and blossom extracts on the cell lines MCF-7, BT-20 and fibroblasts Objective: We tested the effects of phytoestrogen extracts from the blossom and the berry of elder, Sambucus nigra. Examined the effect of the extract becomes on the cell proliferation, cell lethality as well as the metabolism activity at the cell line, MCF-7, BT-20 and at fibroblasts. Materials and methods: Microwave extractions as well as the extractions after Luyengi, a raw extract was won out of the elder berry as well as the elder blossom. Out of the raw extract of the elder berry, which was won by the microwave extractions, 7 parliamentary groups were generated through the HPLC. The raw extracts of the elder after the extractions of Luyengi were used in the concentrations 1000, 500, 250, 100, 50, 20, 10 lg/ml for the subsequent tests. In order to examine the cell lethality, the metabolism activity as well as the cell proliferation, became the LDH test, MTT test and the BrdU test carried out.

Results: The blossom of elder as well as berry extracts as well as the 7 parliamentary groups show in MCF-7 a significant cytotoxic effect of 30%, cell proliferation ca. 40% and the metabolism activity 120%. In contrast to that the extracts show after Luyengi in MCF-7 significant cell lethality of -20%, cell proliferation 20% and metabolism activity around 90-110%.

Conclusions: The elder extracts show antiproliferative and cytotoxic effects on MCF-7. The extraction methods differ in its cytotoxic effect on MCF-7. It is to be supposed been preserved that in the microwave extractions connections, which cytotoxic influence MCF-7. For going on statements, yet numerous tests must be carried out at MCF-7, BT-20 and fibroblasts. A 57 year old postmenopausal woman with an asymptomatic pelvic mass increasing in size on a 1 year follow-up. The pelvic transvaginal ultrasound demonstrated an inhomogenous, solid and highly vascularized tumor mass with an approximate size of 3.6 9 2.9 cm. The patient underwent a laparoscopic adnexectomy. CA-125 was within norm range. Histopathology of the tumor showed a female adnexal tumor of probable Wolffian origin (FATWO). In our patient's specimen signs of malignancy such as high mitotic rates, necrosis or angioinvasions were absent. Wolffian adenoma is a rare neoplasm arising from the remnants of the mesonephric duct. Until 2009 there were only 63 patients with FATWO described. The tumor is considered to be mostly benign but there are also few cases reported which have shown malignancy and even metastasis. Therefore patients with FATWO should receive careful follow-up for possible local recurrence and metastasis. Objective: Merkel cell carcinoma (MCC) is a rare, aggressive, malignant neuroendocrine tumour with an increasing incidence and also a high metastasis-and mortality-rate (five-year-survival rate 30-74%). The tumour cells express, among others, the cytokeratins 8, 18, 19 and 20. The following case report describes an unusual presentation of a breast tumour of a 79 year old female patient with an infiltrating MCC of the right breast. To recognize an early spreading of the cancer and to adapt therapy, we tried to detect micrometastases in the bone marrow. Materials and methods: The procedure was complete excision of the biopsy-proven, CK 20 + MCC and axillary sentinel lymph node biopsy (SLNB). Additionally, we took bone marrow aspirations of both iliac crests. Searching for the cytoskeleton of epithelial cells, a pan-cytokeratin antibody (mAb A45-B/B3) was used to identify cytokeratin 8, 18 and 19 positive cells. After immunohistochemical colour reaction, the samples were analyzed by Ariol SL-50 System automatically. Results: Although the sentinel lymph node was free of tumour cells, we found cytokeratin 8-, 18-and 19-positive epithelial cells within the bone marrow indicating micrometastases. So far spreading of the MCC tumour is routinely only analyzed by SLNB. The patient received radiotherapy of the breast and the axilla. Systemically we administer bisphosphonates for 3 years (Clodronat 1600 mg/die per os or Zoledronat 4 mg i.v. every 6 months), to eliminate the micrometastases as an analogy to encouraging results of treatment of breast cancer micrometastases. Conclusions: Few cases of primary MCC of the breast have been reported in literature only and-to our knowledge-so far no detection of disseminated tumour cells (DTC) as an early sign of spreading of disease. The authors recommend consideration of bone marrow aspiration and identification of potential DTC also with rare tumours of the breast and thus to adapt therapy sufficiently.

PO-Onko 02.83 A tissue's PTEN and ER status modulates AKT activation and tissue-specific reactions upon tamoxifen treatment Objective: Tamoxifen (TAM) is an important selective estrogen receptor (ER) modulator for treatment of ER positive breast cancer. However, TAM is one risk factor for developing endometrial carcinoma (EnCa). This study's aim is to contribute towards our understanding of the molecular mechanisms of TAM's tissue-specific contrary mode of action between mammary and endometrial tissues. Materials and methods: To determine total and phosphorylated protein expression Immunoblotting was performed on endometrial tissues, and with TAM-treated EnCa and Mamma-Ca cell lines time kinetics were analyzed. Using molecular cloning and transfections, the PTEN status of RL95-2 EnCa cells was rescued. Results: We observed deregulation of phosphorylation within the IGF-AKT axis in endometrial tissues from patients with TAM therapy. Protein deregulations occurred in benign pre-stages of EnCa and included increased total protein and phosphorylation levels of ER, AKT, PTEN and mTOR. Kinetic studies following TAM treatment of the PTEN mutated RL95-2 EnCa cell line demonstrated induction of pERa-S118 and pAKT-T308. These effects occurred within minutes, pointing towards an additional non-genomic TAM mode of action. TAM treatment of four EnCa and MaCa cell lines, differing in their ER and PTEN statuses, was performed to compare PI3 K-AKT-mTOR signaling with RL95-2 EnCa cells (ER+, PTEN-) showing highest levels of AKT activation following TAM treatment and the Mamma-Ca HTB-26 line (ER-, PTEN+) exhibiting lowest levels.

Conclusions: We propose that following TAM treatment, the ER and PTEN status of a tissue dictates the level of AKT activation. Ongoing studies to re-express PTEN in RL95-2 cells will provide evidence for the role of PTEN in regulating the response upon TAM. Loss of PTEN occurs in *80% of EnCa and could result in direct and rapid AKT activation upon TAM. Hence, low-molecular weight inhibitors Objective: The histopathological diagnosis of BOTs is based on the criteria of epithelial cellular proliferation without stromal invasion. However, despite an additional number of standardized criteria, there are considerable diagnostic problems when assessing these tumors.

Since the long-term outcome of patients with BOTs is mainly histology-dependent, the prognosis may change with the second reading of the histopathological slides. Materials and methods: Retrospectively we compared the first and second pathologist's diagnosis on all BOTs of our department between January 1998 and December 2008. Furthermore the results of this comparison were correlated to recurrence and survival rates.

Results: In the above mentioned period of time 26 patients (ROBOTtrial) underwent primary laparotomy, laparoscopic procedures or reassessment surgery for BOT diagnosis and/or tumorectomy. The histological diagnosis of 4 cases was altered by the second pathologist: 3 BOTs changed to benign findings (endometriosis, 2 times cystadenoma), 1 BOT was classified as malignant (Psammon-carcinoma. Considering the clinical management after this reclassification, 3 patients had overtreatment and 1 patient had been undertreated. However, until now all 26 patients show a disease-free survival.

Conclusions: The histopathological classification of borderline ovarian tumors is difficult and ambiguous. The clinical management of patients with these tumors can be optimized under study conditions with a second opinion on pathology.

PO-Onko 02.85 Human Tra2-beta1 and acidosis regulate Cyr61 alternative splicing *Marc Hirschfeld 1 , Markus Jaeger 1 , Gerald Gitsch 1 , Elmar Stickeler 1 1 University Hospital Freiburg, Gynaecological Hospital, Freiburg, Germany

Objective: Recently, we first described alternative splicing for the tumor-relevant pro-angiogenic Cyr61 gene. Two mRNA isoforms were identified, whereas the expression of only one isoform that was significantly upregulated by hypoxia contributes to the generation of biologically active Cyr61 protein and could be correlated to an aggressive phenotype in cancers. Our latest studies were subjected to investigate the molecular account of the reversible alterations in Cyr61 alternative splicing caused by hypoxia or its impacts. Materials and methods: Gynaecological cancer cell lines were treated with 0.2% lactic acid at a pH of 6.2 for 24 h. RNA was isolated followed by RT-PCR. Immunocytochemistry was carried out with the avidin/biotin method. Transfections of Tra2-beta1-shRNA-Plasmids were performed in various cell lines.

Results: Analogous to hypoxia, acidosis lead to an increased expression of the protein-generating transcript. The shRNA-mediated elimination of splicing factor Tra2-beta1 initiated the same effect on Cyr61 alternative splicing pattern like hypoxia or acidosis. Interestingly, on the protein level, we were able to show, that Tra2-beta1 protein localization is also influenced by acidosis. Under normal culture conditions cancer cells displayed a nuclear localization of Tra2-beta1 protein. Acidosis caused complete deficiency of nuclear Tra2-beta1 protein, in contrast to a markedly cytoplasmatic expression. The alteration in alternative splicing pattern caused by acidosis could be detected on mRNA and protein level. The Tra2-beta1-knockdown effect on Cyr61 alternative splicing was detectable on the mRNA level only.

Conclusions: According to our recent findings Cyr61 alternative splicing is influenced by acidosis, a concomitant phenomenon of proliferating, hypoxic cancer cells. We hypothesize that Cyr61 alternative splicing is controlled by the splicing factor Tra2-beta1. Proof is provided due to the facts that Tra2-beta1 protein localization is acidosis-dependent, and that elimination of the transcription factor Tra2-beta1 triggers the same effect on Cyr61 alternative splicing like acidosis or hypoxia, respectively. Objective: Laparoscopic surgery is associated with a reduced morbidity. Compared to open access, postoperative pain is reduced. The aim of this study was to analyse the intensity and course of postoperative pain and the influence of co-factors (adipositas, duration of operation, drugs). Materials and methods: 287 patients suffering from genital prolapse higher than I°and laparoscopic sacropexy were included. Patients were asked postoperatively to evaluate their pain using a four point verbal rating scale (VRS). Additionally medical records were analysed concerning drug application and co-factors. Results: Patients could distinguish between abdominal pain and shoulder pain after laparoscopy. Shoulder pain was rarely influenced by drugs, but disappeared after two to three days. Abdominal pain showed a maximum at day one and a good response to non-steroidal antiphlogistics. Best results were found after Diclofenac (3 9 50 mg/ day) and Ibuprofen (2-3 9 400-600 mg/day). The few cases treated with specific Cox-2 inhibitors (Etoricoxib) showed a tendency to very good results (application of only one tablet at all). Conclusions: Laparoscopic sacropexy is associated with a moderate degree of postoperative pain. Non steroidal antiphlogistics are sufficient to treat postoperative abdominal pain during the first days after operation but have no influence on shoulder pain. Alternatively specific Cox-2 inhibitors should be taken into consideration.

PO-Onko 02.87 Robot-assisted surgery in gynecology: experiences and results after 2 years of implementation of the daVinci system eliminated; thus the system is an advancement in MIC technology. In gynecology there is a broad spectrum of possible interventions. Materials and methods: So far 125 patients underwent a surgical procedure with the daVinci system. Recruitment occurred by the outpatient clinic. Selection criterias were complex gynecological pathologies (complex fibroids, cervical and endometrial cancer, etc.). Principal aim was to avoid laparotomy. Results: In 62% total hysterectomy and in 9% subtotal hysterectomy in benign disease has been done, in 3% radical hysterectomy; myomectomy in 20%, 3% LND (pelvic and paraaortic), 2% sacrocolpopexy. Mean uterine weight was 263 g (35-1000), the console time 138 min, the docking time 33 min (skin to console). The mean hemoglobin deficit was -1.4 g/dl; in case of LND 25.2 lymph nodes has been removed. The length of stay was 6d, postoperative need of analgesia 3d. Following complications occurred: 2 conversions to laparotomy (1.6%), 3 bladder lesions (intraoperative repair), 1 re-laparoscopy due to pelvioperitonitis has been done. Up to now no vaginal cuff dehiscence was observed. The rate of abdominal hysterectomies for benign disease between 2007 and 2009 decreased to 25%. Conclusions: Gynecologic surgery is the ideal field for robotic surgery. The implementation of the daVinci surgery is feasible. The main advantage of robot assistance is in complex changes (radical hysterectomy, multiple myomas, etc.). The observed complications are equivalent to conventional laparoscopy. The patient satisfaction is high. There are open questions concerning long-term financing of the robot system and the absence of reference in the DRG system. So far data from prospective RCT are missing, especially in oncologic long term follow up. A critical application of the system in the framework of an surgical master plan is recommended.

PO-Onko 02.88 Activity of bevacizumab (rhuMAB VEGF) in combination with metronomic cyclophosphamide in advanced refractory epithelial ovarian cancer *Esther Bischofs 1 , Julia Aigner 1 , Michael Eichbaum 1 , Christof Sohn 1 1 University of Heidelberg, Obstetrics and Gynaecology, Heidelberg, Germany

Objective: During the last decade new therapeutic strategies for the treatment of ovarian cancer have been evaluated, based on the most advanced knowledge of its molecular biology. Drugs like bevacizumab, either alone or in combination with metronomic chemotherapy, are showing antiangiogenic antitumour activity in ovarian cancer as well in preclinical models as in clinical trials. We present the outcome of a patient's case with recurrent heavily pretreated ovarian cancer which is currently under ongoing therapy with bevacizumab and metronomic cyclophosphamide in combination for 22 months. Materials and methods: A 53 year old woman with no relevant preexisting medical co-morbidities underwent four surgical interventions because of advanced recurrent ovarian cancer, each followed by chemotherapy in the following order: carboplatin, liposomal doxorubicin, paclitaxel, topotecan. Finally, the tumor progressed again with massive ascites that had to be drained several times. As a savage option, an individual therapy concept including bevacizumab 10 mg/ m2 q2w and metronomic cyclophosphamide 50 mg orally per day was induced. Results: The patient showed a rapid improvement of all tumor symptoms and soon did not need any ascites drainages any more. Treatment was tolerated without any significant toxicities and the patient returned to activity with good quality of life. Tumor marker levels normalized and imaging attested a partial remission. Currently, the patient is under treatment for 22 months in fine conditions and ongoing remission. Conclusions: Bevacizumab in combination with oral metronomic cyclophosphamide shows activity and is an option in the palliative therapy of heavily pretreated patients with recurrent ovarian cancer. Further investigations have to clarify if there are molecular predictors like e.g. antiangiogenesis gene polymorphisms for a successful therapy and if there are risk factors that predispose to the complication of e.g. gastrointestinal perforation. Also, the duration of therapy is unclear. Perhaps a maintenance therapy is reasonable.

PO-Onko 02.89 Tumorradiochemosensitivity testing (TRCA) in gynecological cancers *Rita Franz 1 , Steffen Albrecht 1 , Wolfgang Distler 1

Objective: Ovarian cancer is the most lethal of all gynecological malignancies, being responsible for about 50% of all deaths for female genital tract cancer. Although there have been significant advances in treatment, 40-85% of patients who have FIGO stage 3 to 4 disease will relaps after primary therapy. There is a need for developed and improve new modalities of individual therapyregimes. In order to determine the in vitro efficacy of cytostatic drugs in combination with radiotherapy (5-30 Gray), it is necessary to obtain tissue samples representative for the tumor. These samples allow prediction of the in vivo responses towards radiochemotherapy. Materials and methods: 14 patients, affected by advanced metastatic ovarian carcinoma, were treated with primary surgery, typically including a total abdominal hysterectomy, bilateral salpingoophorectomy, omentectomy, and lymphadenectomy. From the resicated tumour-material we produced cell suspensions and than the cell culture plates were treated in vitro with different cytostatic drugs and drug combinations. After this all plates are treated with a one single dose radiotherapy (5-30 Gray). After 7 days the cell culture were evaluated with ATP-TCA. Theoretically the combination of chemoand radiotherapy should achieve the best tumour growth inhibition rates, than each therapy separately, but in reality the results are very individually different. Results: 6 of the 14 tumour tissue show a higher response rate and a better improvement regarding tumour growth inhibition rate with radiochemotherapy, 5 tissue samples have a constant effectiveness with single or combination therapy and 3 samples show a worsen response rate. Conclusions: The results are individually different, each tumour tissue shows different reaction and its difficult to make a prediction. Nevertheless it's a ability to improve end develop the therapy regimes for patients who have exhaust primary therapy.

Relevance of two-marker combinations for discrimination of benign and malignant ovarian diseases quarters of patients have an advanced or disseminated stage of disease by the time of diagnosis. Thus we tried to identify combinations of biomarkers that permit a reliable classification of benign and malignant ovarian diseases. Materials and methods: We measured the concentrations of 11 biomarkers in the blood sera of 133 patients with pelvic masses by Sandwich ELISA systems. The histological analyses of the resectates revealed 47 malignant and 86 benign diseases. Due to the limited sample size we restricted statistical analyses to combinations of only two biomarkers leading to 55 combinations using complete cases. To quantify the predictive power of all combinations we used the AUCs of the biomarkers and the biomarker combinations and calculated 95% confidence intervals by using casewise resampling. Results: The biomarkers that performed best in univariate analyses were CA 125 (AUC 0.944), which has already provided to be a useful marker for monitoring ovarian cancer in the clinical routine and the marker HE4 (AUC 0.897). Predictiveness of CA125 improved by combinations with HE4 (AUC 0.961) and CA 19-9 and slightly improved with mouse-galectin-1, PP1490 and CA 15-3. Conclusions: The performance of CA125 can be improved when combined with HE4, CA 19-9, mouse-galectin-1, PP1490 and CA 15-3. Especially the combination of CA 125 with HE4 seems to be promising. These results show that additional studies with larger cohorts are necessary to validate the discriminatory power between benign and malignant masses of the pelvis when using biomarker and biomarker combinations. Moreover our results could contribute to the development of a screening test for detection ovarian cancer at a curative stage. Objective: Advanced epithelial ovarian cancer (EOC) relapses in the majority of cases due to the growth of residual microscopic tumors. Therefore, new therapeutic strategies to extend remission are required. Compelling evidence has underlined the importance of the immune system in controlling EOC. Based on the fact that the innate immune system is essential to the function of adaptive immunity and thus to the generation of effective immune responses we sought to enhance tumor immunogenicity by activating RIG-I, an intracellular innate immune sensor of viral infection. Materials and methods: We established ascites-derived primary EOC cell cultures. EOC cells were stimulated with RIG-I ligands and effects were assessed (apoptosis, HLA antigens, cytokines and chemokines). Coculture of RIG-I-treated EOC cells with monocytes and monocyte-derived dendritic cells (MoDCs) as well as natural killer (NK) cells was performed and activation determined (phagocytosis, HLA and costimulatory molecules, cytokines and chemokines). Results: The targeted delivery of RIG-I agonists induced primary EOC cells to upregulate HLA-class I, and to secrete pro-inflammatory CXCL10, CCL5, IL-6, TNF-a and IFN-b. Moreover, EOC cells stimulated via RIG-I became apoptotic, and were readily phagocytosed by monocytes and MoDCs, which in turn upregulated HLAclass I/II as well as costimulatory molecules, and released CXCL10 and IFN-a. This overwhelming pro-inflammatory milieu further augmented the cytolytic activity of NK cells.

We provide proof-of-principle that RIG-I ligands are promising candidates for cancer therapy by potentiating EOC cell apoptosis as well as antitumor immune responses and may lead to the development of an effective immunotherapy of EOC.

PO-Onko 02.92 Impact of disseminated tumor cells in bone marrow on clinical outcome in ovarian cancer patients *Pauline Wimberger 1 , Martin Heubner 1 , Rainer Kimmig 1 , Sabine Kasimir-Bauer 1 1 University of Essen, Gynecology and Obstetrics, Essen, Germany

Objective: Data concerning the impact of disseminated tumor cells (DTC) in ovarian cancer on outcome are still rare. In 109 primary epithelial ovarian cancer patients, we evaluated whether first-line therapy including radical tumor debulking and chemotherapy (carboplatinum/paclitaxel) can impact upon DTC in bone marrow (BM) and analyzed associations of DTC on outcome. Materials and methods: DTC were analyzed in bilateral BM-aspirates (10 ml) using density-gradient-centrifugation and immunocytochemistry, applying the anti-CK-antibody A45-B/B3. Disease-free survival (DFS) was estimated using the Kaplan-Meier method and evaluated using a two-sided log-rank test. Associations with other clinical data were tested by the chi-squared-test according to Pearson. A significant increase of DTC was assessed if the difference was 2 CK+ cells. Results: Before chemotherapy, we identified CK + cells in 45% (49/ 109) BM-samples with a mean number of 1.9 cells/9 9 10E6 BMcells (range 0-37). After chemotherapy (n = 67), we detected CK+ cells in 37% (25/67) with a mean number of 3.7 cells/9 9 10E6 BMcells (range 0-100). A significant increase of DTC in BM was noted in 24%. In 31%, chemotherapy eliminated pre-existing CK+ cells. In FIGO III/IV-stages, the presence of [5 CK+ cells before chemotherapy was associated with less macroscopic compete resection rates in primary surgery (p = 0.042). No other significant associations with clinical data including platinum-sensitivity, grading, tumor stage or patients' age were observed. FIGO III/IV-patients showed a trend for a diminished DFS in case of a significant increase of DTC in BM (estimated means: 24.6 and 36.2 months, respectively; p = 0.061). Conclusions: An increase of DTC during therapy might be a prognostic factor in ovarian cancer patients.

PO-Onko 02.93 Gene expression analysis of primary ovarian cancer and corresponding in vitro cultivated cell lines: underlining evidence for the well-known problem of translating from cell culture results into clinical practice Materials and methods: Gene expression data of 23 primary OC and 41 corresponding cultivated cells and ascites cell cultures were analyzed using the Affymetrix-chip HGU133 + 2.0 array. The cell cultures were also analyzed considering proliferation, time of duplication, and defining an IC50 score for specific cytostatic drugs. In order to determine the genomic integrity of individual cells an Interphase-in-situ-hybridisation (I-FISH) set was developed. Results: For 27 cell culture lines an IC50 score was generated. In contrast, no IC50 score was found for 14 cell culture lines. A distinct cluster was seen in primary tumor cells, fast proliferating cell lines and slow proliferating cell lines using the principle component analysis (PCA). These clusters were also seen in paired samples of primary cancer tissue and corresponding cell culture lines. Gene expression profiles of primary OC and cell culture lines did not only differ in proliferation associated genes but also in the expression of stromal, mesenchymal and epithelial markers as well as steroid-modifying enzymes and drug-resistance-genes. Interestingly, an up regulation of drug-resistance-genes was observed in fast proliferating cell culture lines in contrast to primary tumor tissue. I-FISH analysis indicated genomic instability in the fast proliferating cell culture lines. Objective: In ovarian cancer cells prognostic parameters like Her2newor estrogen receptor expression in breast cancer cells are missing, but clinical and pathological features like response to platinum-based chemotherapy, histological grading or FIGO stages display a certain correlation with prognosis in ovarian cancer. Recently it was shown, that especially in ovarian cancer host immunity versus tumor cells is of importance for the course of the disease. Tumor guided immune escape mechanisms have nicely been demonstrated. One of these mechanisms is the secretion of tumor derived Macrophage Migration Inhibitory Factor (MIF) in serum of ovarian cancer patients. MIF suppresses antitumoral responses of CD8+ T-lymphocytes and NK-cells however the clinical relevance of this mechanism still remains unclear. Materials and methods: We evaluated, whether MIF-serum levels in ovarian cancer patients correlate with clinical and pathological predictors of poor prognosis. Points of interest were responsibility to platinumbased chemotherapy, histological grading, FIGO-stages at primary diagnosis and disease free and overall survival. In addition, immunohistochemistry for CD8+ T-cell and NK-cell infiltration in the tumor stroma in tissue samples from the examined patients was performed. Results: In all examined groups high MIF levels in serum correlated with poor prognosis. Tumor stroma infiltration by antitumoral immunologic effector cells correlates with poor prognosis in ovarian cancer. It was evident, that patients with high MIF serum levels displayed significantly less numbers of tumor infiltrating effector cells. Conclusions: We feel encouraged to postulate, that the secretion of MIF in serum of ovarian cancer patients is of clinical significance based on MIF interference with antitumoral immune responses. A correlation between tumor guided MIF secretion and poor prognosis in ovarian cancer should potentially be considered. Objective: The ubiquitin-proteasome system exerts regulatory functions on crucial cellular processes such as cell cycling, differentiation, proliferation, gene transcription, apoptosis and signal transduction. Circulating 20S-proteasomes (c-proteasomes) can be detected in human serum by using the enzyme-linked immunosorbent assays technique. Increased levels of c-proteasomes have been reported in various malignancies including ovarian cancer. We evaluated whether c-proteasomes impact upon the clinical course of ovarian cancer patients. Materials and methods: Circulating 20S-proteasomes were assessed by ELISA in the sera of 120 patients presenting with the initial diagnosis of ovarian cancer. Concentrations were measured by ELISA in blood plasma of all patients before and after (n = 68) primary treatment and 55 healthy controls. The median follow up time was 19 months. Tumor specimens of patients were immunohistochemically stained for 20S-proteasomes to evaluate associations of histopathological PSM expression with c-proteasomes. Results: The median c-proteasome concentration was higher in untreated ovarian cancer patients (457.5 ng/ml, Range: 200-12,540 ng/ml) than in healthy controls (p \ 0.0001; 290 ng/ml, Range: 140-425 ng/ml). Following completion of primary treatment, the median c-proteasome concentration increased significantly relative to baseline (p = 0.003; 595 ng/ml, Range: 200-20,000 ng/ml). The postherapeutic proteasome concentration positively correlated with residual disease in primary surgery (p = 0.031). Patients with c-proteasome concentrations exceeding the cohort's median posttreatment concentration showed a diminished overall survival (p = 0.045). We found no correlation between proteasome concentrations and strength of proteasomal staining in tumor specimens. Conclusions: Circulating proteasome concentrations correlate with residual tumor mass and might be a prognostic variable in ovarian cancer.

Tolerability of long-term use of trabectedin in combination with pegylated liposomal doxorubicin (PLD) in patients (pts) with relapsed ovarian cancer (ROC) trabectedin 1.1 mg/m 2 and PLD 30 mg/m 2 , 3 h-q3 weeks vs. PLD 50 mg/m 2 q4 weeks in pts receiving over 6 cycles was analyzed. Materials and methods: Safety evaluated in 320 (of 663 treated) pts receiving C6 cycles by adverse events (AEs), laboratory data and physical findings (NCI CTC Version 3.0). Results: Balanced baseline characteristics: median age 56 years; ECOG 0: 68%; median platinum-free interval: 9.2 months; prior taxanes: 78%; papillary/serous histology: 72%. (See Table 1 ) Conclusions: This novel non-platinum, non-taxane combination is an efficacious regimen in pts with ROC with reasonable long-term tolerability in pts that received C6 cycles. Hematological toxicity and transaminase elevations were more common in the combination arm, yet transient, and not cumulative; and less frequent than at \6 cycles. HFS, mucosal inflammation and stomatitis were more common with PLD. Discontinuation rates due to AEs were low. Updated data will be presented. Conclusions: An increasing number of pts. with ovarian malignancies were treated in the HSK Wiesbaden in the last 13 years. Pts. with advanced ovarian cancer were treated more aggressively, resulting in higher frequencies of complete resection and a higher-than-average life expectancy, consecutively. All pts. with ovarian malignancies should be offered a treatment in an experienced gynaecologic oncologic centre.

Has bowel resection with R0-resection in advanced ovarian cancer influence on prognosis?

*Cornelia Bachmann 1 , Sören Bachmann 1 , Tanja Fehm 1 , Diethelm Wallwiener 1 , Erich Solomayer 2 1 Universitätsfrauenklinik, Gynäkologie, Tübingen, Germany, 2 Universitätsfrauenklinik, Gynäkologie, Homburg/Saar, Germany

Objective: In advanced ovarian cancer best prognostic factor is optimal tumour debulking with adjuvant platinum-based chemotherapy. Aim of this study is to determine if extent of surgery with bowel resection has influence on prognosis. Materials and methods: 191 patients with primary ovarian cancer in FIGO III/IV were evaluated. All patients operated between 1/2000 and 6/2007 at the university hospital of gynecology and obstetrics, Tübingen. All patients got adjuvant platinum-based chemotherapy. Follow-up was 53.5 months.

Results: 191 patients in FIGO III/IV were evaluated. 157 patients were classified to FIGO III and 34 to FIGO IV. In FIGO III and IV 55 patients got a R0 resection (28.8%); and 135 patients (71.2%) had suboptimal debulking. In FIGO III bowel resection was done in 59 patients (37.6%) and in FIGO IV ini 20 patients (58.8%). Bowel resection showed independent to residual tumour mass no significant positive effect on prognosis in advanced FIGO stages (p = 0.36). In FIGO III/IV optimal debulking with bowel resection was done in 27.8% (n = 22). R0-resection alone showed significant positive prognostic effect on prognosis on OS and PFS in advanced FIGO stages (p \ 0.001). R0-resection with bowel resection showed a significant positive prognostic effect on OS and PFS in FIGO III/IV (p \ 0.001).

Conclusions: R0-resection is a significant prognostic factor for OS and PFS in advanced FIGO stages. Optimal tumour debulking with bowel resection showed a significant prognostic factor for OS and PFS. Estrogen exposure is known to increase breast cancer risk and to promote breast cancer progression. Estrogen actions are mediated by estrogen receptors (ER) a and b, but also require ER-binding of specific coregulatory proteins. ERAP140, also known as NCOA7, is a nuclear receptor coactivator protein which is involved both in ERa and ERb signal transduction. Therefore, polymorphisms in ERAP140 gene might affect breast cancer susceptibility. In this genotype-phenotype association study we analyzed the single nucleotide polymorphism (SNP) rs1567 located in the coding region of ERAP140 gene, which results in an amino acid exchange. We compared its frequency in 352 breast cancer patients and 346 women without any malignancy by means of an allele-specific tetra-primer PCR. After tests for deviation from Hardy-Weinberg equilibrium using the Fisher's exact and the v 2 test, allele frequency, allele positivity and genotype frequencies were determined. Odds Ratio (OR) was calculated using the more frequent homozygous genotypes as reference group. We could not observe any significant difference of allele or genotype frequencies between the cancer and the control group, nor between cancer subgroups. Our data clearly suggest that the ERAP140 SNP tested is not associated with breast cancer susceptibility. The role of gonadotropin-releasing hormone (GnRH) as master regulator of female sexual steroid hormone synthesis arises the question if single nucleotide polymorphisms (SNPs) in its receptor (GnRHR) might influence breast cancer susceptibility. In this genotype-phenotype association study we examined three SNPs in the GnRHR gene and genotyped a total of 565 women, 254 women with breast cancer and 311 women without any malignancy by means of allele-specific tetra-primer-PCR. No significant differences were observed between breast cancer patients and healthy women concerning genotype, allele frequency or allele positivity. In contrast, we observed significant associations after sub-grouping the breast cancer cases according to tumor grading. The C allele as well as the CC genotype of SNP rs13138607 were less frequent in patients with poorly differentiated (G3) tumors than in G1 or G2 tumors or than in the control group (CC: OR: 0.49, p = 0.0208; OR: 0.68, p = 0.0377). Furthermore, women with G1 or G2 tumors more frequently carried the T-allele of SNP rs12644822 than women with G3 tumors (OR: 0.65, p = 0.039 bzw. OR: 0.49, p = 0.013), the same was true for the heterozygous genotype (OR: 0.45, p = 0.019). In conclusion, we observed a significant association of GnRHR SNPs with tumor grading of breast cancer patients, but not with breast cancer susceptibility. The relevance of these data has to be examined in further studies on a larger patient cohort. Objective: Recent clinical studies revealed that adjuvant zoledronic acid (ZA) correlates with a favorable prognosis for the patients: Not only bone metastasis but also overall metastasis was found to be reduced significantly. A surprising observation that supports the hypothesis of early micrometastases in the bone marrow followed by distant metastasis as a further (and later) event. This second step might be inhibited by bisphosphonates. The topical hypothesis of cancer stem cells suggests that dormant tumor cells in the bone marrow consists, at least partly, of stem like cells. We, therefore, evaluated the influence of ZA on migration and invasiveness of an isolated fraction of MDA-231 cells with stem cell properties.

Materials and methods: The stem cell fraction was prepared via spheroids and verified by high expression of CD 44 and low/no CD 24, the generally accepted properties of breast cancer stem cells. Invasiveness was quantified in Boyden chambers, 8 lm filter inserts coated with matrigel. Migration was observed and documented by time-laps videography and quantified with ImageJ software.

Results: Incubation of the cells with ZA reduced the invasiveness in a dose dependent manner. Invading cells were reduced by 62% at 1 lM ZA and by 79% at 10 lM ZA respectively. Migration was reduced even more by 75% at 1 lM and by 88% at 10 lM ZA.

The incubation with ZA results in significantly reduced invasiveness (as shown before for other cellular models). The cellular migration is also reduced severely. The remaining movement made not any headway but was more a kind of trembling on the spot. It seems to be of particular interest that also tumor cells with stem cell properties are reduced in malignancy by zoledronic acid. Objective: It is very important to detect bone loss at an early stage in women with breast cancer during endocrine therapy. In the present study biochemical markers and osteodensity measurements were compared in view of their value to detect bone changes during endocrine therapy. Materials and methods: Postmenopausal women with breast cancer were included in this study. Blood samples were taken before surgery and after one year of endocrine therapy. The serum was analysed for BAP, an enzyme involved in bone formation and for TRACP-5b (BT), an enzyme involved in bone resorption. Bone density was measured by ultrasonic method. Results: So far 22 patients could be analysed. After 1 year, 14 patients (63%) had a lower T-Score as compared to the first measurement. The bone marker BT was significantly increased at the second measurement, whereas BAP did not differed significantly. The ratio BAP/BT was nearly 30% lower at the second measurement point. A significant negative correlation could be found between T-Score and BT-levels.

Conclusions: The present results indicate that biochemical markers of bone metabolism might be valuable as predictive parameters for bone changes during endocrine therapy. To verify these data further patients will be included in this study.

PO-Onko 02.105 Differently regulated proteins in tear fluid of breast cancer patients and age-matched controls

Objective: The early detection of breast cancer is a key factor for a successful treatment. Despite of an increased survival, many patients die from metastatic relapse. Many biomarkers for breast cancer have been investigated, but they still do not provide useful clinical specificity and sensitivity. In this study we used tear fluid from 54 patients with breast cancer and 54 healthy controls to examine the protein profiles in both groups. Results: A panel of 11 significant biomarkers has been detected in both groups with 5 elevated proteins in CA. The specificity of 80% and sensitivity of approximately 70% of the biomarkers for the discrimination between CA and CTRL were achieved with the AUC of 0.77. In preview studies, some decreased peaks in CA were identified as Prolin-rich protein 4 (PRP4). Conclusions: We could show that SELDI-TOF-MS can serve as a potential screening method for detection of breast cancer. The use of tear fluid is a non-invasive and simple method to obtain stable protein profiles. The form of identified PRP4 has been associated with nasopharyngeal carcinoma (NCAPP4). Its role remains unclear but it could have a protective function in the eye such as modulation of the microflora. Further subsequent de novo screening of the discovered biomarkers can help to understand cancer emergence and development and can possibly facilitate the early diagnosis of breast cancer.

PO-Onko 02.106 MRI, mammography and ultrasound compared to histopathological findings in patients with newly diagnosed breast cancer In cases with more than one lesion in one breast the largest lesion was considered for evaluation. Patients undergoing primary systemic therapy were not included. The study was conducted retrospectively from the database of our breast center. Results: The median volume of the breast carcinoma was 2.92 cm 3 according to the histology. In MRI, the median tumor volume was 3.60 and 1.53 cm 3 in ultrasound. More than one lesion occurred histopathologically in 25.9%. In mammography, MRI and ultrasound multiple lesions occurred 7.3, 45.5 and 20.0% respectively. Lymph node involvement was found in 33.9%. 83.0% of the tumours were invasive ductal carcinoma, 11.5% invasive lobular carcinoma, 2.5% tubular carcinoma, 1.5% medullar and 1.5% other carcinoma. During a median follow up of 57.1 months, 16 patients presented progressive disease. The median progression free interval was 32.5 months, the median overall survival 55.2 months. The surgical treatment was influenced by MRI in 27% of all cases. In 5.4% a mastectomy was performed instead of breast conserving surgery due to MRI findings.

Conclusions: MRI and ultrasound are more sensitive than mammography in order to diagnose malignant breast lesions. On the other hand, mammography is in most cases the first procedure to detect a tumor. MRI tends to over-, ultrasound underestimates the size and number of the lesions. MRI results influence the surgical treatment in nearly a third of all cases.

PO-Onko 02.107 A single nucleotide polymorphism (SNP) in close vicinity to CCND1 as potential risk modifier in BRCA related breast cancer Moreover, we analyzed the association of rs606555 with the estrogen receptor (ER) status in BRCA1/2 affected carriers. Materials and methods: A total of 1586 samples (BRCA1/2 positive, affected and non-affected) collected in 12 centres of the GC-HBOC was genotyped for rs606555 by real time PCR. Statistical analysis was performed using Cox-Regression analysis. Association analysis of rs606555 with ER status was performed by multivariate logistic regression analysis. Results: In BRCA2 associated breast cancer, we found the rare allele of rs606555 significantly associated with an increased risk (HR 2.37, 95% CI 1.00-5.62, p value = 0.049). Additionally, the minor allele of rs606555 was associated with an increased risk for ER negative tumors in BRCA1/2 mutation carriers (OR for ER positivity per minor allele 0.56, 95% CI 0.39-0.79, p = 0.001).

Conclusions: We found a significantly increased risk for breast cancer in BRCA2 mutation carriers for the rare allele of rs606555 and an association with ER negative tumors in BRCA1/2 mutation carriers.

Rs606555 is located on chromosome 11q13, 71022 bp upstream of the cell cycle progression protein gene CCND1. Its product, Cyclin D1, is frequently overexpressed in breast cancer. Further investigations will include protein expression experiments and functional analyses to understand the nature of rs606555 and its modifier role in BRCA associated breast cancer.

PO-Onko 02.108 Prognostic significance of Immunoglobulin Kappa C in node-negative breast cancer is conserved across molecular subtypes Objective: Immunological defense mechanisms play an important prognostic role in breast cancer. We examined the prognostic impact of Immunoglobulin Kappa C (IGKC) in 766 node-negative breast cancer patients without adjuvant systemic therapy according to molecular subtypes. Materials and methods: IGKC (probe set ID 211645_x_at) was analysed utilizing microarray based gene-expression data of three independent and previously published cohorts of node-negative breast cancer patients (Mainz, Rotterdam, TRANSBIG). Additionally, we investigated the prognostic significance of IGKC in luminal (ER+/ HER2-), erbB2-like (HER2+), and basal-like (ER-/HER2-) molecular subtypes, respectively. Metastasis-free survival (MFS) was analyzed with univariate and multivariate Cox regression. Results: Patients with higher expression of IGKC showed better MFS in the whole cohort of patients (HR 0.795, 95% CI 0.711-0.890, p \ 0.001). Using multivariate Cox regression, IGKC retained its independent prognostic significance (HR 0.731, 95% CI 0.621-0.861, p \ 0.001). 521 patients (68%) belonged to the luminal subtype, 106 (14%) were erbB2-like, and 139 (18%) basal-like, respectively. Prognostic impact of IGKC was conserved across luminal (HR 0.796, 95% CI 0.688-0.923, p = 0.002), erbB2-like (HR 0.542, 95% CI 0.387-0.757, p \ 0.001), and basal-like (HR 0.760, 95% CI 0.600-0.963, p = 0.023) subtypes, respectively. In multivariate analysis IGKC had independent prognostic significance additionally to molecular subtypes (HR 0.746, 95% CI 0.664-0.837, p \ 0.001).

Conclusions: IGKC has independent prognostic impact in breast cancer. Its prognostic significance is conserved across molecular breast cancer subtypes. Incorporating IGKC should lead to a more appropriate assessment of outcome in node-negative breast cancer.

Objective: By now microarrays are designed for mutation or transcript analysis. This project focuses on the development of a biochip technology platform that can simultaneously detect SNPs and uncover variances in mRNA levels. Furthermore the technology is optimized to analyse also clinical samples in our case formalin-fixed and paraffin-embedded (FFPE) breast cancer tissues. Materials and methods: Specific oligonucleotides were immobilized in a hydrogel mounted on a polymethylmetacrylat (PMMA) chip. In a temperature-controlled flow cell total RNA, was directly on-chip amplified utilizing a labelling multiplex nucleic acid sequence based amplification (NASBA) assay. When the reaction takes place the labelled NASBA products gradually hybridize to the immobilized probes and fluorescence data can be collected. Northern blot analysis confirmed specificity of the NASBA reaction.

Results: In a proof of principle set up we were able to simultaneously amplify and detect on-chip the five targets (RPS18 (ribosomal protein S18), ESR1 (estrogene receptor), ERBB2 (erythroblastic leukemia viral oncogene homolog 2), CASP8 D302H (caspase 8), SOD 2 V16A (manganese superoxide dismutase 2). Furthermore allelic discrimination of the two SNPs was possible. In view of clinical applications, we showed that NASBA as an isothermal nucleic acid amplification assay can be applied to RNA extracted from FFPE breast cancer tissues.

Conclusions: Our study indicates that simultaneous detection of SNPs and measurement of mRNA levels is possible on a single biochipplatform. This test can be easily performed in a single step and also applied to RNA extracted from patient samples such as FFPE tissues making an application in clinical routine throughout imaginable.

patients with negative sentinel node. Our study aims to determine the predictive factors for non-sentinel axillary metastasis, in order to review the current SLNB indications and limits.

We collected data about every SLNB performed in our Department of Surgery between 2002 and 2009, focusing on patient's characteristics, tumor histological type, grading, hormonal receptor status and TNM classification. Data was analysed by R (version 2.10.1), considering significant p \ 0.05. Also multivariate analysis was performed.

Results: Younger age, greater tumor size, higher grading and hormone-receptors negativity, are predictive for the axillary metastatic involvement, while multifocality does not result associated with worse axillary nodal status. By multivariate analysis, only younger age and greater tumor size are confirmed to be significant risk factors for axillary non-sentinel lymphnode metastatic involvement, and DCIS results to be protective factor. Conclusions: Great tumor size and undifferentiation are strongly predictive for non-sentinel lymphnode metastasis, as also the younger age, so that in spite of their tumor size, advanced aged women have a greater prevalence of negative axillary findings. Anyway, in our opinion, also young women continue to deserve SLNB as primary axillary approach, in order to avoid CALND when possible.

PO-Onko 02.111 Digital galactoscopy of the 2nd generation skin or light swelling of Montgommery glands. In addition, microbiological proof of Candida is extremely difficult because it requires special culture mediums to verify it and lysozyms in breast milk can destroy the fungus. A possible way of infection seems to be the transmission of Candida from the maternal vagina during child birth and is than transmitted while breast feeding back to the mother's breast. It is necessary to treat this infection consequently with an antifungal agent to relieve the pain. One might try to treat the breast and the baby at the same time with local application of miconazol. If there is no immediate effect, it is necessary to switch to a systemic treatment with 100-200 mg fluconazol for at least 10-14 days. It is not necessary to stop breastfeeding while treatment. We believe that a many women will not discontinue breastfeeding prematurely if we offer immediate and sufficient help.

PO-Geb 03.02 Diagnosis an conservative management of placenta increta: a case report 

Objective: Abnormally invasive placentation, like placenta accreta, increta or percreta are a rare but important and challenging complication in obstetrics. Hysterectomy seems to be the appropriate therapy but in some patients it seems to be important to preserve fertility and therefore conservative management is preferable.

A 28 year old IIG 0P presented herself at our hospital with premature rupture of membranes with a gestational age of 19 weeks. She had one curettage after miscarriage in her medical history. Intrauterine fetal death was diagnosed with 22 weeks of gestation and delivery was induced with misoprostol. After vaginal delivery a curettage was performed and ultrasound control afterwards revealed a partially hypervasculated placenta, that was deeply invading into the myometrium. A ß-HCG-level of 41 184 IU/l and MRI confirmed the diagnosis of placenta increta. On demand of the patient to preserve fertility a conservative treatment with methotrexat was attempted. The patient received 6 cycles of intravenous bodyweight adapted methotrexat. Ultrasound and MRI controls showed reduced hypervascularisation but still two large vessels at the site of invasion into the myometrium, ß-HCG was decreased to 84 IU/l. A MRI guided embolisation of the remaining arterial vessels into the placental tissue was performed and the following curettage succeeded in complete extraction of the placental tissue. Conclusions: Conservative management and preservation of fertility is an option in selected cases of abnormally invasive placentation.

Methotrexat an arterial embolisation are two options of treatment, close monitoring of the patients is necessary-ultrasound, MRI and ß-HCG-levels are possible diagnostics to monitor the progress of therapy.

PO-Geb 03.03 Case report: internal version and cervical spasm in the 28th gestational week Objective: A 28 year old secundipara was referred to our clinic with PPROM at 28th gestational week. 7 years ago she underwent cold knife conization due to hSIL; GBS and U. urealyticum in cervical swab received antimicrobial therapy until negative results. Cervical incompetence was diagnosed at 23rd week (CL 25 mm, Y-shaped) and cerclage was performed and tocolysis administered. At admission: PPROM, cervix was shortened and dilated 1 cm, cervical suture in situ. Ultrasound revealed cephalic presentation, EFW 1000 g, and normal amniotic fluid collection, CTG without uterine activity. All lab parameters were within acceptable range, intravenous antibiotic prophylaxis, prophylactic tocolysis and corticosteroids were administered. Patient was monitored, and in next several hours decrease of amniotic fluid was observed, as well as changes of fetal lie; firstly transverse dorsosuperior and then dorsoinferior transverse lie. Patient recognized uterine contractions; suture was released. Despite maximal tocolytic therapy contractions became very strong and resulted in cervical dilatation of 8 cm. At that time fetus is in dorsoinferior transverse lie, head left; complicated by immediate prolapse of the leg and umbilical cord. CTG showed fetal bradycardia, immediate delivery was indicated. Patient was intubated to produce uterine relaxation, umbilical cord was pushed back and internal version was performed; followed by breech extraction: traction of the feet, thighs and body, freeing of the hands by Mueller's maneuver. Because of cervical spasm, fetal head could not be delivered and therefore Duehrssen incision was performed and fetal head delivered by MLVS maneuver. Female premature baby was delivered, 1000/38, Apgar score 6/8. Objective: Uterine rupture is rare (ca. 1/1500 births) but a severe complication during delivery. With rising incidence, uterine rupture is associated with significant fetal and maternal risks. The major causes of uterine rupture nowadays are previous operations of the uterus (caesarean section, myomectomy, etc.). However, clinical presentation may vary and does not have to be acute.

A 35 year old woman was delivered by vacuum extraction. In her history, there were no uterine operations beside a conisation and curettage. Intrapartally, the patient reported pain in the right lower abdomen, but clinical examination and CTG were normal. After vacuum extraction, the patient was in good condition without symptoms. She was discharged at the fifth day postpartum with persisting moderate pain in the right groin. She was then again admitted at day 13 post-partum with reduced well-being and severe pain in the abdomen. Vaginal examination showed marked bleeding. Sonography and MRI revealed a large haematoma in the right parametrium as a result of a lateral uterine rupture. Laparotomy confirmed the uterine lesion and reconstructed the uterus after preparation and removal of the haematoma. Intraoperative findings showed a complete right longitudinal uterine rupture, ranging from the isthmus uteri to the fundus. After surgery, the patient developed fever and clinical signs of infection. Due to suspected septic uterus, the indication for the relaparotomy was made and the hysterectomy without adnexa was performed at the 20th day post-partum. After the operation, the patient recovered quickly. The histological examination validated the clinical diagnosis of a septic uterus. Her postoperative recovery was uneventful. She was discharged well on day 32 postpartum.

Conclusions: A traumatic uterine rupture sub partu can occur during first pregnancy/delivery and its symptoms may come late and unspecific. Abdominal pain postpartum requires careful clinical (and sonographic) examination.

PO-Geb 03.05 Differential expression of VE-cadherin and flk-1 in the syncytiotrophoblast of preeclamptic placentas compared to healthy controls

Objective: VE-cadherin is promoting intercellular adhesion of endothelial cells thereby regulating endothelial integrity and permeability. Moreover, VE-cadherin is involved in the regulation of Flk-1 receptor activity and thus cell cycle regulation. Preeclampsia has been associated with impaired syncytial function and altered trophoblast turnover. Therefore we investigated whether altered VE-cadherin and Flk-1 expression might be associated with preeclampsia. Materials and methods: Biopsies of placentas from 19 patients with late onset preeclampsia and 24 healthy term deliveries as well as 20 cases of early onset preeclampsia and 20 preterm controls were stained for VE-cadherin and Flk-1.

Results: All biopsies showed VE-cadherin and Flk-1 expression in placental vessels and in the syncytiotrophoblast. VE-cadherin expression in the syncytiotrophoblast was significantly higher in late onset preeclamptic cases and flk-1 expression was less pronounced compared to term controls. Whereas in early onset preeclampsia VEcadherin was significantly less and flk-1 significantly more expressed compared to preterm controls. Conclusions: Differential expression of VE-cadherin and Flk-1 might contribute to the etiopathologic events at the fetomaternal interface in preeclampsia. Since reduction of VE-cadherin and increase of flk-1 could lead to pronounced cell activation in the syncytiotrophoblast these changes than would enhance necrotic shedding instead of apoptotic shedding. The syncytial material released into the maternal system on necrotic shedding is believed to cause the maternal syndrome of preeclampsia. Thus overexpression of VE-cadherin and downregulation of flk-1 would represent a more stable situation in the syncytiotrophoblast and could possibly display a compensatory mechanism in the late onset cases.

PO-Geb 03.06 Pitfall in case of severe fetal anemia: low middle cerebral artery velocities 

Objective: Clinical standard management to detect severe fetal anemia is the non invasive monitoring of the peak systolic velocities of middle cerebral artery (pMCA). Doppler measurements of the pMCA are a valuable tool for estimating haemoglobin concentration in fetus. The correlation between haemoglobin and pMCA seems to be more accurate as the severity of anemia increases.

We monitored a pregnant gravida 2 para 1 since first trimester screening with a risk of rhesus alloimmunisation (anti D antibody 1:16). Follow-up showed altered antibody titers up to 1:4096 and borderline pMCA always below 1.5 MoM (multiple of median). Results: At 37th week of gestation a suspected cardiotocogram was recognized. The middle cerebral artery showed low resistance indices and low pMCA. The resistance indices of the umbilical artery were decreased and venous flow in the ductus venosus was pathological. An unscheduled caesarean section was performed and a girl with a severe anemia haemoglobin concentration below 5 g/dl was born.

Conclusions: In the literature the detection rate of severe fetal anemia by pMCA monitoring with a cut-off value of 1.5 MoM is up to 100%. In our experience during the last decade pMCA measurements are a very helpful tool in the management of fetuses with the red cell alloimmunisation. We demonstrate a pitfall in case of severe fetal anemia with low pMCA. Due to this case it is important to integrate all clinical parameters of the biophysical profile in last weeks of gestation.

PO-Geb 03.07 Placenta percreta: severe complication after previous caesarean sections. A case report 

Objective: The incidence of caesarean sections (CS) is rising continuously and so are severe complications like placenta percreta are common (incidence higher than 1:1000). The evaluation of placentation by ultrasonography is one of the most important elements of prenatal care, especially after previous CS.

A 39 year old G6 P4, pregnant with diamniotic, dichorionic twins, presented at 30 weeks gestation with abdominal pain localized at the old section scar. Her obstetrical history included three CSs and one forceps delivery. A placenta percreta combined with a covered uterus rupture was suspected by ultrasound.

Results: Increasing abdominal symptoms necessitated an unscheduled CS. Due to severe intraoperative atonal bleeding an emergency hysterectomy was made with the requirement of multiple blood transfusions.

Conclusions: This case report should demonstrate the relevance of modern diagnostic procedure without the requirement of high definition ultrasound equipment. In the daily routine the diagnosis of implantation disorders is considered to be standard consultant proficiency. Especially in the presence of known risk factors, abnormalities have to be excluded. Prior to CS, particularly in the case of elective CS, patients must be informed about the higher risks of implantation disorders and bleeding complications in consecutive pregnancies.

PO-Geb 03.08 Comparison of effectiveness and safety of dinoprostone and misoprostol for labour induction at term Materials and methods: The Jena perinatal database of 5 years (2003) (2004) (2005) (2006) (2007) was analysed, where 644 women initially receiving 50 lg misoprostol and 99 women receiving 1 mg dinoprostone for labour induction were recorded. In the misoprostol group, a repeated dose of 100 lg was applied every 4 h until beginning of regular contractions. A repeated dose of 1-2 mg was applied every 6 h in the dinoprostone group. Control group data was surveyed from 699 records fulfilling the inclusion criteria. Results: Maternal age and body weight, gravidity and parity have independently significant effects on the duration of labour induction. The mean interval from starting misoprostol to delivery was 18.3 ± 12.9 h compared to 25.5 ± 18.3 h in the dinoprostone group.

Within 24 h after the first medical application, 81% of the misoprostol vs. 68% of the dinoprostone group could deliver (P \ 0.05). After misoprostol more women could deliver spontaneously and the number of caesarean sections was less (22 vs. 33%; P \ 0.05). Potential or occurring uterus ruptures were noticed in one and two cases after receiving dinoprostone and misoprostol, respectively. A duration of first and second stage of labour \8 h was recorded significantly more often after misoprostol priming compared to the controls (P \ 0.01), whereas the risks of perineal injuries and anemia's were decreased (P \ 0.01).

Conclusions: Due to essential advantages with regards to effectiveness and safety, a labor induction with misoprostol is strongly suggested following an appropriate assessment of potential contraindications.

PO-Geb 03.09 Antepartum second trimester bleeding and preterm labour Objective: Preterm delivery is one of the most frequent complications during pregnancy. Preterm birth is cause of perinatal mortality and morbidity, indeed 75% of perinatal mortality and morbidity, are due to preterm delivery. Transvaginal cervical evaluation is more accurate than digital examination of the cervix in the assessment of the risk for preterm delivery. Our purpose was to assess the correlation of second trimester bleeding in the prediction of preterm labour. Materials and methods: In a retrospective study, between 1998 and 2008, 150 pregnant women with singleton pregnancies and recurrent vaginal bleeding underwent gynaecological and transvaginal sonographic examination to assess the cervical length and the presence of cervical funnelling. We excluded patients with missed miscarriages in the past, known stillbirths, preeclamptic women and pregnancies with known fetal congenital abnormalities They reported no risk factors for preterm delivery. For statistical analysis, categoric variables were compared with chi-square test.

Results: The management of hemorrhage was in all cases conservative. We have no Blood transfusions administrated. Of 150 women with transvaginal sonographic cervical assessment, 33 (22%) women had abnormal cervical length and abnormal dilatation of the internal cervical os at the same time. In 90% of the subgroup participants with cervical pathology was a preterm labour (mean 34 week) noticed. The remaining cases 117 with vaginal bleedings und no cervical pathology had a term labour. Perinatal fetal outcome was in all cases satisfactory.

Conclusions: Our data confirm that sonographic assessment in the second trimester has more prognostic value than vaginal bleeding for predicting preterm labour.

PO-Geb 03.10 A milk test for determining completeness of the placenta *Susanne Markert 1 , Filiz Markfeld-Erol 1 , Heinrich Pro¨mpeler 1 , Mirjam Kunze 1 1 University Freiburg, Gynecology and Obstetrics, Freiburg, Germany

Objective: Completeness of the placenta is checked immediately after expulsion to ensure that no fragments remain in the uterus. However, visual and ultrasonographic assessment may be difficult in some cases and the assessment of completeness is often determined by the obstetrician experience, rather than objective evaluation. Retained placenta fragments increase the risk of postpartal haemorrhage and infection. In uncertain cases often a curettage of the uterine cavity has to be performed.

We conducted a prospective, randomized and blinded study to evaluate the effectiveness and positive as well as negative predictive value of the so-called ''milk-test''.

After the injection of a certain amount of milk in the umbilical vein of the expulsed placenta its completeness was assessed by a blinded person. After randomisation the placenta was damaged before in a definitely and established way or was remained untouched.

Results: The used milk test provided good positive and good negative predictive values. Exact results will be demonstrated at the DGGG meeting.

The milk test is a valuable, simply and quick aid to the obstetrician during the assessment of the completeness of the placenta postpartal.

PO-Geb 03.11 Treatment of heterotopic cervical and intrauterine pregnancy Objective: To describe a rare case of a heterotopic pregnancy with a gestational sac in the cervix and one in the uterine cavity, managed successfully with subsequent delivery of a healthy neonate. Materials and methods: A 25-year-old IG/0P woman was diagnosed with a twin gestation 8 weeks following IVF treatment for primary infertility of 2 years' duration. Transvaginal ultrasound scan revealed two gestational sacs containing two viable fetuses: one sac inside the uterine cavity and the other sac in the uterine cervix. Interventions: Selective termination of the cervical pregnancy by curettage in combination with cervical cerclage. Main outcome measures: Intra-or postprocedural complications, pregnancy outcome and fertility preservation.

Results: The termination of the cervical pregnancy was successfully performed without intra-or postprocedural complications with preservation of the patient's fertility. The intrauterine pregnancy progressed uneventfully through 391/2 weeks with delivery of a healthy newborn.

Conclusions: Cervical pregnancy is usually considered a life-threatening event. Other factors such as concomitant intrauterine pregnancy and the patient's infertility history generally would be secondary concerns. In this case, we were able to selectively terminate the cervical pregnancy, while preserving the intrauterine one, allowing this couple to have a healthy newborn. Further cases will be necessary to appropriately define risk rates for such an approach.

PO-Geb 03.12 Misoprostol for induction of labour: a safe alternative for twin pregnancies and premature births?

Susanne Dostert 1 , Birgit Seelbach-Go¨bel 1 1 University Hospital, Department of Gynaecology and Obstetrics -St. Hedwig, Regensburg, Germany

Objective: Misoprostol (MP)is being used with increasing frequency to induce labour. The intention was to clarify whether the administration of MP in twin pregnancies and premature deliveries had a different effect on the course of labour and foetal outcome compared with the conventional use of prostaglandin and the normal population. Materials and methods: PGE2 vaginal tablets were replaced with MP in our department beginning in 2006. Thirty parameters concerning course of labour and foetal outcome were compared. In the control group the indication for induced labour was over term pregnancy or rapture of membranes [37 weeks' gestations. The study group comprised twin pregnancies [37 weeks' gestation and pre term pregnancies \37 weeks' gestation with PROM. Both compared to each other and with regarded to the use of MPversus prostaglandin. Results: The goal of this study is to compare induction of labour by oral MP vs. vaginal PGE vs. iv oxytocin application in normal singleton term pregnancies (A) vs. twin gestations C37 weeks (B) vs. preterm pregnancies \37 weeks with PROM (C) with regard to vaginal delivery rate, duration of labour and fetal outcome. Objective: This work evaluated two major documents in German obstetric health legislation: the legal maternity guideline (Mutterschafts-Richtlinie) and the antenatal health care record (Mutterpass). Our aim was to develop a comprehensive picture of the historical formation of their current editions. Materials and methods: We investigated 15 editions of the German legal maternity guidelines and its 22 amendments, as well as nine versions of the antenatal health care record and its predecessor, the ''Sprechstundenblatt.'' We developed two parallel analysis instruments, one tailored to the antenatal record and a second to the legal maternity guideline. Their main categories comprise ''development '', ''layout'' and ''content'' . The development of the German legal maternity guideline and the antenatal health care record has been analyzed according to four periods, each defined by significant events in the documents ' evolution: 1965-1973, 1974-1986, 1987-2003, 2004-2010 (Table 1) . Results: On average, the legal maternity guideline was published increasingly infrequently from the first to the third period (2.7 years first period, 4 years second, 8 years third). In contrast, the mean time interval between revisions in the fourth period was 0.9 years. The number of separately published amendments to the guideline rose during the first three periods (respectively 1, 3, 18) and fell in the fourth (8). The fourth period compares to the first, in that amendments were closely followed by guideline publications. The antenatal health care records were revised every 4.5 years on average. During the third period, an insert was added instead of publishing a new edition. This resulted in only two published antenatal records within this 16-year period. Conclusions: The development of the German legal maternity guideline and the antenatal health care record has occurred unsystematically. Addressing the historical evolution contributes to a better understanding of contemporary aspects of maternity care. Objective: Acranius acardius is characterized by a normally developed fetus and an unformed twin with retrograde blood supply, lacking a heart pump. This severe complication of monochorionic twin pregnancies occurs less than in 1:35,000 births. The higher cardiac output of the healthy twin because of the supply of the acardius increases the risk of heart failure. We present 3 cases of monochorionic diamniotic twin gestations with twin reversed arterial perfusion (TRAP) -sequence with different outcomes. Materials and methods: The first patient was a 35 years old gravida 3 para 2 woman with spontaneously conceived twin gestation with diagnosed TRAP-sequence after missed abortion of the one twin in the 7th week of gestation. Fetoscopic laser photocoagulation was performed in the 2nd trimester. The second patient was a 30 year old woman gravida 2 para 1 who did not fulfil the requirements for laser treatment. The third patient, a 39 years old woman with pronounced uterine leiomyomas, primigravida after intracytoplasmic sperm injection (ICSI) was not referred to a tertiary centre. Objective: The Goldenhar Syndrome (GS), also known as Oculoauricular Dysplasia, was first described by Maurice Goldenhar in 1952. It is a congenital birth defect with an asymmetrical face due to different deformations as partially formed/absent ear and eye, dislocation of the chin and mouth. In addition the skeletal, cardiac, central nervous and renal systems can also be involved. The incidence range from 1:3000-5000. A developmental disorder of the 1st + 2nd branchial arch or a vascular disruption during morphogenesis is assumed. Materials and methods: We present a 35-years old gravidaII, paraI, who was referred due to abnormal results in the first trimester screening for trisomie21 (1:138) at 14 + 2 weeks' gestational age. Her first child has been born without any abnormalities. At this stage of pregnancy we diagnosed a vitium cordis, which was later specified as a double-outlet right ventricle (DORV), multicystic renal dysplasia and retrognathia. A amnioncetesis was performed which showed a normal karyotype (46XY). A syndromic disease was assumed. At all her visits, fetal + maternoplacetal doppler ultrasound, the fetal's development and amniotic fluid was within normal ranges. On January the 14th, a intrauterine fetal death (IFT) was diagnosed, one day later with 35 + 5 weeks' gestational age she gave birth to a dead fetus, weight 2500 g, length 45 cm, head circumference 33 cm with signs of maceration. A autopsy was performed. The most obvious findings were as following: asymmetrical face morphology with an inclined lid, hypoplastia of the mandibular, hypoplasia and dysplasia of the right ear and pre-periauricular attachments, oesophagus atresia, DORV, multicystic renal dysplasia and abnormal structure of the thoracic vertebra. Objective: There is a little information on the incidence and prevalence of Rubella Infection in Lagos/Nigeria. The risk of congenital Rubella in sero-positive pregnant women has been found to produce congenital abnormalities even in developed countries. The aim of the study is to determine the prevalence of rubella virus antibody in prepregnancy class population of men and women. Study and Design: This is a cross sectional study of men and women attending the prepregnancy class facilities in the centre. PO-Geb 03.17 Preeclampsia is associated with elevated plasma ADMA levels and severely decreased placental activity of dimethylarginine dimethylaminohydrolase (DDAH) pathway plays an important role in the pathophysiology of preeclampsia, and elevated ADMA levels were found in women with preeclampsia as compared to healthy pregnancies. ADMA levels are regulated by the enzyme dimethylarginine dimethylaminohydrolase (DDAH). We set out to study whether differences in plasma ADMA levels are mere markers of preeclampsia, or reflect pathophysiological changes in preeclamptic versus normal placenta. Further, we studied the role of single nucleotide polymorphisms (SNPs) of the DDAH gene in this pathophysiology. Materials and methods: We measured plasma levels of L-arginine and ADMA by a validated LC-MS/MS method in 18 pregnant women with preeclampsia and in 28 healthy pregnant women (controls). DDAH activity was determined by measuring the degradation of (2H6)-labeled ADMA in tissue homogenates from placental biopsies in 15 women with preeclampsia and 16 controls. Finally, we determined the influence of a known SNP in the DDAH2 promotor region (rs805305) for DDAH activity and ADMA levels.

Results: Plasma ADMA levels were significantly elevated in preeclampsia as compared to controls (0.51 ± 0.14 vs. 0.42 ± 0.07 lmol/l; p = 0.005). Placental DDAH activity was almost undetectable in preeclampsia (0.03 ± 0.10 nmol [2H6]-ADMA/g protein/min) and significantly lower than in controls (0.32 ± 0.42; p = 0.02). Furthermore, women who were homozygous for the -449G DDAH2 genotype had significantly lower placental DDAH activity (p = 0.04) and a trend towards higher plasma ADMA levels (p = 0.12).

Conclusions: In preeclampsia, elevated ADMA levels in blood reflect major pathophysiological changes in this pathway. Our data suggest that high ADMA levels are caused by decreased activity of its degrading enzyme, DDAH, secondary to polymorphisms in the DDAH2 gene. Determination of ADMA in blood may be a novel, pathophysiology-related biomarker for detection of women at risk of preeclampsia.

PO-Geb 03.18 Evaluation of ßhCG and PAPP-A during first trimester screening as a possible marker for preeclampsia Objective: Preeclampsia is one of the most important disorders affecting 5% of all pregnancies. Until now it was not successful to establish a clinical useful screening test for the prediction of preeclampsia before the onset of clinical symptoms. The existing screening tests are based on the angiogenetic approach or focus on placental function testing. The aim of our study was to investigate a possible correlation between the expressions of the placenta secreted hormones ßhCG and PAPP-A during first trimester screening and the development of preeclampsia later in pregnancy. Materials and methods: One-Hundred-fifty-five patients with uncomplicated singleton pregnancies between 11 + 0 and 13 + 6 weeks of gestation were enrolled in this study. All patients joined our department for the first trimester screening test. None of the fetuses had a numeric chromosomal aberration. Serum samples were collected between 11 + 0 and 13 + 6 weeks of gestation with informed consent and the approval of the Research Ethics Committee, and the PAPP-A and bhCG levels were measured using the KRYP-TOR Ò random-access immunoassay system (KRYPTOR; BRAHMS, Henningsdorf, Germany).

Results: The expression of ßhCG was significantly higher in pregnancies which subsequently developed preeclampsia. The PAPP-A concentration was lower in pregnancies complicated by preeclampsia than in uncomplicated pregnancies, but this failed to reach statistical significance.

Conclusions: The placental expression of ßhCG is significantly higher in pregnancies which subsequently developed preeclampsia than in uncomplicated pregnancies. These findings might offer new possibilities in the prediction of preeclampsia.

PO-Geb 03.19 Coincidental cervical pregnancy with placenta previa partialis and percreta *Friederike Schone 1 , Alexander Keck 1 , Yves Garnier 1 1 Klinikum Osnabrück GmbH, Gynaecology and Obstetrics, Osnabrück, Germany

Objective: The purpose of the present case report is to review the current epidemiological situation of pathological placentation and discuss different treatment options.

A 38 year old gravida 3 para 2 presented at 17 + 0 weeks of gestation with the clinical suspicion of premature rupture of membranes (PROM). Past medical history included a caesarean section 15 years ago and a spontaneous vaginal delivery 11 years ago. Results: On speculum examination purulent discharge was found. Ultrasonography revealed a cervical pregnancy and a placenta previa partialis with placental invasion of the lower uterine segment. Fetometry was adequate for gestational age but no vital signs could be detected. Laboratory results showed significantly elevated inflammatory markers (C-reactive protein: 12.8 mg/dl and leucocytosis). The diagnosis of septic abortion in combination with a pathological placentation led to the decision of undertaking a caesarean hysterectomy. Intraoperatively the uterus could be separated from the urinary bladder. Postoperative treatment included a course of iv Clindamycin and Cefuroxim. The further recovery was uneventful.

Conclusions: Due to rising caesarean section rates, the incidence of placenta previa and percreta is on the rise. At present 1 in 2500 live births is affected. However, cervical involvement is rare occurring in less than 1% of the cases. Abnormal placentation is linked with a significantly increased peripartal morbidity and mortality due to severe haemorrhage, disseminated intravascular coagulation and infections. Treatment of choice is hysterectomy. Alternatively, the placenta can be left in situ. This conservative approach might be followed by a course of iv Methotrexate and/or embolisation of afferent vessels. To decrease the incidence of pathological placentation, the indication of every caesarean section should be considered carefully.

PO-Geb 03.20 Effect of steroids on angiogenic factors in pregnant women with HELLP syndrome Materials and methods: We report two cases of early-onset HELLP syndrome before 34 weeks of gestation where we monitored platelets and sFlt1/PlGF ratio frequently from the point of admission. Both women received a daily dose of 32 mg methylprednisolone IV (patient A four courses prior to delivery, patient B three courses prior to delivery). Results: In both cases, we observed an increase of the platelet count.

In parallel, as a result of increasing maternal serum sFlt-1 concentrations and decreasing maternal serum PlGF concentration, the sFlt-1/PlGF ratio increased (patient B) or remained almost unaffected (patient A) under steroid therapy. As expected, the ratio declined after delivery.

Conclusions: The observed effect as the temporary increase of platelet count seems to be a peripheral steroid effect without direct action on the anti-angiogenic status and therefore the underlying pathogenesis of HELLP syndrome. Thus, the use of glucocorticoids should be critically reviewed and needs further investigation. Objective: To determine symptomatic patients less than 35 weeks of gestation without risk for preterm delivery and therefore avoid overtherapy as hospitalisation, tocolytics or corticoids by using the Actim Partus Test Ò . Materials and methods: Our multicentred prospective randomized trial underwent its pilot phase and includes patients with preterm contractions between 24 + 0 to 33 + 6 weeks of gestation with cervical shortening between 15 and 25 mm but negative Actim Partus Test Ò (rapid bed side test which measures cervical phosphorylated insulin-like growth factor binding protein-1 concentration under 10 lg/ml). 200 symptomatic patients will be enroled in the studygroup and 100 in the control-group. After written consent the studygroup does not received tocolytics nor are corticoids given, only bedrest is recommended. This group is compared by the control-group which receives the standard treatment.

Results: Within the pilot phase 9 study-patients presented with preterm contractions, all of them reached 34 + 0 weeks of gestation. In the control-group 17 patients were enroled so far. Here 2 gave birth before 34 + 0 weeks. Conclusions: The test is rapid and easily applicable and highly anticipates preterm delivery before 35 weeks of gestation in patients at risk. The patients are benefitting from the absence of tocolytics and steroids and are comparing to the control-group not undergoing a higher risk for neonatal complications.

PO-Geb 03.22 Myomectomy of two large myoma in pregnancy: a case report Objective: Illustrating that dissection of large myoma during pregnancy can be a safe procedure. Materials and methods: We present a case of a 31y I/0, who underwent myomectomy of two large myoma at 18 weeks of gestation due to massive abdominal pain and severe displacement symptoms.

Results: In early pregnancy a uterus myomatosus had been diagnosed. Hospital admission was required at 16 + 3 weeks of gestation due to rapid growth of the myoma and increasing symptoms. Magnetic resonance imaging (MRI) revealed 7 myoma measuring up to 190 9 110 mm and detecting a thick myometrium underneath the myoma. The largest myoma were classified as subserous in no distance to the placenta. Due to the patient's condition with till growing myoma a myomectomy was performed at 17 + 5 weeks of gestation (weights: 1583 and 310 g respectively). Operation sites were closed in 3 layers leaving an adequate thick uterus wall. The intra-and postoperative course were without complications. The pregnancy was monitored with weekly ultrasound examinations and another MRI showing constant sizes of the remaining myoma and a stable wall of the uterus (1 cm thickness) without signs of imminent rupture. The pregnancy was prolonged to 35 + 4 weeks of gestation with no maternal symptoms. A cesarean section was performed and a 2490 g girl was delivered. The intraoperative findings revealed the already known remaining myoma and a sufficient myometrium thickness at the resection sites.

Conclusions: Although the majority of myoma are asymptomatic and do not require treatment during pregnancy, their presence may be associated with complications. The location, total number and the dimension of the myoma play an important role for the course of the pregnancy. Optimal treatment of leiomyoma occurring in pregnancy is still controversial. Individual decisions are required. In selected cases myomectomy during pregnancy can be a necessary and safe procedure.

PO-Geb 03.23 Serum-based diagnosis and mouse models for preeclampsia: presentation of a novel protein The overarching goal of this study is to use serum as a blueprint to establish in vivo and in vitro diagnostic and treatment models for pregnancy disorders such as preeclampsia and intrauterine growth restriction (IUGR). When combined, preeclampsia and IUGR complicate 10-15% of all pregnancies worldwide and are a major cause of maternal, fetal and neonatal mortality and morbidity. Despite intense investigation, these complications have remained enigmatic and the mechanisms that contribute to their emergence are largely unknown.

We have recently initiated serum-based studies to establish in vitro and in vivo predictive and mechanistic assays for IUGR/preeclampsia. Our data strongly suggest that serum from preeclampsia/IUGR patients contains an ''activity'' that disrupts cross-talk between placental invading trophoblasts and endothelial cells as well as causes preeclampsia and IUGR like symptoms in pregnant mice. The latter phenotype is particularly apparent in interleukin-10 (IL-10) deficient mice. A major task has been to expand these studies using a larger sample of human samples to verify these novel preliminary results and to identify the dysregulated protein component(s) by state of the art proteomic techniques such as mass spectrometry based Surface Enhanced Laser Desorption and Ionization-Time of Flight (SELDI-TOF). Results will be described with a focus on identification and biochemical and physiological properties of a novel protein (US Patent Application #WIH2009-01) that is invariably deficient in preeclampsia serum. This novel protein is able to counteract the above-mentioned disruption of the interaction between trophoblast PO-Geb 03.24 Strong influence of maternal lipids on fetal growth limited to pregnancies with gestational diabetes?

Objective: To evaluate the potential contribution of maternal glucose and lipids to fetal metabolic environment and growth in pregnancies with normal glucose tolerance in comparison with pregnancies with well controlled gestational diabetes (GDM) previously reported by us. Materials and methods: In 190 pregnancies with normal OGTT (controls), serum triacylglycerol (TAG), cholesterol, free fatty acids (FFA), glycerol, insulin and glucose were determined in maternal serum close to delivery and in cord blood. Birth weight, BMI and neonatal fat mass were obtained after delivery.

Results: Maternal serum glucose, TAG, FFA and cholesterol levels did not differ between controls and GDM, whereas insulin, insulin/ glucose ratio, HOMA and glycerol values were lower in the former. However, in cord blood serum glucose, insulin, insulin/glucose, HOMA, TAG and FFA were lower in controls than in GDMs, with no differences in glycerol and cholesterol. Similar to our findings in GDM, in controls maternal serum glucose, FFA and glycerol correlated with those in cord blood. In contrast to GDM, maternal glucose but not TAG or FFA correlated with neonatal weight, BMI and fat mass. In GDM, FFA levels had been the strongest predictor for neonatal macrosomia. Cord blood glucose, FFA and TAG positively correlated with birth weight and fat mass whereas in GDM a negative correlation between cord blood TAG and neonatal weight or fat mass was previously found. Objective: Primary hyperparathyroidism in pregnancy is rare. Only about 200 cases have been reported in the literature. The prevalence in pregnant patients is underestimated due to changes in the hormonal milieu. Slightly elevated PTH and calcium levels may remain unnoticed. Primary hyperparathyroidism during pregnancy causes risks for mother and fetus, a particularly increased risk for preeclampsia is described. We present a case were persistent hyperemesis led to the diagnosis.

A 35 year old woman IIIG/0P presented in the University Hospital in Kiel at 21 weeks pregnancy with several days history of excessive nausea and vomiting. Hyperemesis had been a problem throughout pregnancy. First-trimester screening presented normal results with regular biochemistry. Ultrasound examination of the fetus and doppler parameters were regular. Calcium levels were elevated to 3.85 mmol/l (2.0-2.6 mmol/l), serum PTH amounted to 3315.7 pg/mol (l 15-65 pg/mol). An ultrasound examination of the neck revealed two hypoechoic lesions of the left posterior lobe of the thyroid gland (2.3 9 1.4 9 0.8 cm), and posterior to the right lobe of the thyroid gland (0.6 cm), thus confirming the diagnosis of primary hyperparathyroidism. The patient subsequently underwent a para-thyroidectomy resulting in normal Calcium levels (2 mmol/l.) postoperatively. The rest of pregnancy was normal with vaginal delivery of a healthy female baby (3355 g).

Conclusions: In the literature, a significantly increased risk for both mother and fetus in untreated primary hyperparathyroidism is described, at a low prevalence of 0.15% in the pregnancy. This seems to rise up to 1.4% if one includes asymptomatic or unrecognized cases. As presented in this case report, the symptom of hyperemesis gravidarum with its unclear etiology led to the diagnosis. 

Objective: A variety of conditions in pregnancy require active obstetric management to end pregnancy. If time is not crucial, inducing labor is a lesser invasive alternative to caesarean section. In this study the cervix length as potentially predictive factor was evaluated regarding success of inducing labor for vaginal delivery. Materials and methods: A retrospective study was performed from 8/ 2008-9/2009 at a university OB/GYN department. Included were all pregnant patients with completed 34th-42nd gestational week in which pregnancy could not be prolonged for fetal or maternal reasons. Excluded were all patients with emergency or elective cesarean section. In all other cases (n = 59) a standardized ultrasound measurement of length of cervix was done. Labor was induced according to DGGG guidelines with prostaglandins. All data was taken from medical files and statistical analysis performed. Results: Patient age was Ø30.9 years (16-44), gravidity 2.0 (1-6) and para 0.6 (0-4). The group included 59 deliveries with 64 neonates. Indication for inducing labor was n = 39 (66.1%) fetal and n = 20 (33.9%) maternal reasons. The vaginal delivery rate after labor induction was n = 33 (55.9%), vaginal-operative n = 5 (8.5%) and cesarean section n = 21 (35.6%). The vaginal delivery ratio with up to 76.5% (n = 13/17) in the 41st gestational week was in all gestational weeks higher or even the cesarean section rate, which prevailed in the 42nd gestational week with 71.4% (n = 5/7). Cervix length in vaginal group was 25.0 mm (4-58 mm), vaginal-operative 21.4 mm vs. vaginal 25.5 mm, in cesarean section group 28.7 mm (12-44).

The preliminary results were n.s. Conclusions: Due to small numbers and study concept, cervix length could not be identified as predictive factor for a successful induction of labor. Individual patient factors as well as professional aspects determine the birth mode, especially the predominating trend for cesarean sections in the 42nd week.

PO-Geb 03.28 Forceps delivery: a practical training DVD Forceps delivery in Germany has declined once more from 1.4% to 0.7% between 2001 and 2008. This development can be explained by the tendency towards caesarean sections and the increasing percentage of vacuum extractions, which has increased from 4.4% to 5.3%. The reason for the decreasing amount of forceps deliveries is probably the attributed elevated maternal morbidity of forceps delivery. However, this delivery technique is an essential of the obstetrical repertoire. Specific indications for forceps delivery still exist especially when vacuum extraction does not work properly or is contraindicated. Among those indications are failed trial of vacuum extraction, premature birth before 35 + 0/7 gestational weeks, extensive caput succedaneum and occiput posterior position. In order to manage forceps delivery professionally it is essential for the obstetrician to know exactly the normal mode of delivery, birth mechanisms in prolonged labour and the technique of forceps delivery itself. In this practical video guide several didactical techniques-e.g. footage from delivery ward, use of obstetric mannequins and computer graphics-are used to present dedicated trainees more than plain text as a motivation to commit to this classical obstetrical method. 

Objective: Ovarian hyperstimulation syndrome occurs frequently after hormonal stimulation with human chorionic gonadotropin (hCG). Thus it must be assumed that hCG is a key factor in the pathogenesis of ovarian hyperstimulation syndrome. An association of aneuploid pregnancy with alterations in maternal serum hCG concentration has been described in the literature.

A 40 year old patient presented to our clinic with severe ovarian hyperstimulation syndrome at 17 weeks of gestation of a spontaneous singleton pregnancy. The pregnancy had to be terminated shortly thereafter due to a vitally critical maternal condition caused by a beginning amnion infection syndrome. Karyotype analysis of the abort material showed a trisomy 16. In the follow-ups at the referring gynaecologist, the sonomorphologic polycystic aspect of the ovaries subsided entirely while serum hCG levels and infection parameters returned to normal values.

Conclusions: In cases of ovarian hyperstimulation syndrome in pregnancy that cannot be traced back to preceding exogenous hormonal stimulation, aneuploidy should be considered as a differential diagnosis.

PO-Geb 03.30 Spontaneous, VE-assisted delivery of a healthy child by a paraplegic woman without epidural anesthesia Objective: Pregnant women with paraplegia have repeatedly been shown to be at an increased risk for autonomous hyperreflexibility and hypertensive crisis during and after delivery. To prevent and counter this condition elective epidural anesthesia is recommended. Results: We report the case of a spontaneous, VE-assisted delivery of a healthy child by a paraplegic woman without epidural anesthesia. Epidural anesthesia is currently recommended for the delivery of paraplegic women as autonomous hyperreflexia and hypertensive crisis may be a complication for delivery. A 28 year old paraplegic GII/P0 with a history of spinomedullary trauma at Th10 presented at 38 weeks of her pregnancy for induction as scheduled according to the recommendations for women with paraplegia. The history of her current pregnancy showed no significant pathological conditions, the induction period progressed well and epidural anesthesia was planned. However, in less than 15 min the cervix had dilated from 4 to 10 cm, followed by a sudden decrease in fetal heart-rate to 50 bpm. Elective epidural anesthesia could not be administered anymore, the call was made to perform a vacuum extraction: in the course a healthy child (APGAR 7/8/9) was born with the mother in continuously stable cardio-circulatory and neuro-muscular status. More specifically, no signs of autonomous hyperreflexibility were observed during the time of delivery and during the first days. This case report shows that autonomous hyperreflexia is not always a complication for spontaneous delivery in paraplegic women. Conclusions: We report the case of a spontaneous, VE-assisted delivery by a paraplegic woman without epidural anesthesia and without development of maternal autonomous hyperreflexibility. Further research is required to identify parameters that may help to predict hyperreflexibility in paraplegic patients in order to plan for elective epidural anesthesia at an early stage of delivery. Objective: The treatment of a patient with a metastatical colorectal carcinoma is mainly palliative. Owing to a combine chemotherapy with 5-FU, FS and Irinotecan, a significant extension of the total survival time and the progressive-free interval has been demonstrated, which can be improved with a supplementary dose of Avastin. There is little knowledge about the effects on a pregnancy, the most common dose is used in the 2./3. trimenon. Materials and methods: A 37-year old 4 gravida 3. para in the 34 + 5 week of gestation is referred to our obstetrical consultation hour. The patient suffers from a rectum carcinoma with hepatic and pulmonal metastasis after operative therapy and an adjuvant chemotherapy according to the FUFIRI-protocol and Avastin (5 + 2 week of gestation). The pregnancy was determined in the 22 + 5 week of gestation with a control computer tomography. After a premature amniorrhexis the decision for a secondary cesarian section was taken as a result of a pathological CTG in the 36 + 4 week of gestation.

Results: Birth of a hypotrophic male premature infant in a moderate diminished general condition of health: birth weight 1770 g, length 42 cm, head circumference 32.5 cm. Additionally to a primary drink laziness the following features occurred: VSD, ASD, pulmonal stenosis, poly-and syndactylia of both hands, both thumbs anomaly and both hips joint luxation.

Conclusions: It is important to give empathically a detailed information to a sexual mature women about contraception before a planned chemotherapy. The patient has to be informed about the unknown facts of a chemotherapy during a pregnancy with all possible consequences. It is also significant to recommend a sufficient contraception after a completed treatment. The compliance of the patient is an indispensable condition for succeeding. We recommend a ß-HCG test before the beginning of a zytostatical therapy or a consultation with a gynecologist.

PO-Geb 03.33 Acute lower limb compartment syndrome after cesarean section: a case report and review of the literature Objective: Acute postpartal compartment syndrome of the lower limb (ACS) is a rare yet severe pathology encountered in obstetric patients, which requires undelayed diagnosis and treatment. The aim of our study was to further identify common causes, associated pathologies, presenting symptoms and treatment options in obstetrics patients with an ACS. Materials and methods: A case report of a patient with ACS treated in our department and a review of the literature concerning ACS in gynecologic and obstetrical care.

Results: Prolonged episodes of hypotension during cesarean section, which might occur during extensive blood loss with subsequent hemorrhagic shock were identified as main risk factors for the development of a postpartal ACS. In the setting of vaginal delivery placenta retention was commonly associated with the onset of a postpartal ACS. Further predisposing factors for a ACS following labor, identified in our analysis were fluid deficit, the use of vasoconstrictive drugs, lithotomy position, prolonged surgery time, compressive bandages and obesity.

Conclusions: As the quality of the functional result in the setting of ACS is directly related to the promptness of diagnosis and surgical intervention, the knowledge of potential risk factors may be a valuable tool to correctly diagnose a postpartal ACS.

Arch Gynecol Obstet (2010) Objective: Impaired fetal lung development is highly associated with decreased AFI in the 2nd trimester. We present the case of prenatal diagnosed unilateral renal agenesis and contralateral hypodysplastic kidney. Materials and methods: Critical clinical case report.

A 32 year old woman presented in our clinic at 30 weeks of gestation with anhydamnio since 24 weeks of gestation, renal agenesis of the right side and contralateral hypoplastic kidney. We ruled out premature rupture of membranes and applied betamethason for lung-maturation-therapy. Examinations by fetal-MRI or genetic testing were rejected by the patient. Fetal echocardiogram was regular but fetal lung-volume appeared to be reduced thus lung-hypoplasia had to be hypothesized. Due to preterm labour the patient was hospitalised at 33 weeks of gestation to get a second turn of lungmaturation-therapy because of limited neonatal prognosis. Fetal growth restriction was diagnosed \3 percentile. At 34 + 5 gestational weeks due to persisting preterm labour and vaginal bleeding delivery by caesarean section was performed (newborn parameters: 1980 g, pH art. 7.25, BE 1.6). The neonate was immediately transferred to the pediatric intensive care unit, where it had to receive peritoneal dialysis via Tenckhoff-catheter for rising renal parameters (creatinine 5.51 g/ml). Lung hypoplasia was confirmed and the child was intubated for 7 days due to beginning cyanosis. No other symptoms in terms of a Potter-Syndrome were detected. After 9 weeks of intensive care the child was dismissed in a sufficient health status. Transplantation of a kidney is planned after weight gain up to 10 kg. Conclusions: Despite the severe bilateral kidney anomalies with oligo-anhydramnio since 24 weeks of gestation and consecutive hypoplasia of the lung the newborn reached satisfying pulmonary function under intensive care management and could be dismissed shortly with spontaneous breathing and adequate health status under peritoneal dialysis to aim for later kidney transplantation.

The impact of prepartum anxiety on the incidence of surgical interventions during labour Objective: Pregnancy and childbirth mostly represent a meaningful event in a woman's life. Especially for women who are pregnant for the first time pregnancy is often related to considerable changes. Although according to DSM-IV prevalence rates of mental axis-1disorders do not generally increase during pregnancy, there are studies that found high prevalence rates of anxiety disorders during the postpartum period. The present study examined the question whether anxieties women suffer from during pregnancy have an impact on the course of childbirth and on the risk of a secondary caesarean section. It is assumed that on a physiologic level, anxiety can disturb the natural process of birth due to altered hormone levels. Moreover, anxious women might have problems to relax. Materials and methods: A sample of N = 248 women was recruited at the University of Heidelberg Women's Hospital. Prepartum anxiety was measured by the Anxiety Screening Questionnaire (ASQ) (anxiety), the State-Trait-Anxiety-Inventory (STAI) (anxiety) and by the Pregnancy Related Anxiety Questionnaire-Revision (PRAQ-R). Dependent variables were duration of labour and incidence of labour inducing procedures.

Results: The data show that pregnancy related anxiety measured by the PRAQ represents an important predictor of duration of labour. General anxiety which was not specific for childbirth did not contribute to duration of labour. Parity, peridural anaesthesia, inducing labour and birth weight were added as control variables to the regression analysis. The incidence of surgical procedures could partly be explained by regression analysis of pregnancy specific anxieties. This effect disappeared when parity and peridural anaesthesia were taken into the regression model as predictors.

Conclusions: Anxieties during pregnancy due to the exceptional situation and to upcoming delivery play an important role for the course of childbirth. Prospective studies should examine models on the aetiology of these anxieties.

Early onset preeclampsia in a twin pregnancy with hydatidiform mole and coexisting fetus Objective: We present a case of early onset preeclampsia in a twin pregnancy with hydatidiform mole after missed abortion of geminus II and a patient with a complete mole and a suspected twin pregnancy with good outcome for mother and neonate. Materials and methods: At 24 + 0 weeks of pregnancy the patient was admitted because of preeclampsia and vaginal bleeding. Clinical chemistry showed severe anemia, HCG of 389855 mIU/ml and a hyperthyreoid situation. Geminus I was vital, geminus II had been transformed to a giant mole. In the further course the symptoms aggravated; thyreostatic therapy was started in order to prevent thyreotoxic crisis. The patient received blood transfusions and antihypertensive medication, and magnesium was started as prevention of eclamptic seizures. Two days later she became oliguric without adequate rise in red blood count despite blood transfusions and abdominal symptoms worsened. In order to prevent further risk primary cesarean section was performed.

Results: The neonate was female; weight 560 g, APGAR score 4/7/7, pH 7.32, BE -3.7. She died after 3 days due to grade IV intracerebral hemorrhage. The mother had an intraoperative blood loss of approx. 2500 ml, postoperatively she was admitted to ICU for acute respiratory distress, interstitial lung edema and thyreotoxic crisis. On day 6 she could be discharged with almost euthyreotic values. In chest Xray there was no sign of metastatic disease. Histology showed a hydatidiform mole without invasive growth. In the second patient, pregnancy could be prolonged until 33 weeks, when a healthy neonate was delivered.

Conclusions: These cases show that obstetricians should be aware of the rare situation after missed abortion of one geminus that there can be a transformation to hydatidiform mole. There need to be very close check-ups in order to prevent risks for the second fetus and the mother. Objective: In neonates with protein C deficiency the homozygous form regularly manifests as severe ophthalmic and cerebral vein thrombosis with purpura fulminans occurring even intrauterinely during late pregnancy. While the incidence of heterozygous congenital protein C deficiency is one in 200-300 births, the homozygous state is extremely rare. In case of a heterozygous protein C deficient mother and father the child has a 25% risk of being compound heterozygous protein C deficient, which equals functional homozygosity.

Results: During pregnancy the mother's only treatment option with an acceptable and well defined risk profile after the first trimester were oral anticoagulants. Indeed, cumarine treatment resulted in significant elevation of the fetal INR as confirmed after delivery and can be viewed as effective in therapeutically inhibiting fetal coagulation. Maternal cumarine treatment was effectively antagonized for early planned cesarean section without influencing the fetuses' anticoagulant therapy at any point. In neonatal severe protein C deficiency the treatment options include fresh frozen plasma and protein C concentrate in the acute phase. The preterm infant was substituted with protein C intravenously until 3 kg of weight and corrected age of 38 weeks of gestation. Then the route of administration was switched to subcutaneous infusion resulting in nearly 40% reduction of protein C concentrate compared to intravenous infusion.

Conclusions: Prenatal diagnosis of fetal compound heterozygous protein C deficiency can be safely managed by maternal treatment with cumarines. Early planned cesarean section before 32 weeks limits significant maternal side effects and avoids the increasing fetal risk to develop intrauterine thromboembolic complications. After delivery intravenously administered protein C during prematurity and switching to subcutaneous infusion at 3 kg body weight resulted in sufficient protein C levels and enabled the family at-home treatment now for 2.5 years with excellent quality of life. Regarding her past obstetrical history she had one early miscarriage and an intrauterine fetal demise most likely due to placentar infarction of unknown origin at 40 weeks of gestational age. During the first trimester of the current pregnancy an ultrasound revealed a uterine wall thickness of maximum 2 mm in the rudimentary horn. At the implantation site of the placenta almost no uterine wall was detected as a possible sign for an accrete placenta. Results: The following options were repeatedly discussed with the patient: continuing the pregnancy with a significant risk of uterine rupture in the second or third trimester followed by severe hemorrhage containing a significant risk of maternal and fetal mortality. Alternatively, the patient was counselled to terminate the pregnancy in order to avoid the mentioned risks. Finally, the patient opted to terminate the pregnancy at 12 weeks of gestational age. Thus, a laparotomy was performed and the rudimentary horn of the bicornuate uterus containing the viable pregnancy was removed completely. The postoperative course was uneventful.

Conclusions: A pregnancy in a rudimentary horn of a bicornuate is a rare condition with a significant risk for rupture of the uterine wall. In the literature there are only a few reports published, with only one out of nine reporting upon a successful pregnancy outcome. Therefore, prolongation of the pregnancy can only be justified with informed consent of the mother after thorough discussion of the risks for herself and the newborn. Objective: Preeclampsia is a major cause of maternal and neonatal morbidity and mortality. Preeclampsia usually manifests after the 20th week of gestation and is unpredictable in onset and progression. Early identification of the risk of developing preeclampsia would provide means for a better surveillance, and thus improve maternal and fetal outcome. In order to develop a strategy for a molecularbased diagnostic assay, we applied a multifactorial differential analysis of serum proteins using mass spectrometry. Materials and methods: Samples from pregnant women with earlyonset preeclampsia (n = 11) and gestational age matched pregnant women with uneventful pregnancies (n = 13) were assayed. Serum proteins were fractionated by magnetic beads (Profiling Kit 100 MB-HIC8, Bruker Daltonik, Bremen) and fractionated precipitation. Spectra were recorded with a Reflex III MALDI ToF MS (Bruker Daltonik) in linear positive ion mode in the mass ranges from 4-25 kDa and 20-250 kDa. Spectra were reproducible and rich of signals with a good signal to noise ratio. Statistical analysis was performed with the ClinProTools (Bruker Daltonik) software package.

Results: The on average most abundant ion signals were observed at m/z 9. 390, 9.103, and 8.886 . The best differentiating ion signals between the two sample groups were found at m/z 13.715, 13.834, and 13.891. The underlying proteins of these three signals were identified as transthyretin along with its posttranslational modified variants. Nephelometric measurements supported the tendency of a lower transthyretin concentration in preeclampsia. Ratios of peak intensities of all six ion signals enabled us to create cut off values by which preeclampsia were successfully classified from controls with a sensitivity of 91% and a specificity of 92%. Conclusions: Our findings support the hypothesis of preeclampsia being a heterogeneous disorder that might be classified by a defined proteome signature in maternal blood using multifactorial analysis of affinity-fractionated serum samples. 

Objective: The aim of this retrospective study was to compare the accuracy of 36 commonly used weight estimation formulae in macrosomic fetuses. Materials and methods: Fetal weight estimation was carried out within seven days up to delivery in 350 singleton fetuses with a birth weight of C4000 g. The accuracy of the different weight estimation formulae was compared by firstly, the mean percentage and absolute percentage error, secondly, by the frequency distribution of differences between estimated fetal weight and fetal birth weight, and thirdly by comparing detection and false positive rates in screening for fetuses with a birth weight of 4000, 4300 and 4500 or more.

Results: Mean PE ranged from -62.2 to 9.6% and was closest to 0 with the Hard formulae. With 12 of the 36 weight estimation formulae mean APE was 10% or less, smallest with the Hart formulae (3.9%). The mean detection rate among all formulae for fetuses with a BW C4000 g, C4300 g and C4500 g was 29, 24 and 22% for respective mean false positive rates of 12% (for C4300 g) and 7% (C4500 g). A detection rate of 50% or more was achieved with five formulae.

Conclusions: Some formulae showed advantages as far as mean and absolute percentage errors were concerned. But none reached a detection rate and false positive rate for fetuses C4500 g that could lead to clinical recommendation. PO-Geb 03.43 Treatment of growth restricted human fetuses with amino acids and glucose supplementation through a chronic fetal intravascular perinatal port system Materials and methods: We report here on intravascular supplementation with amino acids and glucose of IUGR human fetus at 33 weeks of gestation with oligohydramnios and placental insufficiency using the port system (Norfolk Medical, Illinois, USA). The catheter was implanted into the umbilical vein (UV) by cordocentesis, and was then connected to subcutaneously implanted port system. The treatment course included daily infusions of amino acid solution and 10% glucose into UV.

Results: Daily intravascular fetal nutrition significantly improved both fetal condition and fetal weight gain. No complications were seen. The patient was delivered by cesarean section in 38th week of gestation. The female newborn weighted 2130 g and was 47 cm high. Blood sampling from UV after delivery showed no deviations of amino acids in comparison to standardized curves. In 1 year followup the child's development and the weight gain, was like these of children without IUGR in the anamnesis.

Conclusions: This is the first report of successful use of subcutaneously implanted intravascular perinatal port system in IUGR human fetuses for long term administration of nutriments into UV of fetus for treatment of IUGR and prolongation of pregnancy.

Changes of angiogenic factors in severe HELLP-syndrome after fetal termination Objective: Preeclampsia is defined by high blood pressure and proteinuria in pregnancy. As a severe subtype of preeclampsia, HELLP-syndrome exhibits abdominal pain and typical laboratory signs in platelet count, liver enzymes and haemolysis markers. Preeclampsia is accompanied by a rise of angiogenic factors like sFlt1, which is a soluble VEGF receptor fragment and a decline of PlGF (placental growth factor) both produced by the placenta. These factor concentrations are in balanced relation in normal pregnancy. There are numerous studies about dynamics of angiogenic factor in clinical course of severe preeclampsia. Furthermore, there are hints and observations that fetal loss or termination leads to improvement of maternal condition in the case of severe earlyonset preeclampsia. Materials and methods: We report a case of a 29 year old primigravida in the 22 + 1 week presenting with signs and symptoms of an early severe HELLP-syndrome. At admission she was complaining of upper abdominal pain. Severe hypertension required urapidil i.v. medication. In addition, we report elevated liver enzymes and proteinuria of 1.5 g/24 h. Sonography showed a highly echogenic and thickened placenta. Because of the immaturity of the fetus and the severity of the disease, termination of pregnancy with fetocid was indicated. The quotient of sFlt1/PlGF was followed up very closely. Together with platelets and liver enzyme level dynamics of the named parameters are given. After fetocid, the sFlt1/PlGF ratio fell off 41% and raised again later. After expulsion of the placenta, the ratio went down to 41. Conclusions: Termination of pregnancy due to the maternal condition can be necessary in very dramatic and early-onset forms of hypertensive complication in pregnancy. Little is known about effects of fetal death on angiogenic factor concentration. Breakdown of the fetoplacental circulation leads to a partly and temporary decline of the angiogenic ratio. Removal of the placenta is needed to stop finally the production of the anti-angiogenic surge. Objective: Some drugs are known for their fetal nephrotoxicity and are therefore contraindicated during pregnancy. However for many innovative drugs only scant data exist on the effect on the fetus and on their use during pregnancy. We report on three cases of drug-induced renal insufficiency with different intrauterine course and outcome. Materials and methods: Case 1: A pregnant woman suffering from breast cancer received a neoadjuvant trastuzumab (Herceptin Ò ) therapy from 16 weeks onward. Fetal renal insufficiency with anhydramnios and missing visualisation of the fetal bladder developed at 21 weeks of gestation. After discontinuation of Trastuzumab and repeated weekly instillation of amniotic fluid, spontaneous resolution of fetal renal function was noted at 24 weeks. The further course of pregnancy was complicated by massive intrauterine growth restriction. After caesarean section at 32 weeks the postnatal development and the renal function were normal. Case 2 and 3 both received valsartan during pregnancy (case 2 Diovan Ò , case 3 Cordinate Ò ). In Case 2 fetal renal insufficiency with anhydramnios was observed at 21 weeks. After discontinuation of Valsartan spontaneous resolution of fetal renal function was noted and a healthy male neonate with normal renal function was born at term. In case 3 the Valsartantherapy was unknown to the attending physicians. At 32 weeks of gestation she presented with anhydramnios and preterm labour. The kidneys were massively enlarged and a biochemical examination of fetal cord blood confirmed terminal renal insufficiency with elevated cystatin C and beta 2 microglobulin levels. Following preterm delivery the renal function remained insufficient and the infant is requires dialysis. Conclusions: During pregnancy the application of Valsartan and Trastuzumab should be avoided if possible. In pregnancies exposed to Trastuzumab or Valsartan the treatment should be discontinued and the fetus should be closely monitored with particular attention to the amniotic fluid volume as this reflects the fetal renal function. Objective: Early intrauterine growth restriction (IUGR) combined with structural anomalies is a frequent sign of chromosomal abnormalities.

A 43 year old woman who had one prior pregnancy loss and was mother of one healthy child, was referred because of IUGR at 25 weeks gestation. Nuchal translucency examination and fetal karyotyping had been declined. Prenatal ultrasound revealed a dolichocephalus, flat profile, hypertelorism, unilateral renal agenesis and suspected contralateral renal hypoplasia, hypospadia and a single umbilical artery. After detailed counselling the parents decided in favour of the pregnancy and against karyotyping. Weekly ultrasound and Doppler examinations showed inadequate fetal growth and increasing signs of placental insufficiency. At 35 + 5 weeks a male infant was delivered by primary cesarean section (birth weight 1630 g). The major additional postnatal findings were multiple craniofacial stigmata, mild aortic coarctation, anal atresia and scrotum bipartitum. Genetical testing of lymphocytes and fibroblasts showed an additional chromosome in all analysed metaphases which was identified as chromosome 22 by in situ hybridization: 47, XY, +mar.ish22q11 (D22S75 9 3). ish22qter (93). Because of the poor prognosis therapeutic interventions were not intensified. At the age of four weeks the child died of renal insufficiency.

Conclusions: Non-mosaic trisomy 22 is a rare finding in IUGR combined with structural anomalies. Due to multiple malformations the rate of life births as well as the postnatal survival rate is low. In this case the condition could be observed throughout ten prenatal weeks and 4 weeks after birth. Fetal intestinal volvulus is a rare entity, mainly caused by intestinal malrotation or meconium ileus. Meconium ileus in combination with volvulus shows a high perinatal mortality and morbidity Therefore an early diagnosis is essential for optimal treatment in order to improve neonatal outcome. Volvulus presents with a variety of symptoms. A definitive diagnosis by prenatal ultrasound has been described only in a few cases. We report a case of mild fetal bowel dilatation at 30 weeks of gestation with development of extreme bowel dilatation and volvulus, presented by the 'whirlsign', in combination with fetal ascites and polyhydramnios at 33 weeks of gestation. At this time cardiotocography and umbilical artery blood flow were normal. Due to the ultrasound findings, elective cesarean section was performed in spinal anesthesia. A male neonate was delivered weighing 2620 g, Apgar scores of 9 at 1 min and 5 min each. Urgent laparotomy verified the diagnosis of meconium ileus with intestinal volvulation, and intestinal perforation. Resection of a long segment of necrotic ileum and enterostomy were necessary. The genetic testing showed a homozygous mutation DF508 of the CTFR gene. This case shows the importance of careful examination of the fetal intestine by routine ultrasound, and if necessary the need for rapid decisions for elective delivery to optimize neonatal intensive care and to allow early surgical treatment.

PO-Geb 03.49 Successful pregnancy after myocardial infarction Objective: Pregnancies after myocardial infarction are rare. Main reasons in young women are adipositas, smoking, hypertension, diabetes and frequently disorders of fat metabolism. Due to improved survival after myocardial infarction these young patients will be seen in a pregnant condition. We report of a 27 year old 1. Gravida/Nullipara (163 cm/54 kg) and status post inferior myocardial infarction at the age of 23 with cardiovascular arrest, ventricular fibrillation and reanimation. Coronary angiography showed an occlusion of the right coronary artery, which was re-canalized by stent in the same intervention. No history of smoking or thrombembolic events in her own or family history was stated. After exclusion of thrombophile risk factors a hyperlipoproteinaemia was discovered. Among therapy with statins and Omega-3-Acidethylester normal blood fat results were achieved. Secondary prevention for coronary artery disease takes with acetylsalicylacid (ASS) 100 mg/ day and metoprolol 47.5 mg/day. After diagnosis of pregnancy medical care in our high risk pregnancy outpatient clinic took place every 4 weeks. The cardiologist performed cardiac control. Left ventricular ejection fraction was normal. Statins were dropped, Omega-3-Acidethylester, ASS 50 mg and metoprolol were continued. Cesarean in intubation narcosis was planned for 38 weeks of gestation (WOG) and anti thrombotic therapy after cesarean medication was changed to ASS 100 mg/day and low fragmented heparin after pre-deliver interdisciplinary counseling. But emergency cesarean was performed under ASS 50 mg/day at 34 weeks of gestation due to a vaginal bleeding (healthy newborn). Post caesarean course was normal, no clinical complains, ECG-variations or troponin T increasement were observed. Statin treatment was recontinued due to post partum increased maternal blood fat results, heparin discontinued. Conclusions: Pregnancy after myocardial infarction represents a risk factor. An early interdisciplinary surveillance is mandatory during the whole pregnancy. The best way of delivery is cesarean about the 38th WOG. Objective: Fibroadenomas represent the vast majority of breast pathologies in young women. 2-4% of the fibroadenomas exceeds 5 cm in size or 500 g in weight and are called giant fibroadenomas. Due to their excessive growth they are usually enucleated to clarify a malignant origin and to prevent persisting deformities of the breast. The benign giant fibroadenoma has to be differentiated from phylloides tumors which hold a malignant potential. Materials and methods: We present a 17 year old female who was pregnant in the 24th week and suffered from a giant fibroadenoma in the right breast. Besides massive and painful swelling of the breast since 8 weeks no other abnormalities were found. On clinical examination we found a mobile tumor of more than 10 cm in size with dilated veins and an erythema on the skin surface. A prior performed biopsy and ultrasound could not definitely differentiate the mass from a phylloides tumor. Because of the rapid growth and progressive deformation of the breast an enucleation was performed without complications under perioperative control of the fetal well-being by CTG and ultrasound. After pathologic examination the tumor-size was determined 13 9 12.5 9 4.5 cm with a final weight of 456 g. Histologically a fibroadenoma with signs of chronic inflammation was confirmed. The patient did well in the long-term follow up with an adequate cosmetical result. A reconstruction because of the pronounced ptosis was delayed until the end of puerperal. No affection of the newborn was noticed after delivery. Conclusions: We present a rare case of a giant fibroadenoma in a pregnant young woman. Because of the progressive structural damage of the breast immediate surgical enucleation was indicated. Safety of the fetus was provided by perioperative monitoring. Besides the preoperative differentiation from phylloides tumor is still challenging. Objective: Ultrasound as the primary screening modality is used to detect fetal anomalies. The fetal MRI is further an increasingly used method to detect fetal anomalies. Because of the excellent soft tissue contrast and the large field of view sonographic gastrointestinal findings could be completed or further anomalies could be discovered. The aim of the study was to prove the additional value of fetal magnetic resonance imaging (MRI) for the diagnosis especially of fetal anomalies except of extracerebral anomalies. Materials and methods: In 44 pregnant women with fetal anomalies diagnosed at US were evaluated. The gestational ages of the fetuses

Arch Gynecol Obstet (2010) 282 (Suppl 1):S63-S270 ranged from 18-38 weeks. In these fetuses, prenatal MR imaging was performed within 14 days of US. 39 examinations were performed with a 1.5-T system, 5 examinations were performed with a 3-T system. TRUFI, HASTE and T1fl2D sequences were acquired. Prenatal US and MR imaging findings were compared with postnatal diagnosis.

Results: Fetal anomalies involved the cardiopulmonary system, the musculoskeletal system, the genitourinary system and the gastrointestinal system. In 19 diagnostic cases, US and MR imaging findings were in complete agreement with postnatal diagnoses. MR imaging correctly provided additional information to the US determined diagnosis in another 6 cases and correctly changed the US diagnosis in 4 cases. MR imaging provided more information than did US in 7 cases, In 2 cases, the diagnoses at both US and MR imaging were incorrect when correlated with the postnatal outcome. The US yields a sensitivity of 67% and a specificity of 90%, the fetal MRI yields a sensitivity of 82% and specificity of 95%.

Conclusions: Our results showed that fetal MRI has a high impact as an addition to ultrasound in evaluating of fetal anomalies. The aim of the present study was to determine the reoperation rate within 10 years after primary surgery for POP. Materials and methods: In a retrospective study we reviewed all patients who underwent primary surgery for POP at 4 large regional centers in 1997 and 1998. Hospital databases were searched to determine whether the patients had been reoperated through 2008. Reoperations for incontinence were not counted.

Results: A total of 456 patients underwent a primary operation for POP in 1997 and 1998. The most common primary operation was vaginal hysterectomy with colporrhaphy (89% of primary procedures). We identified 13 reoperations for prolapse, for a reoperation rate of (at least) 2.9%. The median interval between the operation und reoperation was 5.5 (1.5-10) years. The sacrospinous ligament fixation (Amreich-Richter) was the most common reoperation method (46%, n = 6) used.

The mean age at the time of primary operation was 62 (31-93) years.

Conclusions: The reoperation rate for prolapse after primary vaginal hysterectomy and colporrhaphy for prolapse in this series appears to be modest. Surgery for pelvic floor disorders is common but it remains difficult to determine the long-term efficacy of these procedures and even to define success.

PO-Gyn 03.04 Pelvic floor ultrasound evaluation of TVT-O: do we place the tape where it is supposed to be? Objective: Significant differences exist in urethral length and mobility in incontinent women. Therefore, Individual and exact placement of any anti-incontinence tape is assumed to be crucial for success. The aim of this study was to explore the differences between planned and achieved position of TVT-O. Materials and methods: TVT-O surgery was performed in 63 incontinent women. The first 29 operations were performed according to the 1/3 rule-incision starting at 1/3 of the ultrasonographically measured urethral length (standard technique for TVT placement at our department). Due to unsatisfying results, we then switched to start the incision at 1/2 of the urethral length. Ultrasonographically assessed TVT-O biomechanics showed reduced mobility of the TVT-O compared with the TVT. We changed our approach assuming that results can be improved by TVT-O placement closer to the high pressure zone. Success was assessed 6 months after surgery, calculating the difference between planned and achieved TVT-O position according to the formula: planned LUTL (longitudinal urethral tape localization) minus achieved LUTL. + means a deviation toward the bladder base, -to the external urethral orifice. Results: Deviations in the group operated according to the 1/2 and 1/3 rule were between + and -3 mm in 76% of women and between + and -3.5 mm in 84%. The greatest deviation was-8 mm in one case; all other deviations ranged between-6.8 mm and +4.3 mm.

Conclusions: In most cases, deviations did not exceed ±3.5 mm, suggesting that the technique is precise and that the tape stayed where it was planned and placed and did not move after insertion at the 6-month follow-up. Objective: Patients with genital prolapse often suffer from coloproctological diseases like the rectumprolapse with symptoms of obstipation and/or fecal incontinence. The purpose of the investigation was to determine the functional aspects of the anatomical defects by reconstruction of the anatomy. For example the symptom of fecal incontinence was examined before and after combined interdisciplinary prolapse-surgery. Materials and methods: In the years 2004-2008, 313 patients with genital prolapse were treated in the Saint Josefs-Hospital in Wiesbaden. 38 of these women (average age 61.3 years) had a complete genital prolapse with rectum prolapse III°. The patients were seen by a gynecologic pelvic surgeon and a coloproctologist for initial diagnostic workup. The diagnostic workup of symptoms included the standard gynaecological speculum examination, bimanual examination, proctoscopy and colonoscopy. The patient was seen and examined 6 month post-operatively, after the specific surgical procedure was performed as determined by the interdisciplinary team. The examination results were evaluated to compare the pre-and post-operative findings.

Results: None of the 38 women had a recurrence of genital-or rectal prolapse. None reported genital discomfort. 4 patients with urinary incontinence were improved or cured subjectively. 6 women reported worsening of urinary incontinence symptoms and 6 reported incontinence who had no prior symptoms. Half of the patients with fecal incontinence were cured or were improved. Conclusions: While surgical repair of pelvic prolapse is not a specific treatment for incontinence, in its preference it is a obligatory prerequisite for effective surgical treatment for urinary and fecal incontinence. Before the treatment of a combined urogynecological or coloproctological suffering the patient must be cleared up about the fact that an intervention like reconstruction of the anatomy is not synonymous with the immediate regaining of the organ function, and that for this if necessary another intervention or therapy could be necessary. Objective: Due to the variety of surgical methods using prostheses to treat pelvic floor prolapse and incontinence, there is a need to objectify the surgical outcome and individualise treatment for postoperative recurrences and complications. Utilising pelvic floor ultrasonography enables new insights regarding the position of the graft, its shape and their relation to adjacent structures and organs. Materials and methods: Pelvic floor ultrasonography is a new ultrasound concept which combines introitual, vaginal and abdominal ultrasonography. With this combination it is possible to gain a threedimensional image of all pelvic floor compartments, offering a good view on both the anatomical structures and the implanted prostheses as well at rest as during movement.

Results: The technique allows distinguishing between an urethrocele with and without funnelling and differentiation between tractions-and pulsion cystoceles, all implying different therapeutic strategies. A latent incontinence can be diagnosed preoperative to counsel the patient accordingly. Furthermore, it is possible to differentiate between rectocele and enterocele in posterior vaginal wall prolapse which allows the surgeon to get all necessary information whether an operation with or without an implant will be more successfully. After implantation of a sling or a mesh, the material can be examined and documented in size, shape and position. An essential benefit is to evaluate the relation between the anatomical structures and the implant in vivo, as this may offer a possible prediction of long term surgical success. Complications with the implant can often be fixed in a minimally invasive fashion, as ultrasound can identify exactly the possible causes of the underlying problem.

Conclusions: The pelvic floor sonography presents a method to gain objective and reproducible diagnoses in an uncomplicated and fast way. It allows the development of therapeutic concepts for the treatment of pelvic floor disorders as well as the goal-oriented interventions of postoperative complications. PO-Gyn 03.14 Robot-assisted surgery in gynecology: early experience with the daVinci surgical system Objective: To present our preliminary data on the feasibility, safety, advantages, and disadvantages along the learning curve with robotic surgery in general gynecology. Materials and methods: The daVinci robotic system (dVS) with a port set-up for 3 operating arms was used in all cases. Before we performed the first operations in Dresden, 2 experienced surgeons, 2 younger physicians, and 2 nurses participated in a training course at the IRCAD in Strassbourg/France for 3 days, followed by 2 days of robotic surgery under supervision at our department. Objective: Endoscopic intracorporal knotting and suture techniques demand sophisticated surgical skill. Young surgeons can be trained to perform endoscopic intracorporal techniques using dummies. This study examines whether talent or practice is more likely to predict how well an endoscopic surgeon performs endoscopic intracorporal techniques. Coexisting factors including sinistrality and myopia were sub-analysed. Materials and methods: 25 medical students participated in an endoscopic suture teaching program (ESTP). The program included two three-hour sessions of intensive training at the pelvic trainer. In the first session, each student executed three complete knots followed by one continuous suture that starts and ends with a knot. During the second session (one week later) the students completed a single knot followed by two continuous sutures (two knots). Each complete knot consists of a double knot in one direction and a single knot in the reverse direction. Each student's skill level was determined by measuring their knotting times. Individual factors such as size, weight, length, gender, age, myomia, sinistrality etc., and education, including previous hours of laparoscopic assistance, industrial arts and co-factors (sports, music, were accounted for with a selfadministered questionnaire.

Results: No correlation between individual and co-factors was found and there was no significant difference between the performance of right and left handed individuals. Students with more than 20 h of experience assisting endoscopic operations had significantly faster knotting times for the first three knots than students who had less than 20 h or no experience assisting endoscopic operations.

Conclusions: The development of the skills required to perform endoscopic knotting and suture techniques can be attributed to experience rather than talent.

PO-Geb 03.16 Port site and abdominal wall metastases after laparoscopy and laparotomy in advanced ovarian cancer: a retrospective long-run analysis of incidence and impact on survival Objective: In the field of gynecological oncology the laparoscopic surgery becomes more and more impact. The Disadvantage of laparoscopic surgery in cancer is the risk of port site or abdominal wall metastases. We analyzed a group of patients with advanced ovarian cancer to investigate the incidence of port site metastases and the impact on survival. Materials and methods: Patients with ovarian cancer who got neoadjuvant chemotherapy after diagnostic laparoscopy or laparotomy were subject of our study. 30 patients got a laparoscopy before starting neoadjuvant chemotherapy, 17 patients got a laparotomy. The time of first operation has been between 1997 and 2001. This analysis was retrospective by using a database of our patients with ovarian cancer. All patients have an advanced ovarian cancer beginning at stadium FIGO IIIB. Results: All 47 patients were followed up after the primary therapy until now. The occurrence of abdominal wall metastasis after laparotomic staging is 13% versus 12%; the difference is not significant. The median overall survival of all patients is 36.5 months; the median overall survival in the group of laparotomy is 49.5 months, in the group of laparoscopy 32.5 months. The difference between median overall survival in both groups is not significant (using t test). The observed value of expected survival in both groups correlates to the normal distribution.

Conclusions: Port site metastases are a potential complication of laparoscopic cancer surgery. The highest observed incidence is in ovarian cancer with 9-16%. In our retrospective analysis the occurrence of port site metastasis was correlates with the data in the literature. Reflecting the data of survival the diagnostic operation procedure before neoadjuvant chemotherapy has no impact on median survival thus port site metastases also do not influence the survival in our group.

PO-Geb 03.17 Well-leg compartment syndrome after surgery for gynecologic cancer: a case report Objective: Mastectomy can be a harming procedure for mental wellbeing of affected women, which underlines the importance of reconstructive surgery. There are several strategies. At first the use of autologous material like tram flap, latissimus dorsi flap or deep inferior epigastric perforator flap (diep), associated with the disadvantage of long operation durations, the risk of flap necrosis as well as scars in areas outside the breast or thorax. At second the expander/implant approach, that sometimes leads to a cranial position of implants, less natural form of the breast, dislocation of the implant and the need for a two stage procedure. A single stage reconstruction with good cosmetical outcome and no risk of flap necrosis would certainly mean progress. Acellular dermal matrix (ADM) has been popularized in other countries as an adjunct to tissue expander or implant breast reconstruction given its utility in providing additional coverage and support for the inferior pole. In Germany there is no government approval for alloderm Ò (acellular cadaveric dermis) therefore other materials like acellular dermal matrix based on pig skin (Strattice Ò ) have to be used. Materials and methods: We have used ADM for reconstructive surgery after radical, skin sparing or subcutaneous mastectomy. The subpectoral pocket is opened laterally at the insertion of the pectoralis muscle. The submuscular and ADM pocket is subsequently formed. The acellular dermal matrix is used to create a nice submammarian fold which helps to give the permanent prosthesis a more caudal and therefore more natural position. The tissue expander (when necessary) or permanent prosthesis is then placed in the pocket and the pectoralis muscle is connected through interrupted stitches to the ADM. Without the use of ADM lower pole expansion is rather restricted. Conclusions: Encouraged by the good cosmetic results we will further use this technique, although longer follow up is needed. Vulvar cancer is a rare disease with an incidence of 2.5/100,000 and a mortality of 1.3/100,000 patients per year, whereas squamous cell carcinomas are the vast majority. One of the most important prognostic factors in vulvar carcinoma patients is the presence of lymph node metastases. The surgical therapy of vulvar carcinoma patients includes radical local excision or a partial/complete vulvectomy accompanied by uni-or bilateral inguinofemoral lymphadenectomy depending on the tumour infiltration depth. Although complete inguinofemoral lymph node dissection is accompanied by a high morbidity, the evaluation of the diagnostic accuracy of the sentinel lymph node biopsy as an alternative method with less side effects is not yet complete. In a multicenter survey, we asked gynecological surgeons of 41 hospitals about their experience with the sentinel lymph node biopsy. The majority of these surgeons are fully adapted to perform this technique in patients with vulvar carcinoma (73%, n = 30). Among our survey hospitals, 27% (n = 11) perform inguinofemoral lymphadenectomy as a standard procedure, 10% (n = 3) of them apply the sentinel lymph node technique alone, and in 63% (n = 26) of the hospitals both procedures are used in combination. Only 20% (n = 6) of the surveyed institutions apply the sentinel lymph node biopsy in patients with vulvar carcinoma according to the consensus criteria/S2 guideline. Moreover, in our survey we further asked, whether the surgeons always complete the sentinel lymph node biopsy in patients with vulvar cancer by complete inguinofemoral lyphadenectomy in addition: This was standard in 24% (n = 10) of the hospitals. We are planning a prospective randomised multicenter study in patients with vulvar cancer to compare the effectiveness of Objective: Screening of more than 7000 German breast and ovarian cancer families by PCR based techniques revealed mutation frequencies in the two known BRCA genes between 35-50%. In contrast, mutations in other predisposing genes like CHEK2 and ATM were detected with very low prevalence. As a still significant proportion of our families are lacking mutations in these known genes, we decided to screen them for mutations in another predisposing gene for breast cancer, called PALB2. In addition, we included sporadic cases. Materials and methods: We performed a comprehensive mutation screening of PALB2 in 818 familial and 820 sporadic cases of breast cancer from Germany. All affected index patients had been screened for small nucleotide alterations in BRCA1 and BRCA2 by dHPLC and/or by direct DNA-sequencing and tested negative for pathogenic mutations. Eight out of 13 PALB2 exons were analysed, covering 100% of the mutations previously reported in PALB2 positive breast cancer families. Results: We found eight truncating mutations (seven of them novel), five in 818 BRCA1/2-mutation-negative families with familial breast cancer and three in 820 sporadic cases. Moreover, three novels potentially disease causing missense mutations were found. In contrast, none of the previously published deleterious mutations found in other populations, except one, were identified. Conclusions: Our observations indicate firstly, low prevalence of deleterious PALB2 mutations and secondly, a distinct mutation profile within the German population. More intriguing however, our data indicate that mutations in PALB2 are not restricted to familial, but can rarely occur, like CHEK2 gene mutations, in sporadic cases.

PO-Onko 03.03 Prediction of disease-free nipple-areola complex in patients with extended DCIS by computer-assisted detection in breast MRI Objective: Important preoperative information to decide for skinsparing mastectomy (SSM), a surgical option in selected patients with extended ductal carcinoma in situ (DCIS), is a disease-free nippleareola complex (NAC). Breast MRI can be used to detect patients with disease in ductal tissue behind the NAC. The purpose of this study was to evaluate the impact of computer-assisted detection (CAD) with breast MRI as an additional diagnostic tool in the prediction of preoperative tumor extension with respect to the NAC.

Materials and methods: A routine case series of 28 patients with extended DCIS underwent 3D (Gd)-enhanced 1.5T MR mammography preoperatively using a T1-w FLASH pulse sequence. Two radiologists assessed the images in consensus reading. According to the enhancement distance towards the NAC 3 groups were defined: Group (1): NAC reached; (2): C 4-6 mm (intraoperative assessment of surgical margins required) and (3): C6 mm (disease-free). Histopathological analysis served as standard of reference.

Results: Contrast uptake was in 84% ductal and in 16% segmental. Without CAD n = 2 false-positive cases for retroareolar tumor involvement were found in group (1), a marginal disease-free NAC of n = 9/28 was in group (2); n = 17/28 were categorized disease-free in group (3). With additional CAD n = 20/28 were now classified (2) (+32.1%), n = 1 re-classified from (1) to (2) and n = 10 re-classified from (3) to (2) In the subgroup that received a mastectomy there was a significantly higher rate of metastases, which corresponds to the fact that in more advanced breast cancer a higher rate of mastectomies is performed. There was no significant correlation between age and the kind of operation or the mastectomy rate. The self-perceived physical wellbeing did not differ between the age groups. Women who were suffering from metastases generally reported a lower level of psychological wellbeing. The desire of sexuality was overall much lower than the desire of closeness. Interestingly there was no correlation between the operation method and the desire of sexuality. 36% of 266 reported an increased fear of sexual intercourse, especially regarding pain and loss of attractiveness.

Conclusions: Overall, we observe some significant differences in sexuality and wellbeing depending on the method of treatment, age and prevalence of metastases. Further research is needed to confirm and specify these influences. The large amount of personal comments in the questionnaires shows the importance of this topic. Objective: In malignant tumors predictive markers have been developed with respect to targeted therapies. One of the first targeted therapies was hormone blocking treatment of tumors of the male and female reproductive system. A typical therapy in breast cancer is the use of the selective estrogen receptor modulator (SERM) tamoxifen. However, only part of the patients, positive for the target molecules, responds to the selected therapy. It would, therefore, be highly desirable to have a tool to timely assess the therapeutic efficacy of the applied agent in the individual patient. Materials and methods: We, here, report on the successful use of CETC as a unique tool to monitor therapy response in 178 breast cancer patients followed prospectively during hormone therapy. Requiring only 1 ml of peripheral blood using a fluorochromelabelled antibody against surface-epithelial antigen and image analysis allowed calculation of CETC numbers with relation to blood volume and monitoring over the course of treatment.

Results: An increase of more than tenfold in CETC during therapy was a strong indicator of looming relapse (p = 0.0001 hazard ratio 5.5; 95% confidence interval 1,297-23,626) and a cox regression analysis of age, tumor size, receptor expression, nodal status and previous treatment resulted in a regression model in which CETC behavior was the parameter with the highest independent correlation to relapse-free survival. Objective: Breast cancer (BC) is the most frequently diagnosed malignancy during pregnancy. Important treatment considerations include counseling abortion, surgery and chemotherapy during pregnancy or delayed treatment after pregnancy. The objective of this case report is to describe the challenges faced in the treatment of a patient with metastatic BC during pregnancy. Materials and methods: Case report and review of the literature.

Results: A 34-year-old woman, G4P3 at 24 weeks of gestation presented with a palpable mass in the right breast and enlarged axillary and supraclavicular lymph nodes. Biopsy revealed an invasive ductal carcinoma with negative hormone receptor status. The past medical history is significant for invasive breast cancer of the left breast (G3 pT2 pN1 (2/9) M0 L1) which was treated elsewhere with anthracycline-based chemotherapy, radiation and endocrine therapy with tamoxifen 6 years ago. Staging by non-contrast MRI revealed advanced bone metastases without other metastatic loci. Five applications of paclitaxel weekly induced severe hematologic toxicity making transfusion necessary and led to treatment discontinuation due to thrombocytopenia. Due to the onset of an atypical pneumonia a cesarian section was performed at 33 weeks of gestation with the birth of a healthy newborn. Postoperatively the patient was transferred to the intensive care unit due to progressive respiratory distress and progression of disease. The patient died 19 days postpartum. Several points of caution with respect to the clincial management are discussed: the use of supportive therapy (steroid type and dose, 5HT3serotonin antagonists, G-CSF) during pregnancy; the use of analgetics (neonatal abstinence syndrome), response evaluation criteria (validity of tumor markers, imaging) as well as reevaluation of hormone receptor status post-partum (down regulation during pregnancy).

Conclusions: Weighting the impact on maternal prognosis and perinatal outcome, treatment of metastatic BC poses a significant challenge. The lack of evidence, different symptoms and patterns of disease require individualized treatment.

The effects of classical massage therapy on stress perception and cortisol in breast cancer patients Objective: We conducted a randomized, controlled trial to investigate the efficacy of classical massage treatment in reducing stress perception, cortisol and mood disturbances.

Materials and methods: Women diagnosed with primary breast cancer were randomized into an intervention group and control group. The intervention group received a 30 min classical massage of back and head-neck-area, twice a week, for a period of 5 weeks. The control group received no additional treatment to their routine health care. For evaluating treatment efficacy the questionnaires: Perceived Stress Questionnaire (PSQ) and Berlin Mood Questionnaire (BSF) were administered and the patient's blood was collected at baseline (t1), at the end of intervention (t2) and to follow up after 11 weeks (t3).

Conclusions: Thirty-four eligible women (mean age 59 years, n = 17 each group) were enrolled. Compared with control group, women in the intervention group reported significantly lower mood disturbances, especially for anger (p = 0.048) and anxious depression (p = 0.03) at t2, and tiredness at t3 (p = 0.01). Perceived stress and cortisol serum levels (p = 0.03) were significantly reduced after massage therapy only in the intervention group. However, the intervention group exhibited no different serotonin levels. Further research is needed to validate our findings. Breast tuberculosis is a very rare disease and commonly misdiagnosed either as a non-specific abscess, granulomatous mastitis or carcinoma. We report the case of a 51 year old Chinese woman with a breast abscess initially and recurrently diagnosed as granulomatous mastitis but finally proven to be tuberculosis of the breast. She presented with a mass in her right breast associated with pain and ulceration. In the last 12 months 3 incision biopsies had been performed. We decided to perform a complete excision of the mass and a reconstruction with a thoracoepigastric flap. Objective: Occurrence of granular-cell tumours in the female mammary gland tissue indeed represents a rarity. What is special about these tumours is that, in the imaging process, they usually appear malignant, but are histologically usually benign. We report observations made on such a tumour which proved to be a challenge for all the disciplines involved. Materials and methods: In the upper inner quadrant of the right breast of a 69-year-old patient a compact, pressure-painful, readily displaceable resistance on the thoracic wall with plateau phenomenon was felt.

The patient was otherwise clinically healthy. All laboratory values were normal. Sonography, mammography, pre-operative minimal-invasive diagnosis and operative removal of the tumour were undertaken. Results: Sonography: at 2 o'clock, 6 cm from the right nipple, a low echo; lengthwise oval focus, interruption of the bordering structure of the connective tissue of 12 9 9910 mm. Dorsal echo extinction. Mammography: 10 cm behind and 4.5 cm medial to the nipple in a specially set-up latero-medial shot, a 7 mm radio-dense focus. No microcalcification. Under strong suspicion of invasive carcinoma, application of sonographic-controlled high-speed punches that held parts of a granularcell tumour without histological criteria of malignancy. Then complete operative removal of tumour. Histological identical tumour tissue as in the high-speed punching. Immunohistological reactions: S100 protein, vimentin, pan-cytokeratin, oestrogen and progesterone receptors, Her2neu, p53, Mib1, LCA, neurofilaments, neurone-specific enolase and actin. Apart from this PAS. Normal post-operative course. Tumour-and symptom-free follow-up over 2 6/12 years.

The rare granular-cell tumours of the female breast give indications during imaging of being malignant, but are usually histological benign and thus constitute a considerable diagnostic challenge. Human endogenous retroviruses (HERV) embody over 8% of the human genome and are derived from ancestral germ line retroviral infection. Some HERV envelope (env) proteins are essential for mediating cell-cell-fusion of cytotrophoblasts to the syncytiotrophoblast in human placentogenesis, but are also implicated in tumorigenesis. Hypomethylated 5 0 Long-Terminal-Repeats (5 0 LTR) of HERVs correlating with increased expression have been shown for HERV-W and HERV-K in different human carcinomas. Previously, we demonstrated a significant step-wise increase of the Syncytin-1 HERV-W env gene at both mRNA and protein levels for EnCa and prestages compared to controls. The purpose of this study was to determine expression of five HERV envelope genes in Endometrial Carcinomas (EnCa) and correlation with CpG-methylation of the 5 0 LTR of HERV-W in EnCa and prestages compared to matched control tissues. We established methods for absolute quantification (qPCR) for five different HERV-env genes and methylation-specific-PCR (MSP) using bisulfite treated genomic DNA. Methylated CpGs were verified by cloning and sequencing. Gene expression of benign and malignant endometrial tissues (EnCa n = 44, polyps n = 21, hyperplasia n = 12) compared to control postmenopausal endometrium (n = 33) showed that the HERV-env genes Syncytin-1, HERV-K, ERV-3, HERV-P(b) and Syncytin-2 were significantly up-regulated. In control and benign prestages ERV3 was the highest expressed HERV-env, whereas in EnCa Syncytin-1 was the most prominent. Methylation studies of the HERV-W 5 0 LTR of Syncytin-1 showed that seven out of 20 CpGs were significantly hypomethylated in EnCa compared to control endometrial tissue from the same patient (n = 7). These sites correlated with transcription factor binding sites. Studies using the demethylation agent 5 0 Aza-2 0 Cytidine with EnCa cell lines resulted in a 2.5-fold increase of Syncytin-1 gene expression. In conclusion, up-regulation of Syncytin-1 in EnCa is due to specific hypomethylation of the 5 0 LTR. Understanding epigenetic regulation of HERV-env genes will contribute to the molecular etiology of EnCa and stepwise induction from benign prestages.

PO-Onko 03.20 Estrogen receptor b2 is associated with expression of growth regulatory genes p21/WAF1, SCUBE2 and MYBL2 in endometrial adenocarcinoma Objective: Endometrial cancer is known to be a hormone-dependent neoplasia which is caused by a stepwise accumulation of molecular alterations in cellular pathways regarding proliferation and differentiation. Several studies have discussed a possible tumor suppressor role for ERb in the carcinogenesis of hormone-dependent target tissues. In this study, we examined the association between expression of the three ERb isoforms ERb1, ERb2 and ERb5 and expression of eleven cancer-associated genes to further approach the function of ERb in endometrial cancer.

We analyzed expression of steroid hormone receptors ERb1, ERb2, ERb5, ERa and PR and of eleven candidate genes (proliferation genes or cancer biomarkers) in 76 human endometrium samples and endometrial cancer specimens by means of real time RT-PCR and tested their association by means of a Spearman correlation.

Results: ERb splice variants were differentially expressed in endometrial cancer and exhibited an isoform-specific co-expression with marker genes. While ERb1 expression was not altered in endometrial cancer but was weakly associated with HER2 mRNA levels, ERb2 expression was significantly weaker in endometrial cancer than in normal tissue and was associated with expression of the growthinhibitory genes SCUBE2 and p21/WAF1 and with cell cycle gene MYBL2. In contrast, ERb5 transcript levels were significantly elevated in the endometrial cancer group and also were weakly associated with MYBL2. ERa expression, while being decreased in the G3 subgroup, was not only strongly associated with PR, but also with expression of SCUBE2 (p \ 0.001). Furthermore, we identified a highly significant co-expression pattern of aurora kinase A, Ki-67, cyclin B1 and MYBL2 in endometrial cancer. Conclusions: The differential expression of ERb splice variants 1, 2 and 5 as well as their specific association with marker genes supports their distinct role in endometrial carcinogenesis. The obtained coexpression data will allow further studies on its functional relevance in endometrial cancer.

Paclitaxel has apoptotic as well as non-apoptotic effects on different endometrial carcinoma cells Objective: Taxanes are important substances in gynaecological oncology. Their classical effects are to interfere with microtubules, which are important for cell division, and to induce apoptosis. However, they also have non-apoptotic effects. Because importance of a systemic approach in the therapy of endometrial cancer is unclear, this work deals with the effect of Paclitaxel on endometrial carcinoma cells in vitro. Materials and methods: The endometrial carcinoma cell lines ECC-1, RL95-2 and AN3 CA were incubated with Paclitaxel. The rate of apoptosis, cell cycle analysis and proliferation were detected using flow cytometry and viability assays. The activation of the signaling pathways p44/42-, p38-MAPK (mitogen activated protein kinase), JNK (c-jun N-terminal kinase) and NF (nuclear factor)-jB was measured via in-cell western assay. The secretion of chemokines was quantified using ELISAs.

Results: Paclitaxel mediated a dose-dependent inhibition of proliferation in all three cell lines. This effect was accompanied by an accumulation of the cells in the G2/M-phase and an increased rate of apoptotic cells. The extent of these effects varied between the different cell lines. In contrast to p38-MAPK, JNK and NF-jB, the p44/ 42-MAPK signaling pathway was highly activated upon Paclitaxel stimulation. In addition, Paclitaxel caused a differential regulation of the chemokines IL (interleukin)-8, MCP (monocyte chemo attractant protein)-1 and RANTES (regulated and activated normal T-cell expressed and secreted) in the different cell lines.

Conclusions: Paclitaxel inhibits proliferation and induces apoptotis in endometrial carcinoma cells. Moreover this taxane has regulatory effects on main signaling pathways as well as the secretion of chemokines, dependent on the differentiation level of the cells. From a clinical point of view these results extend the knowledge of the spectrum of taxane activity, arising new options for these substances in the therapy of endometrial cancer. Objective: The aim is to evaluate the preoperative staging preciseness of clinical examination and MR-Imaging using an endorectal surface coil (eMRI) comparing the histopathological outcome in patients with endometrial cancer. Materials and methods: 10 consecutive patients with biopsy-proven endometrial cancer were clinically staged according to the FIGOclassification and underwent eMRI prior to surgery. MR-Imaging was performed with 4-10 mm slice thickness using T2-weighted turbo spin-echo (tse) sequences in sagittal, coronal and transversal orientation and T1-weighted spin-echo (SE) sequences (transversal) with fat-saturation (fs) and additional contrast medium on a 1.5T MRI. Dynamic MR-Imaging in sagittal orientation was carried out after 25 s and 60 s with a 3 mm slice thickness.

Results: Regarding tumor size 5 patients were staged correctly according to the FIGO-classification, one was overstaged and one understaged comparing the histopathological outcome. In 3 patients the myometrial infiltration was not mentioned in which case a comparison was not possible. With endorectal coil MRI all tumors were depicted. Four patients were staged correctly regarding tumor size and myometrial invasion, 5 were overstaged regarding myometrial invasion and one was understaged. In terms of lymph-node diagnostics the eMRI staged correctly in 9 patients and overstaged one patient. Cervical tumor invasion was described by the pathologist in two cases. One patient was evaluated correctly by the radiologist. Conclusions: In this study eMRI could detect and describe the endometrial cancer nearly as precise as did the FIGO-staging in terms of size and myometrial invasion. Lymph-nodes were shown accurately on eMR-images and were excluded in cases with limited tumors. Concluding, the eMRI showed high quality images of the female pelvis and easily depicted the cancer. At this point of practice tumor staging in patients with endometrial cancer with help of eMRI seems to be promising imaging modality and needs to be assessed in larger studies.

PO-Onko 03.23 Pilot study for pretherapeutical evaluation of the axillary lymph node status (ax LNS) in primary breast cancer patients by ultrasound compared to interventional assessment by fine needle aspiration (FNA) Objective: The axillary lymph-node status (LNS) is considered to be the most important prognostic factor in breast cancer. Therefore identification of the LNS is important for the determination of the overall therapeutical concept. However, an appraisal of the axillary lymph node status that is solely based on clinical and/or image-based judgement would lead to an overtreatment of 40% of the patients. In order to reduce the rate of unnecessary axillary dissection (AD), a pretherapeutical interventional clarification is necessary, which provides closer information about the histological condition of the lymph node. Materials and methods: In a pilot study 27 primary breast cancer patients have been evaluated by sonographic assessment of the axillary lymph nodes' dignity, following preoperative interventional clarification by fine needle aspiration (FNA). Results: Results of the FNA and the postoperative histological staging were compared to pretherapeutical clinical/sonographical evaluation of lymph node dignity. An adequate sonographic assessment on the basis of standardized sonomorphological criteria is crucial for further interventional clarification. In 37% of cases with pN0 we could identify normal lymph nodes by FNA, although clinical nodal status presented to be suspect. Therefore an overtreatment with unnecessary rate of ADs could be avoided by preoperative clarification with FNA. This implicates the fact, that FNA should be included in the preoperative evaluation of the lymph node status, beside the existing clinical/ sonographical examination. Our findings will be further investigated in prospective studies.

Postoperative infections due to bladder catheters after anterior colporrhaphy: a prospective, randomized three-arm study Objective: The introduction of certification into medicine has had considerable impact on improving the quality of care provided by German breast centres. Substantial investments (in staff, software, working time, etc.) are necessary to establish and maintain a quality management system (ISO 9001:2000) and to generate the key performance data required for certification, to conduct audits, etc. ITbased systems greatly facilitate the implementation and maintenance of QM systems in oncology and generate learning and synergy effects. QmMed.net enables the creation, via the QmMed.net internet portal, of an internet-based digital QM manual (QMM) based on ISO 9001:2000 as well as the adaptation of existing certified QM contents generated by academic certified breast centres. In addition, certification procedures according to the OnkoZert requirements are supported by means of document management, document control as well as document versioning. Senopedia.org is based on experience and designed as a knowledge portal. As of the fourth quarter of 2010, the portal will be made available free of charge to all breast centres by the German Society of Obstetrics and Gynaecology (DGGG) beyond the study period. Study objectives:

• To evaluate the status quo of medical quality assurance processes by implementing internet-based QM systems at breast centres and conducting functional analysis

• To analyse the use of web-based tumour boards • To improve the quality of cancer care • To determine and compile the resources necessary for the process of (re)certification • To promote the centres' internal and external communication • To provide standard operating procedures (SOPs) and system processes on the Senopedia.org portal

The implementation questionnaire addressed important aspects such as time saving during QMM implementation, the use of resources for QMM transfer to the QMMed.net platform, the update status of the tumour board software at the various centres and the potential for optimization and evaluation of curricular continued education.

Conclusions: QuaSiMa and Senopedia.org enable breast centres to establish their own certification-relevant quality assurance and quality systems by providing:

• Access to a complete library of procedural instructions and quality-related documents for breast centres and gynaecological cancer centres • Intuitive integration of in-house contents and adaptation of centrespecific processes • Introduction and support during initiation by participation in training courses and video conferences • Participation in the evaluation programme for (re-)certified centres.

PO-Onko 03.30 A perivascular epitheloid cell neoplasm of the uterus, arising from the right ovarian vein to the right atrium of the heart causing acute bilateral lung embolism Objective: Perivascular epitheloid cell tumor (PEComa) is a very rare mesenchymal tumor, however the uterus is one of the most frequently affected organs. Therefore we want to report the rare case of an angioleiomyolipoma of the uterus presenting as thrombosis and pulmonary embolism in a woman.

A 52 year old woman was hospitalized in the department of vascular surgery in November 2009 because of an acute pulmonary embolism and a thrombosis of the right atrium of the heart, the inferior vena cava, the left vena iliaca communis, the left vena iliaca interna and the left vena ovarica. A CT-scan of the abdomen displayed a large conglomerate in the field of the uterus and the right ovary with a diameter of 8 cm in addition to the extended thrombosis. At first a fractional excision of the thrombosis in the right atrium and the inferior vena cava was performed and the histological examination revealed a myxoma. Thereafter excision of the residual thrombosis and hysterectomy with removal of both ovaries in collaboration with vascular surgery were performed in January 2010. Histological staining showed an uterine angioleiomyolipoma, a tumor of the perivascular epitheloid cell neoplasm (PEComa) family. Follow-up visits of the patient including CT scans performed on a monthly basis have shown normal findings so far.

Conclusions: Despite the fact, that PEComa is a very rare finding, the uterus is one of the most frequently reported anatomic location of its origin. Thus physicians should have in mind, that enlargement of the uterus in conjunction with thrombosis of the inferior vena cava or pulmonary embolism could be caused by a perivascular epitheloid cell neoplasm of the uterus. 3,212 patients who have been on anastrozole for 3-6 months will be enrolled at 700 breast centres and practices throughout Germany. Patients will be stratified to initial adjuvant anastrozole or switch from tamoxifen. All patients will receive regular standardized information about breast cancer from baseline through to week 20 after study start to support treatment compliance. Data on demographics, arthralgias, therapy of arthralgia, and quality of life will be collected at baseline, 3, 6 and 9 months. Primary endpoints are scaled data on arthralgia and compliance within the first year of anastrozole therapy. Secondary endpoints include the incidence of arthralgias, therapy costs, reasons for non-compliance, and influence of arthralgias on clinical outcome. For a subgroup of patients data on arthralgia therapy and compliance will be validated with corresponding accounting data of participating health insurance funds. Results: NA.

Conclusions: COMPACT aims to provide valid data on AI-associated arthralgias, treatment, and treatment costs. This may help to better inform patients and health care providers about these clinically important issues with the aim to improve adherence to anastrozole treatment, breast cancer outcomes, and therapy costs.

Influence of Galectin-1 on apoptosis, proliferation and the expression of receptor tyrosine kinases in breast cancer cell lines We assembled an Affymetrix dataset of n = 579 TNBC (finding cohort n = 394, validation cohort n = 185). Unsupervised methods identified principal metagenes differing among TNBC in this clean cohort. Clinical data were correlated to these metagenes for the basal-like phenotype, the apocrine phenotype, different types of immune cells, a stromal signature, the claudin-CD24 signature, markers of blood and adipocytes, as well as an angiogenesis signature and an inflammatory signature.

Results: 73% of TNBC displayed a basal-like phenotype which correlates with poor histological grading and younger age. However, no effect of basal-like phenotype on survival was observed. A good prognosis was obtained for expression of immune cell metagenes and a poor prognosis was associated with metagenes for inflammation, angiogenesis and stromal cells. Objective: ShearWave TM Elastography (SWE) offers a new and independent method of investigating tissue characteristics. The BE1 study tested its ability to refine breast mass diagnosis with conventional BI-RADS ultrasound by adding SWE features. To evaluate specificity without reducing sensitivity. Materials and methods: Patients scheduled for a breast ultrasound were recruited to the BE1 study which was approved by the IRB of each center. B-mode-US were performed on the institution's own system and on the new system, followed by a SWE scan. 1000 lesions from 17 sites were entered. 910 had proven pathology, 90 are being followed-up. The reproducibility of SWE images and measurements was assessed on 3 consecutive acquisitions. The best three-variable model, including the BI-RADS score and 2 SWE features, was determined using multivariate regression analysis and used for reclassification. Objective: The aim of this study was the evaluation of the efficacy and clinical outcome of patients who underwent conization during pregnancy. We compared the preoperative cytological and histological results with the postoperative results. Prenatal and peripartal complications were evaluated. Materials and methods: We performed a file review and found 27 patients who underwent conization during pregnancy between 2003 and 2009. Suspect cytological or histological findings (colposcopic assisted biopsy) lead to LLETZ conization. Furthermore, the data collection contains HPV-testing, intraoperative and postoperative complications and affection of the margins. Additionally, a questionnaire was created to get further information about the mode of delivery, postpartum cytological results and procedures. Results: Three patients showed an invasive cancer, in 22 patients a CIN3 and one CIN2 lesion were found histologically. In one case the histological result could not be evaluated. 24 of 25 were tested positive for high-risk HPV DNA (13 HPV16, 1 HPV18, 1 HPV31, 1 HPV39 + 51, 1 HPV52). In 8 patients HPV could not be subtyped. No intraoperative complications were observed. One patient showed a postoperative missed abortion. In 15 patients we found positive microscopic resection margins. In 10 cases colposcopy and biopsy and in 11 cases colposcopy and conization revealed identical results, respectively. Histological results of the biopsy and the conization matched in 9 cases. All cases of cervical cancer were classified as no more than Pap IV or CIN3 before conization. Conclusions: The performance of a conization during pregnancy is important in patients where invasive cancer cannot be excluded. We showed a rate of 11.1% of invasive cancer that could not be detected prior to conization. LLETZ conization can be performed as curative therapeutic option in pregnancy with a low intraoperative, postoperative and peripartal complication rate.

PO-Onko 03.42 Public awareness and practice of cervical cancer prevention in Greece Objective: Pelvic and paraaortic sentinel lymph nodes (SLN) in cervical and vaginal cancer are detected by lymphoscintigraphy and intraoperative by gamma probe. In this study we evaluated the value of single photon emission computed tomography combined with computed tomography (SPECT/CT) for the detection of SLN in cervical/vaginal cancer. Materials and methods: Between August 2008 and March 2010 the SLN of 28 women with cervical cancer and 2 women with vaginal cancer were marked pre-operatively using peri-tumoral injections of 10 MBq technetium-99 m-nanocolloid (4 9 2.5 MBq; 0.5 ml each). After 45 min p.i. planar lymphoscintigraphy was performed followed by SPECT/CT and surgery. Intra-operatively the SLN were searched using a gamma probe. We analyzed the following information's: number and anatomical location of SLN on lymphoscintigraphy as well as on SPECT/CT. In addition SLN in non-typical anatomic locations were recorded. Results: The planar lymphoscintigraphy alone detected SLN in 25 of 30 patients. SPECT/CT detected SLN in 28 of 30 patients. In 7 patients the SPECT/CT showed 1 to 3 lymph nodes more the planar mapping. On the one hand these additional lymph nodes were really SLNs located near the injection places; on the other hand lymph nodes that impressed as one in the planar images identified themselves as multiple SLNs in the SPECT/CT. In 27 of 28 patients the lymph nodes detected in SPECT/CT could be found and removed Objective: Crucial factors determining persistent HPV-infection and development of precancerous and cancerous lesions are largely unknown. We previously identified a putative stem cell population within the cervical epithelium which preferentially binds virus-like particles. This study aimed to develop a 3D organotypic culture system to monitor HPV-infection. Materials and methods: Organotypic cervical explant models were designed based on a modified raft culture system using fragments of human uterine cervix. HPV-16 pseudoviruses (PsV), GFP-coupled and packaged with RFP reporter plasmids, were used to assess virus binding and infection of cervical epithelial cells. Fluorescence microscopy and FACS-analysis were employed to monitor integration of encapsidated plasmids into the host cell genome and to define the phenotype of the respective epithelial target cells.

Results: We report on the successful development of a cervical organ culture model maintaining original organ architecture, tissue heterogeneity and expression of cellular markers for up to 4 weeks. These cervical explants provided the basis for monitoring virus binding and the course of infection within the regenerating epithelium after exposure to HPV-16 PsV. Long term infection was detected in only a small number of cells within the basal cell layer. These cells possess characteristics and functional properties of stem cells, thus suggesting that stem cells are the targeted cell type to achieve viral persistence. Conclusions: Our studies describe the development of the first cervical organ culture system maintaining all cell types of squamous epithelium over a 4-week period, permitting monitoring high risk HPV-infection. This explant model is a valuable in-vitro system to study mechanisms and time course of epithelial regeneration and viral infection. Our data indicate that infection of stem cells within the cervical epithelium is indeed necessary to establish long term infection. These findings represent an important step forward to define the role of stem cells in HPV-associated carcinogenesis.

PO-Onko 03.45 Detection of high-risk HPV mRNA in liquid based cytology (LBC) specimens with the APTIMA Ò HPV assay Objective: SLeA is a carbohydrate motif that mediates adhesion between tumour cells and endothelium. It is usually not expressed in non-malignant tissue. Malignant transformation is associated with abnormal glycosylation, resulting in synthesis and expression of altered carbohydrate determinants, including SLeA. Aim of this study was to investigate the expression of SLeA in normal cervical squamous epithelium, cervical dysplasia grade 1-3 (CIN I-III), carcinoma in situ and invasive cervical squamous cancer. Materials and methods: Tissue was collected from conisation specimen, fixed and embedded in paraffin. Slides were fixed and incubated with monoclonal antibodies against SLeA (IgM). Staining reaction was performed with ABC reagent. The intensity of immuno-histochemical reaction was analyzed using the Remmele-Score. We evaluated 10 samples each of normal squamous epithelium, CIN I, CIN II, CIN III, carcinoma in situ and invasive squamous cancer which had been classified before by standard pathological examination. Evaluation was done by two independent observers including a pathologist.

Results: Median Score for normal squamous epithelium was 7, for CIN I was 10, for CIN II was 7; for CIN III was 9, for Carcinoma in situ was 7 and for invasive squamous cancer was 3. There was no measureable difference between the non-invasive cervical dysplasias and normal squamous epithelium. Comparing non-invasive to invasive samples there was a measureable loss of staining in invasive squamous cancer. In cancer specimen there were totally unstained tumours. Tumours with loss of differentiation and/or necrosis showed strong staining of SLeA Conclusions: Expression of SLeA in normal cervical squamous epithelium can be explained by physiological function in human reproduction. Loss of expression in invasive cancer may resemble the loss of differentiation according to physiological function. Positive staining in above described tumour areas may refer to higher potential for hematogen metastasis via selectin mediated binding to blood vessels or other unexplained mechanism.

PO-Onko 03.49 Establishing a highly sensitive and specific assay for quantifying circulating tumour cells in patients with cervical carcinoma Objective: There is mounting evidence that the detection of circulating tumour cells (CTC) in the blood of cancer patients may be useful for therapy monitoring and for the prediction of early relapse. We aim to establish a highly sensitive and specific assay for quantifying CTC in the blood of cervical carcinoma patients. Materials and methods: Our assay is based on HPV oncogene transcripts which are characteristic molecular markers for cervical cancer cells. Therefore we have designed a real-time one-step-RT-PCR for the detection of cells expressing spliced HPV16/18-E6 mRNA. By combining Ficoll-separation and ThinPrep-fixation of mononuclear blood cells (MNBC) with digital RT-PCR it is possible to detect individual CTCs independent of the viral transcript levels of individual tumour cells.

Results: Experiments with cultured HPV-positive cells in a background of HPV-negative cells demonstrated the high sensitivity of our assay (detection of one HPV16/18-positive cultured cell in 100,000 up to 500,000 HPV-negative cells). Furthermore by performing spikein experiments with 10 HPV-positive cells per 1 ml EDTA-blood we obtained concordant positive results in PCR experiments and immunocytochemical analyses using MNBCs equivalent to 100 ll blood. At present we are analyzing blood samples of patients with cervical carcinomas of FIGO stage III/IV. Conclusions: Using a highly sensitive one-step RT-PCR in combination with intact, fixed cells we could quantify low numbers of HPV16/18-E6 expressing cells even in a high background of HPVnegative cells. This practicable method for the detection of circulating tumour cells in whole blood of cervical carcinoma patients seems to be very promising and might become a valuable tool for the early detection of relapse and response to systemic chemotherapy. Objective: Menarche is one of the most important biologic signals in the life of a woman. The first cycles tend to be anovulatory and vary widely in length. Menarche occurs between the ages of 10 and 16 years in most girls in developed countries. The aim of this study is to examine the association between the menarcheal age and menstrual cycle abnormalities. Materials and methods: In this survey-based study, college-aged Medicin and Pedagogic-girls University of Alexandroupolis (n = 85) were screened by completing a questionnaire concerning their menarcheal and menstrual attitudes experiences. The results of detail endocrinologic workup were appropriate. A transvaginal sonographic examination, accompanied if necessary by a transabdominal examination was performed on all participants. Results: The average age at menarche for the girls was 11.6 ± 1.3. Girls who had extremely early menarche (Group A = 40) or extremely late menarche (Group B = 45) returned to complete questionnaires concerning current menstrual attitudes experiences. Girls in the group B reported more menstrual cycle abnormalities. (Group A = 15/45 vs. Group B = 9/40) respectively. The levels of hormonal parameters and endometrial thickness were normal in all cases. In the Group A the teenagers with menstrual cycle abnormalities reported about irregular bleeding in 66% and prolonged bleeding in the remaining cases. In the Group B the teenagers with menstrual cycle abnormalities had complaint of amenorrhea in 29.5% cases, 34.5% had infrequent and 26% frequent bleeding.

The diagnosis and management of menstrual disorders in adolescent girls is a particular challenge. A detailed and confidential medical and psychosocial history are necessary.

PO-Onko 03.51 Unusual complication after core needle biopsy of the breast: therapy resistant mastitis after core needle biopsy of a phyllodes tumour *Nikola Kasprowicz 1 , Gerd J. Bauerschmitz 1 , Alexandra Schoenherr 1 , Wolfgang Janni 1 , Svjetlana Mohrmann 1 1 University Hospital, Department of Gynaecology and Obstetrics, Breast Center, Düsseldorf, Germany

Objective: Percutaneous US-guided core needle biopsy (CNB) is a safe standard procedure in the work-up of suspicious breast lesions with a low complication rate.

A 48 year-old patient presented to our department in 8/2009 because of a routine mammography (BIRADS IV bilaterally). Ultrasonographically, numerous lesions suspect of fibroadenoma were seen (BIRADS IV). CNB was performed and histology revealed a cyst (right breast) and a benign phyllodes tumour (left breast). She had no significant past medical history, but was status post open biopsy of the right breast (1981) and two reduction surgeries bilaterally (1991, 2005) . Ten days after biopsy, the patient developed a diffuse mastitis. Despite intensive therapeutic measures such as oral and intravenous antibiotics as well as conservative measures the mastitis had not shown relevant improvement over months. The infection was extensive (ca. 15 9 12 cm) with signs of fluid necrosis of the fatty tissue. At no time an abscess had developed. Results: We recommended excision of the phyllodes tumour of the left breast. Because of her past surgical history and with the risk of subsequent operations the patient refused a breast-conserving surgery. She preferred bilateral mastectomy which was performed seven months after the CNB with following adequate wound healing. Histology revealed a phyllodes tumour 3 cm in size (left breast) and a benign phyllodes tumour of 1 cm as well as a fibroadenoma (right breast).

Conclusions: Percutaneous US-guided CNB is a standard procedure in the work-up of suspicious breast lesions with a low complication rate. The most common complications are haematoma and infection with each less than 1:1000. In this case, the prolonged course of breast infection after CNB was not as expected. Possibly due to her previous surgeries, the impaired tissue of the breast resulted in a mastitis that was resistant to conservative therapies.

PO-Onko 03.52 Comparison of conventional Papanicolaou smear and liquid-based cytology taken from the vaginal cuff after gynecological malignoma and radiation therapy Objective: The conventional Papanicolaou (CP) smear and liquidbased cytology (LBC) are today's available cytological methods for the preventive gynecological examination. Literature about an advantage of one method is inconsistent. This study evaluates the difference between these two methods in terms of unclear results in an oncologic follow-up care setting. Materials and methods: We examined 81 patients in the context of follow-up care after therapy of gynecological malignoma in our oncological ambulance. All patients underwent hysterectomy and radiation therapy (±chemotherapy). We performed a CP smear and a LBC taken from the vaginal cuff in every patient switching the order after every patient. The samples were fixated in a standard procedure and were stained using the Papanicolaou protocol. The evaluation was performed by one experienced gynecological cytologist using the Munich II nomenclature. Results: All 162 samples were evaluable. There were no results in the group Pap III D or higher. In the LBC group we found a Pap II in 74 cases and a Pap III in 7 cases. In the CP group there were 66 cases of Pap II and 15 cases of Pap III. That means that inconclusive results were more than double as high in the CP group than in the LBC group.

Conclusions: Even though the advantage of one of the discussed methods as a standard procedure in the preventive gynecological examination is disputed, we found in our small group of patients a surprisingly high difference concerning Pap III results with much less unclear results in the LBC group. Objective: Recent evidence suggests equivalent efficacy in terms of local control for adjuvant vaginal brachytherapy (VBT) compared to external beam radiotherapy after surgery in patients with intermediate-high endometrial cancer. The objective of this study is to compare the quality of life (QoL) and sexual function of women with endometrial cancer that were treated with either surgery alone or surgery in combination with postoperative VBT. Materials and methods: Women were interviewed at least 5 years after initial treatment for endometrial cancer. QoL was evaluated by using the European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire C30 and the cervical cancer module, CX-24. Sexual function was evaluated by using the Female Sexual Function Index (FSFI). Eligible women had early stage disease, were currently disease-free, and had undergone surgery and adjuvant VBT, but neither external beam radiotherapy nor systemic treatment. This study group were then compared using univariate and multivariate analyses with an age-matched control group comprising of endometrial cancer patients without adjuvant VBT. Results: Fifty-five patients (29 surgery + VBT and 26 surgical controls without VBT) were included for analysis. With respect to QoL including physical, role, cognitive, emotional, and social functioning in the C30 questionnaire or symptom experience and body image in the CX24 questionnaire, univariate and multivariate analyses did not show significant differences between the study group and controls. Likewise, in terms of sexual function statistical analyses did not show significant differences between patients with VBT and controls on any of the outcome measures in the FSFI questionnaire. Objective: Nucleoside Reverse Transcriptase Inhibitors (NRTIs) can reduce the risk of mother to child HIV transmission. Besides their effect on viral reverse transcriptase, NRTIs can influence the mitochondrial DNA replication. To analyse the toxic effect of NRTIs on maternal and fetal mitochondria the amount of mitochondrial DNA (mtDNA) was detected. Materials and methods: HIV-infected NRTI-treated pregnant women and healthy controls were included in the study. The amount of mtDNA (copies/cell) in maternal and fetal (umbilical cord blood) peripheral mononuclear cells (PBMCs) was detected by Taqman-PCR. The mtDNA value in PBMCs of newborns was followed up after 3 months.

Results: Compared to their HIV-and NRTI-exposed children and the healthy controls, PBMCs of HIV-infected NRTI-treated women showed a significant reduction in mtDNA copies per cell. No significant effect could be detected in mtDNA value of healthy controls.

In HIV-and NRTI-exposed newborns no significant mtDNA depletion could be measured compared to newborns of healthy controls at birth and after 3 months.

Conclusions: The use of antiretroviral drugs, in particular NRTIs, in HIV-infected pregnant women can induce mitochondrial toxicity. In their newborns no matchable reduction in mtDNA at the time of birth and after 3 months could be detected compared to healthy controls. Furthermore a toxic time dependent effect in NRTI-exposed HIVnegative newborns is unclear. Objective: Cells of solid tumors frequently show unbalanced chromosome distributions. The deficient segregation is accompanied by upregulated expression of the aurora kinases pathway involving AURKa, AURKb and STK6. Here we are able to show that the expression of these genes correlates with the tumour grade in ovarian cancer and breast cancer like proliferation markers do. Materials and methods: The expression pattern of AURKa, AURKb, STK6, Ki67, CDC2 and CDK2 were examined on paraffin embedded tissue sections of 21 normal breast and 42 breast cancer samples by immunohistochemistry. In addition 89 ovarian cancer specimens were stained for AURKa, AURKb, STK6 and Ki67. For statistical analysis Pearson's correlation coefficient and Jonkheere-Terpstra-Test were performed. Clinical Data was obtained from the hospitals own data base.

Results: As expected expression levels for all proteins were raised in tumor cells compared to benign tissue. In all explored specimens AURKa, AURKb and STK6 significantly correlate amoung each other (p \ 0.001) and also with established proliferation markers like Ki67, CDC2 and CDK2 (p \ 0.001). Expression of Aurka, Aurkb and STK6 was significantly increased in higher grade tumors compared to that in lower grade tumours (p \ 0.001). Reduced recurrence free survival for breast cancer and ovarian cancer patients is detected if the aurora kinase pathway is upregulated. Conclusions: Apart from well known proliferation markers like Ki67, CDC2 and CCK2, tumorproliferation is also represented by the upregulation of the aurora kinase pathway. The increased expression of these proteins which regulate chromosome segregation is also associated with the tumor grade and reduced progression free survival. We conclude that there is a causal correlation between incorrect chromosome segregation and carcinogenesis, whereas the question arises, whether the incorrect chromosome segregation leads to carcinogenesis or average tumor cell proliferation always gives rise to deficient chromosome segregation. Objective: Lymphedema is a major cause of morbidity following surgical treatment that involves lymph node dissection in cancer patients. However, the impact of lymph node removal on the prevalence of lower extremity lymphedema in patients with gynecological malignancies is largely unknown. The aim of this study was to determine prevalence of such lymphedema, its relationship to the extension of lymphadenectomy, and risk factors for its occurrence. Patients with lower limb lymphedema were identified through any medical records available. Cases of lymphedema diagnosed prior to surgery or related to other causes were excluded. Results: 313 patients receiving treatment for gynecological malignancies which involved initial lymphadenectomy were evaluated. 37% of patients were diagnosed with lymphedema within 1 year after surgery. Incidence of lymphedema correlated positively with the number of lymph nodes dissected. Patients suffering from wound infections and lymphocysts had a significant increased risk to develop lymphedema. Association with TNM-classification, chemo-/radiotherapy, age, BMI, history of previous abdominal surgery and venous insufficiency/thrombosis is under current statistical analysis and will be presented at the DGGG meeting.

Conclusions: Lymphedema is a frequent complication after treatment of gynecological cancers. Our data stress the need for prospective evaluations of lower limb lymphedema after surgery involving lymphadenectomy. These results will not only guide the physician in identifying high-risk patients but also provide the basis to sufficiently inform the patient about such complications that potentially have a significant impact on postoperative quality of live. Furthermore, the risk for post-treatment prevalence of lower body lymphedema must be taken into consideration during treatment planning as we gain increasing knowledge about the therapeutic benefit of systematic lymphadenectomy in patients with different stages of gynecological malignancies.

PO-Onko 03.57 A rare presentation of an isolated stromal compartment endometriosis of the lung: a variation that may mimic metastases of a low malignant stromal sarcoma Objective: Endometriosis is thought to affect 30% of women in reproductive age. Most commonly, the pelvic organs are involved. The manifestation of extragenital endometriosis is still rarely presented. In addition, there are just a few cases that report on the manifestations of thoracic endometriosis, defined by the presence of endometrial tissue in the lungs or pleura. Furthermore, histological findings of thoracic endometriosis with a solitary stromal component have barely been described so far. Histologically, endometriosis resembles endometrium consisting of both stroma and glands with cuboidal to cylindrical epithelium in different proportions. Materials and methods: We report an unusual case of a 38 year old female who was referred to our hospital with a medical history of recurrent pneumothoraces from 2001 to 2008 primarily caused by unknown origin. In the later histological findings thoracic endometriosis was suspected. The patient was seen by consultants from the pulmonary, thoracic surgery and obstetrics/gynecology departments. The CT scan showed a cystic transformation of the lung in both sides. Physical examinations and laboratory investigations were unremarkable. Thoracoscopic procedures with biopsy, pleurodesis and partial wedge resection of the lung were performed on both sides. The histological findings according to the morphology and the immunohistochemical expression patterns showed endometrial stroma cells. Further investigations like a hysteroscopy with fractional curettage and diagnostic pelviscopy with peritoneal and ovarian biopsies were demonstrated without detection of intraperitoneal endometriosis. Finally, in synopsis of all results a thoracic endometriosis with an isolated stromal component in the absence of epithelial cells was suspected. Differential diagnosis of this entity included benign metastasing leiomyoma and metastatic low-grade-endometrial stromal sarcoma. Conclusions: We report on recurrent pneumothoraces caused by thoracic stroma cell endometriosis, which is still rarely described. The diagnosis of this variation of thoracic endometriosis is difficult and extensive histopathological and immunohistochemical analysis is needed.

PO-Onko 03.58 Role of the new estrogen receptor GPR30 in endometrial pathology after tamoxifen for breast cancer *Atanas Ignatov 1 , Tanja Ignatov 1 , Andrzej Semczuk 2 , Thomas Kalinski 3 , Serban Dan Costa 1 headache or a non-specific viral-like illness and continues with psychiatric and severe neurological symptoms.

Objective: Confirmation of suspected diagnoses in anti-NMDA antibody positive encephalitis and teratoma as a possible cause and consideration of surgical treatment in this respect of the radical ovarectomy on both sides. Materials and methods: (1) A 1 Gravida/1 Para patient of 33 years with no history of gynecological disease. She was admitted in intensive care unit through the emergency department with sudden onset of neurological and psychiatric symptoms. Intubation and ventilation were necessary. Ultrasound showed ovaries with echogenic structure. We performed a laparoscopy with left ovarectomy and biopsy of the right ovary. The histology confirmed the diagnosis of a mature teratoma of the left ovary.

(2): A 34 years IG/IP. A diagnosis of meningoencephalitis with detection of NMDA antibodies led to a gynecological consultation. In sonography the right ovary showed an echogenic structure compatible with a teratoma. We also performed a laparoscopy with right ovarectomy and a wedge biopsy of the left ovary. Histologically an ovarian teratoma was confirmed.

Conclusions: The suspected diagnoses of an Anti-NMDA Encephalitis is in association with an ovarian teratoma in these two cases were ratified. After the surgery with ovarectomy the recovery of the patients could be observed. Objective: The discrimination between malignant and benign adnexal masses prior to laparoscopic exploration is important for the optimal therapeutic management. We compared the discriminative power of the most commonly used preoperative diagnostic strategies. Materials and methods: We analyzed all cases from 2002 to 2005 with the diagnosis of an adnexal mass and subsequent laparoscopic exploration at our institution. 1302 women were included (870 premenopausal, 432 post-menopausal). Sensitivity, specificity, the diagnostic odds ratio (DOR) and Cohen's kappa were calculated for CA 125, expert sonography, the combination of both and the RMI by Jacobs and applied to all cases and to postmenopausal patients only.

Results: A total of 49 malignant lesions were found, including 19 borderline lesions. Sensitivity for CA 125 was 0.48, specificity yielded 0.83. DOR yielded 4.51 and kappa was 0.1. For post-menopausal women, sensitivity was 0.59 and specificity was 0.84; DOR was 7.59 and kappa yielded 0.22. Sonography reached a sensitivity of 0.67 and a specificity of 0.96. Values increased to 0.78 for sensitivity and 0.92 for specificity in the post-menopause. DOR yielded 47.9 overall and 39.3 in the post-menopause; kappa yielded 0.46 overall and 0.48 for the post-menopause. By combining both methods, DOR increased to 72 and kappa to 0.6 in the post-menopause. RMI achieved a sensitivity of 0.3 and a specificity of 0.97, DOR yielded 13.29 and kappa 0.35. In the post-menopause an increase of discriminative power was observed, DOR yielded 19.6 and kappa 0.41. Conclusions: Expert sonographic examination proved itself to be the gold standard in classification of an adnexal mass with a high specificity in pre-and postmenopausal women. For the postmenopause, adding a measurement CA125 lead to an increase of discriminative power. RMI as a diagnostic strategy did not show a satisfying discriminative values. Objective: Primary neuroendocrine carcinoma of the vagina is extremely rare. It occurs mostly in elder patients. Because of its rareness there is no evidenced based therapy. Materials and methods: We report on a 71 year old woman who had breast cancer in 1995. Five years later she was suspected to have a metastasis of the breast cancer in the vagina and so a partial colpectomy was performed. Because of a very early relapse-diagnosed by punch biopsy-after 6 months a radiation was done and the patient was treated by an antihormonal therapy. In 2007 and 2008 the patient had repeated conspicuous smears without any macroscopic lesion. A MRI scan of the pelvis showed no signs of a relapse. In June 2008 a punch biopsy was done again and the histological investigation showed a neuroendocrine carcinoma in situ of the vagina with merkel cell phenotype. Retrospectively it can be assumed that the vaginal neoplasia detected in 2000 was also a neuroendocrine tumor rather than a metastasis of the breast cancer. The tumor cells were positive for cytokeratin 20. As there was no macroscopically visible tumor and neither operation nor radiation was possible, a vaporisation of the residual vagina with argon beamer was performed. Until now there are no signs of a relapse.

Conclusions: Positive expression of CK 20 in neuroendocrine carcinoma of the vagina might represent a Merkel cell carcinoma subtype. The occurrence in the vagina is very rare. Surgery, radiation and vaporisation might be a treatment option.

PO-Onko 03.62 Case report: primary angiosarcoma of the breast in a 39 year old woman Objective: Angiosarcoma of the breast is a rare malignant neoplasm which accounts for .04% of all primary malignant breast tumors and approximately 8% of mammary sarcomas. Compared to other angiosarcomas, the angiosarcoma of the breast affects younger women between the age of 30 and 40 years.

A 39 year old woman presented with a selfdiscovered, rapidly enlarging angiomatous and angiolipomatous tumor of the left breast, initially showing no signs of malignancy in a core needy biopsy. Ultrasound, mammography and magnetic resonance imaging merely displayed a heterogeneously hypoechoic mass with cystic lesions. A resection in toto was recommended. Breast conserving therapy lead to an initial R1 resection, resulting in a skin sparing mastectomy and the implantation of an expander. Axillary lymph node dissection was not necessary due to the predominant hematogenous metastatic spread of the tumor entity. Results: 7 cm Angiosarcoma pT3, pNx, G3 (FNCLCC)/ G2(NCI),R0,M0. Due to the extent of the tumor, the decision for adjuvant radiotherapy was made (total dose 55.8 Gy-1.8 Gy 59/ week). Adjuvant chemotherapy has no proven effect. A postoperative CT scan (thorax/abdomen), performed due to the special at-risk situation of the patient, showed a lesion in the right middle lung lobe,

Arch Gynecol Obstet (2010) 282 (Suppl 1):S63-S270 measuring 1 mm. A second suspicious lesion in the left breast was examined via jet biopsy and showed no signs of recurring disease. Continuous follow-up examinations are planned in close cooperation with the department of Internal Medicine. Conclusions: Angiosarcoma is an aggressive malignancy with a poor prognosis. Recently, an increase in incidence has been reported in the form of secondary angiosarcomas following breast conserving surgery and radiotherapy. Mammograms and cored needle biopsies may be deceptively normal and early adequate biopsy is needed to confirm the diagnosis and start treatment. New findings suggest Taxanes/ Trabectedin as a possible treatment option in the future. Objective: A 46 years old patient has been referred because of an actually increasing finding of approximately 6 cm in the right mamma, existing since 2 years. The patient for more than 20 years takes HRT, currently with Activelle (R). The patient also has a positive family history of breast cancer (mother with 66 years).

First of all an ultrasonography as well as a mammography has been done. After that a Tru-cut biopsy and finally the excision has been done as well. The postoperative developing was without any problems. Results: The imaging shows a 6 9 6 cm wide, complex soft tissue tumor with displacing growth and with inhomogenic density. The expansion is between the subcutaneous tissue and the fascia of the pectoral muscle. Doppler sonography shows a strong perfusion. Diagnosis: mixed tumor, hamartoma, giant adenoma, atypical giant fibroma, phylloid tumor. No typical appearance of a lipoma. Density ACR:I, classification BIRADS:4. The Tru-cut biopsy only showed fibrolipomateus soft tissue with focal fibrosis and with hyaline aspect. In the final histology myofibroblastoma with typical character was confirmed: A sharply bounded tumor, characterised by dumpy collagenous connective tissue with small lesions of partial fascicular or reticulated spindle cells. Mitosis are rare. Necrosis are absent. Typical immunohistochemical markers like Vimentin, Aktin, Desmin, CD 34 and oestrogenreceptors shows positive results. Conclusions: In this patient with a palpable tumor, positive family history of breast cancer, longtime hormone replacement therapy and a mammography with classification of BIRADS 4, the suspicion of breast cancer is high. Nevertheless the radiological image is very untypical.

Only the final histology examination brings clarity. This case demonstrates that the numbers of possible diagnosis in senology are very complex and inexhaustible big. Those differential diagnosis often provide for surprising results and only could be clarified with a histological examination and sometimes needs specific immunohistology. Objective: It is unclear whether there are differences of psychological distress in cancer patients during the initial phase of treatment. This study investigates levels of psychological distress in patients of a breast cancer centre and a gynaecological cancer centre at different stages in the beginning of treatment. Materials and methods: Psychological distress was measured using the Hornheider Screening Inventory (HSI). Data were obtained during acute care hospital stay, i.e. condition 1 (n1 = 30), and at the first and second appointments for ambulant chemotherapy, i.e. condition 2 (n2 = 31) and condition 3 (n3 = 23), respectively. Condition 1 was compared to conditions 2 and 3 using the Mann-Whitney-U-Test for independent samples. Within-subject comparisons between conditions 2 and 3 were calculated using the Wilcoxon-Ranks-Test. Additionally, patients of the two cancer centres were compared using the Whitney-U-Test.

Results: Highest levels of psychological impairment were found in condition 1, i.e. during the acute hospital stay. The HSI scores of conditions 1 and 2 were significantly higher than the score assessed in condition 3 during ambulant chemotherapy (both p \ 0.05). In condition 1, patients of the gynaecological cancer centre were significantly more distressed than breast cancer patients (p \ 0.01).

Conclusions: Patients were most distressed during oncological inhouse treatment and the initial phase of ambulant chemotherapy. By the time of second chemotherapy treatment, which was 3 weeks after first chemotherapy, psychological distress was reduced significantly and to a level below indication of psychooncological support needs. Hence, psychological support for cancer patients is particularly important during the initial stages of treatment. Differences of distress levels within this time frame can be identified using a brief screening inventory. Future research is required to explore levels of distress at further phases of oncological treatment and to investigate specific needs for psychooncological interventions in these phases.

PO-Onko 03.65 Cooperation between breast centers and private practice: the Cologne model Objective: The certification of breast centers (BC) in North Rhine Westphalia (NRW) is based on the implementation of a close cooperation between gynecologists working in private practice in an outpatient setting (OBGYN) and the team in the breast center to fulfill the needs of patients and the certification criteria. In densely populated areas such as NRW, OBGYN often work in cooperation with several BCs.

To improve the quality of cooperation between OBGYN and BC, a project was started together with private practice physicians (OBGYN), the medical association (Ä rztekammer Westphalen-Lippe) and members of the BCs, to develop a certified cooperation model, named the Zertifizierung als Kooperationspartner der Brustzentren in NRW nach dem Kölner Modell. The certification is based on three elements: 1. Medical qualification: participation in an interdisciplinary and case-oriented curriculum with final theory examination, tumorboard participation and observational rotation in the BC. 2. Certification of the outpatient practice within the Cologne model as an interface between outpatient care and BC (by Ä K Zert). The interface has been pre-defined for both partners in an obligatory and reviewable fashion. 3. Optional certification of the outpatient practice concerning quality management structures (if no other QM system available) (by Ä K Zert). Both partners apply for certification at the medical association, the certificate is then valid for 3 years.

Conclusions: In January 2010 the first certification round started with more than 80 participants from the private practice setting and from the three Cologne BCs with the aim to improve and standardize cooperative care for breast cancer patients. The model can be transferred to other BCs and regions in NRW and beyond. We will report first experiences in development and implementation of the model. Further information is available: www.aekwl.de, Stichwort Zertifizierung Kooperationspartner.

PO-Onko 03.66 New tissue acquisition tools for translational research in gynecology *Jaak Janssens 1 ,

Objective: Histological and molecular examinations are a prerequisite to understand diseases, determine optimal individualized care, and identify targets for potential novel therapies. Despite this key role of tissue based research the act of biopsy still remains troublesome for senological and gynecological applications. Materials and methods: For the breast, the tru-cut and vacuumassisted biopsy requires more than one sample resulting in increased contamination. Contamination with non-target tissue or blood makes quantitative analysis unreliable. For cervical tissues both mucosa and underlying stroma need to be present. Punch biopsy forceps harvest almost entirely epithelial parts. Results: New direct and frontal biopsy technologies are emerging with the aim to alleviate the bottleneck of inappropriate minimal invasive interventions. Their recent availability provides a good occasion to look into the subject of tissue acquisition problem, i.e. not enough high quality tumor tissue in sufficient quantity. Recent literature provides evidence that macrobiopsies, like Spirotome and Coramate, give tissue samples between 150 and 300 mg of highly specified parts of the diseased area in a way very similar to open surgery. In addition, the biopsy procedures are increasingly more patient friendly with appropriate comfort and safety. The new macrobiopsies are less expensive, making molecular biology at reach for every gynecological patient, company and health care provider. Conclusions: Direct and frontal macrobiopsies open new avenues for future bio-banking, pharmacogenomics and personalized medicine. It is anticipated that drug discovery and clinical implementation will be highly facilitated and that clinical research time will be significantly shortened.

PO-Onko 03.69 Sorafenib-mediated downregulation of mcl-1 induces chemosensitization of gynecological cancer cells Objective: Overexpression of the anti-apoptotic mitochondrial membrane protein mcl-1 is an often cause of acquired or pre-existing resistance of cancer cells against chemotherapeutic drugs. We tested the effect of the multikinase inhibitor sorafenib on signaling pathways that contribute to the upregulation of mcl-1 in gynecological cancer cells. Materials and methods: A variety of breast, ovarian, and cervical cancer cells was treated with sorafenib and analyzed for mcl-1 expression, MAP-Kinase signaling pathways, mitochondrial membrane potential, and overall cell survival.

Results: Pretreatment of gynecological cancer cells with sorafenib induced a significant downregulation of mcl-1 expression, associated with an inhibition of the ERK1/2 phosphorylation cascade, subsequently resulting in a mitochondrial membrane disruption. Sorafenib could effectively be combined with other chemotherapeutic drugs, especially those which itself did not sufficiently induce a disruption of the mitochondrial membrane potential.

Conclusions: Sorafenib, an already approved drug for the treatment of renal cancer, reveals a high efficacy and good combination potential for the use in gynecological cancer.

PO-Onko 03.70 Paraneoplastic cerebellar degeneration as presenting symptom of recurrent endometrial stromal sarcoma with sex-cord elements ESS are rare (6-20% of uterine sarcomas), may contain sex-cord elements, have a metastasis-and recurrence-potential (36-56%, 3 months-23 years), so that long-term follow-up is mandatory (5-year survival 62-93%). Clinical manifestations: vaginal bleeding, abdominal pain, enlarged uterus (often misinterpreted as fibroid uterus). Recurrence in pelvis, intraperitoneal, distant metastases (lungs, bones). Treatment guidelines do not exist. Total hysterectomy, BSO without routine pelvic/periaortic lymphonodectomy is the standard operating procedure. In case of recurrences, surgeries are an option. ESS express oestrogen and progesterone receptors, therefore an adjuvant hormonal treatment (progestins-medroxyprogesterone, megestrol-or aromatase inhibitors-letrozole, anastrozole) can reduce recurrence rates. Adjuvant chemotherapy (cisplatinum/adriamycin, ifosfamide, ifosfamide/epirubicin/cisplatinum or doxorubicin/ ifosfamide) is reserved for hormone receptor negative cases, progression/recurrence under hormonal treatment or high grade malignancy. We report a case in which paraneoplastic cerebellar atrophy (PCA) was preceding the diagnosis of multifocal recurrent ESS with sex-cord elements 16 years after diagnosis and surgery (abdominal hysterectomy and BSO without adjuvant therapy). The patient presented with gait ataxia, truncal imbalance, blurred vision, horizontal and vertical gaze-evoked nystagm and dysarthria. MRI/CT revealed cerebellar atrophy mainly involving the upper vermis, bilateral pulmonary metastases infiltrating thoracic vertebrae without evidence of local recurrence. Histologically that lesions were metastases of the formerly diagnosed ESS, containing sex-cord elements. 80% of the cells expressed ER and 10% PR. The slight progression of the metastases within four months and the unlikely response to chemotherapy due to low proliferation index, led us to perform debulking surgery (lobectomy-10 metastases, mediastinal lymphonodectomy, vertebra-metastasis removement requiring postoperative focal radiation). Anastrozole was administrated with the intention to delay further recurrence. After 3 months she is without evidence of tumor. Neurological examination showed a virtually complete resolution of ataxia by persisting oculomotor abnormalities.

Conclusions: We show that PCA can also occur in combination with late recurrent ESS.

PO-Onko 03.71 Specific antibody microarray tool for the early detection of invasive breast cancer Objective: Breast cancer is one of the leading causes worldwide for women mortality. Although the survival rate has increased, many patients die from metastatic relapse. One of crucial factors for breast cancer healing is its early detection. At the present time, no suggested biomarkers for breast cancer have been established for the use in clinical assays as a putative diagnostic tool. The aim of our study was a comparison of protein expression in sera of breast cancer patients and control group. Materials and methods: We involved in our study 100 participants including 50 women with primary diagnosed breast carcinoma without metastasis and another 50 healthy age-matched women without known malignancies. We constructed an antibody microarray tool to compare the regulation different acute phase proteins, interleukins and complement factors in both groups. For that purpose, we incubated selected antibodies on nitrocellulose microarray slides with sera of test persons and compared the reaction intensities with different statistical algorithms. Results: We obtained a panel of significantly different regulated proteins in breast cancer patients. The neural network could distinguish cancer patients from the control group with sensitivity of % and the specificity of %. The area under curve (AUC) of 0.xy was obtained. The most significant regulation differences were shown by acute-phase proteins like heat-shock proteins HSP60, 27 and 90 and complement factor c3/3a. Conclusions: In this study with the use of antibody microarrays we were able to compare the regulation of different proteins in sera of cancer patients and healthy controls. Also we generated a panel of putative serum protein biomarkers which could distinguish the cancer group from the controls with a high specificity and sensitivity. Our next aim will be the prospective validation of obtained biomarkers in an independent clinical study. Moreover, our findings could contribute to a development of a clinically useful biomarker assay. University, Gynaecology, Homburg, Germany

Objective: Realtime-sonoelastography is an ultrasound technique that enables a highly depiction of tissue elasticity distribution. Malignant breast lesions tend to be harder than benign ones. The usage of elastography in combination with B-Mode and Doppler-ultrasound could lead to more accurate differential diagnosis of breast lesions. The risk of malignancy of BIRADS 4 lesions ranges from 3-90%. Accordingly the optimal treatment recommendation is hard to find. The purpose of this study is to improve the patient's treatment. On the one hand, to avoid unnecessary biopsies and on the other hand to clarify suspect lesions earlier. Objective: Cancer-testis antigens (CTA) are a family of proteins normally expressed in the human germ cells such as in the testis or placenta. They also have been found in various types of malignant tumors including breast cancer. Because of their restricted expression pattern they are frequently able to elicit T-cell immune responses, and therefore they are considered as ideal targets for cancer immunotherapy. Breast differentiation antigen NY-BR-1 has also immunogenic properties. The aim of this study was to explore the CTA expression in breast cancer and detect possible clinical correlations.

Materials and methods: The expression patterns of 6 CTAs (MAGE A1-MA454, MAGE A3-M3H67, MAGE A4-57B, NY-ESO-1-E978, GAGE, MAGE A-6C1) and NY-BR-1 were examined by immuno-histochemistry in a series of 210 non-selected patients with primary invasive breast cancer using the tissue microarray technique. The intensity of the stain was scored semi-quantitatively in a scale 0 to +3. The expression of the antigens was correlated to established clinicopathological parameters as well as disease-free and overall survival. Results: CTA expression exhibited a predominantly cytoplasmic and occasionally nuclear localization. At least one CTA was identified in 37.2% of cases with expression of each antigen varying from 4.5 to 15%. NY-BR-1 was positive in 46.6% of tumors, with the well differentiated tumors showing more frequent expression. MAGE A4-57B (p = 0.048 and 0.015) and MAGE A3-M3H67 (p = 0.001 and 0.004, respectively) positive staining was significantly correlated to shorter overall and disease-free survival. Additionally, the mortality rate increased substantially if co-expression of 3 or more CTAs was observed.

Conclusions: Our findings suggest that CTAs could serve as potential prognostic markers in primary breast cancer patients. The exclusive expression of CTAs in tumor tissues as well as the frequent expression of NY-BR-1 could define potential new targets for specific breast cancer therapies. Objective: Women with HER2-overexpressing breast cancer are treated with trastuzumab. Genistein is a phytoestrogen and natural tyrosine kinase inhibitor that can inhibit growth of breast cancer cells.

Genistein is an agonist of estrogen receptor b (ERb), which is able to exert antitumoral functions. Considering these pleiotropic effects on breast cancer cells, a combined treatment with genistein and trastuzumab could be a promising therapeutic approach. In this in vitro study, we tested to what extent genistein would be able to enhance the antitumoral action of trastuzumab. Materials and methods: First we characterized the HER2-, ERb1-, ERb2-, ERb5-and ERa-expression in the three breast cancer cell lines SK-BR-3, BT-474 and MDA-MB-231 by real time RT-PCR. With a proliferation assay, we measured the influence of combinations of ERa-agonist (PPT), ERb-agonist (DPN) or genistein with trastuzumab on the growth of these cell lines over a time span of six days. Relevant gene changes were measured by PCR. Results: Treatment with genistein (10 lM) significantly increased the growth-inhibitory effect of trastuzumab on HER2-overexpressing, ERa/b-positive BT-474 breast cancer cells, but not on ERa-negative SK-BR-3 cells. ERb agonist DPN exerted similar effects on trastuzumab-treated BT-474 cells. In contrast, neither addition of 17-b estradiol, ERa agonist PPT nor tamoxifen did affect the antiproliferative action of trastuzumab. On the molecular level, treatment with genistein reduced HER2 transcript levels and inhibited trastuzumabtriggered upregulation of ERa-and c-fos expression. Though both drugs inhibited expression of proliferation genes Ki-67 and MYBL2, no additive effect was observed. Both drugs notably increased ERb2 transcript levels, and their combination further elevated mRNA levels of this receptor variant. Conclusions: Our data suggest, that the antiproliferative effect is triggered by genistein binding to ERb and is dependent on presence of ERa. Particularly women with HER2-overexpressing and ERa/b positive breast cancer might benefit from such combinatory treatment.

Arch Gynecol Obstet (2010) Objective: Tumor-specific memory T-cells (TCs) are detectable in the bone marrow (BM) of a majority of breast cancer patients. The clinical relevance, however, and the conditions for their generation remain unclear yet. In this study, we characterized conditions that determine immune responses in primary breast cancer patients and evaluated their potential prognostic implications. Materials and methods: We used ex vivo IFN-c EliSpot assays and ELISA in 207 untreated patients to evaluate tumor-specific TCs in the BM or MUC1-specific antibodies in the peripheral blood. In this context, 27 intratumoral cytokines, chemokines, and growth factors were quantified by multiplex analysis. Results were compared with multiple pathologic and clinical parameters and correlated to the general patients' prognosis by Adjuvant! Online calculation. Results: In 45% of patients we detected tumor-specific memory TCs in the BM. The presence of type-I memory TCs correlated significantly to primary tumors with high differentiation, estrogen receptor expression, low proliferative activity and reduced cancer mortality risk. High tumor cell differentiation correlated with increased concentrations of IFN-a and reduced levels of transforming growth factor TGFb1 in the primary tumor tissue. In 50% of patients we found tumor-specific B cell responses in the peripheral blood mainly in form of IgM isotype. Dichotomically, B cell responses correlated with increased TGFb1 and reduced IFN-a in the primary tumor tissue as well as with advanced tumor stage and the absence of TC responses in BM. Conclusions: For the first time we can show a strong correlation of cellular tumor-immune responses with prognosis-relevant parameters in tumor pathobiology. We were able to define specific intratumoral cytokine microenvironments that are dichotomically linked to distinct immune responses in the individual patient. These findings shed light on the relation between immune response and cancer prognosis.

PO-Onko 03.76 Role of GPR30 in the mechanisms of tamoxifen resistance in breast cancer MCF-7 cells *Tanja Ignatov 1 , Thomas Kalinski 2 , Serban Dan Costa 1 , Atanas Ignatov 1 1 Otto-von-Guericke University Magdeburg, Oncology, Magdeburg, Germany, 2 Otto-von-Guericke University Magdeburg, Pathology, Magdeburg, Germany

Objective: Tamoxifen is the most frequently used anti-hormonal drug for treatment of women with hormone-dependent breast cancer. The aim of this study was to investigate the mechanism of tamoxifen resistance and the impact of the new estrogen G-protein coupled receptor (GPR30). Materials and methods: MCF-7 cells were continuously exposed to tamoxifen for 6 months to induce resistance to the inhibitory effect of tamoxifen.

Results: These tamoxifen resistant cells (TAM-R) exhibited enhanced sensitivity to 17-ß-estradiol and GPR30 agonist, G1, compared to the parental cells. In TAM-R cells, tamoxifen was able to stimulate the cell growth and MAPK phosphorylation. These effects were abolished by EGFR inhibitor AG1478, GPR30 anti-sense oligonucleotide, and the selective c-Src inhibitor PP2. Only EGFR basal expression was slightly elevated in the TAM-R cells, whereas GPR30 expression and the basal phosphorylation of Akt and MAPK remained unchanged compared to the parental cells. Interestingly, estrogen treatment significantly increased GPR30 translocation to the cell surface, which was stronger in TAM-R cells. Continuous treatment of MCF-7 cells with GPR30 agonist G1 mimics the long-term treatment with tamoxifen and increases drastically its agonistic activity.

Conclusions: This data suggests the important role of GPR30/EGFR receptor signaling in the development of tamoxifen resistance. The inhibition of this pathway is a valid option to improve anti-hormone response in breast cancer.

PO-Onko 03.77 ERBB2 induces an anti-apoptotic expression pattern of Bcl-2 family members in node negative breast cancer

Background: Based on own results using laser micro dissected cells of invasive ductal (IDC) and ductal in situ (DCIS) breast cancer of the same tumor combined with Affymetrix microarray technology 445 differentially transcribed candidate genes have been identified (Schütz et al., 2006) . In this project differential expression of miRNAs and mRNAs was investigated in the same DCIS/IDC breast cancers and pure DCIS fixed in formalin and embedded in paraffin (FFPE).

Objective: (1) Identification of miRNAs and their target mRNAs differentially exrpessed between DCIS and IDC;

(2) Identification of a miRNA/mRNA set to characterize aggressive DCIS with a high invasive potential. Materials and methods: Bioinformatic analysis using support vector machine and principle component analyses was applied to extract a prognostic gene set from the set of differentially expressed genes and qRT-PCR validation was carried out on micro-dissected FFPE epithelial cells. Additionally, microarray technology was applied for mRNA/miRNA expression analysis. Results: We obtained a 9-gene progression set which is able to correctly classify DCIS and IDC in 23 out of 24 cases (95.8%). Eight of the 9 possible marker genes were correctly validated in FFPE tissues. Further, expression of these genes also varied between pure DCIS and DCIS areas of DCIS/IDC mixed tumors-expression validation is currently done with qRT-PCR. Nineteen miRNAs were differentially expressed between DCIS and IDC, of which 4 had already been described in tumors. These 4 miRNAs have binding sites on 5 of the 9 candidate genes.

Conclusions: A small gene set of potential progression markers obtained by microarray analysis of native breast carcinomas was successfully validated on FFPE tissues. In addition, a set of targeting miRNAs was identified that might thus serve as prognostic markers. Further analyses are still ongoing.

PO-Onko 03.82 Simultaneous breast reconstruction following mastectomie: multidisciplinary approach improves both, aesthetic result and tumour control The timing of breast reconstruction following mastectomie has been an area of controversy. Immediate breast reconstruction allows the patient to adjust to the loss of a breast by restoring her body image. However, simultaneous reconstruction has not been widely accepted due to concerns about interference with locoregional recurrence control and possible delay in adjuvant chemotherapy or radiation. A video presentation of a Deep Inferior Epigastric Artery Perforator (DIEP) Flap will serve as introduction of an approach, where all cases with local advanced breast cancer are considered for skin or nipple sparing mastectomy and simultaneous breast reconstruction. Every case has been discussed in a multidisciplinary breast team including pathologists, radiologists, gynecologists, reconstructive plastic surgeons, and medical and radiation oncologists. Special attention has been given to the main factors involved in the decision making process, such as type, stage, and location of the tumour, the necessity for adjuvant therapy, the techniques used for breast reconstruction and follow up data. All patients with local advanced invasive or in situ breast cancer, where mastectomy is indicated to obtain optimal tumour control should be considered for immediate breast reconstruction after individual multidisciplinary discussion and counselling. With an multidisciplinary approach, immediate breast reconstruction is the method of choice without loss of locoregional recurrence control or delay in adjuvant therapy in the majority of cases. Conclusions: In 25-40% with patients under age of 35 years breast cancer originates hereditary. 50% of family cases are due to hereditary breast cancer genes, BRCA1 or BRCA2, that normally go along with a worse prognosis. Several in vitro, in vivo as well as clinical analysis have shown differences in chemosensitivity between BRCA1/2 derived tumors in comparison to sporadic variants but there has been no clear guidelines for mutation carriers. Neoadjuvant chemotherapy has its place in non-metastatic situations in order to decrease tumor bulk ideally to a complete pathological response. An in vivo response to chemotherapy in a neoadjuvant setting is monitored due to regular clinical as well as imaging appearance and could allow an individual chemotherapeutic adaption depended on response in future. The knowledge of mutation status and its difference in chemosensibility has not yet influenced chemotherapy protocols.

Multivariate analysis identified tumor involvement of the middle abdomen and peritoneal carcinomatosis as independent predictors of complete tumor-resection. Conclusions: Postoperative tumor-residual-disease remains the strongest predictor of survival even in TCS-setting. To identify the optimal candidates for TCS, the predictive value of ascites and peritoneal carcinomatosis should be confirmed by future prospective trials.

PO-Onko 03.88 Immunhistochemical analysis for expression of Calpain 1, Calpain 2 and calpastatin in ovarian cancer Objective: Calpains, are intracellular, non-lysosomal cytoplasmic cysteine endopeptidases. Their endogenous specific inhibitor is cilastatin. The calpain system plays an important role in many processes including apoptosis, necrosis, ischemia formation and exocytosis. So far, there exist many reports on studies about the influence of calpains in different tumors (skin, breast, renal cell or prostate cancers), but there are no studies on calpains being involved in the pathogenesis of ovarial cancer. This was the goal of this work. Materials and methods: The tissue samples consisted of 21 ovarian cancers and 15 non-cancerous tissue samples. The tissue was embedded in paraffin blocks. For representation of Calpain 1 and Calpastatin monoclonal antibodies were used, which were obtained from ascites fluid of mice. Calpain 2 has been shown with polyclonal antibodies, which were obtained from antiserum of rabbits. Results: We evaluated the correlation between enzyme expression in malign and benign ovarian tissues. In malignant ovarian tissue, we found a decreased expression, staining intensity and immunoreactive score of cilastatin. With higher grading of the ovarial carcinoma, staining intensity and immunoreactive score of Calpain 1 decreased. Staining intensity of Calpain 2 in ovarial carcinoma was decreased with increasing lymph node status. We clearly demonstrated differences between enzyme expressions in malign and benign tissue.

Conclusions: This study could not find any specific function of calpains in patients with ovarian cancer. Only few studies in literature have been found to deal with calpain evaluation of ovarial cancer. Additional studies including more patients are required to elucidate the functional role and impact of calpain in tumors. Objective: Intratumoral regulatory T cells (Treg) correlate with reduced overall-survival in patients with ovarian carcinoma. Intratumoral expression of the chemokine CCL22 serves as a mechanism for the attraction of Treg to the tumor site. In the present study we investigated which cells in the tumor are responsible for the production of CCL22 and thus for the attraction of Treg. Materials and methods: Tumor-infiltrating immune cells were isolated from freshly resected human epithelial ovarian cancers and cultured in vitro for three days followed by measurement of CCL22 in the supernatants. Furthermore CCL22 levels were determined in the supernatants of different ovarian cancer cell lines. Results: We detected high levels of CCL22 in the supernatants of tumor-infiltrating immune cells. In contrast, no secretion of CCL22 was observed by any of the analyzed tumor cell lines (OVCAR-3, COV18, CaoV-3, OV-1). The supernatants from tumor-infiltrating immune cells were capable to attract Treg in vitro, showing that tumor-infiltrating immune cells rather than the cancer cells themselves may be involved in the attraction of Treg to the tumor tissue.

To determine which population of immune cells is responsible for CCL22 secretion we isolated CD14+ monocytes from freshly resected tumors. Interestingly, CCL22 was detected in the supernatants of the intratumoral CD14+ monocytes, but not in the CD14-depleted fraction of tumor-infiltrating immune cells. By staining CCL22 histologically, we could show high levels of CCL22 in ovarian carcinoma tissue. Serum of ovarian carcinoma patients also contained an elevated level of CCL22. PO-Onko 03.91 Long time results of 1131 women with ovarian cancer: results of the multicenter tumour register of the tumour centre of Berlin during tumor development (e.g. oxalate). Moreover, IL 6 seems to be associated with the progression of the disease. IL 8, 18, 20 and 21 could also show a correlation with respect to the amount of metastasis. The steroid hormones estrogen, testosterone, androstendione, DHEA and DHEA-S are known substances with involvement in tumorigenesis. We aim to reveal a possible clinical relevance of the above mentioned biochemical markers in breast cancer patients, taking into consideration the clinical status and the established tumor marker CA 15-3. Materials and methods: The samples of serum were taken from 54 patients of our clinic. The detection of the tumor marker CA 15-3 was done using the LIA-methode. Oxalate was detected via a chemiluminescence method. The detection of the cytokines was performed with the ELISA method. DHEA, DHEA-S, androstendione and testosterone were detected with a radioimmunoassay, estrogen with a chemiluminescence immunoassay. Results: Oxalate: The tumor free group (mean = 20.88 lmol/l) showed a significant difference compared with the group of 3 to 4 metastasis localizations (mean = 16.24 mol/l) (mean difference = 4.64 mol/l/p = 0.033). IL 6: The tumor free group (mean = 0.13 pg/ml) showed a significant difference compared with the group of 1 to 2 metastasis localisations (mean = 6.97 pg/ml) (p \ 0.0005) and the group with 3 to 4 metastasis localisations (mean = 10.00 pg/ml) (p \ 0.0005). A statistical difference between the groups of different amounts of metastasis localizations could also be observed (p = 0.087) (Mann-Whitney-Test).

Conclusions: Oxalate showed during progression of the disease an inverse correlation compared to CA 15-3. Independent of inflammatory conditions the serum concentration of IL 6 increased during tumor progression.

PO-Onko 03.98 Clinical examination, ultrasound and magneticresonance-imaging are sufficient for diagnosing the Mayer-Rokitansky-Kü ster-Hauser-Syndrome Materials and methods: The microbiological results of tubal swab specimens are compared with those from cervical swabs of patients with laparoscopically diagnosed salpingitis. C.t. was identified by means of PCR and/or LCR. Results: Between 1/94 and 12/09 342 patients out of 1188 with suspected PID were laparoscopically diagnosed to suffer of acute salpingitis, 95 due to C.t. (n = 342): cervix 46 + 4*, tubes 66, tubes only 27 + 18**, all 95 (*cervix specimen only; **tubes specimen only).

Conclusions: The difficulty in gaining access to the fallopian tubes is the major obstacle in microbiologic evaluation of salpingitis, however, a large proportion of C.t. positive cases would be missed not performing laparoscopy.

PO-Onko 03.101 A comparison of dequalinium chloride vaginal tablets (FluomizinÒ) and clindamycin vaginal cream in local treatment of bacterial vaginosis Materials and methods: A 36 year old Gravida II Para I with an hitherto inconspicuously developing gravidity was hospitalized in week 28 of gestation with premature contractions (without cervical shortening). A lung maturation was induced. Kidney pains and normal urinalysis led to a renal sonography. It showed a renal calcinosis. On enquiry the patient complained about fatigue, polydipsia and polyuria. The clinical pattern revealed hypercalcaemia, hypophosphataemia, calciuria and anaemia with increased levels of parathyroid hormone (PTH). Sonography stated an adenoma-suspect finding parapharyngeal, possibly explaining the pHPT. Different therapy-options were discussed on an interdisciplinary level with the patient. Due to the risks of a severe neonatal hypocalcaemia as a consequence of a postpartal secondary hypoparathyroidism of the infant, an operative exploration of the parathyroid glands was indicated. An adenoma of the parathyroid gland was removed without any complications.

Operative the PTH normalized. Serum calcium regularized with oral calcium-and vitaminD3-substitution. Nine days after surgery the patient was released into ambulant care.

Conclusions: The therapeutic options of pHPT during gravidity are limited. Conservative treatment is confined to hydration and calcium restriction with frequent clinical follow-ups, medicinal therapy is limited: relatively contra-indicated are diuretics, contra-indicated are bisphosphonates, not approved during gravidity are Cinecalcet and Calcitonin. Few case studies show that PTE, done in the second, but also in the third trimenon often seems to have less complications than the conservative management of pHPT.

PO-Onko 03.104 Ileal conduit and continent Ileo-cecal pouch for patients undergoing pelvic exenteration *Dirk Michael Forner 1 , Bjoern Lampe 1 1 Kaiserswerther Diakonie, Department of Gynaecology and Obstetrics, Düsseldorf, Germany

Objective: Over the last years creating a continent urinary pouch has become an alternative to the ileal conduit for patients undergoing exenteration for advanced gynecologic malignancies. Materials and methods: In this study we compared intra-and postoperative complications and Quality of Life scores for the modified ileo-cecal-pouch and the ileal conduit in anterior or total pelvic exenteration.

Results: In 31 out of 85 patients an ileal pouch (IP) was created, the other 54 were treated by an ileal conduit (IC). Creating and IP prolonged the exenterative procedure by 88 min. compared to fashioning an IP (IC = 462 min. vs. IP = 550 min.; p = 0.009). Overall complication rate was similar but patients with an IP suffered significantly more complications of urinary diversion (n = 15; 48.4%) than patients with an IC (n = 15; 27.7%; p = 0.03). The SF 12 score estimating quality of life was significantly better in the IP group (IC: median 56 vs. IP median 81; p = 0.01).

Conclusions: A continent IP is an alternative to the IC in cases of pelvic exenteration. Early complications are less frequent than with an IC but quality of life is better with an IP.

The effects of a TVTR and the TVTO on the pelvic floor and the musculoskelettal system Objective: According to current studies approximately 10-41% of the female population suffers from stress incontinence (SUI). After exhausting all conservative measures for treatment and clear indication the TVTR or TVTO are the preferred operative interventions. Current publications frequently compare the two surgical options and also describe the occurrence of postoperative pain in the adductor muscles. None of the investigations looked at pre-and postoperative functional status of the musculoskeletal system. Question: What are the effects of the TVT and the TVTO on the musculoskeletal system regarding the quality of life (QoL), the strength of the pelvic floor muscles and the musculoskeletal system in general?

Materials and methods: The study was prospective and randomized with N = 70 of which 37 patients received a TVTO and 33 patients a TVT. Pre-surgery diagnostic was done. On the day of pre-medication for the surgery and six weeks post operatively a physical therapy evaluation was done which included the following: evaluation of posture and mobility of the spine, diaphragmatic breathing, strength testing of the pelvic floor muscles and manual tests of the pelvic girdle. All patients suffered from a verified dominant 2nd degree SUI.

In addition a visual analog scale (VAS) was used for measuring the QoL. A perineal sonography was done the digital grading of pelvic floor strength using the Oxford and Laycock grading scale. Objective: Vaginal sacrospinal uteropexy is supposed to be a secure, time sparing and effective option in prolapse surgery. Materials and methods: Retrospective analysis of 35 patients with at least stage II genital prolapse (according to ICS classification). Patients were operated with vaginal sacrospinal uteropexy, accompanying cystoceles and rectoceles were corrected simultaneously by using traditional techniques. Postoperative prolapse and clinical examination were classified by the Pelvic organ prolapse quantification system (POP-Q), approved by the International Continence Society (ICS) and the American Urogynecology Society (AUGS). In addition, patients completed a standardised questionnaire about urinary and anal incontinence, sexuality and quality of life. Results: More than 50% of the patients have been examined in this ongoing study postoperatively up till now. Objective results are promising, patients satisfaction is very high. Exact data concerning prolaps stage before and after surgery and subjective outcome will be presented later. Objective: The intussusception of the rectal and/or sidmoidealmucosa represents a longitudinal descensus of the rectosigmoid (inner rectal mucosal prolapse). The unidisciplinary correction of only one of these combined defects often ends in unsatisfactory or insufficient results, which include residual problems or recurrent prolapse. The combination of rectal mucosa intussusceptions and vaginal prolapsed particularly favours an interdisciplinary approach Materials and methods: 18 patients were operated on rectosigmoideal intussusceptions symptomatic with stool outlet obstruction and vaginal prolapse grade III-IV or recurrent prolapse grade II (POP-Q/ICS). Median age was 62 years. The resection rectopexy is conducted by laparoscopy. The vaginal mesh-colposuspension (Prolift Ò , Ethicon Gynecare) is carried out according to the technique which has been developed by the French TVM Group. Postoperative follow up was done at 12 and 36 months. Results: Outcome: 15/15 patients after 36 months were healed from vaginal descensus following the anatomical criterias (POP-Q grade 0-I°). 2 patients reported local discomforts. 1 patient had a current rectocele as reported at the follow up trial after 12 months showed a reduction to POP-Q Grad I°after 36 months. 14/15 Patientinnen were without symptomatical intussusception or defecal obstructions. 1 patients complained discomforts, declaiming optional surgery. 1 patient showed tissue erosion at the vaginal ending after discontinuing hormone therapy after 6 months with spontaneous remission after refreshing local therapy. 2 patients are lost to follow up. Conclusions: Interdisciplinary approach by abdominal surgeons and gynecologists does not involve a higher peri-operative risk for the patient. In this small treatment sequence there was no infection that required surgical intervention nor any insufficient anastomosis. The success rate of 93% is an encouragement for positive long-term results over 36 months.

PO-Repro 03.01 Advanced procedures for the analysis of follicular fluids Objective: The analysis of oocytes before fertilization is restricted to morphological aspects. Therefore, we aimed to establish new methods for the analysis of follicular fluids (FF) and granulosa cells (GC). Materials and methods: We analyzed 112 FF and 18 serum samples by Surface Enhanced Laser Desorption Ionisation-Time Of Flight (SELDI-TOF) mass spectrometry is a further advanced method to reduce overlapping signals from different substances. Furthermore, we analyzed more than 60 GC immediately after isolation or after up to 10 days of culture by multiplex single cell PCR plus several samples of 2 or more GC for the expression of inhibin A, inhibin B, insulin-like growth factor binding protein 1 (IGFBP1), IGFBP4, IG-FBP5, anti-Mulerrian hormone (AMH), AMH receptor (AMHR) and CD45 (control for lymphocyte exclusion). Results: By using IMAC copper protein chips for SELDI-TOF, 28 high signal proteins ([10 lA) were detected exclusively in serum and 16 exclusively in FF. Further 4 proteins have been detected in almost all FF, but in only 13-35% of sera samples. Approximately 80% of GC expressed IGFBP5. The other genes were expressed less frequently. After 10 days of culture GC expressed up to 5 out of the analyzed genes, while GC from short term culture did not express more than 2 genes. The combination of expressed genes was very variable and no preferential pattern could be detected yet.

Conclusions: FF specific proteins may serve as a new tool for prognostic evaluation of follicle and oocyte quality with respect to fertilization and implantation. Presence of proteins which should be absent in FF may be used for blood contamination control or may indicate pathologic processes. Gene expression in individual GC is very inhomogenous. The level of variability or the dominance of specific patterns may become an indicator for follicle and oocyte quality.

PO-Repro 03.02 AKT phosphorylation and insulin/growth factors I-II receptors gene expression modulation in decidualized endometrial stromal cells and the potential effect of metformin Objective: Insulin and the insulin growth factors I and II play an important role in the fetomaternal interaction during implantation. Through their paracrine signalling pathways decisive signals for nidation are exchange between the embryo and the maternal cells.

Metformin, an anti-diabetes drug, can potentially influence this mechanism and is often used in anovulatory women with polycystic ovaries. To assess the local metformin effect on AKT phosphorylation and insulin/IGFI/IGF II receptors expression in decidualized endometrial stromal cells (ESC) after stimulation with insulin, IGF I and II. Materials and methods: ESC were obtained and isolated from healthy, regularly cycling women (n = 5). After two passages cells were decidualized with estrogen and progesterone with or without metformin. Then cells were incubated with insulin, IGF I or IGF II for 5, 10 and 20 min to assess AKT-phosphorylation by Western blot. In order to assess insulin, IGF I and IGF II receptor gene expression in ESC realtime PCR was performed after stimulation with insulin, IGF I and IGF II for 6 and 24 h. Results: We demonstrated statistical significant phosphorylation of AKT after 5 min insulin, IGF I and IGF II stimulation in ESC in both control (control 0.0819 ± 0.031 vs insulin 0.737 ± 0.189, IGF1 0.678 ± 0.220, IGF2 0.526 ± 0.132, p \ 0.05) and metformin (control 0.035 ± 0.013 vs insulin 0.747 ± 0.111, IGF1 0.738 ± 0.146, IGF2 0.673 ± 0.094, p \ 0.05) cells. However, there was no difference between ESC treated with or without metformin. Each receptor gene expression changed significantly after addition of insulin, IGF I and IGF II in control with minimal changes after metformin pretreatment. Conclusions: Insulin, IGF I and IGF II induce AKT phosphorylation and lead to changes in the gene expression of their receptors in ESC.

two-arm, parallel group trial with a primary study phase of 12 months and subsequent 60 months follow-up. The program is sponsored by AstraZeneca Germany and supported by breast cancer advocates. Postmenopausal women on anastrozole for hormone-receptor positive (HR+) EBC were randomized to routine clinical care alone or additional standardized information for the first 12 months of adjuvant therapy. Primary endpoint is the compliance rate after 12 months. Secondary endpoints include reasons for non-compliance, influence of baseline characteristics, and clinical outcome parameters. Compliance is evaluated via patient questionnaires, prescription data and physician recall

Materials and methods: Retrospective analysis of calculated DRGrevenues for material expenses for implants from DRG-Browser 2007/2009HA, issued by InEK, and comparison with actual costs of the OB/GYN department for implants in 2009 from annual report and eisTIK-data base of the controlling department. Calculation of relative cost-coverage for implants by number of DRGs J06Z or J16Z performed multiplied with DRG-calculated material expenses for implants divided by implant costs for 2009. Results: At our institution n = 98 J06Z and n = 18 J16Z were performed in 2009. DRG-calculated material expenses for implants were 69.65€ for each J06Z and 123.07€ for each J16Z, a total of 9

The objective of this study was to compare the APTIMA HPV assay (AHPV; Gen-Probe Inc.) that detects E6/E7 mRNA from 14 high-risk types and the Hybrid Capture 2 HPV DNA test

Materials and methods: A total of 424 clinical specimens were included in this study, stored in liquid based cytology (LBC) vials at room temperature for up to 3 years and then tested by both AHPV and HC2. Specimens processed with the HC2 test that yielded no pellet after centrifugation and were HC2 negative were excluded to avoid bias against HC2. Assay results were compared to each other and to cytology and histology. Results: The overall agreement between AHPV and HC2 was 88.4%. The sensitivity (specificity) of AHPV, HC2, and cytology for the detection of CIN2+ was 92

Feasibility of simultaneous radio-chemotherapy in cervical cancer: implementation of standards in daily routine in a tertiary gynecologic oncology unit *Nina Ewald-Riegler 1

Materials and methods: ERBB2 regulated Bcl-2 family members were identified by inducible expression of ERBB2 in MCF-7 breast cancer cells and by correlation analysis with ERBB2 expression in breast carcinomas. The prognostic relevance of ERBB2-regulated and all additional Bcl-2 family members was determined in 782 untreated node-negative breast cancer patients. The biologic relevance of ERBB2-induced inhibition of apoptosis was validated in a murine tumor model allowing conditional ERBB2 expression. Results: ERBB2 caused an anti-apoptotic phenotype by upregulation of MCL-1, TEGT, BAG1, BNIP1 and BECN1 as well as downregulation of BAX, BMF, BNIPL, CLU and BCL2L13. Upregulation of the anti-apoptotic MCL-1 (P = 0.001, HR = 1.5) and BNIP3 (P = 0.024, HR = 1.4) was associated with worse prognosis considering metastasis-free interval

Materials and methods: Of the 295 pts, 103 were PPS. Three trabectedin schedules were studied: 0.58 mg/m 2 3-h weekly 3xq4w, 1.3 mg/m 2 3-h and 1.5 mg/m 2 24-h q3 weeks, administered to 41, 34 and 25% patients, respectively. Efficacy and safety of patients are reported. Results: Baseline characteristics: median age 58 years (35-80), ECOG PS0/1: 72%/27%; papillary/serous histology 76%

The most common adverse events were neutropenia and transaminase elevations, which were manageable and without serious clinical consequences. Conclusions: Trabectedin monotherapy is active in patients with ROC, including patients with PPS disease (PFI: 6-12 months), with a 30% ORR plus 40% SD, with a median TTP of 5.3 months. Activity was retained in pts with liver metastasis, with 36% ORR and almost identical TTP. These single-agent results support the findings of the randomized phase III trial OVA-301 where trabectedin + PLD demonstrated superior clinical benefit over PLD alone in the overall population

Materials and methods: We systematically evaluated all consecutive patients undergoing TCS. Tumor-dissemination-pattern, operativemorbidity, tumor-residuals and survival are described based on a validated intraoperative documentation-tool. Predictors of survival and complete tumor-resection are analyzed with Cox-regression or logistic-regression-models. Results: Between 10/2000 and 12/2008, 135 patients (median-age: 51 years; range: 22-80) of mainly initial FIGO-stage CIII (106 patients;78.5%) were evaluated

Materials and methods: Patients with stage IIIC-IV OVCA presenting with C500 ml ascites underwent laparoscopy for biopsy to receive IDS (n = 74) after 2-3 courses of platinum-based chemotherapy (CT), completing courses to a total of 6 after surgery. Clinical outcomes were noted. Results: 61 patients were staged FIGO IIIC, 13 FIGO IV. Median follow up was 22 months (range 3-67 months). PFS was 16 months (95% CI 11-21 months). OS was 34 months (95% CI 21-46) (FIGO IIIC: 17 and 37 months respectively)

Vivantes Campus Auguste-Viktoria

We report on the first analysis of epidemiological and outcome data derived from the clinical cancer register of the Tumour Center Berlin consisting of eight centers in Berlin. All together 1131 patients have been evaluated. The median age of the patients with ovarian cancer was 61 years

During the observation period 241 patients died. The 3-year survival was 60%, the median overall survival was not reached yet. The survival rates correlated significantly with the FIGO stage and pathological tumor stage

Materials and methods: Patients had been primary diagnosed and treated for ovarian cancer at our institution between 1990 and 2002. Patient characteristics and histological data including histological subtype, tumor stage and grading and follow-up data were available. Immunohistological staining was performed to determine LH and FSH receptor expression. Correlation analysis for the receptor expression was applied for histological subtype, tumor stage, grading and clinical data. Statistical significance was assumed at p \ 0.05. Results: Paraffin embedded tissue of 156 ovarian cancer patients was available. Most patients had presented with progressive disease at primary diagnosis [FIGO I: n = 35 (22.6%)

Conclusions: The LH and FSH receptor are often expressed in ovarian cancer tissue. Both receptors have prognostic significance and can be used for the choice of adjuvant treatment. Since they are specific for ovarian tissue, they may serve as targets for new cancer therapies

Natural HLA-ligands provide novel T-cell antigens for immunotherapy of ovarian carcinoma

Among the 83 identified HLA-ligands were several peptides derived from established tumor antigens or proteins linked to tumorgenesis. Peptides corresponding to these sequences were synthesized, loaded onto dendritic cells and B cells and used to stimulate peripheral blood mononuclear cells (PBMC) of healthy donors. After 4-6 rounds of stimulation, peptide-specific CD8+ T-cells were identified by intracellular cytokine staining. Results: So far, five HLA-ligands induced peptide-specific interferongamma production, suggesting they represent novel T-cell epitopes. CD8+ T-cells specific for two novel epitopes (Tho complex 4 (THOC4) and HLA-B associated transcript 3 (BAT3)) were multifunctional, expressing also TNF-alpha as well as CD107a. Conclusions: These results suggest that analysis of HLA-ligands from tumor samples may

Battista 1 , Marcus Schmidt 1 , Nicole Zabel 1 , Martina Mahlke 1 , Daniel Bo¨hm 1 , Gert Naumann 1

The results of 2006 and 2009 were compared using Fisher's exact test. The results were correlated with the departments' number of beds (NB) and number of cases of EC (NC) calculating quartiles and Pearson's chisquare test. The results concerning LNE were compared to the guideline of AGO. Results: 258/775 (33.3%) responses in 2009 and 179/500 (35.8%) in 2006 were available. LSC was performed more often in 2009 as in 2006 (21.1% vs. 11.4%, p = 0.012). LSC is more often used by NB [ 69 and NC [ 29 as by NB \ 40 and NC \ 16 (2006: 8.1% (NB \ 40) vs. 34.7% (NB [ 69), p = 0.01). Pelvic LNE was performed independently of NB and NC according to guideline in 2009 and

Objective: To evaluate whether vaginal application of non-absorbable dequalinium chloride (dequalinium) is as efficient as vaginal clinda

Slovakia and Switzerland in accordance with the Declaration of Helsinki and the Guidelines on Good Clinical Practice. Clinical cure based on the Amsel's criteria (absence of clue cells and a negative result for at least 2 other criteria) was the primary outcome variable at one week and one month after treatment. Secondary outcome variables included among others rate of treatment failures and recurrence

A trend to less common post-treatment VVC in the dequalinium chloride group as compared to the clindamycin group was observed. No serious adverse events and mainly local events were observed. Conclusions: This new treatment with vaginal tablets containing 10 mg dequalinium chloride (Fluomizin) shows equal efficacy as clindamycin 2% cream, is well tolerated, and is a valid alternative treatment for women with BV, even in pregnancy as dequalinium chloride absorption is negligible. The broad antimicrobial spectrum of dequalinium chloride can offer a stronger benefit for patient, particularly as there is no defined causative microorganism and no microbiological diagnosis for BV. Also there is a decreased likelihood for Candida infection after treatment when compared with clindamycin. PO-Onko 03.102 Influence of protein-isolates on the proliferation and cytotoxity of mammacarcinoma-cells and healthy cells *Stefanie Duda 1

BrdU-test: high proliferating (70-200%) effect of all 3 lupin types (at 70, 35 lg/ll). Lower concentrations: 0-20% proliferation pH did not change MCF-7: LDH-test: no cytotoxity MTT-test: about 15-25% proliferation at 35 and 70 lg/ll, inhibition up to 20% at lower concentrations. BrdUtest: low proliferative effects (Probor: about 5%), pH did not change. BT20: LDH-test: 8-17% cytotoxity at 70 lg/ll, lower concentrations: no cytotoxity MTT-test: lupin Boregine: at 70 lg/ll about 10% proliferation, lower concentrations up to 30% inhibition. BrdU-test: 60-150% proliferation at 70 and 35 lg/ll pH stayed the same. Conclusions: Interesting for patients with connective tissue-softness

Primary hyperparathyroidism with parathyroidectomy in the third trimenon: a case report

Objective: Surgical outcome in AOC is the most important prognostic factor. We report our results before and after introduction of a quality management program (QM) in AOC in 2001. The QM included: OP by dedicated surgical teams only, routine interdisciplinary pre-OP consultation, 2nd opinion intra-OP before closure in all patients with any macroscopic residuals deemed inoperable, and annual quality conferences. Materials and methods: Analysis of 396 patients with primary surgery for AOC FIGO IIB-IV in our institution (1997) (1998) (1999) (2000) (2001) (2002) (2003) (2004) (2005) (2006) (2007) (2008) . Results: Between 1997-2000 19/51 patients (37%) had complete debulking. This rate increased to 51% in 2001-2003 (n = 86) and 64% in 2004-2008 (n = 259) . The corresponding rates of debulking to B1 cm residual tumor were 72, 87, and 90%, respectively. The utilisation of extended surgical procedures increased over time, e.g. bowel resection (33-67%), splenectomy (4-18%), diaphragmal stripping (2-44%), and paraaortic lymphadenectomy (29-81%). Patients with complete resection had 5-YSR of 57% (median OS = 68 months) compared to 15.7% (median OS = 30.7 months) in patients with residuals 1-10 mm, and 15.1% (median OS = 17 months) in patients with residuals [1 cm (p \ 0.001). The median OS increased from 30.7 months 1997-2000 to 37.0 months 2001-2003 and 53.3 months in 2004-2008 (p = 0.049) . Conclusions: Optimizing surgical skills and introduction of QM improved surgical and overall outcome. However, centralization effects were observed in parallel indicating that cluster effects and volume-training aspects might have contributed to this evolution. Further analysis will focus on evolution of morbidity rates over time as well.PO-Onko 02.98 Primary therapy of malignant ovarian tumours.

Objective: Suburethral slings achieve excellent success with high continence rates in stress urinary incontinence. Conventional retropubic or transobturator tapes actually are preferred by most surgeons, but shows side effects and complications because of the blind passage of the tape. The sling AjustTM has eliminated the need for blind trocar passing, utilizing a single vaginal incision and a push-in technique and allows a post-insertion bi-directional adjustability (loosen and tighten) after strong anchoring in obturator membrane. This study evaluates the efficacy and safety of this new procedure with 1 year clinical outcome. Materials and methods: In our prospective, single-arm, observational study 52 patients with a mean age of 62.8 years (range 39-88 years.) were treated from November 2008 to March 2009 with AjustTM in 4 centres. Each patient had a fully urogynecological assessment. Quality of Life was to be assessed using Kings Health Questionnaire, Patient Perception of Intensity of Urgency Scale, Visual Analog Score for pain and global satisfaction and short form of UDI 6 and IIQ7. Results: These are first results after 1 year of 52 patients. All but 1 (98.1%, 51/52) of the Ajust Sling placement procedures was initially successful, changing in 1 case intraoperatively to TOT system. No complication of bleeding [200 ml, bladder lesions, erosions, perforations, hematomas or bladder outlet obstructions occurred during the period covered by this analysis. Overall, out of the 50 subjects who successfully received the Ajust Sling, 48 subjects demonstrated total restoration (86.5%) of their continence, 1 subject demonstrated improvement (2.0%). Conclusions: First results showed a high efficacy with excellent continence rates because of the strong anchoring in the obturator membrane and no severe side effects in fact of using a small mini-sling and possibility of bi-directional adjustability after insertion. Further prospective studies with a longer follow-up have to prove the high efficacy.PO-Gyn 03.03 Reoperation for pelvic organ prolapse within 10 years of primary surgery for prolapse Objective: During the past few years, a variety of high frequency sealing devices for vessel ligation has been introduced. So far, the vast majority of these devices are disposable. The purpose of this study was an in-vivo comparison of efficacy of the new reusable vessel sealing device MarSeal Ò (MS) with the conventional standard disposable LigaSure Ò (LS) device in an animal model.

In 13 sheep, the carotid and femoral arteries were dissected bilaterally and sealed randomly with MS unilaterally and consecutively with LS contralaterally in-vivo. Afterwards the burst pressure was determined for each artery. Study endpoints included sealing time, failure rate, and burst pressure. Students t test for continuous and chi-square test for categorical variables were used and p \ 0.05 was considered statistically significant. Results: The mean diameter of all arteries sealed did not differ significantly between both groups (MS 5.40 mm vs. LS 5.35 mm, p = 0.79). The mean sealing time was significantly shorter using the reusable device (MS 5.2 s vs. LS 9.1 s, p \ 0.0001). With respect to sealing failure rate, we did not find a significant difference between both groups (MS 7.0% vs. LS 9.1%, p = 0.28). In addition, analysis of mean burst pressure did not reveal a significant difference between the different devices (MS 429 mmHg vs. LS 484 mmHg, p = 0.16). Conclusions: In our in-vivo animal study, the new reusable MS device appears to be equivalent effective for vessel sealing when compared to the conventional disposable LS device. Objective: A sufficient margin assessment when excising a DCIS of the breast is difficult. Frozen section is unreliable and intraoperative radiography of the specimen gives only information about the size of the noticed lesion or the microcalcifications. This trial was conducted to study the benefit of a novel device (MarginProbe Ò , Dune Medical Devices. Ltd.) in intraoperative margin assessment for BCS of DCIS and the associated reduction in re-operations. Materials and methods: A multi center, single arm study was conducted to determine the added benefit of the device use. The device was used as an adjunctive tool to the current practice. The surgeon received real time device output and reacted surgically intraoperatively. Based on the permanent histology report outcome, the added benefit of device use is demonstrated. Analyzed were the first 16 pts. enrolled in our institution (Sept. 2009 -March 2010 . This preliminary analysis was done because of the excellent results. The final analysis might be presented at 58th DGGG meeting. Results: Patients who benefit from MarginProbe Ò were analyzed (9/16). Device use was associated with improved correct surgical reaction, defined as patients in which all histologically detected positive margins on the main specimen were identified by the device and resected intraoperatively. In 55% (5/9, 55%) a repeat operation was avoided, in 2 pts. the device did not detect all positive margins (2/9, 22%) and two patients turned out to have invasive cancer (2/9 22%). Conclusions: Intraoperative use of the MarginProbe Ò for positive margin detection is safe, fast and effective in BCS and decreases the rate of repeat operations by 55%.

Objective: Simultaneous radio-chemotherapy (SRCT) is standard of care for locally advanced cervical cancer. Achieving adequate dose intensity as established in several studies is essential for treatment success. Our aim was to evaluate compliance with study driven standards in clinical reality in a general patient population. Materials and methods: Retrospective analysis of all patients with cervical cancer in our tumor registry between 2000 and 2007, treated at our institution with SRCT. Patients with FIGO IB2-IIIB (primary) or FIGO IA1-IB1 with adjuvant therapy due to postoperative upstaging, positive lymph nodes, lymphangiosis or G3 adenocarcinomas were included. Results: 77 Patients, scheduled for SRCT were included. 31 of these patients were planned for primary, 46 patients for adjuvant radiochemotherapy (RCT). 74%, respective 76% of patients in both cohorts (primary/ adjuvant) received full planned dose-intensity. 6 patients never started and 14 patients discontinued RCT: 10 for medical, 4 for personal reasons. Out of these 14 patients, 11 patients achieved full radiation dose and 2 of them received at least 34.2 Gy; 13 patients completed at least 2 cycles of chemotherapy. After 52 months of median follow-up we observed 8 recurrences in the adjuvant group: 2 (25%) of them with incomplete primary therapy. 11 recurrences of whom 3 (27%) had incomplete therapy in the primary treatment group. 5-year-survival after adjuvant treatment was 75% and 45% after primary RCT. 1 Otto-von-Guericke University Magdeburg, Oncology, Magdeburg, Germany, 2 Lublin Medical University, 3IIND Department of Gynecology, Lublin, Poland, 3 Otto-von-Guericke University Magdeburg, Pathology, Magdeburg, GermanyObjective: This study was undertaken to evaluate the potential role of G-protein-coupled estrogen receptor, GPR30, in endometrial pathology associated with tamoxifen treatment of breast cancer patients. Materials and methods: We investigated whether the GPR30 plays a role in mediating proliferating effect of tamoxifen in endometrial carcinoma cell lines. These results were compared to the GPR30 expression pattern in endometrial tissue from a cohort of 95 breast cancer patients, who received tamoxifen or another adjuvant therapy. Results: In vitro tamoxifen significantly stimulated the mitogen-activated protein kinase (MAPK) phosphorylation and cell proliferation of endometrial cell lines. This effect was blocked by knocking down GPR30 by specific anti-sense oligonucleotides. In vivo, there was a significant correlation between GPR30 expression and the tamoxifeninduced endometrial pathology (p = 0.006). Tamoxifen-associated endometrial pathology was observed in 40 of 58 (69%) specimens positive for GPR30 and in only 13 of 38 (24.5%) tissues immunostained negatively for GPR30. Moreover, GPR30 positivity was predictive of an earlier development of symptoms, such as bleeding or suspect endometrial thickness, induced by tamoxifen therapy (p = 0.019). Conclusions: GPR30 is more possibly an important player of tamoxifen-induced endometrial abnormalities.PO-Onko 03.59 Ovarian teratoma associated with Anti-N-Methyl D-Aspartate (NMDA) antibodies and severe encephalitis Objective: Epithelioid sarcoma of the vulva is an extremely rare and aggressive tumor, accounting for approx. 1% of all vulvar malignancies. Symptoms and growth are usually asymptomatic, therefore lesions are often mistaken for benign processes, leading to diagnosis at later stages. A case report with therapy including recurrence and follow up is presented. Materials and methods: Case report of a recurrent epithelioid vulva sarcoma from a university gynecological cancer center with follow up of 16 months. Results: A 19-year-old patient was admitted with a slowly growing, slightly painful tumor at the left labium that developed over previous 2 years before resected in 11/2008. Proximal type of an epithelioid sarcoma was diagnosed by immunohistology. Staging by CT of thorax and abdomen showed no metastases. Since R0 status was unconfirmed in first procedure e.m., second surgery was done in 02/ 2009 and a residual tumor of 1.5 cm was removed. The diagnosis of vulva-sarcoma pT1b, pN0, M0, G3, R0 with close margins was confirmed. Subsequently, adjuvant radiation with 54 + 9 Gy in the tumor region was administered from 5-7/2009. Re-staging in 7/ and 10/2009 showed no evidence of disease. In 11/2009 a suspect left inguinal lymph node was detected by ultrasound. Biopsy proved relapse of sarcoma and patient underwent inguinal and pelvic lymph node dissection with only n = 1/53 positive lymph node. Radiation of left groin was recommended but refused by patient. In 1/2010 CT revealed inguinal lymph nodes suspicious for second relapse but another biopsy performed was benign. Recent follow up in 3/2010 was uneventful. Conclusions: Complete operative resection according to guidelines is crucial for therapy of vulva-sarcomas. Surgery combined with radiotherapy offer better local control and should be considered for G3-tumors or too close surgical margins. Chemotherapy can be administered in metastatic disease with unconfirmed success. Therefore follow-ups should be done in short intervals.

Hyperthermia abrogates the Y-box binding protein-1 (YB-1) expression *Severine Iborra 1 , Markus Jager 1 , Marc Hirschfeld 1 , Gerald Gitsch 1 , Elmar Stickeler 1 1 University Hospital Freiburg, Department of Obstetrics and Gynaecology, Freiburg, GermanyObjective: The application of hyperthermia as a therapy against various types of cancer started more than 100 years ago. Nowadays, in the clinic, hyperthermia can be used concomitant to chemotherapy or radiotherapy and may improve the effect of those classical treatments. In previous projects, we investigated the expression of different splicing factors, such as YB-1, in malignancies. Overexpression of YB-1 in malignant cells has been described in various studies and YB-1 seemed to play an important role in the development of tumors as well as in the occurrence of resistances to chemotherapies. In the present study we focussed on the effect of hyperthermia at a molecular level, specifically its impact on the expression YB-1 in cancers. Materials and methods: Various gynaecological cancer cell lines were cultured under hyperthermia (2 h, 42°C) followed by maintenance under normal conditions (4 h, 37°C). RNA and protein were isolated using TRIzol Ò method and expression levels were subsequently analysed by RT-PCR and Western Blot. Results: The analyses revealed a markedly decreased level of YB-1 RNA and protein in the breast, cervical, endometrial as well as ovarian cancer cell lines treated with hyperthermia compared to the cell lines treated under normal condition. Conclusions: Our results suggest that hyperthermia could have an impact on the expression of splicing factors such as YB-1. Thus, hyperthermia might be a way to influence the progression of malignancies and could improve the response to chemotherapeutical treatments. Heinrich-Heine-University, Department of Obstetrics and Gynaecology, Düsseldorf, Germany, 2 Heinrich-Heine-University, Department of Pathology, Düsseldorf, Germany, 3 University of British Columbia, Department of Pediatrics, Vancouver, CanadaObjective: There is recent evidence that BRCA1 is required for terminal differentiation of mammary epithelial cells in vitro and in vivo probably due to direct impact on mammary stem or progenitor cell fate. Loss of apico-basal orientation and cell-cell contacts which are dependent on non-centrosomal microtubule (MT) nucleation are important step in malignant progression. Moreover, BRCA associated breast cancers show an undifferentiated ''basal-like'' phenotype suggesting that MT nucleation which requires an orchestrated interplay of MT-associated proteins is disturbed in BRCA1 tumors. We aimed to investigate the expression pattern of the MT-associated proteins phosphorylated hyaloronan receptor (pT703RHAMM) and its activating kinase aurora (AURKA) in undifferentiated breast cancers with of without inactivating BRCA1 mutations. Materials and methods: Paraffin embedded specimen from sporadic differentiated and undifferentiated breast cancers and control tissue from reduction mammoplasties were subjected to immunohistochemistry with primary antibodies targeted against pT703RHAMM and AURKA. Stained slides were scored by two blinded investigators. Results: Tumor specimen showed a homogenous cytoplasmic staining pattern of AURKA. RHAMM-phosphorylation occurred at the nuclear envelope of some nuclei, but mitotic chromosomes in pro-and meta-but not in ana-or telophase showed a strong pT703RHAMM staining. Conclusions: Whereas AURKA distribution appears to be more or less homogenous RHAMM phosphorylation occurs at the nuclear envelope in interphase nuclei, and at mitotic chromosomes in pro-and anaphase in breast cancer tissues. Differences in staining intensity and pattern between different subsets of tumours are subject to ongoing analyses.

The unfavorable prognostic effect among patients with TNBC is conserved among stratification for patient age Objective: Recurrent breast cancer is a therapeutical dilemma in cases where the recurrent disease is presenting as an inflammatory breast cancer and especially if the tumor is triple negative. On one hand there are no data about the value of systemic therapy in recurrent disease, on the other hand the situation requires neoadjuvant treatment and endocrine therapy is no option. Bevacizumab as well as Carboplatin has shown activity in triple negative breast cancer. Materials and methods: We are reporting the case of a patient who had her first diagnosis of breast cancer in the left breast in 1991 at the age of 42. She had BCT with axillary dissection, radiation and 5 y tamoxifen as a primary therapy. 2005 she developed breast cancer in her right breast, was treated with MRM with SLNB and refused any adjuvant therapy. In July 2008 she presented with an inflammatory triple negative recurrence in her left breast, the tumor diameter was 5 cm, no distant metastases were found. We started neoadjuvant chemotherapy with TAC, after 2 cycles we stopped the therapy because of progressive disease. In this desperate situation we discussed off-lable therapy with the patient and started 6 cycles of Bevacizumab/ Carboplatin. Clinically we saw a complete remission, the pathologic report after MRM in December 2008 showed a yrpTmic, with residual disease of 1 mm. We decided to continue Bevacizumab mono up to 1 year and discontinued therapy in August 2009. The patient still shows no signs of disease in March 2010 (FU 15 months). Conclusions: Therapy of triple negative inflammatory breast cancer with Bevacizumab and Carboplatin is far from being a standard. But in the desperate case of recurrent disease not responding to standard chemotherapy it may be an option and should be more thoroughly evaluated. Objective: Aim of the study was to identify novel biomarkers, which may be useful for the stratification of patients with ovarian cancer in responder and non-responder subgroups with respect to platinumbased chemotherapies in combination with gemcitabine, pemetrexed and enzastaurin.

We investigated the RNA expression of a panel of 73 candidate genes and further panel of 54,000 human transcripts using Affymetrix GeneChip analysis in the ovarian cancer cell line HEY and its drug-resistant subclones against cisplatin, etoposide, docetaxel, paclitaxel, pemetrexed, gemcitabine, TRAIL and enzastaurin that had been stimulated with 10 lM enzastaurin for 1 and 24 h, respectively. First, unstimulated naïve HEY cells were compared to each of the other chemoresistant HEY cell types in order to get possible insight into resistance mechanisms. Second, gene expression were analyzed before and after the treatment time with enzastaurin at 1 and 24 h for each chemoresistant HEY cell type, in order to identify genes that are differentially expressed under enzastaurin stimulation. Results: Interestingly, treatment with enzastaurin for 24 h led to remarkable change of differential gene expression in the most enzastaurin-sensitive cisplatin-resistant HEY subclone, but also in the enzastaurin-resistant HEYs compared to the parental and other drugresistant HEY cell lines (24 genes (39 probe-sets) and more than 30 genes (64 probe-sets)). Conclusions: These findings indicate that (i) enzastaurin may be synergistic to cisplatin and (ii) enzastaurin could be used as a second line treatment to overcome enzastaurin resistance and (iii) the newly identified genes may be used as a biomarker kit for clinical trials in ovarian cancer using enzastaurin and cisplatin. Further investigations are necessary to confirm which subset of these potential markers is best suited as accompanying biomarker for the respective drugs in clinical trials.

Objective: To explore the information needs and preferences of OC patients with special focus on doctor-patient communication we conducted the following survey in Germany. Materials and methods: A questionnaire was developed and validated in a phase-I study and was then administered to OC patients via internet (online) or as a print-version. Results: A total of 676 patients were interviewed (201 online, 475 print version). In the online group 97% had an own internet access 49% in the print group. The median age of the online group was 49 years (range 19-73), for the print group 62 years (26-92). 39% of the patients had recurrent OC. The most effective and ''patient-relevant'' source of information and explanation of treatment options was the consultation with their physician (88%). All patients judged the therapeutic consultation by their physician on a likert scala (1: very bad, 10: very well): Completeness: 8; understanding: 8; response to questions: 9; competence of physician: 10; shared decision: 9 and involvement of relatives into therapy decision: 8. When asked to suggest areas for improvement, most frequent answers were: doctors should have more time for explanations (46%); no alopecia under treatment (35%); therapy should be made to be more effective (31%). The most stated answers to ''How do you measure the success of a therapy?'' were: based on my current well-being (55%); response of the tumour marker CA 125 (45%); based on the feedback that I receive from my doctor (38%). An independent second opinion centre was desired by 70% of the patients, but only 20% know such an institution. Borderline tumours of the ovary (BOT) are rare tumour entities thateven though they can display characteristics of malignant tumoursdo not show any destructive or invasive growth in the majority of cases. BOT represent about 8-10% of all ovarian tumours, but the differential diagnosis remains difficult. The mucinous subtype can also originate from the appendix, and ovarian metastases can mimic primary ovarian BOT, often accompanied by peritoneal manifestation in terms of pseudomyxoma peritonei. In cases where a concomitant appendiceal tumour is present, it may prove difficult to determine the primary tumour. Therefore in most guidelines involving a mucinous borderline tumour an additional appendectomy is recommended as a routine surgical procedure. We present a special case with a concrete example for the complexity of the differential diagnosis of pseudomyxoma peritonei, especially if a case is simultaneously linked to appendiceal and ovarian cancer. Moreover, this case is exceptional for its unusual manifestation of BOT in the cervix. According to our information, only one other case of endocervical manifestation of a BOT has been reported so far. The fact that borderline cells were found in the endocervix indicates the ability of this tumour to form metastases outside of the abdominal cavity. Until now the widely accepted opinion is that this tumour can only spread by direct seeding. Irrespective of the place of origin, whether it is the ovary or the appendix, this mode and site of metastatic dispersal is uncommon and might indeed be capable of indicating a sign of increased metastatic activity and thus malignancy. Objective: Despite radical surgery and chemotherapy at primary diagnosis, most patients with ovarian cancer develop recurrence and die due to progressive disease. To stratify patients for optimal therapy, prognostic and predictive factors are needed. We therefore examined the role of CA-125 in this context. Materials and methods: A total of 233 patients with primary ovarian cancer who presented for surgery at our institution between 1996 and 2004 were included in this study (25% stage I/II and 75% stage III/ IV). The prognostic and predictive significance of CA-125 serum concentrations before and after surgery and correlation with clinicopathological variables were analyzed. Results: Median preoperative CA-125 in stage I/II was 61.6 kU/l (9-1867 kU/l) and 533.15 kU/l in stage III/IV (10-22617 kU/l). 67% of FIGO I/II patients had elevated CA-125 levels ([35 kU/l) before surgery and 96% of FIGO III/IV patients. There was a significant decrease of CA-125 after surgery (61.6 vs. 43.4kU/l, p = 0.001 and 533.15 vs. 92.3 kU/l, p \ 0.001, respectively). Neither preoperative and postoperative CA-125 concentration nor its decrease had prognostic relevance for recurrence and survival in any stage. Conclusions: Although CA-125 serum levels differ significantly before and after surgery in early and advanced stage ovarian cancer patients we could not find a prognostic or predictive value for this marker.

The clinical relevance of certain cytokines, steroid hormones and oxalate in mamma carcinoma patients Objective: Possible parameters for the biochemical monitoring of breast tumors are reactive C1-and C2-molecules, that are generated Objective: For the identification of genital malformations in patients with Mayer-Rokitansky-Küster-Hauser-Syndrome (MRKH-syndrome) there are the following means of diagnosis: clinical examination, ultrasound imaging, magnetic-resonance-imaging (MRI) and laparoscopy. This study compared the different diagnostic means in order to classify the genital malformations in the best way. Materials and methods: The assessment of the genital malformations was based on the VCUAM-classification. For the individual organs the following reference methods were settled: vagina-clinical examination, cervix, uterus and adnexa-laparoscopy, kidney-MRI. The study analysed the concordance of the different diagnostic methods with the reference methods in 138 patients with MRKH-syndrome. Results: The MRI did not turn out to be an ideal method for assessing the vagina when compared with the reference method of diagnosing the vagina (kappa = 0.74). It was not possible to make any substantial findings regarding the vagina using Ultrasound and laparoscopy. Because the examination results rarely mentioned the cervix separately, it was also not possible to assess the best classification of the cervix. MRI was a very good means in terms of classifying the uterus (kappa = 0.93) but also ultrasound imaging showed a high rate of agreement (kappa = 0.83). None of the imaging methods was able to achieve a sufficient classification of the adnexa. Ultrasound imaging was held to be a good method to find renal malformations in comparison with the reference method (kappa = 0.87). Conclusions: Mainly clinical examination, MRI and ultrasound are sufficient for the assessment of genital malformations in MRKHpatients. However malformations of the adnexa were not sufficiently diagnosed using both imaging techniques. In order to correctly assess the adnexa it is compulsory to perform laparoscopy which all patients receive when creating a neovagina. 

Objective: The thyroid gland has a key position in the complex endocrine system, which itself is intimately associated with the body's immune function. Autoimmune thyroid disorders, which may result in an abnormal/damaged thyroid follicular structure, are characterized by the presence of anti-thyroid antibodies (Ab). A potential relationship with impaired fertility and increased pregnancy loss has been suggested, but results of most trials are inconclusive. Materials and methods: A total of 222 women who presented for the first time in our outpatient endocrine clinic with (pre/post-)menopausal complaints (median age 49 years) were screened for thyroid function (TSH, T3, T4), and for thyreoglobulin(TG), thyroid peroxidase(TPO)-and TSH receptor(TR)-Ab using standard serum assays. The same day all patients were interviewed for previous obstet./gyn. events as part of a complete medical history. Results: Thyroid autoimmunity was detected in 22.5% (50/222) women: TG-Ab in 20.7% (46/222), TPO-Ab in 12.6% (28/222), with a significant relationship between both parameters (p \ 0.0001), TR-Ab in 1.4%. Less patients with elevated TG-Ab levels had given birth to at least one child: 47.8% (22/46) compared to 65.3% of women without TG-Ab (p \ 0.03), and 46.4% of individuals with TPO-Ab (13/28) compared to 63.9%. Significantly more women with pathological TG-Ab levels reported on previous abortions: in 21.7% compared to 9.7% in the group without TG Ab (p \ 0.03), and in 25.0% in case of elevated TPO-Ab compared to 10.4%. The prevalence of these Ab was without difference in patients \/[49 years, but TPO-Ab were more frequent in women [56 years (75% age perc.) (p \ 0.05), no relationship was found with the BMI. Conclusions: The results demonstrate that thyroid autoimmunity is very frequent in peri/post-menopausal women (TG-and/or TPO-Ab in 22.5%), and that this autoimmunologic reaction is significantly associated with a higher risk of abortion and a lower life-birth rate on retrospective analysis. Objective: Uterine contractility is important not only for labor, but also for the transport of semen and gametes, and successful embryo implantation. Uterine activity is regulated by complex and mutual interactions among sex-steroids, neurohypophysial-hormones, and neurotransmitters. It also involves the integration of many signaltransducing events, resulting in precise coordination of myometrial contractile activity. There are many uterotonic agents and also many intracellular effectors that are known to be crucial for efficient uterine smooth-muscle contraction-such as oxytocin, various prostaglandins, and muscarinic receptor-agonists. Some of these compounds are also present in seminal plasma. It has been known since the 1930s that seminal plasma can induce contractions and even cramps in humans. The aim of this study was to test an experimental uterus perfusion model as to whether it can be used to analyze uterine contraction patterns after the administration of human seminal plasma. Materials and methods: Each swine uterus was perfused in a perfusion system with Krebs-Ringer solution. After 45 min with rhythmical spontaneous contractions present, human seminal plasma was administered via a catheter intrauterine and the intrauterine pressure was recorded. Results: An increase in intrauterine pressure (IUP) in the isthmus uteri and corpus uteri was observed after the administration of seminal plasma or buffer solution. The direct comparison of the intrauterine pressure over time after administration of seminal plasma or buffer solution shows a significant pressure rise with seminal plasma. Conclusions: This study demonstrates that seminal plasma has an effect in these preliminary experiments in that it stimulates uterine contractions and may enhance sperm transport. The clinical implication of the results of our pilot study would be that the application of seminal plasma in artificial insemination could increase the chance of conception also in humans, due to the increase of uterine contractility.

The 5-methyltetrahydrofolate-homocysteine methyltransferase reductase 66A[G/I22 M mutation is associated with decreased anti-Müllerian hormone concentrations and lower number of retrieved oocytes after controlled ovarian hyperstimulation Objective: The one-carbon metabolism is an essential process in the biological network that regulates the biosynthesis of nucleosides and the methylation of proteins, lipids, and DNA. Epidemiological evidence suggests that genetic variants of enzymes in the one-carbon metabolism pathway as well as folate intake influence ovarian function. We have shown that A.R.T patients carrying the T allele of the 5,10-methylenetetrahydrofolate reductase (MTHFR) 677C[T mutation require more FSH for controlled ovarian hyperstimulation and produce fewer oocytes. To study this association more closely, we investigated the 66A[G/I22 M mutation of the MTRR enzyme which is also involved in one-carbon metabolism. Materials and methods: This study included 235 patients undergoing IVF/ICSI for male factor (n = 171) or tubal factor infertility (n = 64). AMH as a marker of ovarian reserve was measured after ten days of gonadotropin-releasing hormone super agonist treatment and prior to COH. Oocytes were collected following ovulation induction and counted microscopically after follicle puncture. The MTRR 66A[G genotype was characterized by a TaqMan 5' nuclease assay. Results: The MTRR 66A[G/I22 M genotype distribution (AA: n = 46; AG: n = 119; GG: = 70) was in Hardy-Weinberg equilibrium (x2 = 0.129; p = 0.719). Average AMH levels and number of oocytes retrieved (NOR) of MTRR 66GG patients (AMH: 1.87 ± 1.55 ng/ml; NOR: 9.28 ± 5.95) were significantly lower than those of individuals homozygous for the MTRR 66A allele (AMH: 2.53 ± 1.68 ng/ml; p = 0.014; NOR: 12.73 ± 7.58; p = 0.017). Heterozygous patients had intermediate values (AMH: 2.22 ± 2.26 ng/ml; NOR: 11.75 ± 7.99).

We report for the first time that homozygous carriers of the MTRR 66G allele have significantly lower NOR and AMH serum concentrations compared to wild-type. Our findings support the notion, that enzymes involved in one-carbon metabolism may be involved in ovarian function.PO-Repro 03.06 Changes in AMH levels following ovarian cortex removal: implications for fertility preservation *Nana Bu¨ndgen 1 , Silke Lu¨ke 1 , Klaus Diedrich 1 , Georg Griesinger 1 1 Universitätsklinikum Schleswig-Holstein, Kllinik für Frauenheilkunde und Geburtshilfe, Lübeck, GermanyObjective: One option of fertility-preservation is cryopreservation of ovarian cortex before chemotherapy. However, not all chemotherapies result in a complete eradication of the follicular-reserve, thus the biopsy itself may impair fertility after chemotherapy. Therefore, we aimed to establish a model assessing the relative change in Anti-Müllerian-Hormone following ovarian biopsies of varying sizes. Materials and methods: Participants of this longitudinal, prospective, interventional study underwent caesarean-section. AMH was measured by ELISA, 2-15 h before section (d0), as well as 70-75 h (d3) and 3 month (m3) after. At section, cortical pieces from one ovary were removed. Controls had blood sampling at the same time-points but no biopsy. The follicular-density was determined in HE-stained slides. Assessed were absolute and relative short-term (d0-d3), longterm AMH-changes (d0-m3) and correlation between cortex weight, follicular-density and relative AMH-change.Results: Interim-analysis of 12 women with biopsy und 2 controls: In the study-group an absolute and relative median short-term AMHchange of -0.16 ng/ml (-0.61 to 0.01) and -18.45%, were observed, 0.27 ng/ml (0.03-0.50) and 171.21%, respectively in the controls (p = 0.028). The long-term AMH-changes in the study-group were 0.84 ng/ml (0.06-3.03) and 131.9%, 0.67 ng/ml (0.44-0.90) and 283.03%, respectively in the controls (p = 0.27). A correlation between the weight of the biopsy and the relative short-term AMHchange could not be established with statistical significance as well as a correlation between follicular density and AMH d0 or absolute and relative changes. Conclusions: This study shows that even small ovarian biopsies (36-230 lg) result in a short-term AMH-change of -18%. An unexpected finding was the long-term increase in AMH in contrast to a previous study. Thus, AMH behaviour during pregnancy and puerperium needs a re-assessment. The interim-analysis was underpowered to show significant correlations. This is the first study in healthy women estimating the follicular-reserve reduction caused by cortex biopsies.PO-Repro 03.07 Case report: ovarian pregnancy after IVF Objective: Ovarian pregnancy is a rare condition of ectopic pregnancy. The risk of ectopic pregnancy after in vitro fertilization is increased. Due to the increasing number of assisted reproduction the incidence of ectopic pregnancies has risen. The precise etiology of ovarian pregnancy after IVF is still unknown. Materials and methods: We report on a 33-year old primipara, who underwent IVF because of a male factor. During the second IVF-cycle the patient was stimulated with recombinant FSH and GnRH-antagonist. After transvaginal oocyte pickup the patient was admitted to our unit because of OHSS where she has been treated symptomatically. Two embryos were replaced in utero under ultrasound guidance. At gestational age of 8 weeks +1 the patient was admitted again as a result of no ultrasonic sign of intra-or extrauterine viable pregnancy. At this time the patient was asymptomatic. Serum ß-hCG level was 2018 mU/ml, 48 h later ß-hCG was 1892 mU/ml. The asymptomatic patient insisted in expecting management. At 8 weeks +3 days she developed lower abdominal pain and got hemodynamically instable. Ultrasound revealed an ectopic pregnancy with positive heart action and free echogenic fluid. On laparoscopy there was blood in the upper and lower abdomen. The right ovary showed a ruptured ovarian pregnancy. Placental tissue and a gestational sac could be removed. Bleeding was stanched and the ovary could be preserved. Both tubes were normal and separated from the ovaries. The postoperative period was uneventful. Pathology report confirmed an ovarian pregnancy. Conclusions: Ovarian pregnancy is unfrequent and difficult to diagnose. Increasing number of assisted reproduction and therefore increasing risk of ectopic pregnancies demands intensive monitoring (ß-hCG levels, ultrasound). Laparoscopy is the traditional treating method whereas methotrexat therapy can be considered at early diagnosis. Our case fulfills Spielberg criteria for ovarian pregnancy.PO-Repro 03.08 Slow-freezing vs. vitrification in ovarian tissue preservation Objective: Cancer patients benefit from advanced treatments by chemo-and radiotherapy. Gonadotoxic treatments, however, often result in infertility and premature ovarian failure. Slow-cooling is currently the standard for cryopreservation of ovarian tissue prior to chemotherapy. Vitrification could be an effective alternative, however the data on the efficacy of the procedure are still conflicting. We therefore performed a systematic comparison of cryodamage after vitrification versus slow-freezing of human ovarian tissue. Materials and methods: This study was performed at the Department of Obstetrics and Gynecology, University of Lübeck. Ovarian tissue biopsies were collected from 17 patients undergoing Caesarean sections. The tissue was cut to pieces, which were randomly frozen using either slow-freezing or vitrification. Vitrification was performed according to the protocol described by Hasegawa (2004) and Wang (2008) . An acupuncture-needle was used as a carrier. Slow-freezing was performed according to the protocol described by Gosden (1994) and Donnez (2008) . After incubation in the cryoprotectant the samples were cooled to minus 150°C following a multiple step freezingprotocol. Vitrification and slow-freezing samples were stored for at least 2 weeks in liquid-N2. After thawing, the number of viable and damaged follicles was counted, and the proportion of primordial and primary follicles of high-morphological-quality was assessed according to Maltaris (2007) . Results: 277 primordial and primary follicles (137 slow-freezing; 140 vitrification) were counted and analyzed. 23.5% of the samples in the slow-cooling-group showed no high-morphology follicles as compared to 5.8% in the vitrification-group (Fisher's Exact test, p = 0.17). Vitrification resulted in a mean 25.6% increase of primordial and primary follicles with high-morphological-quality (t test for paired samples, p = 0.08).Conclusions: Vitrification shows a trend towards better morphological integrity as compared to slow freezing. Inferiority of vitrification for this outcome is thus unlikely. Taking the ease of vitrification into account, this procedure might become a first choice option for freezing ovarian tissue.PO-Repro 03.09 Oocyte retrieval as an option for fertility preservation of female-to-male transexual patients: a case report *Ioannis Zervomanolakis 1 , Dimitrios Papadopoulos 1 , Mitrodora Botzaki 1 , Afroditi Sialakouma 1 , Dimitrios Garinis 1 , Giles Palmer 1 1 Mitera Clinic, Assisted Reproduction Unit, Marousi, Athens, GreeceObjective: Transexual people have to undergo hormonal and surgical treatments before transition to their desired gender, leading to loss of their reproductive potential. We report a case of a female-to-maletranssexual patient, who underwent oocyte retrieval. Materials and methods: A 30-year-old female-to-male transsexual patient underwent hormonal treatment for over 2 years. The patient received 11.25 mg of Leuprorelin acetate (Trenantone Ò , Takeda Pharma, Germany) for pituitary suppression subcutaneously (s.c.) every 3 months under simultaneous transdermal daily application of 50 mg testosterone (Testogel Ò , Bayer Vital, Germany). A bilateral mastectomy has already been performed, the patient wished to undergo fertility preservation measures before hysterectomy and oophorectomy. After pausing testosterone treatment, the patient received 225 IU highly purified urinary FSH (Altermon Ò , IBSA, Greece) s.c. daily for ten days, followed by 300 IU s.c. daily for three days according to the step-up protocol without pausing leuprorelin treatment. On stimulation day 14 the patient received 250 lg recombinant Choriongonadotropin alfa s.c. (Ovitrelle Ò , Merck Serono, Greece) for ovulation induction, 36 h before oocyte retrieval. Estradiol level on this day reached 4210 pg/ml. Donor sperm (Cryos International, Denmark) was used for in vitro fertilization. Results: 11 of 14 metaphase-II retrieved oocytes were fertilized after ICSI procedure, achieving a fertilization rate of 78.6%. On day 2 after follicle retrieval six 4-cell embryos were vitrified (Medicult Vitrification Cooling Ò , Medicult Denmark). Conclusions: This is the first transexual patient undergoing oocyte retrieval in our clinic. Long-term testosterone application could have a positive impact on oocyte production and oocyte quality, as shown by high number of retrieved oocytes and high fertilization rate. Despite ethical aspects concerning the attitude of medical world, legislation and society towards this group of patients, fertility preservation measures, such as in vitro fertilization, sperm, oocyte or ovarian tissue banking, should be discussed and offered to transexual people undergoing gender reassignment therapy.PO-Repro 03.10 Ongoing pregnancy after hMG stimulation/timedintercourse in a 40 year old woman with undetectable AMH levels Objective: In adult women, Anti-Mullerian hormone (AMH) is synthesized by granulosa cells in primary to early antral follicles. Serum levels of AMH correlate closely with the antral follicular count and predict ooctye yield in ovarian stimulation cycles. Furthermore, AMH serves as a marker of ovarian reserve, and the gradual decline in the primordial follicle pool is best represented by decreasing levels of AMH. Women with an extremely low AMH level have a severely diminished ovarian reserve and have a severely reduced prospect for clinical pregnancy using IVF. Materials and methods: This is a case report of a 40 year old female patient with AMH levels below the detection limit (.05 ng/ml) measured by active MIS/AMH ELISA (Beckman Coulter). The patient had a history of secondary infertility for 2 years. Two pregnancies were achieved in a previous relationship resulting in live births in 1997 and 2005. In 2004 the diagnosis of premature ovarian failure had already been established by her gynecologist. Despite this diagnosis, the patient underwent a treatment trial with clomifene 50 mg at a different gynecologic department and she conceived by timed intercourse in 2004. In a new relationship in 2007 she tried to conceive again spontaneously, without success. In 2009 she came to our department with childwish and oligomenorrhea. The evaluation of early follicular phase hormone levels revealed a FSH of 26mIU/ml and AMH .05 ng/ml. Results: Before treatment was started the antral follicular count was 2. Early follicular phase hormone levels were measured: Progesterone 0.7 ng/ml, E2 42 pg/ml, LH 8.2 mIU/ml, FSH 26 mIU/ml, prolactin 7.6 ng/ml, testosterone 2.49 nmol/l, DHEA-sulfate 1.9 lg/ml. The semen analysis showed teratozoospermia. The first cycle was stimulated with clomifene 50 mg as performed previously (resulting in live birth in 2005), but E2 remained low (peak level 18 pg/ml) and no follicular development was observed. A second treatment cycle was performed with daily 75 IU of menopausal gonadotrophin stimulation. Two follicles developed with a pre-ovulatory E2 level of 174 pg/ ml, and ovulation induction was performed with 5,000 IU of hCG subcutaneously on cycle day 10. The couple had timed intercourse resulting in a pregnancy which is at 23 ? 6 weeks at the time writing. Conclusions: Two pregnancies were achieved by a patient despite of undetectable AMH levels, a low antral follicle count, elevated FSH and oligomenorrhoea. This leads to the conclusion that low AMH levels should be interpreted with caution when predicting the chance of pregnancy for individual cases. Further investigations of low or undetectable AMH levels and spontaneous pregnancies are needed to evaluate the incidence.